GOBP POTASSIUM ION HOMEOSTASIS
|
6
|
3.44e-04
|
7.93e-03
|
1.15000
|
0.870000
|
-0.755000
|
2.25e-04
|
1.38e-03
|
GOBP POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE
|
5
|
2.98e-03
|
3.92e-02
|
1.08000
|
0.723000
|
-0.804000
|
5.18e-03
|
1.87e-03
|
GOBP CELLULAR RESPONSE TO OXYGEN RADICAL
|
5
|
5.69e-03
|
5.83e-02
|
1.02000
|
-0.732000
|
0.714000
|
4.67e-03
|
5.77e-03
|
GOBP RESPONSE TO OXYGEN RADICAL
|
5
|
5.69e-03
|
5.83e-02
|
1.02000
|
-0.732000
|
0.714000
|
4.67e-03
|
5.77e-03
|
GOBP CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES
|
5
|
5.18e-03
|
5.67e-02
|
0.98300
|
0.526000
|
-0.830000
|
4.19e-02
|
1.31e-03
|
GOMF FERROUS IRON BINDING
|
6
|
4.88e-03
|
5.40e-02
|
0.94200
|
-0.612000
|
0.715000
|
9.52e-03
|
2.45e-03
|
GOBP POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS
|
9
|
2.61e-04
|
6.18e-03
|
0.92200
|
0.773000
|
-0.502000
|
5.99e-05
|
9.38e-03
|
GOBP RENAL SODIUM ION ABSORPTION
|
6
|
1.63e-03
|
2.58e-02
|
0.91500
|
0.841000
|
-0.359000
|
3.63e-04
|
1.29e-01
|
GOBP RENAL SODIUM ION TRANSPORT
|
6
|
1.63e-03
|
2.58e-02
|
0.91500
|
0.841000
|
-0.359000
|
3.63e-04
|
1.29e-01
|
GOBP SOMITE DEVELOPMENT
|
5
|
1.22e-02
|
9.24e-02
|
0.90400
|
0.492000
|
-0.758000
|
5.74e-02
|
3.36e-03
|
GOBP SOMITOGENESIS
|
5
|
1.22e-02
|
9.24e-02
|
0.90400
|
0.492000
|
-0.758000
|
5.74e-02
|
3.36e-03
|
GOMF NEUTRAL L AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY
|
5
|
7.15e-03
|
6.75e-02
|
0.89800
|
0.812000
|
-0.384000
|
1.69e-03
|
1.38e-01
|
GOBP PROTEIN FOLDING IN ENDOPLASMIC RETICULUM
|
5
|
2.35e-03
|
3.33e-02
|
0.88300
|
-0.858000
|
0.210000
|
8.97e-04
|
4.18e-01
|
GOBP LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE
|
5
|
3.62e-03
|
4.44e-02
|
0.88200
|
0.843000
|
-0.260000
|
1.10e-03
|
3.14e-01
|
GOBP RECEPTOR CATABOLIC PROCESS
|
5
|
2.11e-02
|
1.26e-01
|
0.88200
|
0.652000
|
-0.594000
|
1.17e-02
|
2.16e-02
|
GOBP LIPOPROTEIN LOCALIZATION
|
5
|
2.12e-02
|
1.26e-01
|
0.87800
|
0.667000
|
-0.570000
|
9.91e-03
|
2.75e-02
|
GOBP POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS
|
6
|
7.87e-03
|
7.13e-02
|
0.86800
|
0.724000
|
-0.478000
|
2.15e-03
|
4.31e-02
|
GOBP GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT
|
5
|
7.65e-03
|
7.03e-02
|
0.85500
|
0.306000
|
-0.798000
|
2.37e-01
|
2.02e-03
|
GOBP ALPHA AMINO ACID BIOSYNTHETIC PROCESS
|
7
|
6.73e-03
|
6.57e-02
|
0.85100
|
-0.594000
|
0.609000
|
6.61e-03
|
5.39e-03
|
GOBP LENS DEVELOPMENT IN CAMERA TYPE EYE
|
5
|
2.15e-02
|
1.26e-01
|
0.84700
|
0.468000
|
-0.706000
|
7.08e-02
|
6.32e-03
|
GOBP TRICARBOXYLIC ACID CYCLE
|
9
|
1.52e-03
|
2.50e-02
|
0.84600
|
-0.536000
|
0.654000
|
5.47e-03
|
6.94e-04
|
GOBP SEGMENTATION
|
7
|
7.05e-03
|
6.71e-02
|
0.84400
|
0.564000
|
-0.628000
|
9.91e-03
|
4.08e-03
|
GOBP SERINE FAMILY AMINO ACID METABOLIC PROCESS
|
9
|
1.21e-03
|
2.10e-02
|
0.84300
|
-0.483000
|
0.691000
|
1.24e-02
|
3.39e-04
|
GOMF MONOATOMIC ANION MONOATOMIC CATION SYMPORTER ACTIVITY
|
6
|
1.50e-02
|
1.04e-01
|
0.84200
|
0.579000
|
-0.611000
|
1.43e-02
|
9.71e-03
|
GOMF MONOATOMIC ANION SODIUM SYMPORTER ACTIVITY
|
6
|
1.50e-02
|
1.04e-01
|
0.84200
|
0.579000
|
-0.611000
|
1.43e-02
|
9.71e-03
|
GOCC NUCLEOID
|
9
|
1.83e-03
|
2.78e-02
|
0.82800
|
-0.506000
|
0.656000
|
8.73e-03
|
6.75e-04
|
GOBP RESPONSE TO VITAMIN D
|
5
|
2.88e-02
|
1.49e-01
|
0.82500
|
0.670000
|
-0.480000
|
9.55e-03
|
6.34e-02
|
GOBP SHORT CHAIN FATTY ACID METABOLIC PROCESS
|
5
|
5.43e-03
|
5.75e-02
|
0.81800
|
-0.191000
|
0.795000
|
4.62e-01
|
2.09e-03
|
GOBP GLYCEROLIPID CATABOLIC PROCESS
|
6
|
3.78e-03
|
4.49e-02
|
0.81700
|
0.265000
|
-0.773000
|
2.63e-01
|
1.05e-03
|
GOBP REGULATION OF GLYCOLYTIC PROCESS
|
8
|
4.18e-03
|
4.87e-02
|
0.81500
|
0.654000
|
-0.487000
|
1.39e-03
|
1.74e-02
|
GOBP RESPONSE TO CADMIUM ION
|
6
|
8.40e-03
|
7.51e-02
|
0.81100
|
-0.354000
|
0.730000
|
1.35e-01
|
2.00e-03
|
GOBP MRNA EXPORT FROM NUCLEUS
|
5
|
2.41e-02
|
1.35e-01
|
0.80900
|
0.398000
|
-0.705000
|
1.24e-01
|
6.44e-03
|
GOBP PROTEIN LOCALIZATION TO ENDOSOME
|
5
|
1.99e-02
|
1.22e-01
|
0.80900
|
0.362000
|
-0.724000
|
1.62e-01
|
5.12e-03
|
GOBP D GLUCOSE IMPORT
|
7
|
1.10e-02
|
8.76e-02
|
0.80800
|
0.566000
|
-0.577000
|
9.73e-03
|
8.37e-03
|
GOBP MODIFIED AMINO ACID BIOSYNTHETIC PROCESS
|
7
|
1.05e-02
|
8.50e-02
|
0.80500
|
-0.618000
|
0.516000
|
4.71e-03
|
1.85e-02
|
GOBP PROTEIN DEPHOSPHORYLATION
|
6
|
1.66e-02
|
1.09e-01
|
0.80400
|
0.456000
|
-0.663000
|
5.37e-02
|
5.02e-03
|
GOBP TRICARBOXYLIC ACID METABOLIC PROCESS
|
6
|
3.68e-03
|
4.49e-02
|
0.80100
|
-0.230000
|
0.767000
|
3.31e-01
|
1.16e-03
|
GOBP GOLGI TO PLASMA MEMBRANE TRANSPORT
|
7
|
7.22e-03
|
6.76e-02
|
0.79800
|
0.412000
|
-0.683000
|
5.97e-02
|
1.79e-03
|
GOBP BENZENE CONTAINING COMPOUND METABOLIC PROCESS
|
8
|
6.65e-03
|
6.51e-02
|
0.79700
|
-0.569000
|
0.558000
|
5.42e-03
|
6.43e-03
|
GOBP ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS
|
7
|
1.25e-02
|
9.35e-02
|
0.79500
|
-0.536000
|
0.587000
|
1.44e-02
|
7.30e-03
|
GOBP POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT
|
5
|
3.91e-02
|
1.76e-01
|
0.79400
|
0.478000
|
-0.634000
|
6.49e-02
|
1.42e-02
|
GOBP POSITIVE REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT
|
5
|
3.91e-02
|
1.76e-01
|
0.79400
|
0.478000
|
-0.634000
|
6.49e-02
|
1.42e-02
|
GOBP REGULATION OF CHOLESTEROL EFFLUX
|
5
|
4.45e-02
|
1.89e-01
|
0.79400
|
0.561000
|
-0.561000
|
3.00e-02
|
3.00e-02
|
GOMF NAD BINDING
|
13
|
1.66e-04
|
4.43e-03
|
0.78800
|
-0.428000
|
0.662000
|
7.85e-03
|
3.73e-05
|
GOBP LONG TERM MEMORY
|
5
|
3.99e-03
|
4.69e-02
|
0.78500
|
0.779000
|
-0.089900
|
2.57e-03
|
7.29e-01
|
GOMF CARGO RECEPTOR ACTIVITY
|
6
|
1.86e-02
|
1.17e-01
|
0.77900
|
0.412000
|
-0.661000
|
8.11e-02
|
5.11e-03
|
GOMF LIGAND GATED MONOATOMIC CATION CHANNEL ACTIVITY
|
6
|
2.75e-02
|
1.44e-01
|
0.77800
|
0.528000
|
-0.571000
|
2.54e-02
|
1.57e-02
|
GOBP POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT
|
5
|
5.02e-02
|
2.02e-01
|
0.77400
|
0.507000
|
-0.585000
|
5.00e-02
|
2.37e-02
|
GOBP REGULATION OF DENDRITIC SPINE DEVELOPMENT
|
5
|
5.02e-02
|
2.02e-01
|
0.77400
|
0.507000
|
-0.585000
|
5.00e-02
|
2.37e-02
|
GOBP REGULATION OF LIPID STORAGE
|
7
|
1.52e-02
|
1.05e-01
|
0.77400
|
0.587000
|
-0.503000
|
7.25e-03
|
2.14e-02
|
GOBP BIOLOGICAL PROCESS INVOLVED IN INTRASPECIES INTERACTION BETWEEN ORGANISMS
|
7
|
9.59e-03
|
8.13e-02
|
0.77300
|
0.396000
|
-0.664000
|
7.04e-02
|
2.41e-03
|
GOBP COLLATERAL SPROUTING
|
5
|
4.66e-02
|
1.94e-01
|
0.77000
|
0.456000
|
-0.620000
|
7.80e-02
|
1.65e-02
|
GOBP LONG CHAIN FATTY ACID TRANSPORT
|
7
|
1.55e-02
|
1.06e-01
|
0.76700
|
0.599000
|
-0.479000
|
6.17e-03
|
2.87e-02
|
GOBP NOREPINEPHRINE TRANSPORT
|
5
|
5.55e-02
|
2.13e-01
|
0.76400
|
-0.520000
|
0.560000
|
4.44e-02
|
3.05e-02
|
GOBP CHOLESTEROL STORAGE
|
5
|
4.41e-02
|
1.88e-01
|
0.76300
|
0.420000
|
-0.637000
|
1.05e-01
|
1.38e-02
|
GOCC MICROBODY LUMEN
|
17
|
6.29e-05
|
2.07e-03
|
0.76100
|
-0.549000
|
0.526000
|
9.61e-05
|
1.83e-04
|
GOBP REGULATION OF CALCIUM ION IMPORT
|
5
|
3.86e-02
|
1.75e-01
|
0.76000
|
0.658000
|
-0.379000
|
1.09e-02
|
1.43e-01
|
GOCC CYTOSOLIC SMALL RIBOSOMAL SUBUNIT
|
11
|
5.90e-09
|
5.67e-07
|
0.75900
|
0.404000
|
0.643000
|
2.10e-02
|
2.30e-04
|
GOMF PROTEIN FOLDING CHAPERONE
|
5
|
3.44e-02
|
1.62e-01
|
0.75600
|
-0.672000
|
0.347000
|
9.41e-03
|
1.80e-01
|
GOCC CYTOSOLIC REGION
|
5
|
4.60e-02
|
1.92e-01
|
0.75600
|
0.634000
|
-0.411000
|
1.42e-02
|
1.12e-01
|
GOCC POSTSYNAPTIC CYTOSOL
|
5
|
4.60e-02
|
1.92e-01
|
0.75600
|
0.634000
|
-0.411000
|
1.42e-02
|
1.12e-01
|
GOBP PLASMA LIPOPROTEIN PARTICLE CLEARANCE
|
7
|
1.65e-02
|
1.09e-01
|
0.75500
|
0.604000
|
-0.453000
|
5.74e-03
|
3.83e-02
|
GOMF CARBOXY LYASE ACTIVITY
|
5
|
5.01e-02
|
2.02e-01
|
0.75400
|
-0.430000
|
0.619000
|
9.64e-02
|
1.67e-02
|
GOBP FAT SOLUBLE VITAMIN METABOLIC PROCESS
|
5
|
2.48e-03
|
3.50e-02
|
0.75400
|
0.754000
|
0.028100
|
3.56e-03
|
9.14e-01
|
GOBP POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR
|
5
|
3.08e-02
|
1.55e-01
|
0.75400
|
-0.322000
|
0.682000
|
2.14e-01
|
8.41e-03
|
GOBP REGULATION OF D GLUCOSE IMPORT
|
5
|
5.94e-02
|
2.20e-01
|
0.75300
|
0.498000
|
-0.565000
|
5.43e-02
|
2.90e-02
|
GOBP LYMPHOCYTE APOPTOTIC PROCESS
|
5
|
2.20e-03
|
3.16e-02
|
0.75200
|
0.751000
|
0.046400
|
3.68e-03
|
8.58e-01
|
GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY TRANSPOSING C C BONDS
|
6
|
2.06e-02
|
1.25e-01
|
0.75200
|
-0.366000
|
0.657000
|
1.21e-01
|
5.39e-03
|
GOBP PROTEINOGENIC AMINO ACID BIOSYNTHETIC PROCESS
|
5
|
5.98e-02
|
2.21e-01
|
0.75200
|
-0.496000
|
0.565000
|
5.51e-02
|
2.90e-02
|
GOBP ADULT BEHAVIOR
|
11
|
1.52e-03
|
2.50e-02
|
0.75100
|
0.432000
|
-0.614000
|
1.34e-02
|
4.37e-04
|
GOBP POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION
|
7
|
1.13e-02
|
8.85e-02
|
0.74900
|
0.364000
|
-0.654000
|
9.62e-02
|
2.77e-03
|
GOBP POST GOLGI VESICLE MEDIATED TRANSPORT
|
11
|
1.53e-03
|
2.50e-02
|
0.74200
|
0.407000
|
-0.620000
|
2.00e-02
|
3.80e-04
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN REDUCED FLAVIN OR FLAVOPROTEIN AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN
|
6
|
1.01e-04
|
3.06e-03
|
0.74000
|
0.295000
|
0.679000
|
2.13e-01
|
4.05e-03
|
GOMF AMINOPEPTIDASE ACTIVITY
|
5
|
6.70e-02
|
2.37e-01
|
0.73900
|
-0.536000
|
0.509000
|
3.82e-02
|
4.91e-02
|
GOBP PRESYNAPSE ORGANIZATION
|
5
|
6.38e-02
|
2.30e-01
|
0.73900
|
0.573000
|
-0.466000
|
2.68e-02
|
7.16e-02
|
GOBP LEUKOCYTE APOPTOTIC PROCESS
|
6
|
2.72e-03
|
3.67e-02
|
0.73800
|
0.734000
|
-0.080100
|
1.87e-03
|
7.35e-01
|
GOBP NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS
|
5
|
1.79e-02
|
1.14e-01
|
0.73700
|
0.202000
|
-0.709000
|
4.35e-01
|
6.12e-03
|
GOBP RENAL ABSORPTION
|
10
|
2.59e-03
|
3.60e-02
|
0.73700
|
0.628000
|
-0.386000
|
6.08e-04
|
3.52e-02
|
GOBP RESPONSE TO STEROL
|
5
|
6.88e-02
|
2.41e-01
|
0.73600
|
0.503000
|
-0.537000
|
5.20e-02
|
3.80e-02
|
GOBP CELLULAR RESPONSE TO VITAMIN
|
5
|
6.01e-02
|
2.21e-01
|
0.73300
|
0.599000
|
-0.423000
|
2.07e-02
|
1.03e-01
|
GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY
|
12
|
1.63e-03
|
2.58e-02
|
0.73000
|
-0.563000
|
0.466000
|
7.70e-04
|
5.39e-03
|
GOCC TRICARBOXYLIC ACID CYCLE HETEROMERIC ENZYME COMPLEX
|
6
|
4.26e-02
|
1.84e-01
|
0.73000
|
-0.509000
|
0.524000
|
3.14e-02
|
2.66e-02
|
GOBP SODIUM ION TRANSMEMBRANE TRANSPORT
|
17
|
9.94e-05
|
3.06e-03
|
0.73000
|
0.579000
|
-0.445000
|
3.87e-05
|
1.60e-03
|
GOBP NEGATIVE REGULATION OF WOUND HEALING
|
5
|
8.91e-03
|
7.81e-02
|
0.72700
|
0.086600
|
-0.722000
|
7.38e-01
|
5.22e-03
|
GOBP PROTEIN CONTAINING COMPLEX REMODELING
|
5
|
7.02e-02
|
2.44e-01
|
0.72500
|
0.455000
|
-0.565000
|
7.90e-02
|
2.91e-02
|
GOBP FOAM CELL DIFFERENTIATION
|
5
|
7.51e-02
|
2.52e-01
|
0.72400
|
0.508000
|
-0.517000
|
4.99e-02
|
4.59e-02
|
GOCC RESPIRATORY CHAIN COMPLEX IV
|
9
|
8.92e-07
|
4.41e-05
|
0.72300
|
0.369000
|
0.622000
|
5.59e-02
|
1.27e-03
|
GOBP NEGATIVE REGULATION OF LIPID LOCALIZATION
|
8
|
1.10e-02
|
8.76e-02
|
0.72300
|
0.607000
|
-0.392000
|
3.00e-03
|
5.56e-02
|
GOBP PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE
|
8
|
4.43e-03
|
5.06e-02
|
0.72100
|
0.668000
|
-0.271000
|
1.09e-03
|
1.86e-01
|
GOBP NEUTRAL AMINO ACID TRANSPORT
|
8
|
1.40e-02
|
1.00e-01
|
0.72100
|
0.577000
|
-0.433000
|
4.85e-03
|
3.47e-02
|
GOBP CARBOHYDRATE TRANSPORT
|
8
|
1.70e-02
|
1.11e-01
|
0.71800
|
0.494000
|
-0.521000
|
1.58e-02
|
1.09e-02
|
GOBP MONOSACCHARIDE TRANSMEMBRANE TRANSPORT
|
8
|
1.70e-02
|
1.11e-01
|
0.71800
|
0.494000
|
-0.521000
|
1.58e-02
|
1.09e-02
|
GOBP SULFUR COMPOUND CATABOLIC PROCESS
|
12
|
1.31e-03
|
2.25e-02
|
0.71700
|
-0.602000
|
0.390000
|
3.18e-04
|
1.99e-02
|
GOBP FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE
|
5
|
7.97e-02
|
2.65e-01
|
0.71600
|
-0.495000
|
0.516000
|
5.56e-02
|
4.60e-02
|
GOBP RESPONSE TO DIETARY EXCESS
|
6
|
1.55e-02
|
1.06e-01
|
0.71400
|
0.672000
|
-0.244000
|
4.45e-03
|
3.03e-01
|
GOBP NEURAL NUCLEUS DEVELOPMENT
|
7
|
3.05e-02
|
1.54e-01
|
0.71100
|
-0.512000
|
0.493000
|
1.93e-02
|
2.42e-02
|
GOBP SUBSTANTIA NIGRA DEVELOPMENT
|
7
|
3.05e-02
|
1.54e-01
|
0.71100
|
-0.512000
|
0.493000
|
1.93e-02
|
2.42e-02
|
GOCC ACTIN FILAMENT BUNDLE
|
8
|
1.40e-02
|
1.00e-01
|
0.71000
|
0.399000
|
-0.587000
|
5.12e-02
|
4.13e-03
|
GOBP SUPEROXIDE METABOLIC PROCESS
|
9
|
1.06e-02
|
8.50e-02
|
0.70900
|
-0.549000
|
0.449000
|
4.46e-03
|
2.02e-02
|
GOBP REGULATION OF AEROBIC RESPIRATION
|
5
|
8.24e-02
|
2.69e-01
|
0.70800
|
-0.532000
|
0.467000
|
3.98e-02
|
7.10e-02
|
GOBP FILOPODIUM ASSEMBLY
|
5
|
8.29e-02
|
2.71e-01
|
0.70800
|
0.470000
|
-0.529000
|
6.96e-02
|
4.08e-02
|
GOMF TRANSFERASE ACTIVITY TRANSFERRING NITROGENOUS GROUPS
|
6
|
5.20e-02
|
2.05e-01
|
0.70600
|
-0.489000
|
0.510000
|
3.84e-02
|
3.10e-02
|
GOBP ACTIN FILAMENT BASED MOVEMENT
|
10
|
3.71e-03
|
4.49e-02
|
0.70300
|
0.347000
|
-0.611000
|
5.81e-02
|
8.38e-04
|
GOMF 2 IRON 2 SULFUR CLUSTER BINDING
|
8
|
2.00e-02
|
1.22e-01
|
0.70200
|
-0.470000
|
0.522000
|
2.18e-02
|
1.07e-02
|
GOBP ONE CARBON METABOLIC PROCESS
|
5
|
8.80e-02
|
2.80e-01
|
0.70100
|
-0.481000
|
0.510000
|
6.31e-02
|
4.87e-02
|
GOBP SULFUR AMINO ACID METABOLIC PROCESS
|
7
|
3.32e-02
|
1.61e-01
|
0.70100
|
-0.517000
|
0.473000
|
1.82e-02
|
3.06e-02
|
GOBP MITOCHONDRIAL ELECTRON TRANSPORT CYTOCHROME C TO OXYGEN
|
10
|
1.53e-06
|
7.36e-05
|
0.70100
|
0.247000
|
0.656000
|
1.77e-01
|
3.41e-04
|
GOBP IMPORT INTO THE MITOCHONDRION
|
10
|
8.20e-03
|
7.39e-02
|
0.69800
|
-0.499000
|
0.488000
|
6.43e-03
|
7.71e-03
|
GOMF HYDRO LYASE ACTIVITY
|
7
|
3.17e-02
|
1.58e-01
|
0.69600
|
-0.549000
|
0.429000
|
1.21e-02
|
5.01e-02
|
GOBP L AMINO ACID CATABOLIC PROCESS
|
19
|
1.33e-04
|
3.73e-03
|
0.69200
|
-0.491000
|
0.488000
|
2.27e-04
|
2.54e-04
|
GOCC CYTOSOLIC RIBOSOME
|
31
|
1.40e-17
|
6.30e-15
|
0.69100
|
0.200000
|
0.661000
|
5.75e-02
|
2.26e-10
|
GOBP GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS
|
10
|
5.86e-03
|
5.92e-02
|
0.68900
|
-0.371000
|
0.581000
|
4.31e-02
|
1.51e-03
|
GOBP ADULT LOCOMOTORY BEHAVIOR
|
8
|
1.31e-02
|
9.65e-02
|
0.68900
|
0.335000
|
-0.602000
|
1.02e-01
|
3.28e-03
|
GOCC CYTOSOLIC LARGE RIBOSOMAL SUBUNIT
|
18
|
6.05e-10
|
7.43e-08
|
0.68800
|
0.154000
|
0.670000
|
2.61e-01
|
9.16e-07
|
GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSPORT
|
5
|
4.54e-02
|
1.92e-01
|
0.68700
|
0.256000
|
-0.638000
|
3.23e-01
|
1.37e-02
|
GOMF TELOMERIC DNA BINDING
|
5
|
9.11e-02
|
2.84e-01
|
0.68600
|
0.422000
|
-0.541000
|
1.03e-01
|
3.65e-02
|
GOBP NEGATIVE REGULATION OF KINASE ACTIVITY
|
10
|
7.24e-03
|
6.76e-02
|
0.68100
|
0.379000
|
-0.566000
|
3.86e-02
|
2.01e-03
|
GOBP CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE
|
6
|
2.96e-02
|
1.51e-01
|
0.68000
|
0.624000
|
-0.271000
|
8.23e-03
|
2.52e-01
|
GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE
|
6
|
2.96e-02
|
1.51e-01
|
0.68000
|
0.624000
|
-0.271000
|
8.23e-03
|
2.52e-01
|
GOBP GLYCINE METABOLIC PROCESS
|
5
|
6.41e-02
|
2.30e-01
|
0.68000
|
-0.307000
|
0.607000
|
2.35e-01
|
1.90e-02
|
GOCC PEPTIDASE COMPLEX
|
12
|
6.71e-04
|
1.41e-02
|
0.68000
|
-0.633000
|
0.248000
|
1.53e-04
|
1.39e-01
|
GOBP PERIPHERAL NERVOUS SYSTEM DEVELOPMENT
|
5
|
1.43e-02
|
1.01e-01
|
0.67800
|
-0.675000
|
0.059500
|
9.01e-03
|
8.18e-01
|
GOBP POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS
|
8
|
1.79e-02
|
1.14e-01
|
0.67800
|
0.577000
|
-0.356000
|
4.85e-03
|
8.22e-02
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS
|
6
|
6.33e-02
|
2.29e-01
|
0.67700
|
-0.519000
|
0.436000
|
2.81e-02
|
6.54e-02
|
GOBP PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX
|
8
|
2.71e-02
|
1.43e-01
|
0.67500
|
-0.496000
|
0.459000
|
1.55e-02
|
2.51e-02
|
GOBP PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE
|
8
|
2.71e-02
|
1.43e-01
|
0.67500
|
-0.496000
|
0.459000
|
1.55e-02
|
2.51e-02
|
GOBP REGULATION OF CARBOHYDRATE CATABOLIC PROCESS
|
10
|
7.29e-03
|
6.79e-02
|
0.67300
|
0.570000
|
-0.358000
|
1.87e-03
|
5.12e-02
|
GOCC ACTOMYOSIN
|
9
|
1.61e-02
|
1.08e-01
|
0.67200
|
0.413000
|
-0.530000
|
3.24e-02
|
6.06e-03
|
GOMF UNFOLDED PROTEIN BINDING
|
12
|
1.98e-03
|
2.95e-02
|
0.67100
|
-0.590000
|
0.321000
|
4.22e-04
|
5.57e-02
|
GOBP DIGESTION
|
10
|
1.04e-02
|
8.49e-02
|
0.67000
|
0.529000
|
-0.412000
|
3.91e-03
|
2.45e-02
|
GOCC ENDOPEPTIDASE COMPLEX
|
11
|
8.46e-04
|
1.67e-02
|
0.67000
|
-0.639000
|
0.200000
|
2.49e-04
|
2.53e-01
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PEROXIDE AS ACCEPTOR
|
8
|
9.23e-03
|
7.94e-02
|
0.66900
|
-0.249000
|
0.621000
|
2.24e-01
|
2.40e-03
|
GOCC FICOLIN 1 RICH GRANULE LUMEN
|
13
|
2.66e-03
|
3.64e-02
|
0.66900
|
-0.406000
|
0.532000
|
1.16e-02
|
9.48e-04
|
GOBP RECEPTOR METABOLIC PROCESS
|
7
|
4.31e-02
|
1.86e-01
|
0.66600
|
0.415000
|
-0.521000
|
5.83e-02
|
1.72e-02
|
GOBP REGULATION OF FATTY ACID TRANSPORT
|
5
|
1.59e-02
|
1.08e-01
|
0.66600
|
0.664000
|
-0.051500
|
1.03e-02
|
8.42e-01
|
GOBP NEGATIVE REGULATION OF RESPONSE TO WOUNDING
|
8
|
6.48e-03
|
6.40e-02
|
0.66500
|
0.202000
|
-0.633000
|
3.25e-01
|
1.96e-03
|
GOCC PROTEASOME COMPLEX
|
8
|
1.60e-02
|
1.08e-01
|
0.66500
|
-0.588000
|
0.309000
|
4.04e-03
|
1.31e-01
|
GOMF SOLUTE MONOATOMIC CATION SYMPORTER ACTIVITY
|
12
|
5.60e-03
|
5.80e-02
|
0.66300
|
0.474000
|
-0.463000
|
4.63e-03
|
5.65e-03
|
GOMF SOLUTE SODIUM SYMPORTER ACTIVITY
|
12
|
5.60e-03
|
5.80e-02
|
0.66300
|
0.474000
|
-0.463000
|
4.63e-03
|
5.65e-03
|
GOBP ACTIN MEDIATED CELL CONTRACTION
|
6
|
6.36e-02
|
2.30e-01
|
0.66300
|
0.382000
|
-0.541000
|
1.06e-01
|
2.20e-02
|
GOBP PEPTIDYL TYROSINE MODIFICATION
|
7
|
4.61e-02
|
1.93e-01
|
0.66200
|
0.425000
|
-0.508000
|
5.22e-02
|
2.02e-02
|
GOMF MODIFIED AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY
|
6
|
7.29e-02
|
2.47e-01
|
0.66200
|
0.500000
|
-0.434000
|
3.44e-02
|
6.66e-02
|
GOBP AMINO ACID CATABOLIC PROCESS
|
28
|
7.46e-06
|
3.10e-04
|
0.65700
|
-0.469000
|
0.460000
|
2.02e-05
|
2.91e-05
|
GOBP POSITIVE REGULATION OF RECEPTOR INTERNALIZATION
|
5
|
1.10e-01
|
3.16e-01
|
0.65700
|
0.402000
|
-0.520000
|
1.20e-01
|
4.45e-02
|
GOBP VASCULAR TRANSPORT
|
12
|
5.74e-03
|
5.83e-02
|
0.65600
|
0.423000
|
-0.502000
|
1.15e-02
|
2.71e-03
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH GROUP OF DONORS NAD OR NADP AS ACCEPTOR
|
5
|
1.07e-01
|
3.10e-01
|
0.65500
|
-0.532000
|
0.382000
|
3.97e-02
|
1.40e-01
|
GOBP NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS
|
5
|
1.16e-01
|
3.26e-01
|
0.65400
|
0.504000
|
-0.417000
|
5.14e-02
|
1.07e-01
|
GOBP PROTEINOGENIC AMINO ACID METABOLIC PROCESS
|
32
|
8.88e-07
|
4.41e-05
|
0.65400
|
-0.389000
|
0.526000
|
1.67e-04
|
3.33e-07
|
GOBP BRANCHED CHAIN AMINO ACID METABOLIC PROCESS
|
7
|
3.55e-02
|
1.64e-01
|
0.65000
|
-0.564000
|
0.323000
|
9.91e-03
|
1.41e-01
|
GOBP NEGATIVE REGULATION OF MAP KINASE ACTIVITY
|
5
|
1.06e-01
|
3.08e-01
|
0.65000
|
0.362000
|
-0.540000
|
1.62e-01
|
3.69e-02
|
GOBP CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT
|
5
|
1.16e-01
|
3.25e-01
|
0.64700
|
0.519000
|
-0.386000
|
4.49e-02
|
1.36e-01
|
GOBP EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT
|
5
|
1.16e-01
|
3.25e-01
|
0.64700
|
0.519000
|
-0.386000
|
4.49e-02
|
1.36e-01
|
GOBP NADH DEHYDROGENASE COMPLEX ASSEMBLY
|
12
|
1.90e-03
|
2.85e-02
|
0.64600
|
-0.262000
|
0.590000
|
1.18e-01
|
4.16e-04
|
GOBP REGULATION OF TRANSPORTER ACTIVITY
|
7
|
2.43e-02
|
1.35e-01
|
0.64500
|
0.594000
|
-0.253000
|
6.65e-03
|
2.47e-01
|
GOCC GABA ERGIC SYNAPSE
|
6
|
4.60e-02
|
1.92e-01
|
0.64500
|
0.585000
|
-0.271000
|
1.32e-02
|
2.51e-01
|
GOBP CHOLESTEROL EFFLUX
|
9
|
2.50e-02
|
1.37e-01
|
0.64500
|
0.454000
|
-0.458000
|
1.87e-02
|
1.76e-02
|
GOCC CLATHRIN COATED ENDOCYTIC VESICLE MEMBRANE
|
6
|
5.36e-02
|
2.09e-01
|
0.64400
|
0.572000
|
-0.297000
|
1.55e-02
|
2.10e-01
|
GOBP SODIUM ION TRANSPORT
|
28
|
8.45e-06
|
3.41e-04
|
0.64400
|
0.508000
|
-0.395000
|
3.89e-06
|
3.34e-04
|
GOBP MATURATION OF SSU RRNA
|
5
|
1.83e-03
|
2.78e-02
|
0.64400
|
0.394000
|
0.508000
|
1.28e-01
|
4.94e-02
|
GOBP REGULATION OF D GLUCOSE TRANSMEMBRANE TRANSPORT
|
6
|
8.32e-02
|
2.71e-01
|
0.64300
|
0.414000
|
-0.493000
|
8.01e-02
|
3.71e-02
|
GOBP REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL
|
10
|
1.34e-02
|
9.82e-02
|
0.64300
|
0.371000
|
-0.525000
|
4.28e-02
|
4.19e-03
|
GOCC CYTOCHROME COMPLEX
|
18
|
8.43e-10
|
9.90e-08
|
0.64200
|
0.263000
|
0.585000
|
5.47e-02
|
1.86e-05
|
GOCC NUCLEOSOME
|
6
|
4.82e-02
|
1.98e-01
|
0.64200
|
-0.272000
|
0.581000
|
2.50e-01
|
1.39e-02
|
GOBP NEUTRAL LIPID BIOSYNTHETIC PROCESS
|
5
|
6.41e-02
|
2.30e-01
|
0.64100
|
0.599000
|
-0.227000
|
2.05e-02
|
3.80e-01
|
GOMF CARBOHYDRATE DERIVATIVE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
5
|
8.19e-02
|
2.68e-01
|
0.64100
|
-0.275000
|
0.578000
|
2.87e-01
|
2.54e-02
|
GOBP CARDIAC CONDUCTION
|
7
|
5.11e-02
|
2.03e-01
|
0.64000
|
0.377000
|
-0.518000
|
8.53e-02
|
1.79e-02
|
GOBP CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC
|
9
|
1.78e-02
|
1.14e-01
|
0.64000
|
0.338000
|
-0.544000
|
8.04e-02
|
4.85e-03
|
GOMF SYMPORTER ACTIVITY
|
14
|
3.50e-03
|
4.43e-02
|
0.63700
|
0.414000
|
-0.484000
|
7.54e-03
|
1.79e-03
|
GOBP CIRCADIAN REGULATION OF GENE EXPRESSION
|
12
|
4.45e-03
|
5.06e-02
|
0.63700
|
0.548000
|
-0.324000
|
1.05e-03
|
5.32e-02
|
GOMF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
12
|
5.25e-03
|
5.70e-02
|
0.63500
|
0.537000
|
-0.338000
|
1.32e-03
|
4.35e-02
|
GOMF ACYL COA BINDING
|
5
|
2.78e-02
|
1.46e-01
|
0.63400
|
-0.629000
|
0.075500
|
1.50e-02
|
7.71e-01
|
GOBP SODIUM ION HOMEOSTASIS
|
8
|
2.17e-02
|
1.27e-01
|
0.63400
|
0.567000
|
-0.284000
|
5.62e-03
|
1.66e-01
|
GOBP POSITIVE REGULATION OF TRANSPORTER ACTIVITY
|
5
|
3.20e-02
|
1.58e-01
|
0.63300
|
0.626000
|
-0.095400
|
1.56e-02
|
7.13e-01
|
GOBP DEPHOSPHORYLATION
|
10
|
1.98e-02
|
1.22e-01
|
0.63000
|
0.463000
|
-0.427000
|
1.15e-02
|
1.98e-02
|
GOMF CARBON OXYGEN LYASE ACTIVITY
|
10
|
1.74e-02
|
1.12e-01
|
0.63000
|
-0.501000
|
0.382000
|
6.23e-03
|
3.74e-02
|
GOBP RESPONSE TO HEAT
|
9
|
2.62e-03
|
3.62e-02
|
0.62900
|
-0.619000
|
0.110000
|
1.32e-03
|
5.69e-01
|
GOBP DIGESTIVE SYSTEM PROCESS
|
9
|
2.67e-02
|
1.42e-01
|
0.62800
|
0.498000
|
-0.383000
|
9.88e-03
|
4.75e-02
|
GOBP POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS
|
7
|
5.37e-02
|
2.09e-01
|
0.62800
|
-0.352000
|
0.520000
|
1.08e-01
|
1.75e-02
|
GOBP TYROSINE METABOLIC PROCESS
|
5
|
1.04e-01
|
3.07e-01
|
0.62800
|
-0.302000
|
0.550000
|
2.43e-01
|
3.35e-02
|
GOBP HYDROGEN PEROXIDE CATABOLIC PROCESS
|
5
|
1.36e-01
|
3.50e-01
|
0.62400
|
-0.380000
|
0.495000
|
1.42e-01
|
5.56e-02
|
GOBP ARTERY MORPHOGENESIS
|
7
|
6.83e-02
|
2.41e-01
|
0.62100
|
0.467000
|
-0.409000
|
3.29e-02
|
6.15e-02
|
GOBP NEURAL RETINA DEVELOPMENT
|
5
|
1.05e-01
|
3.08e-01
|
0.62100
|
0.549000
|
-0.290000
|
3.39e-02
|
2.63e-01
|
GOBP RETINA MORPHOGENESIS IN CAMERA TYPE EYE
|
5
|
1.05e-01
|
3.08e-01
|
0.62100
|
0.549000
|
-0.290000
|
3.39e-02
|
2.63e-01
|
GOBP POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS
|
7
|
6.91e-02
|
2.41e-01
|
0.62100
|
0.462000
|
-0.414000
|
3.48e-02
|
5.84e-02
|
GOMF TRANSAMINASE ACTIVITY
|
5
|
1.51e-01
|
3.72e-01
|
0.61800
|
-0.459000
|
0.413000
|
7.59e-02
|
1.11e-01
|
GOMF PEPTIDE ANTIGEN BINDING
|
5
|
3.26e-02
|
1.60e-01
|
0.61600
|
0.613000
|
-0.067600
|
1.79e-02
|
7.94e-01
|
GOMF GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY
|
17
|
1.79e-03
|
2.75e-02
|
0.61600
|
0.437000
|
-0.434000
|
1.91e-03
|
2.07e-03
|
GOBP REGULATION OF RESPONSE TO NUTRIENT LEVELS
|
5
|
5.29e-02
|
2.07e-01
|
0.61500
|
0.598000
|
-0.144000
|
2.08e-02
|
5.77e-01
|
GOBP T CELL PROLIFERATION
|
6
|
1.02e-02
|
8.46e-02
|
0.61500
|
0.615000
|
-0.001640
|
9.26e-03
|
9.94e-01
|
GOBP LIPID EXPORT FROM CELL
|
6
|
7.08e-02
|
2.44e-01
|
0.61500
|
0.544000
|
-0.286000
|
2.14e-02
|
2.26e-01
|
GOMF RIBOSOMAL SMALL SUBUNIT BINDING
|
5
|
1.56e-01
|
3.74e-01
|
0.61400
|
-0.429000
|
0.440000
|
9.76e-02
|
8.95e-02
|
GOBP APPENDAGE DEVELOPMENT
|
9
|
2.28e-02
|
1.30e-01
|
0.61400
|
0.312000
|
-0.529000
|
1.07e-01
|
6.16e-03
|
GOMF G PROTEIN ACTIVITY
|
7
|
7.47e-02
|
2.51e-01
|
0.61300
|
-0.436000
|
0.432000
|
4.66e-02
|
4.86e-02
|
GOBP AEROBIC RESPIRATION
|
63
|
5.69e-19
|
5.12e-16
|
0.61300
|
-0.066100
|
0.609000
|
3.77e-01
|
1.38e-16
|
GOBP ATP SYNTHESIS COUPLED ELECTRON TRANSPORT
|
38
|
8.91e-15
|
2.67e-12
|
0.61200
|
0.075700
|
0.607000
|
4.27e-01
|
1.30e-10
|
GOBP PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY
|
5
|
3.19e-02
|
1.58e-01
|
0.61100
|
0.608000
|
-0.053900
|
1.87e-02
|
8.35e-01
|
GOBP NUTRIENT STORAGE
|
14
|
4.44e-03
|
5.06e-02
|
0.61100
|
0.356000
|
-0.497000
|
2.20e-02
|
1.36e-03
|
GOBP POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION
|
7
|
1.54e-02
|
1.05e-01
|
0.61000
|
0.597000
|
-0.128000
|
6.35e-03
|
5.60e-01
|
GOBP FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY
|
5
|
6.51e-02
|
2.32e-01
|
0.60700
|
0.166000
|
-0.584000
|
5.21e-01
|
2.39e-02
|
GOMF NADP BINDING
|
10
|
2.39e-02
|
1.34e-01
|
0.60700
|
-0.478000
|
0.373000
|
9.03e-03
|
4.20e-02
|
GOBP RIBOSOMAL LARGE SUBUNIT BIOGENESIS
|
5
|
2.50e-02
|
1.37e-01
|
0.60500
|
-0.003920
|
0.605000
|
9.88e-01
|
1.94e-02
|
GOBP REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL
|
5
|
1.27e-01
|
3.40e-01
|
0.60400
|
0.301000
|
-0.524000
|
2.45e-01
|
4.29e-02
|
GOBP MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE
|
19
|
3.17e-06
|
1.45e-04
|
0.60400
|
-0.055900
|
0.601000
|
6.75e-01
|
6.30e-06
|
GOCC POSTSYNAPTIC MEMBRANE
|
9
|
3.97e-02
|
1.77e-01
|
0.60300
|
0.411000
|
-0.441000
|
3.35e-02
|
2.24e-02
|
GOBP AMINO ACID BIOSYNTHETIC PROCESS
|
9
|
4.01e-02
|
1.77e-01
|
0.60200
|
-0.412000
|
0.439000
|
3.30e-02
|
2.30e-02
|
GOBP REGULATION OF STRIATED MUSCLE CONTRACTION
|
7
|
6.02e-02
|
2.22e-01
|
0.60200
|
0.309000
|
-0.516000
|
1.59e-01
|
1.83e-02
|
GOCC RESPIRATORY CHAIN COMPLEX
|
45
|
9.65e-18
|
5.21e-15
|
0.60000
|
0.117000
|
0.589000
|
1.83e-01
|
1.27e-11
|
GOCC RNA POLYMERASE II HOLOENZYME
|
6
|
1.18e-01
|
3.29e-01
|
0.60000
|
-0.408000
|
0.440000
|
8.43e-02
|
6.29e-02
|
GOBP REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS
|
9
|
4.13e-02
|
1.80e-01
|
0.59900
|
0.435000
|
-0.412000
|
2.43e-02
|
3.29e-02
|
GOBP CELL KILLING
|
6
|
1.14e-02
|
8.92e-02
|
0.59900
|
0.013900
|
0.599000
|
9.53e-01
|
1.12e-02
|
GOCC MITOCHONDRIAL MATRIX
|
89
|
1.42e-14
|
3.75e-12
|
0.59900
|
-0.345000
|
0.489000
|
4.67e-08
|
6.80e-15
|
GOBP POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS
|
19
|
4.15e-04
|
9.27e-03
|
0.59900
|
0.525000
|
-0.288000
|
8.01e-05
|
3.13e-02
|
GOBP APPENDAGE MORPHOGENESIS
|
8
|
4.12e-02
|
1.80e-01
|
0.59700
|
0.302000
|
-0.515000
|
1.41e-01
|
1.18e-02
|
GOBP OXIDATIVE PHOSPHORYLATION
|
52
|
7.44e-18
|
5.02e-15
|
0.59600
|
0.036100
|
0.595000
|
6.59e-01
|
2.01e-13
|
GOBP CELLULAR COMPONENT MAINTENANCE
|
6
|
1.63e-02
|
1.09e-01
|
0.59600
|
0.596000
|
-0.027800
|
1.17e-02
|
9.06e-01
|
GOCC NADH DEHYDROGENASE COMPLEX
|
19
|
7.28e-07
|
3.93e-05
|
0.59600
|
0.021200
|
0.595000
|
8.74e-01
|
7.73e-06
|
GOBP REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY
|
5
|
1.28e-02
|
9.53e-02
|
0.59600
|
0.125000
|
0.582000
|
6.31e-01
|
2.44e-02
|
GOBP CELLULAR RESPIRATION
|
70
|
3.72e-20
|
5.02e-17
|
0.59500
|
-0.053400
|
0.593000
|
4.53e-01
|
2.78e-17
|
GOBP POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS
|
9
|
1.30e-02
|
9.61e-02
|
0.59400
|
0.560000
|
-0.199000
|
3.73e-03
|
3.03e-01
|
GOCC LARGE RIBOSOMAL SUBUNIT
|
26
|
1.16e-08
|
9.20e-07
|
0.59400
|
-0.007350
|
0.594000
|
9.49e-01
|
1.86e-07
|
GOBP REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS
|
7
|
4.02e-02
|
1.77e-01
|
0.59400
|
0.223000
|
-0.550000
|
3.09e-01
|
1.19e-02
|
GOBP OLIGOSACCHARIDE METABOLIC PROCESS
|
5
|
5.23e-03
|
5.70e-02
|
0.59300
|
-0.494000
|
-0.327000
|
5.61e-02
|
2.07e-01
|
GOBP POSITIVE REGULATION OF GTPASE ACTIVITY
|
7
|
8.98e-02
|
2.82e-01
|
0.59100
|
0.418000
|
-0.418000
|
5.60e-02
|
5.63e-02
|
GOBP ALPHA AMINO ACID METABOLIC PROCESS
|
40
|
8.98e-07
|
4.41e-05
|
0.59100
|
-0.364000
|
0.465000
|
8.42e-05
|
4.84e-07
|
GOBP PROTON MOTIVE FORCE DRIVEN ATP SYNTHESIS
|
28
|
2.36e-09
|
2.36e-07
|
0.59000
|
0.005650
|
0.590000
|
9.59e-01
|
7.77e-08
|
GOBP FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE
|
5
|
1.77e-01
|
4.03e-01
|
0.59000
|
-0.444000
|
0.389000
|
8.64e-02
|
1.33e-01
|
GOBP SULFUR COMPOUND BIOSYNTHETIC PROCESS
|
23
|
2.52e-04
|
6.07e-03
|
0.58800
|
-0.483000
|
0.337000
|
6.86e-05
|
5.60e-03
|
GOBP MITOCHONDRIAL TRANSMEMBRANE TRANSPORT
|
14
|
8.65e-03
|
7.63e-02
|
0.58800
|
-0.407000
|
0.424000
|
8.75e-03
|
6.24e-03
|
GOCC BASEMENT MEMBRANE
|
6
|
8.01e-02
|
2.66e-01
|
0.58700
|
0.251000
|
-0.530000
|
2.88e-01
|
2.48e-02
|
GOBP NEGATIVE REGULATION OF LIPID TRANSPORT
|
6
|
8.55e-02
|
2.75e-01
|
0.58700
|
0.524000
|
-0.264000
|
2.65e-02
|
2.65e-01
|
GOMF NADH DEHYDROGENASE ACTIVITY
|
17
|
1.56e-05
|
6.20e-04
|
0.58700
|
-0.036800
|
0.586000
|
7.94e-01
|
3.14e-05
|
GOBP T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE
|
5
|
3.37e-02
|
1.61e-01
|
0.58600
|
0.586000
|
-0.015400
|
2.35e-02
|
9.53e-01
|
GOBP EYE PHOTORECEPTOR CELL DIFFERENTIATION
|
6
|
1.31e-01
|
3.45e-01
|
0.58600
|
0.418000
|
-0.411000
|
7.73e-02
|
8.23e-02
|
GOBP PHOTORECEPTOR CELL DIFFERENTIATION
|
6
|
1.31e-01
|
3.45e-01
|
0.58600
|
0.418000
|
-0.411000
|
7.73e-02
|
8.23e-02
|
GOMF LIGAND GATED CHANNEL ACTIVITY
|
7
|
9.21e-02
|
2.86e-01
|
0.58600
|
0.387000
|
-0.439000
|
7.70e-02
|
4.47e-02
|
GOBP MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C
|
10
|
5.19e-04
|
1.12e-02
|
0.58400
|
0.053000
|
0.582000
|
7.73e-01
|
1.48e-03
|
GOBP INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE
|
12
|
1.14e-02
|
8.92e-02
|
0.58400
|
0.497000
|
-0.307000
|
2.99e-03
|
6.67e-02
|
GOMF THIOLESTER HYDROLASE ACTIVITY
|
5
|
8.21e-02
|
2.69e-01
|
0.58400
|
-0.164000
|
0.560000
|
5.26e-01
|
3.03e-02
|
GOBP NEGATIVE REGULATION OF PHOSPHORYLATION
|
12
|
1.25e-02
|
9.35e-02
|
0.58400
|
0.318000
|
-0.490000
|
5.77e-02
|
3.44e-03
|
GOBP SYNAPTIC TRANSMISSION GLUTAMATERGIC
|
6
|
1.29e-01
|
3.43e-01
|
0.58300
|
0.375000
|
-0.447000
|
1.13e-01
|
5.87e-02
|
GOMF ACTIN FILAMENT BINDING
|
21
|
9.41e-04
|
1.74e-02
|
0.58100
|
0.390000
|
-0.431000
|
2.10e-03
|
6.93e-04
|
GOBP ELECTRON TRANSPORT CHAIN
|
43
|
1.64e-14
|
3.75e-12
|
0.58100
|
0.049500
|
0.579000
|
5.81e-01
|
7.57e-11
|
GOBP POTASSIUM ION TRANSPORT
|
15
|
6.83e-03
|
6.61e-02
|
0.58100
|
0.430000
|
-0.390000
|
4.09e-03
|
9.29e-03
|
GOBP REGULATION OF CELLULAR RESPIRATION
|
7
|
9.65e-02
|
2.91e-01
|
0.58000
|
-0.435000
|
0.384000
|
4.71e-02
|
7.95e-02
|
GOBP POSITIVE REGULATION OF ADIPOSE TISSUE DEVELOPMENT
|
5
|
5.08e-02
|
2.03e-01
|
0.58000
|
0.071200
|
-0.575000
|
7.83e-01
|
2.62e-02
|
GOBP REGULATION OF ADIPOSE TISSUE DEVELOPMENT
|
5
|
5.08e-02
|
2.03e-01
|
0.58000
|
0.071200
|
-0.575000
|
7.83e-01
|
2.62e-02
|
GOBP NEGATIVE REGULATION OF CELL ACTIVATION
|
9
|
3.20e-02
|
1.58e-01
|
0.57900
|
0.506000
|
-0.282000
|
8.78e-03
|
1.45e-01
|
GOMF O ACYLTRANSFERASE ACTIVITY
|
7
|
9.92e-02
|
2.97e-01
|
0.57900
|
0.410000
|
-0.408000
|
6.09e-02
|
6.22e-02
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H QUINONE OR SIMILAR COMPOUND AS ACCEPTOR
|
18
|
4.64e-06
|
2.06e-04
|
0.57800
|
0.005780
|
0.578000
|
9.66e-01
|
2.37e-05
|
GOBP NUCLEUS LOCALIZATION
|
7
|
4.93e-02
|
2.01e-01
|
0.57800
|
0.222000
|
-0.534000
|
3.11e-01
|
1.47e-02
|
GOBP PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER
|
5
|
6.95e-02
|
2.42e-01
|
0.57800
|
0.122000
|
-0.565000
|
6.38e-01
|
2.91e-02
|
GOBP DEVELOPMENTAL CELL GROWTH
|
24
|
4.47e-04
|
9.84e-03
|
0.57400
|
0.404000
|
-0.408000
|
6.83e-04
|
5.98e-04
|
GOMF STRUCTURAL CONSTITUENT OF RIBOSOME
|
40
|
1.67e-14
|
3.75e-12
|
0.57400
|
0.111000
|
0.563000
|
2.31e-01
|
1.04e-09
|
GOMF TRANSLATION FACTOR ACTIVITY RNA BINDING
|
5
|
1.54e-01
|
3.74e-01
|
0.57300
|
-0.280000
|
0.500000
|
2.80e-01
|
5.35e-02
|
GOBP AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS
|
6
|
1.25e-01
|
3.37e-01
|
0.57300
|
-0.323000
|
0.473000
|
1.72e-01
|
4.55e-02
|
GOBP ERYTHROSE 4 PHOSPHATE PHOSPHOENOLPYRUVATE FAMILY AMINO ACID CATABOLIC PROCESS
|
6
|
1.25e-01
|
3.37e-01
|
0.57300
|
-0.323000
|
0.473000
|
1.72e-01
|
4.55e-02
|
GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION
|
11
|
2.67e-02
|
1.42e-01
|
0.56900
|
0.451000
|
-0.347000
|
9.86e-03
|
4.75e-02
|
GOCC EXCITATORY SYNAPSE
|
6
|
1.08e-01
|
3.12e-01
|
0.56700
|
0.270000
|
-0.498000
|
2.53e-01
|
3.50e-02
|
GOBP LIPOPROTEIN METABOLIC PROCESS
|
9
|
4.74e-02
|
1.95e-01
|
0.56700
|
0.468000
|
-0.319000
|
1.54e-02
|
9.87e-02
|
GOMF METALLOPEPTIDASE ACTIVITY
|
8
|
3.52e-02
|
1.64e-01
|
0.56500
|
-0.525000
|
0.209000
|
1.03e-02
|
3.07e-01
|
GOBP DETOXIFICATION
|
22
|
8.60e-04
|
1.68e-02
|
0.56500
|
-0.351000
|
0.443000
|
4.71e-03
|
3.52e-04
|
GOBP DENDRITE EXTENSION
|
5
|
1.54e-01
|
3.74e-01
|
0.56500
|
0.501000
|
-0.262000
|
5.30e-02
|
3.11e-01
|
GOBP ACYLGLYCEROL HOMEOSTASIS
|
7
|
8.07e-02
|
2.67e-01
|
0.56500
|
0.281000
|
-0.490000
|
1.99e-01
|
2.52e-02
|
GOCC INNER MITOCHONDRIAL MEMBRANE PROTEIN COMPLEX
|
10
|
2.01e-02
|
1.22e-01
|
0.56400
|
-0.238000
|
0.512000
|
1.95e-01
|
5.24e-03
|
GOBP POSITIVE REGULATION OF BLOOD CIRCULATION
|
5
|
2.02e-01
|
4.36e-01
|
0.56300
|
0.355000
|
-0.438000
|
1.70e-01
|
9.09e-02
|
GOMF OXIDOREDUCTION DRIVEN ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
28
|
6.09e-09
|
5.67e-07
|
0.56300
|
0.032500
|
0.562000
|
7.69e-01
|
3.22e-07
|
GOBP REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION
|
7
|
1.09e-01
|
3.13e-01
|
0.56200
|
0.433000
|
-0.359000
|
4.80e-02
|
1.01e-01
|
GOMF ANTIGEN BINDING
|
7
|
4.02e-02
|
1.77e-01
|
0.56200
|
0.538000
|
-0.161000
|
1.39e-02
|
4.63e-01
|
GOCC OXIDOREDUCTASE COMPLEX
|
48
|
3.57e-15
|
1.20e-12
|
0.56200
|
0.052700
|
0.559000
|
5.36e-01
|
3.38e-11
|
GOCC RESPIRATORY CHAIN COMPLEX III
|
9
|
6.70e-04
|
1.41e-02
|
0.56100
|
0.154000
|
0.540000
|
4.27e-01
|
5.15e-03
|
GOMF PROTEIN TYROSINE PHOSPHATASE ACTIVITY
|
5
|
1.44e-01
|
3.64e-01
|
0.56100
|
0.238000
|
-0.508000
|
3.59e-01
|
4.94e-02
|
GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY
|
7
|
1.13e-01
|
3.21e-01
|
0.56100
|
-0.384000
|
0.410000
|
7.96e-02
|
6.14e-02
|
GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION
|
6
|
7.85e-02
|
2.61e-01
|
0.56100
|
0.194000
|
-0.526000
|
4.11e-01
|
2.60e-02
|
GOMF ANTIOXIDANT ACTIVITY
|
14
|
9.02e-03
|
7.86e-02
|
0.56100
|
-0.306000
|
0.470000
|
4.87e-02
|
2.44e-03
|
GOCC RIBOSOMAL SUBUNIT
|
42
|
6.08e-14
|
1.26e-11
|
0.56000
|
0.081400
|
0.554000
|
3.69e-01
|
7.43e-10
|
GOCC SMALL SUBUNIT PROCESSOME
|
9
|
2.60e-04
|
6.18e-03
|
0.56000
|
0.277000
|
0.486000
|
1.51e-01
|
1.18e-02
|
GOBP POSITIVE REGULATION OF MONOATOMIC ION TRANSPORT
|
8
|
8.40e-02
|
2.72e-01
|
0.56000
|
0.379000
|
-0.412000
|
6.43e-02
|
4.43e-02
|
GOBP NEGATIVE REGULATION OF PROTEIN SECRETION
|
5
|
2.05e-01
|
4.38e-01
|
0.55900
|
0.437000
|
-0.349000
|
9.12e-02
|
1.78e-01
|
GOBP RIBOSOME ASSEMBLY
|
7
|
1.89e-03
|
2.85e-02
|
0.55900
|
0.250000
|
0.500000
|
2.54e-01
|
2.22e-02
|
GOMF VOLTAGE GATED CHANNEL ACTIVITY
|
10
|
4.64e-02
|
1.94e-01
|
0.55800
|
0.407000
|
-0.382000
|
2.64e-02
|
3.71e-02
|
GOBP RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM
|
6
|
8.23e-02
|
2.69e-01
|
0.55800
|
-0.198000
|
0.522000
|
4.02e-01
|
2.72e-02
|
GOMF DNA BINDING TRANSCRIPTION ACTIVATOR ACTIVITY
|
23
|
7.08e-04
|
1.47e-02
|
0.55700
|
0.445000
|
-0.335000
|
2.44e-04
|
5.83e-03
|
GOBP REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS
|
6
|
1.59e-01
|
3.79e-01
|
0.55600
|
0.412000
|
-0.373000
|
8.13e-02
|
1.14e-01
|
GOCC FILOPODIUM
|
9
|
5.80e-02
|
2.17e-01
|
0.55500
|
0.332000
|
-0.445000
|
8.54e-02
|
2.13e-02
|
GOBP MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY
|
20
|
2.33e-04
|
5.66e-03
|
0.55200
|
-0.181000
|
0.522000
|
1.66e-01
|
5.93e-05
|
GOBP FACE MORPHOGENESIS
|
5
|
2.18e-01
|
4.53e-01
|
0.55200
|
0.423000
|
-0.354000
|
1.02e-01
|
1.71e-01
|
GOBP POSITIVE REGULATION OF MRNA PROCESSING
|
5
|
1.18e-01
|
3.28e-01
|
0.55100
|
0.524000
|
-0.173000
|
4.31e-02
|
5.05e-01
|
GOBP REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION
|
6
|
1.66e-01
|
3.87e-01
|
0.55100
|
0.388000
|
-0.392000
|
1.01e-01
|
9.75e-02
|
GOBP POLYSACCHARIDE BIOSYNTHETIC PROCESS
|
8
|
6.87e-02
|
2.41e-01
|
0.55000
|
0.283000
|
-0.472000
|
1.67e-01
|
2.13e-02
|
GOBP CORTICAL ACTIN CYTOSKELETON ORGANIZATION
|
7
|
1.14e-01
|
3.21e-01
|
0.55000
|
0.330000
|
-0.440000
|
1.32e-01
|
4.45e-02
|
GOMF ALDO KETO REDUCTASE NADPH ACTIVITY
|
6
|
1.58e-01
|
3.78e-01
|
0.55000
|
-0.433000
|
0.339000
|
6.67e-02
|
1.52e-01
|
GOBP POSITIVE REGULATION OF LIPID TRANSPORT
|
13
|
1.40e-02
|
1.00e-01
|
0.54900
|
0.466000
|
-0.290000
|
3.74e-03
|
7.16e-02
|
GOBP POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY
|
12
|
1.37e-02
|
9.88e-02
|
0.54900
|
0.248000
|
-0.490000
|
1.40e-01
|
3.40e-03
|
GOBP ARACHIDONATE METABOLIC PROCESS
|
9
|
8.67e-04
|
1.68e-02
|
0.54900
|
0.157000
|
0.526000
|
4.18e-01
|
6.40e-03
|
GOCC MITOCHONDRIAL PROTEIN CONTAINING COMPLEX
|
31
|
7.80e-05
|
2.48e-03
|
0.54900
|
-0.330000
|
0.439000
|
1.67e-03
|
2.78e-05
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A HEME GROUP OF DONORS
|
7
|
2.10e-03
|
3.06e-02
|
0.54900
|
0.271000
|
0.477000
|
2.15e-01
|
2.93e-02
|
GOBP NEGATIVE REGULATION OF ORGAN GROWTH
|
5
|
2.26e-01
|
4.61e-01
|
0.54900
|
0.381000
|
-0.395000
|
1.41e-01
|
1.27e-01
|
GOMF DEACYLASE ACTIVITY
|
7
|
1.04e-01
|
3.06e-01
|
0.54800
|
-0.296000
|
0.461000
|
1.76e-01
|
3.52e-02
|
GOBP NEURAL CREST CELL DIFFERENTIATION
|
9
|
7.01e-02
|
2.44e-01
|
0.54800
|
0.389000
|
-0.386000
|
4.43e-02
|
4.55e-02
|
GOBP LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS
|
10
|
2.35e-02
|
1.32e-01
|
0.54800
|
-0.222000
|
0.500000
|
2.25e-01
|
6.31e-03
|
GOCC MITOCHONDRIAL LARGE RIBOSOMAL SUBUNIT
|
8
|
9.33e-02
|
2.88e-01
|
0.54700
|
-0.367000
|
0.406000
|
7.30e-02
|
4.76e-02
|
GOBP POSITIVE REGULATION OF CELL MORPHOGENESIS
|
5
|
1.60e-01
|
3.80e-01
|
0.54700
|
0.234000
|
-0.495000
|
3.66e-01
|
5.59e-02
|
GOBP ORGANIC ACID CATABOLIC PROCESS
|
62
|
8.30e-09
|
7.24e-07
|
0.54500
|
-0.315000
|
0.445000
|
2.77e-05
|
2.69e-09
|
GOMF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
22
|
8.17e-04
|
1.63e-02
|
0.54500
|
0.464000
|
-0.285000
|
1.79e-04
|
2.20e-02
|
GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX
|
7
|
1.03e-02
|
8.46e-02
|
0.54400
|
0.047500
|
0.542000
|
8.28e-01
|
1.32e-02
|
GOMF PROTON CHANNEL ACTIVITY
|
7
|
1.03e-02
|
8.46e-02
|
0.54400
|
0.047500
|
0.542000
|
8.28e-01
|
1.32e-02
|
GOMF PROTON TRANSPORTING ATP SYNTHASE ACTIVITY ROTATIONAL MECHANISM
|
7
|
1.03e-02
|
8.46e-02
|
0.54400
|
0.047500
|
0.542000
|
8.28e-01
|
1.32e-02
|
GOMF BETA CATENIN BINDING
|
8
|
9.67e-02
|
2.92e-01
|
0.54400
|
0.400000
|
-0.368000
|
5.08e-02
|
7.23e-02
|
GOMF POLYPEPTIDE CONFORMATION OR ASSEMBLY ISOMERASE ACTIVITY
|
5
|
1.18e-01
|
3.28e-01
|
0.54300
|
0.158000
|
-0.520000
|
5.41e-01
|
4.45e-02
|
GOCC TERTIARY GRANULE LUMEN
|
7
|
1.27e-01
|
3.39e-01
|
0.54300
|
-0.348000
|
0.416000
|
1.12e-01
|
5.71e-02
|
GOBP REGULATION OF CALCIUM ION TRANSPORT
|
18
|
5.11e-03
|
5.61e-02
|
0.54200
|
0.345000
|
-0.418000
|
1.17e-02
|
2.28e-03
|
GOBP KETONE CATABOLIC PROCESS
|
5
|
2.56e-02
|
1.39e-01
|
0.54200
|
0.124000
|
0.528000
|
6.32e-01
|
4.14e-02
|
GOBP CELLULAR RESPONSE TO VIRUS
|
8
|
4.74e-02
|
1.95e-01
|
0.54200
|
-0.502000
|
0.204000
|
1.42e-02
|
3.19e-01
|
GOBP REGULATION OF ERYTHROCYTE DIFFERENTIATION
|
5
|
1.19e-02
|
9.14e-02
|
0.54100
|
0.437000
|
0.320000
|
9.16e-02
|
2.16e-01
|
GOBP PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS
|
5
|
2.35e-01
|
4.68e-01
|
0.54100
|
-0.367000
|
0.398000
|
1.56e-01
|
1.24e-01
|
GOBP CELLULAR OXIDANT DETOXIFICATION
|
15
|
1.00e-02
|
8.42e-02
|
0.54100
|
-0.308000
|
0.445000
|
4.03e-02
|
2.97e-03
|
GOBP AROMATIC AMINO ACID METABOLIC PROCESS
|
9
|
5.80e-02
|
2.17e-01
|
0.53900
|
-0.285000
|
0.457000
|
1.40e-01
|
1.79e-02
|
GOBP ERYTHROSE 4 PHOSPHATE PHOSPHOENOLPYRUVATE FAMILY AMINO ACID METABOLIC PROCESS
|
9
|
5.80e-02
|
2.17e-01
|
0.53900
|
-0.285000
|
0.457000
|
1.40e-01
|
1.79e-02
|
GOBP GLUTATHIONE METABOLIC PROCESS
|
14
|
1.62e-02
|
1.08e-01
|
0.53900
|
-0.330000
|
0.426000
|
3.37e-02
|
5.98e-03
|
GOCC FICOLIN 1 RICH GRANULE
|
21
|
2.50e-03
|
3.50e-02
|
0.53800
|
-0.357000
|
0.403000
|
4.93e-03
|
1.50e-03
|
GOBP ANTERIOR POSTERIOR PATTERN SPECIFICATION
|
16
|
3.42e-03
|
4.36e-02
|
0.53800
|
0.226000
|
-0.488000
|
1.20e-01
|
7.66e-04
|
GOBP DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS
|
25
|
7.84e-04
|
1.59e-02
|
0.53800
|
0.348000
|
-0.410000
|
2.81e-03
|
4.31e-04
|
GOCC CLATHRIN COATED ENDOCYTIC VESICLE
|
9
|
6.22e-02
|
2.26e-01
|
0.53800
|
0.449000
|
-0.297000
|
2.02e-02
|
1.25e-01
|
GOBP AMINO ACID METABOLIC PROCESS
|
49
|
7.23e-07
|
3.93e-05
|
0.53800
|
-0.325000
|
0.429000
|
1.11e-04
|
3.16e-07
|
GOMF CALMODULIN BINDING
|
11
|
3.88e-02
|
1.75e-01
|
0.53700
|
0.324000
|
-0.429000
|
6.43e-02
|
1.41e-02
|
GOMF HEPARIN BINDING
|
13
|
7.37e-03
|
6.84e-02
|
0.53700
|
0.197000
|
-0.499000
|
2.21e-01
|
1.90e-03
|
GOCC MICROVILLUS MEMBRANE
|
5
|
1.55e-01
|
3.74e-01
|
0.53700
|
0.496000
|
-0.205000
|
5.53e-02
|
4.29e-01
|
GOCC RIBOSOME
|
47
|
2.55e-13
|
4.30e-11
|
0.53700
|
0.037400
|
0.535000
|
6.63e-01
|
3.45e-10
|
GOBP PROTEIN LOCALIZATION TO CYTOSKELETON
|
6
|
5.67e-02
|
2.16e-01
|
0.53600
|
0.094800
|
-0.528000
|
6.88e-01
|
2.55e-02
|
GOBP POSITIVE REGULATION OF LIPID LOCALIZATION
|
15
|
1.43e-02
|
1.01e-01
|
0.53500
|
0.401000
|
-0.355000
|
7.51e-03
|
1.80e-02
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH GROUP OF DONORS
|
7
|
1.23e-01
|
3.34e-01
|
0.53500
|
-0.307000
|
0.438000
|
1.60e-01
|
4.54e-02
|
GOMF GATED CHANNEL ACTIVITY
|
13
|
2.60e-02
|
1.39e-01
|
0.53400
|
0.392000
|
-0.363000
|
1.48e-02
|
2.43e-02
|
GOCC PODOSOME
|
5
|
1.92e-01
|
4.22e-01
|
0.53400
|
0.253000
|
-0.470000
|
3.29e-01
|
6.92e-02
|
GOBP NEGATIVE REGULATION OF IMMUNE RESPONSE
|
5
|
2.05e-01
|
4.38e-01
|
0.53400
|
-0.459000
|
0.272000
|
7.63e-02
|
2.93e-01
|
GOMF LYASE ACTIVITY
|
32
|
1.29e-04
|
3.66e-03
|
0.53300
|
-0.342000
|
0.409000
|
9.45e-04
|
7.45e-05
|
GOBP NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS
|
5
|
2.27e-01
|
4.61e-01
|
0.53200
|
0.435000
|
-0.307000
|
9.29e-02
|
2.36e-01
|
GOBP NADP METABOLIC PROCESS
|
6
|
6.23e-03
|
6.23e-02
|
0.53100
|
0.300000
|
0.438000
|
2.04e-01
|
6.39e-02
|
GOMF SH3 DOMAIN BINDING
|
6
|
1.83e-01
|
4.11e-01
|
0.53100
|
0.338000
|
-0.409000
|
1.53e-01
|
8.35e-02
|
GOMF AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY
|
11
|
3.10e-02
|
1.55e-01
|
0.53000
|
0.459000
|
-0.265000
|
8.57e-03
|
1.30e-01
|
GOBP BODY MORPHOGENESIS
|
8
|
1.07e-01
|
3.10e-01
|
0.52900
|
0.340000
|
-0.405000
|
9.73e-02
|
4.79e-02
|
GOBP HEAD MORPHOGENESIS
|
8
|
1.07e-01
|
3.10e-01
|
0.52900
|
0.340000
|
-0.405000
|
9.73e-02
|
4.79e-02
|
GOMF ATP DEPENDENT CHROMATIN REMODELER ACTIVITY
|
5
|
1.54e-01
|
3.74e-01
|
0.52900
|
0.187000
|
-0.494000
|
4.70e-01
|
5.61e-02
|
GOBP CYTOPLASMIC TRANSLATION
|
40
|
7.85e-13
|
1.12e-10
|
0.52800
|
0.128000
|
0.513000
|
1.68e-01
|
2.80e-08
|
GOBP BONE GROWTH
|
6
|
8.94e-02
|
2.82e-01
|
0.52800
|
0.155000
|
-0.505000
|
5.11e-01
|
3.26e-02
|
GOCC MYOSIN COMPLEX
|
6
|
8.96e-02
|
2.82e-01
|
0.52800
|
0.155000
|
-0.505000
|
5.12e-01
|
3.27e-02
|
GOBP SMAD PROTEIN SIGNAL TRANSDUCTION
|
8
|
1.06e-01
|
3.08e-01
|
0.52800
|
0.412000
|
-0.329000
|
4.42e-02
|
1.08e-01
|
GOMF METALLOEXOPEPTIDASE ACTIVITY
|
6
|
1.11e-01
|
3.18e-01
|
0.52600
|
-0.490000
|
0.192000
|
3.80e-02
|
4.18e-01
|
GOBP RIBOSOMAL SMALL SUBUNIT BIOGENESIS
|
13
|
5.16e-05
|
1.72e-03
|
0.52600
|
0.195000
|
0.489000
|
2.26e-01
|
2.36e-03
|
GOBP ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY
|
11
|
6.60e-03
|
6.48e-02
|
0.52600
|
0.517000
|
-0.096300
|
3.07e-03
|
5.82e-01
|
GOBP CELLULAR RESPONSE TO HEAT
|
7
|
2.14e-02
|
1.26e-01
|
0.52500
|
-0.525000
|
0.009590
|
1.63e-02
|
9.65e-01
|
GOBP POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT
|
5
|
2.37e-01
|
4.70e-01
|
0.52500
|
0.428000
|
-0.305000
|
9.84e-02
|
2.39e-01
|
GOBP OVULATION CYCLE
|
5
|
1.96e-01
|
4.28e-01
|
0.52500
|
0.240000
|
-0.467000
|
3.54e-01
|
7.12e-02
|
GOBP CALCIUM ION IMPORT
|
6
|
1.44e-01
|
3.63e-01
|
0.52400
|
0.466000
|
-0.241000
|
4.89e-02
|
3.08e-01
|
GOBP NUCLEAR MIGRATION
|
6
|
1.00e-01
|
2.99e-01
|
0.52200
|
0.164000
|
-0.496000
|
4.88e-01
|
3.58e-02
|
GOMF METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
36
|
7.56e-05
|
2.43e-03
|
0.52200
|
0.371000
|
-0.367000
|
1.42e-04
|
1.65e-04
|
GOBP BONE REMODELING
|
9
|
8.44e-02
|
2.73e-01
|
0.52200
|
0.326000
|
-0.408000
|
9.21e-02
|
3.48e-02
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OH GROUP OF DONORS
|
24
|
1.35e-03
|
2.30e-02
|
0.52100
|
-0.314000
|
0.416000
|
8.21e-03
|
4.72e-04
|
GOBP CARDIAC CELL DEVELOPMENT
|
8
|
1.10e-01
|
3.14e-01
|
0.51900
|
0.312000
|
-0.415000
|
1.28e-01
|
4.26e-02
|
GOCC PORE COMPLEX
|
5
|
2.33e-01
|
4.67e-01
|
0.51800
|
-0.277000
|
0.438000
|
2.85e-01
|
9.07e-02
|
GOBP REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT
|
12
|
3.05e-02
|
1.54e-01
|
0.51800
|
0.276000
|
-0.438000
|
9.95e-02
|
8.85e-03
|
GOBP PROTEIN TRANSMEMBRANE TRANSPORT
|
10
|
7.12e-02
|
2.44e-01
|
0.51800
|
-0.379000
|
0.352000
|
3.86e-02
|
5.47e-02
|
GOBP REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL
|
8
|
5.44e-02
|
2.11e-01
|
0.51800
|
-0.176000
|
0.487000
|
3.90e-01
|
1.75e-02
|
GOBP NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY
|
7
|
1.22e-01
|
3.34e-01
|
0.51700
|
0.259000
|
-0.448000
|
2.37e-01
|
4.08e-02
|
GOBP NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION
|
8
|
6.45e-02
|
2.31e-01
|
0.51700
|
0.477000
|
-0.200000
|
1.99e-02
|
3.30e-01
|
GOBP REGULATION OF HEART GROWTH
|
5
|
2.66e-01
|
5.00e-01
|
0.51700
|
0.387000
|
-0.343000
|
1.35e-01
|
1.85e-01
|
GOCC SMALL RIBOSOMAL SUBUNIT
|
16
|
5.69e-06
|
2.45e-04
|
0.51700
|
0.221000
|
0.467000
|
1.28e-01
|
1.29e-03
|
GOBP HUMORAL IMMUNE RESPONSE
|
8
|
1.62e-03
|
2.58e-02
|
0.51600
|
0.302000
|
0.418000
|
1.40e-01
|
4.13e-02
|
GOBP CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL
|
10
|
5.95e-02
|
2.20e-01
|
0.51500
|
0.285000
|
-0.429000
|
1.20e-01
|
1.93e-02
|
GOBP POSITIVE REGULATION OF AXON EXTENSION
|
5
|
1.44e-01
|
3.63e-01
|
0.51500
|
0.145000
|
-0.494000
|
5.75e-01
|
5.62e-02
|
GOBP LONG TERM SYNAPTIC POTENTIATION
|
8
|
1.05e-01
|
3.07e-01
|
0.51500
|
0.429000
|
-0.285000
|
3.63e-02
|
1.65e-01
|
GOBP RIBOSOMAL SMALL SUBUNIT ASSEMBLY
|
5
|
2.28e-02
|
1.30e-01
|
0.51200
|
0.237000
|
0.454000
|
3.60e-01
|
7.95e-02
|
GOBP PHOSPHATE ION HOMEOSTASIS
|
6
|
2.13e-01
|
4.46e-01
|
0.51200
|
0.363000
|
-0.361000
|
1.25e-01
|
1.27e-01
|
GOBP REGULATION OF LIPID LOCALIZATION
|
25
|
1.05e-03
|
1.88e-02
|
0.51200
|
0.424000
|
-0.286000
|
2.71e-04
|
1.42e-02
|
GOMF CARBON CARBON LYASE ACTIVITY
|
10
|
1.59e-02
|
1.08e-01
|
0.51100
|
-0.110000
|
0.499000
|
5.47e-01
|
6.43e-03
|
GOBP POSITIVE REGULATION OF CALCIUM ION TRANSPORT
|
7
|
1.60e-01
|
3.80e-01
|
0.51100
|
0.328000
|
-0.393000
|
1.35e-01
|
7.29e-02
|
GOBP REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS
|
14
|
2.10e-02
|
1.26e-01
|
0.51100
|
0.424000
|
-0.286000
|
6.30e-03
|
6.54e-02
|
GOBP NEGATIVE REGULATION OF MUSCLE HYPERTROPHY
|
5
|
1.36e-01
|
3.50e-01
|
0.51100
|
0.495000
|
-0.126000
|
5.57e-02
|
6.27e-01
|
GOBP SULFUR COMPOUND METABOLIC PROCESS
|
56
|
8.28e-07
|
4.30e-05
|
0.51100
|
-0.377000
|
0.344000
|
1.62e-06
|
1.25e-05
|
GOBP REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION
|
30
|
4.06e-04
|
9.18e-03
|
0.51100
|
0.316000
|
-0.401000
|
3.00e-03
|
1.69e-04
|
GOCC ENDOPLASMIC RETICULUM PROTEIN CONTAINING COMPLEX
|
20
|
8.40e-04
|
1.67e-02
|
0.51000
|
-0.481000
|
0.170000
|
2.15e-04
|
1.92e-01
|
GOBP GLUTAMATE METABOLIC PROCESS
|
5
|
4.18e-02
|
1.82e-01
|
0.51000
|
0.104000
|
0.499000
|
6.88e-01
|
5.38e-02
|
GOBP POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS
|
9
|
8.36e-02
|
2.71e-01
|
0.50900
|
0.283000
|
-0.424000
|
1.44e-01
|
2.83e-02
|
GOMF TRANSFERASE ACTIVITY TRANSFERRING ALKYL OR ARYL OTHER THAN METHYL GROUPS
|
8
|
8.12e-02
|
2.68e-01
|
0.50900
|
-0.220000
|
0.459000
|
2.83e-01
|
2.51e-02
|
GOBP VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE
|
16
|
5.28e-03
|
5.70e-02
|
0.50800
|
0.199000
|
-0.468000
|
1.70e-01
|
1.27e-03
|
GOBP PATTERN SPECIFICATION PROCESS
|
25
|
9.78e-04
|
1.78e-02
|
0.50800
|
0.270000
|
-0.430000
|
2.04e-02
|
2.24e-04
|
GOBP BLOOD VESSEL ENDOTHELIAL CELL MIGRATION
|
5
|
2.76e-01
|
5.08e-01
|
0.50800
|
-0.329000
|
0.387000
|
2.04e-01
|
1.35e-01
|
GOBP POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY
|
6
|
2.05e-01
|
4.38e-01
|
0.50800
|
0.307000
|
-0.404000
|
1.95e-01
|
8.71e-02
|
GOBP PROTEIN LOCALIZATION TO CELL SURFACE
|
5
|
2.79e-01
|
5.11e-01
|
0.50700
|
0.340000
|
-0.376000
|
1.89e-01
|
1.46e-01
|
GOMF CHLORIDE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
10
|
7.08e-02
|
2.44e-01
|
0.50700
|
0.408000
|
-0.301000
|
2.60e-02
|
1.01e-01
|
GOBP REGULATION OF LEUKOCYTE CHEMOTAXIS
|
9
|
1.03e-01
|
3.05e-01
|
0.50600
|
0.358000
|
-0.358000
|
6.40e-02
|
6.37e-02
|
GOBP POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS
|
5
|
2.53e-01
|
4.87e-01
|
0.50600
|
0.424000
|
-0.277000
|
1.02e-01
|
2.84e-01
|
GOBP PROTEIN O LINKED GLYCOSYLATION
|
6
|
9.60e-03
|
8.13e-02
|
0.50600
|
-0.303000
|
-0.405000
|
2.01e-01
|
8.64e-02
|
GOBP DICARBOXYLIC ACID METABOLIC PROCESS
|
23
|
8.71e-04
|
1.68e-02
|
0.50600
|
-0.220000
|
0.455000
|
7.01e-02
|
1.75e-04
|
GOBP HYDROGEN PEROXIDE METABOLIC PROCESS
|
10
|
7.38e-02
|
2.49e-01
|
0.50600
|
-0.306000
|
0.402000
|
9.49e-02
|
2.83e-02
|
GOMF ATPASE COUPLED TRANSMEMBRANE TRANSPORTER ACTIVITY
|
9
|
1.05e-01
|
3.07e-01
|
0.50500
|
0.360000
|
-0.354000
|
6.21e-02
|
6.73e-02
|
GOBP POSITIVE REGULATION OF RESPONSE TO WOUNDING
|
6
|
3.35e-02
|
1.61e-01
|
0.50400
|
-0.502000
|
-0.048200
|
3.36e-02
|
8.38e-01
|
GOBP REGULATION OF SODIUM ION TRANSPORT
|
6
|
2.22e-01
|
4.58e-01
|
0.50400
|
0.364000
|
-0.349000
|
1.24e-01
|
1.40e-01
|
GOBP CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION
|
6
|
2.04e-01
|
4.38e-01
|
0.50400
|
0.292000
|
-0.411000
|
2.16e-01
|
8.23e-02
|
GOBP REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION
|
10
|
6.08e-02
|
2.23e-01
|
0.50400
|
0.261000
|
-0.432000
|
1.56e-01
|
1.86e-02
|
GOBP EXTRACELLULAR MATRIX DISASSEMBLY
|
5
|
2.77e-01
|
5.09e-01
|
0.50400
|
0.393000
|
-0.315000
|
1.29e-01
|
2.24e-01
|
GOBP ADIPOSE TISSUE DEVELOPMENT
|
16
|
1.60e-02
|
1.08e-01
|
0.50400
|
0.402000
|
-0.304000
|
5.67e-03
|
3.64e-02
|
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE
|
6
|
1.09e-01
|
3.13e-01
|
0.50400
|
0.483000
|
-0.144000
|
4.11e-02
|
5.43e-01
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN NAD P H AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN
|
8
|
1.21e-01
|
3.32e-01
|
0.50300
|
-0.292000
|
0.410000
|
1.54e-01
|
4.53e-02
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H
|
21
|
4.67e-05
|
1.60e-03
|
0.50300
|
-0.032800
|
0.502000
|
7.97e-01
|
7.60e-05
|
GOBP POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS
|
10
|
3.69e-03
|
4.49e-02
|
0.50300
|
0.500000
|
0.047100
|
6.31e-03
|
7.97e-01
|
GOBP CELLULAR EXTRAVASATION
|
6
|
2.61e-02
|
1.40e-01
|
0.50200
|
-0.094000
|
-0.493000
|
6.91e-01
|
3.68e-02
|
GOBP IRON ION TRANSPORT
|
5
|
5.71e-02
|
2.17e-01
|
0.50200
|
0.059500
|
0.498000
|
8.18e-01
|
5.41e-02
|
GOMF NUCLEOSIDE TRIPHOSPHATASE REGULATOR ACTIVITY
|
42
|
2.99e-05
|
1.08e-03
|
0.50100
|
0.314000
|
-0.391000
|
5.19e-04
|
1.55e-05
|
GOBP REGULATION OF EXTENT OF CELL GROWTH
|
10
|
7.98e-02
|
2.65e-01
|
0.50000
|
0.310000
|
-0.392000
|
9.09e-02
|
3.24e-02
|
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE
|
6
|
1.48e-01
|
3.68e-01
|
0.50000
|
-0.196000
|
0.460000
|
4.08e-01
|
5.16e-02
|
GOMF PROTON TRANSMEMBRANE TRANSPORTER ACTIVITY
|
41
|
8.97e-10
|
1.01e-07
|
0.50000
|
0.009220
|
0.500000
|
9.20e-01
|
4.36e-08
|
GOCC PROTEIN LIPID COMPLEX
|
6
|
6.44e-02
|
2.30e-01
|
0.50000
|
0.046900
|
-0.497000
|
8.43e-01
|
3.53e-02
|
GOMF TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY
|
9
|
9.61e-02
|
2.91e-01
|
0.49900
|
0.288000
|
-0.408000
|
1.37e-01
|
3.46e-02
|
GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION
|
6
|
2.28e-01
|
4.61e-01
|
0.49900
|
-0.368000
|
0.337000
|
1.20e-01
|
1.54e-01
|
GOMF MONOCARBOXYLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY
|
8
|
6.87e-02
|
2.41e-01
|
0.49900
|
0.173000
|
-0.468000
|
3.98e-01
|
2.24e-02
|
GOBP REGULATION OF EPITHELIAL CELL DIFFERENTIATION
|
12
|
5.09e-02
|
2.03e-01
|
0.49900
|
0.320000
|
-0.383000
|
5.65e-02
|
2.23e-02
|
GOBP REGULATION OF LIPID TRANSPORT
|
22
|
1.39e-03
|
2.33e-02
|
0.49700
|
0.449000
|
-0.212000
|
2.90e-04
|
8.76e-02
|
GOCC RNA POLYMERASE COMPLEX
|
7
|
1.30e-01
|
3.43e-01
|
0.49700
|
-0.226000
|
0.442000
|
3.02e-01
|
4.33e-02
|
GOBP REGULATION OF MICROTUBULE POLYMERIZATION
|
5
|
2.32e-02
|
1.32e-01
|
0.49700
|
-0.382000
|
-0.318000
|
1.40e-01
|
2.20e-01
|
GOBP MONOSACCHARIDE CATABOLIC PROCESS
|
8
|
1.43e-01
|
3.62e-01
|
0.49700
|
-0.362000
|
0.339000
|
7.69e-02
|
9.75e-02
|
GOBP SUPEROXIDE ANION GENERATION
|
5
|
2.94e-01
|
5.27e-01
|
0.49500
|
-0.376000
|
0.322000
|
1.46e-01
|
2.14e-01
|
GOBP RESPONSE TO TESTOSTERONE
|
6
|
2.34e-01
|
4.68e-01
|
0.49400
|
0.329000
|
-0.369000
|
1.64e-01
|
1.19e-01
|
GOBP AMYLOID FIBRIL FORMATION
|
8
|
4.18e-02
|
1.82e-01
|
0.49400
|
0.485000
|
-0.096300
|
1.80e-02
|
6.38e-01
|
GOMF CYTOKINE ACTIVITY
|
6
|
1.91e-02
|
1.19e-01
|
0.49300
|
0.463000
|
0.172000
|
5.03e-02
|
4.67e-01
|
GOMF LIGAND MODULATED TRANSCRIPTION FACTOR ACTIVITY
|
9
|
4.51e-02
|
1.90e-01
|
0.49300
|
0.469000
|
-0.151000
|
1.51e-02
|
4.35e-01
|
GOBP POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT
|
13
|
3.07e-02
|
1.54e-01
|
0.49200
|
0.252000
|
-0.423000
|
1.18e-01
|
8.60e-03
|
GOBP REGULATION OF CIRCADIAN RHYTHM
|
12
|
1.76e-02
|
1.13e-01
|
0.49200
|
0.466000
|
-0.157000
|
5.35e-03
|
3.49e-01
|
GOBP REGULATION OF HEART CONTRACTION
|
15
|
1.95e-02
|
1.20e-01
|
0.49000
|
0.256000
|
-0.418000
|
8.85e-02
|
5.29e-03
|
GOBP HEART GROWTH
|
9
|
1.16e-01
|
3.26e-01
|
0.49000
|
0.316000
|
-0.374000
|
1.02e-01
|
5.28e-02
|
GOBP REGULATION OF FATTY ACID OXIDATION
|
6
|
2.35e-01
|
4.69e-01
|
0.48900
|
0.379000
|
-0.309000
|
1.09e-01
|
1.91e-01
|
GOBP PROTEIN HOMOTETRAMERIZATION
|
11
|
2.23e-02
|
1.28e-01
|
0.48800
|
-0.140000
|
0.468000
|
4.22e-01
|
7.44e-03
|
GOBP PROTEIN TETRAMERIZATION
|
11
|
2.23e-02
|
1.28e-01
|
0.48800
|
-0.140000
|
0.468000
|
4.22e-01
|
7.44e-03
|
GOBP REGULATION OF CHOLESTEROL METABOLIC PROCESS
|
5
|
1.93e-01
|
4.24e-01
|
0.48800
|
0.461000
|
-0.160000
|
7.48e-02
|
5.37e-01
|
GOMF IRON ION BINDING
|
21
|
1.71e-03
|
2.67e-02
|
0.48700
|
-0.186000
|
0.450000
|
1.44e-01
|
3.91e-04
|
GOMF PHOSPHATIDYLSERINE BINDING
|
5
|
2.19e-01
|
4.54e-01
|
0.48600
|
0.187000
|
-0.449000
|
4.70e-01
|
8.30e-02
|
GOBP EYE MORPHOGENESIS
|
10
|
9.72e-02
|
2.93e-01
|
0.48600
|
0.330000
|
-0.357000
|
7.23e-02
|
5.13e-02
|
GOBP NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION
|
8
|
9.32e-02
|
2.88e-01
|
0.48400
|
0.444000
|
-0.193000
|
3.00e-02
|
3.47e-01
|
GOCC INTERMEDIATE FILAMENT CYTOSKELETON
|
10
|
6.41e-02
|
2.30e-01
|
0.48400
|
0.222000
|
-0.430000
|
2.26e-01
|
1.91e-02
|
GOBP POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE
|
6
|
4.37e-02
|
1.88e-01
|
0.48400
|
0.481000
|
0.047700
|
4.17e-02
|
8.40e-01
|
GOMF INTEGRIN BINDING
|
11
|
7.81e-02
|
2.61e-01
|
0.48300
|
0.318000
|
-0.364000
|
6.94e-02
|
3.72e-02
|
GOBP SMALL MOLECULE CATABOLIC PROCESS
|
77
|
1.21e-08
|
9.31e-07
|
0.48300
|
-0.268000
|
0.401000
|
7.93e-05
|
2.78e-09
|
GOMF GTPASE ACTIVATOR ACTIVITY
|
26
|
1.64e-03
|
2.58e-02
|
0.48200
|
0.263000
|
-0.404000
|
2.13e-02
|
4.05e-04
|
GOBP REGULATION OF MITOTIC NUCLEAR DIVISION
|
8
|
1.55e-01
|
3.74e-01
|
0.48200
|
0.372000
|
-0.306000
|
6.95e-02
|
1.35e-01
|
GOBP NEGATIVE REGULATION OF LIPID METABOLIC PROCESS
|
5
|
2.29e-01
|
4.63e-01
|
0.48100
|
0.191000
|
-0.442000
|
4.62e-01
|
8.76e-02
|
GOBP MITOCHONDRIAL TRANSLATION
|
15
|
3.34e-02
|
1.61e-01
|
0.48100
|
-0.342000
|
0.338000
|
2.25e-02
|
2.42e-02
|
GOBP REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL
|
5
|
3.29e-02
|
1.61e-01
|
0.48100
|
-0.251000
|
-0.410000
|
3.33e-01
|
1.13e-01
|
GOBP INTERLEUKIN 2 PRODUCTION
|
6
|
5.89e-02
|
2.19e-01
|
0.48000
|
0.480000
|
0.004630
|
4.21e-02
|
9.84e-01
|
GOBP RECEPTOR MEDIATED ENDOCYTOSIS
|
19
|
1.17e-02
|
9.08e-02
|
0.48000
|
0.290000
|
-0.383000
|
2.99e-02
|
4.13e-03
|
GOBP INTEGRIN MEDIATED SIGNALING PATHWAY
|
14
|
1.11e-02
|
8.82e-02
|
0.48000
|
0.151000
|
-0.455000
|
3.31e-01
|
3.34e-03
|
GOBP MEMORY
|
15
|
1.31e-02
|
9.65e-02
|
0.47900
|
0.440000
|
-0.192000
|
3.36e-03
|
2.02e-01
|
GOBP PROTEIN N LINKED GLYCOSYLATION
|
7
|
1.94e-01
|
4.25e-01
|
0.47900
|
-0.380000
|
0.292000
|
8.23e-02
|
1.83e-01
|
GOBP LEUKOCYTE MEDIATED IMMUNITY
|
7
|
9.44e-02
|
2.88e-01
|
0.47900
|
-0.134000
|
0.460000
|
5.42e-01
|
3.54e-02
|
GOCC MICROBODY
|
28
|
1.33e-03
|
2.27e-02
|
0.47900
|
-0.391000
|
0.277000
|
3.84e-04
|
1.22e-02
|
GOBP PROTEIN LIPID COMPLEX ORGANIZATION
|
6
|
2.02e-01
|
4.37e-01
|
0.47900
|
0.226000
|
-0.422000
|
3.39e-01
|
7.39e-02
|
GOCC NUCLEAR CHROMOSOME
|
8
|
1.16e-01
|
3.25e-01
|
0.47800
|
0.218000
|
-0.425000
|
2.87e-01
|
3.78e-02
|
GOBP PROTON TRANSMEMBRANE TRANSPORT
|
42
|
1.23e-09
|
1.33e-07
|
0.47800
|
0.033300
|
0.477000
|
7.13e-01
|
1.25e-07
|
GOMF TRANSLATION FACTOR ACTIVITY
|
12
|
6.15e-02
|
2.24e-01
|
0.47800
|
-0.380000
|
0.290000
|
2.34e-02
|
8.31e-02
|
GOMF MANGANESE ION BINDING
|
7
|
2.05e-01
|
4.38e-01
|
0.47800
|
-0.357000
|
0.317000
|
1.03e-01
|
1.48e-01
|
GOCC TRIGLYCERIDE RICH PLASMA LIPOPROTEIN PARTICLE
|
5
|
1.63e-01
|
3.82e-01
|
0.47700
|
0.101000
|
-0.466000
|
6.97e-01
|
7.16e-02
|
GOMF ACTIVE MONOATOMIC ION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
33
|
3.88e-08
|
2.69e-06
|
0.47700
|
0.062600
|
0.473000
|
5.39e-01
|
3.19e-06
|
GOMF DOUBLE STRANDED RNA BINDING
|
5
|
2.98e-01
|
5.31e-01
|
0.47700
|
-0.265000
|
0.397000
|
3.07e-01
|
1.25e-01
|
GOBP RIBOSOME BIOGENESIS
|
26
|
2.48e-06
|
1.18e-04
|
0.47600
|
0.041800
|
0.474000
|
7.15e-01
|
3.25e-05
|
GOBP MONOCARBOXYLIC ACID CATABOLIC PROCESS
|
38
|
4.92e-05
|
1.66e-03
|
0.47600
|
-0.219000
|
0.423000
|
2.11e-02
|
8.40e-06
|
GOBP ICOSANOID METABOLIC PROCESS
|
17
|
1.74e-03
|
2.69e-02
|
0.47600
|
-0.084800
|
0.468000
|
5.48e-01
|
8.84e-04
|
GOBP RRNA PROCESSING
|
16
|
9.00e-04
|
1.71e-02
|
0.47500
|
-0.017000
|
0.475000
|
9.07e-01
|
1.07e-03
|
GOMF EXOPEPTIDASE ACTIVITY
|
9
|
7.20e-02
|
2.45e-01
|
0.47500
|
-0.440000
|
0.179000
|
2.28e-02
|
3.56e-01
|
GOBP INORGANIC ANION TRANSMEMBRANE TRANSPORT
|
11
|
7.84e-02
|
2.61e-01
|
0.47400
|
0.281000
|
-0.382000
|
1.08e-01
|
2.89e-02
|
GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN
|
5
|
1.61e-01
|
3.80e-01
|
0.47400
|
-0.465000
|
0.092800
|
7.24e-02
|
7.20e-01
|
GOBP PROTEIN LOCALIZATION TO SYNAPSE
|
8
|
1.14e-01
|
3.21e-01
|
0.47400
|
0.207000
|
-0.427000
|
3.13e-01
|
3.72e-02
|
GOBP NEPHRON EPITHELIUM DEVELOPMENT
|
12
|
5.27e-02
|
2.07e-01
|
0.47400
|
0.403000
|
-0.249000
|
1.60e-02
|
1.37e-01
|
GOCC SYNAPTIC MEMBRANE
|
18
|
1.66e-02
|
1.09e-01
|
0.47400
|
0.286000
|
-0.377000
|
3.67e-02
|
5.91e-03
|
GOBP T CELL RECEPTOR SIGNALING PATHWAY
|
8
|
2.56e-02
|
1.39e-01
|
0.47200
|
0.472000
|
0.006760
|
2.11e-02
|
9.74e-01
|
GOCC CORTICAL ACTIN CYTOSKELETON
|
6
|
2.63e-01
|
4.97e-01
|
0.47200
|
0.358000
|
-0.308000
|
1.30e-01
|
1.93e-01
|
GOBP STEROL HOMEOSTASIS
|
19
|
1.54e-02
|
1.05e-01
|
0.47200
|
0.311000
|
-0.355000
|
2.00e-02
|
7.72e-03
|
GOMF ACTIN BINDING
|
43
|
1.00e-04
|
3.06e-03
|
0.47200
|
0.332000
|
-0.335000
|
2.06e-04
|
1.77e-04
|
GOMF GLYCOSAMINOGLYCAN BINDING
|
15
|
3.06e-02
|
1.54e-01
|
0.47100
|
0.268000
|
-0.388000
|
7.40e-02
|
9.72e-03
|
GOCC SPINDLE POLE
|
7
|
2.09e-01
|
4.43e-01
|
0.47100
|
0.296000
|
-0.366000
|
1.76e-01
|
9.47e-02
|
GOBP POSITIVE REGULATION OF LIPID METABOLIC PROCESS
|
15
|
1.99e-02
|
1.22e-01
|
0.47000
|
0.420000
|
-0.212000
|
5.13e-03
|
1.58e-01
|
GOBP REGULATION OF CARBOHYDRATE METABOLIC PROCESS
|
26
|
2.17e-03
|
3.13e-02
|
0.46900
|
0.396000
|
-0.251000
|
5.22e-04
|
2.82e-02
|
GOBP CYTOSOLIC TRANSPORT
|
15
|
3.40e-02
|
1.61e-01
|
0.46900
|
0.279000
|
-0.377000
|
6.33e-02
|
1.19e-02
|
GOBP FATTY ACID CATABOLIC PROCESS
|
31
|
1.83e-04
|
4.76e-03
|
0.46900
|
-0.181000
|
0.432000
|
8.41e-02
|
3.71e-05
|
GOBP HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION
|
9
|
1.43e-01
|
3.62e-01
|
0.46800
|
0.345000
|
-0.316000
|
7.40e-02
|
1.02e-01
|
GOBP GLAND MORPHOGENESIS
|
9
|
6.68e-02
|
2.36e-01
|
0.46600
|
0.441000
|
-0.152000
|
2.24e-02
|
4.31e-01
|
GOBP ALPHA LINOLENIC ACID METABOLIC PROCESS
|
6
|
2.75e-01
|
5.08e-01
|
0.46600
|
-0.342000
|
0.317000
|
1.48e-01
|
1.80e-01
|
GOMF SULFUR COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY
|
10
|
7.05e-02
|
2.44e-01
|
0.46500
|
0.197000
|
-0.422000
|
2.83e-01
|
2.14e-02
|
GOBP LIPOPROTEIN BIOSYNTHETIC PROCESS
|
5
|
3.44e-01
|
5.76e-01
|
0.46500
|
0.325000
|
-0.332000
|
2.09e-01
|
1.99e-01
|
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE
|
10
|
4.95e-02
|
2.01e-01
|
0.46500
|
0.441000
|
-0.149000
|
1.62e-02
|
4.16e-01
|
GOMF TRANSLATION INITIATION FACTOR ACTIVITY
|
9
|
1.45e-01
|
3.64e-01
|
0.46500
|
-0.351000
|
0.305000
|
6.91e-02
|
1.15e-01
|
GOBP LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL
|
7
|
2.23e-02
|
1.28e-01
|
0.46500
|
-0.113000
|
-0.451000
|
6.07e-01
|
3.93e-02
|
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY
|
9
|
9.23e-02
|
2.86e-01
|
0.46500
|
0.421000
|
-0.196000
|
2.92e-02
|
3.10e-01
|
GOMF HYDROLASE ACTIVITY ACTING ON GLYCOSYL BONDS
|
7
|
4.37e-02
|
1.88e-01
|
0.46400
|
-0.464000
|
-0.010800
|
3.39e-02
|
9.61e-01
|
GOBP MULTICELLULAR ORGANISMAL MOVEMENT
|
5
|
7.09e-02
|
2.44e-01
|
0.46400
|
-0.454000
|
-0.097900
|
7.96e-02
|
7.05e-01
|
GOBP DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING
|
5
|
2.34e-01
|
4.68e-01
|
0.46400
|
0.161000
|
-0.435000
|
5.35e-01
|
9.29e-02
|
GOMF STEROID BINDING
|
17
|
3.59e-03
|
4.44e-02
|
0.46400
|
0.451000
|
-0.109000
|
1.38e-03
|
4.41e-01
|
GOBP GLIAL CELL DEVELOPMENT
|
7
|
2.46e-02
|
1.36e-01
|
0.46300
|
-0.452000
|
-0.101000
|
3.88e-02
|
6.45e-01
|
GOCC ORGANELLE INNER MEMBRANE
|
101
|
1.99e-15
|
7.69e-13
|
0.46200
|
-0.083400
|
0.455000
|
1.65e-01
|
1.75e-14
|
GOBP ANIMAL ORGAN REGENERATION
|
5
|
3.46e-01
|
5.76e-01
|
0.46100
|
0.350000
|
-0.301000
|
1.77e-01
|
2.45e-01
|
GOBP POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT
|
14
|
1.73e-02
|
1.12e-01
|
0.46100
|
0.154000
|
-0.435000
|
3.21e-01
|
5.07e-03
|
GOBP ENDOCRINE HORMONE SECRETION
|
5
|
2.74e-01
|
5.08e-01
|
0.46100
|
0.199000
|
-0.416000
|
4.43e-01
|
1.08e-01
|
GOCC CLEAVAGE FURROW
|
5
|
2.11e-01
|
4.44e-01
|
0.46100
|
0.129000
|
-0.442000
|
6.17e-01
|
8.76e-02
|
GOBP NEURON PROJECTION EXTENSION
|
14
|
5.16e-02
|
2.04e-01
|
0.46100
|
0.355000
|
-0.294000
|
2.22e-02
|
5.85e-02
|
GOBP CELLULAR PIGMENTATION
|
5
|
3.18e-01
|
5.52e-01
|
0.46000
|
0.248000
|
-0.388000
|
3.39e-01
|
1.34e-01
|
GOBP B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE
|
5
|
3.06e-01
|
5.40e-01
|
0.46000
|
0.232000
|
-0.397000
|
3.71e-01
|
1.25e-01
|
GOBP TELENCEPHALON GLIAL CELL MIGRATION
|
5
|
3.45e-01
|
5.76e-01
|
0.45900
|
0.288000
|
-0.358000
|
2.67e-01
|
1.67e-01
|
GOBP POSITIVE REGULATION OF INFLAMMATORY RESPONSE
|
5
|
2.13e-01
|
4.46e-01
|
0.45900
|
0.128000
|
-0.441000
|
6.22e-01
|
8.85e-02
|
GOBP CELLULAR RESPONSE TO INTERLEUKIN 1
|
9
|
1.54e-01
|
3.74e-01
|
0.45900
|
0.308000
|
-0.340000
|
1.11e-01
|
7.87e-02
|
GOBP CARTILAGE DEVELOPMENT
|
17
|
1.53e-02
|
1.05e-01
|
0.45900
|
0.210000
|
-0.407000
|
1.36e-01
|
3.84e-03
|
GOCC PRERIBOSOME
|
10
|
1.99e-03
|
2.95e-02
|
0.45700
|
0.248000
|
0.384000
|
1.76e-01
|
3.62e-02
|
GOMF TRANSMEMBRANE SIGNALING RECEPTOR ACTIVITY
|
24
|
7.56e-03
|
6.97e-02
|
0.45600
|
0.309000
|
-0.336000
|
9.51e-03
|
4.69e-03
|
GOBP POLYSACCHARIDE METABOLIC PROCESS
|
17
|
8.43e-03
|
7.51e-02
|
0.45600
|
0.155000
|
-0.429000
|
2.72e-01
|
2.33e-03
|
GOBP POSITIVE REGULATION OF AXONOGENESIS
|
8
|
1.00e-01
|
2.99e-01
|
0.45600
|
0.148000
|
-0.431000
|
4.69e-01
|
3.53e-02
|
GOBP SENSORY SYSTEM DEVELOPMENT
|
24
|
7.83e-03
|
7.12e-02
|
0.45600
|
0.325000
|
-0.319000
|
6.30e-03
|
7.28e-03
|
GOBP METAL ION TRANSPORT
|
70
|
8.14e-07
|
4.30e-05
|
0.45600
|
0.354000
|
-0.287000
|
5.60e-07
|
5.31e-05
|
GOBP NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION
|
7
|
1.19e-02
|
9.14e-02
|
0.45500
|
0.347000
|
0.295000
|
1.13e-01
|
1.77e-01
|
GOBP CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION
|
5
|
3.20e-01
|
5.54e-01
|
0.45500
|
0.389000
|
-0.238000
|
1.33e-01
|
3.59e-01
|
GOBP MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION
|
7
|
3.40e-02
|
1.61e-01
|
0.45500
|
0.067800
|
0.450000
|
7.57e-01
|
3.98e-02
|
GOBP POSITIVE REGULATION OF MEMBRANE PERMEABILITY
|
7
|
3.40e-02
|
1.61e-01
|
0.45500
|
0.067800
|
0.450000
|
7.57e-01
|
3.98e-02
|
GOBP POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY
|
7
|
3.40e-02
|
1.61e-01
|
0.45500
|
0.067800
|
0.450000
|
7.57e-01
|
3.98e-02
|
GOBP REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS
|
7
|
3.40e-02
|
1.61e-01
|
0.45500
|
0.067800
|
0.450000
|
7.57e-01
|
3.98e-02
|
GOBP NEURON PROJECTION GUIDANCE
|
12
|
8.13e-02
|
2.68e-01
|
0.45500
|
0.281000
|
-0.358000
|
9.34e-02
|
3.27e-02
|
GOBP POSITIVE REGULATION OF DEVELOPMENTAL GROWTH
|
11
|
6.90e-02
|
2.41e-01
|
0.45500
|
0.208000
|
-0.404000
|
2.35e-01
|
2.07e-02
|
GOBP POSITIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS
|
7
|
2.07e-01
|
4.39e-01
|
0.45500
|
0.240000
|
-0.386000
|
2.72e-01
|
7.80e-02
|
GOMF PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY
|
8
|
1.69e-01
|
3.92e-01
|
0.45400
|
0.246000
|
-0.382000
|
2.30e-01
|
6.22e-02
|
GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS
|
11
|
8.73e-02
|
2.78e-01
|
0.45300
|
-0.243000
|
0.382000
|
1.65e-01
|
2.87e-02
|
GOBP CARDIAC MUSCLE CONTRACTION
|
9
|
1.23e-01
|
3.34e-01
|
0.45300
|
0.221000
|
-0.395000
|
2.53e-01
|
4.08e-02
|
GOBP GLYCERALDEHYDE 3 PHOSPHATE METABOLIC PROCESS
|
6
|
3.68e-02
|
1.68e-01
|
0.45200
|
0.155000
|
0.425000
|
5.13e-01
|
7.24e-02
|
GOMF ELECTRON TRANSFER ACTIVITY
|
41
|
4.44e-08
|
3.00e-06
|
0.45200
|
0.007000
|
0.452000
|
9.39e-01
|
7.57e-07
|
GOMF CHOLESTEROL TRANSFER ACTIVITY
|
7
|
2.44e-01
|
4.80e-01
|
0.45200
|
0.329000
|
-0.310000
|
1.33e-01
|
1.57e-01
|
GOBP CHONDROCYTE DIFFERENTIATION
|
10
|
1.28e-01
|
3.41e-01
|
0.45100
|
0.281000
|
-0.353000
|
1.25e-01
|
5.42e-02
|
GOBP NEUROMUSCULAR JUNCTION DEVELOPMENT
|
8
|
1.66e-01
|
3.87e-01
|
0.45100
|
0.233000
|
-0.386000
|
2.55e-01
|
5.96e-02
|
GOBP CAMERA TYPE EYE MORPHOGENESIS
|
7
|
2.22e-01
|
4.58e-01
|
0.45100
|
0.372000
|
-0.254000
|
8.89e-02
|
2.45e-01
|
GOBP RETROGRADE TRANSPORT ENDOSOME TO GOLGI
|
14
|
4.93e-02
|
2.01e-01
|
0.45100
|
0.251000
|
-0.375000
|
1.06e-01
|
1.58e-02
|
GOBP NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION
|
5
|
5.76e-02
|
2.17e-01
|
0.45100
|
-0.187000
|
-0.410000
|
4.71e-01
|
1.13e-01
|
GOBP AXIS ELONGATION
|
5
|
2.44e-01
|
4.80e-01
|
0.45000
|
0.145000
|
-0.426000
|
5.74e-01
|
9.97e-02
|
GOBP AMINE METABOLIC PROCESS
|
8
|
1.01e-01
|
3.00e-01
|
0.45000
|
-0.428000
|
0.138000
|
3.65e-02
|
5.00e-01
|
GOBP CONNECTIVE TISSUE DEVELOPMENT
|
32
|
1.76e-03
|
2.72e-02
|
0.45000
|
0.292000
|
-0.342000
|
4.70e-03
|
9.40e-04
|
GOBP REGULATION OF TISSUE REMODELING
|
7
|
1.41e-01
|
3.58e-01
|
0.44900
|
0.145000
|
-0.425000
|
5.07e-01
|
5.20e-02
|
GOBP NEGATIVE REGULATION OF TRANSFERASE ACTIVITY
|
14
|
5.79e-02
|
2.17e-01
|
0.44900
|
0.276000
|
-0.354000
|
7.54e-02
|
2.27e-02
|
GOBP ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS
|
86
|
1.62e-13
|
2.92e-11
|
0.44800
|
-0.052800
|
0.445000
|
4.14e-01
|
3.41e-12
|
GOCC CELL CORTEX
|
30
|
2.15e-03
|
3.13e-02
|
0.44800
|
0.264000
|
-0.362000
|
1.35e-02
|
6.73e-04
|
GOMF OXIDOREDUCTASE ACTIVITY
|
134
|
6.39e-13
|
1.01e-10
|
0.44800
|
-0.218000
|
0.391000
|
3.66e-05
|
7.10e-14
|
GOBP POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION
|
6
|
1.60e-01
|
3.80e-01
|
0.44800
|
-0.112000
|
0.434000
|
6.36e-01
|
6.66e-02
|
GOCC PRESYNAPTIC MEMBRANE
|
8
|
1.56e-01
|
3.74e-01
|
0.44800
|
0.211000
|
-0.395000
|
3.04e-01
|
5.37e-02
|
GOBP NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY
|
7
|
9.98e-02
|
2.98e-01
|
0.44800
|
0.083500
|
-0.440000
|
7.03e-01
|
4.45e-02
|
GOBP FATTY ACYL COA METABOLIC PROCESS
|
6
|
1.17e-01
|
3.26e-01
|
0.44700
|
-0.445000
|
0.051200
|
6.00e-02
|
8.28e-01
|
GOBP FATTY ACID BETA OXIDATION
|
23
|
8.94e-03
|
7.81e-02
|
0.44600
|
-0.259000
|
0.363000
|
3.32e-02
|
2.77e-03
|
GOBP STEM CELL DEVELOPMENT
|
5
|
3.68e-01
|
5.92e-01
|
0.44600
|
0.344000
|
-0.283000
|
1.83e-01
|
2.74e-01
|
GOCC ER TO GOLGI TRANSPORT VESICLE MEMBRANE
|
6
|
1.15e-01
|
3.25e-01
|
0.44600
|
-0.046100
|
0.443000
|
8.46e-01
|
6.06e-02
|
GOBP REGULATION OF HORMONE METABOLIC PROCESS
|
5
|
3.49e-01
|
5.79e-01
|
0.44600
|
0.369000
|
-0.251000
|
1.54e-01
|
3.33e-01
|
GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY
|
9
|
3.28e-02
|
1.60e-01
|
0.44600
|
0.023700
|
-0.445000
|
9.03e-01
|
2.12e-02
|
GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY
|
7
|
2.11e-01
|
4.44e-01
|
0.44400
|
0.220000
|
-0.386000
|
3.16e-01
|
7.82e-02
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS
|
8
|
1.75e-01
|
4.01e-01
|
0.44300
|
-0.381000
|
0.226000
|
6.30e-02
|
2.70e-01
|
GOCC NEUROMUSCULAR JUNCTION
|
8
|
1.84e-01
|
4.12e-01
|
0.44300
|
0.239000
|
-0.373000
|
2.44e-01
|
6.88e-02
|
GOBP PROTEIN LOCALIZATION TO MITOCHONDRION
|
19
|
2.20e-02
|
1.27e-01
|
0.44200
|
-0.260000
|
0.358000
|
5.11e-02
|
7.34e-03
|
GOCC CILIARY MEMBRANE
|
6
|
1.09e-01
|
3.13e-01
|
0.44200
|
0.027500
|
-0.441000
|
9.07e-01
|
6.22e-02
|
GOBP REGULATION OF IMMUNE EFFECTOR PROCESS
|
13
|
4.93e-03
|
5.44e-02
|
0.44100
|
0.441000
|
0.017100
|
6.14e-03
|
9.16e-01
|
GOCC MITOCHONDRION
|
264
|
1.08e-21
|
2.92e-18
|
0.44100
|
-0.212000
|
0.387000
|
1.07e-07
|
9.28e-23
|
GOBP ENDODERM FORMATION
|
5
|
3.68e-01
|
5.92e-01
|
0.44000
|
0.262000
|
-0.354000
|
3.11e-01
|
1.72e-01
|
GOBP LYMPHOCYTE MIGRATION
|
5
|
3.66e-01
|
5.91e-01
|
0.44000
|
0.258000
|
-0.357000
|
3.19e-01
|
1.68e-01
|
GOBP REGULATION OF MAP KINASE ACTIVITY
|
9
|
1.63e-01
|
3.83e-01
|
0.44000
|
0.254000
|
-0.359000
|
1.89e-01
|
6.34e-02
|
GOCC CILIARY PLASM
|
5
|
2.48e-01
|
4.84e-01
|
0.43900
|
-0.128000
|
0.420000
|
6.21e-01
|
1.04e-01
|
GOBP PLATELET AGGREGATION
|
9
|
1.82e-01
|
4.09e-01
|
0.43900
|
-0.317000
|
0.303000
|
1.00e-01
|
1.17e-01
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS
|
9
|
1.40e-01
|
3.57e-01
|
0.43800
|
-0.383000
|
0.213000
|
4.76e-02
|
2.69e-01
|
GOBP CYTOCHROME COMPLEX ASSEMBLY
|
5
|
3.58e-01
|
5.88e-01
|
0.43800
|
-0.241000
|
0.366000
|
3.52e-01
|
1.57e-01
|
GOBP NEURON PROJECTION ORGANIZATION
|
11
|
1.23e-01
|
3.34e-01
|
0.43800
|
0.333000
|
-0.285000
|
5.71e-02
|
1.04e-01
|
GOMF TRANSCRIPTION COACTIVATOR BINDING
|
6
|
2.55e-01
|
4.87e-01
|
0.43800
|
0.391000
|
-0.197000
|
9.80e-02
|
4.05e-01
|
GOBP DENDRITIC CELL DIFFERENTIATION
|
7
|
4.49e-02
|
1.90e-01
|
0.43800
|
-0.061300
|
-0.433000
|
7.80e-01
|
4.77e-02
|
GOBP POSITIVE REGULATION OF WNT SIGNALING PATHWAY
|
17
|
2.18e-02
|
1.27e-01
|
0.43800
|
0.199000
|
-0.390000
|
1.58e-01
|
5.66e-03
|
GOBP REGULATION OF AXON EXTENSION
|
8
|
1.97e-01
|
4.29e-01
|
0.43700
|
0.244000
|
-0.363000
|
2.34e-01
|
7.64e-02
|
GOBP VIRAL RNA GENOME REPLICATION
|
5
|
3.89e-01
|
6.11e-01
|
0.43700
|
-0.297000
|
0.321000
|
2.52e-01
|
2.15e-01
|
GOBP REGULATION OF NUCLEOTIDE METABOLIC PROCESS
|
15
|
2.41e-02
|
1.35e-01
|
0.43700
|
0.406000
|
-0.162000
|
6.81e-03
|
2.82e-01
|
GOBP PROGESTERONE RECEPTOR SIGNALING PATHWAY
|
5
|
3.24e-01
|
5.60e-01
|
0.43700
|
0.199000
|
-0.389000
|
4.42e-01
|
1.33e-01
|
GOBP GLYCOSPHINGOLIPID METABOLIC PROCESS
|
7
|
2.10e-02
|
1.26e-01
|
0.43600
|
-0.384000
|
-0.208000
|
7.95e-02
|
3.43e-01
|
GOBP REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION
|
9
|
1.85e-01
|
4.13e-01
|
0.43600
|
-0.314000
|
0.303000
|
1.04e-01
|
1.17e-01
|
GOBP NEGATIVE REGULATION OF WNT SIGNALING PATHWAY
|
17
|
4.08e-02
|
1.79e-01
|
0.43600
|
0.333000
|
-0.281000
|
1.83e-02
|
4.61e-02
|
GOMF HYDROLASE ACTIVITY HYDROLYZING O GLYCOSYL COMPOUNDS
|
6
|
7.03e-02
|
2.44e-01
|
0.43500
|
-0.430000
|
-0.066000
|
6.88e-02
|
7.80e-01
|
GOBP ETHER METABOLIC PROCESS
|
6
|
1.55e-01
|
3.74e-01
|
0.43500
|
-0.427000
|
0.080100
|
7.08e-02
|
7.35e-01
|
GOBP GLYCEROL ETHER METABOLIC PROCESS
|
6
|
1.55e-01
|
3.74e-01
|
0.43500
|
-0.427000
|
0.080100
|
7.08e-02
|
7.35e-01
|
GOBP DENDRITIC SPINE MORPHOGENESIS
|
6
|
2.48e-01
|
4.84e-01
|
0.43400
|
0.182000
|
-0.394000
|
4.41e-01
|
9.55e-02
|
GOBP REGULATION OF DENDRITIC SPINE MORPHOGENESIS
|
6
|
2.48e-01
|
4.84e-01
|
0.43400
|
0.182000
|
-0.394000
|
4.41e-01
|
9.55e-02
|
GOBP EXTERNAL ENCAPSULATING STRUCTURE ORGANIZATION
|
14
|
7.17e-02
|
2.45e-01
|
0.43400
|
0.275000
|
-0.336000
|
7.69e-02
|
3.05e-02
|
GOMF TETRAPYRROLE BINDING
|
17
|
9.53e-04
|
1.75e-02
|
0.43400
|
0.034100
|
0.432000
|
8.09e-01
|
2.15e-03
|
GOBP REGULATION OF TRANSMEMBRANE TRANSPORT
|
33
|
1.05e-03
|
1.88e-02
|
0.43300
|
0.216000
|
-0.376000
|
3.43e-02
|
2.19e-04
|
GOBP SULFUR COMPOUND TRANSPORT
|
12
|
1.09e-01
|
3.13e-01
|
0.43300
|
0.320000
|
-0.292000
|
5.62e-02
|
8.14e-02
|
GOBP POSITIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS
|
5
|
2.21e-01
|
4.58e-01
|
0.43300
|
-0.424000
|
0.088900
|
1.02e-01
|
7.31e-01
|
GOBP CALCIUM ION TRANSPORT
|
32
|
3.01e-03
|
3.94e-02
|
0.43200
|
0.320000
|
-0.290000
|
1.93e-03
|
5.08e-03
|
GOBP ORGAN GROWTH
|
18
|
2.27e-02
|
1.30e-01
|
0.43200
|
0.212000
|
-0.376000
|
1.23e-01
|
6.02e-03
|
GOMF AMYLOID BETA BINDING
|
12
|
6.13e-02
|
2.24e-01
|
0.43200
|
0.395000
|
-0.175000
|
1.85e-02
|
2.96e-01
|
GOBP REGULATION OF CARTILAGE DEVELOPMENT
|
7
|
2.12e-01
|
4.46e-01
|
0.43200
|
0.194000
|
-0.386000
|
3.76e-01
|
7.82e-02
|
GOBP DIGESTIVE SYSTEM DEVELOPMENT
|
13
|
3.96e-02
|
1.77e-01
|
0.43100
|
0.152000
|
-0.404000
|
3.46e-01
|
1.21e-02
|
GOBP ENDOCARDIAL CUSHION DEVELOPMENT
|
6
|
3.34e-01
|
5.72e-01
|
0.43100
|
0.312000
|
-0.297000
|
1.88e-01
|
2.09e-01
|
GOBP CELLULAR RESPONSE TO TOXIC SUBSTANCE
|
22
|
1.37e-02
|
9.87e-02
|
0.43100
|
-0.239000
|
0.358000
|
5.41e-02
|
3.93e-03
|
GOBP UNSATURATED FATTY ACID METABOLIC PROCESS
|
26
|
2.86e-03
|
3.85e-02
|
0.43000
|
-0.181000
|
0.391000
|
1.14e-01
|
6.32e-04
|
GOBP MICROTUBULE ORGANIZING CENTER LOCALIZATION
|
6
|
1.73e-01
|
3.99e-01
|
0.43000
|
0.094300
|
-0.419000
|
6.90e-01
|
7.60e-02
|
GOBP MITOCHONDRIAL GENE EXPRESSION
|
17
|
4.02e-02
|
1.77e-01
|
0.43000
|
-0.256000
|
0.346000
|
6.98e-02
|
1.42e-02
|
GOBP CANONICAL WNT SIGNALING PATHWAY
|
28
|
4.45e-03
|
5.06e-02
|
0.43000
|
0.240000
|
-0.357000
|
2.98e-02
|
1.21e-03
|
GOBP RHO PROTEIN SIGNAL TRANSDUCTION
|
16
|
2.74e-02
|
1.44e-01
|
0.43000
|
0.183000
|
-0.389000
|
2.09e-01
|
7.37e-03
|
GOBP POSITIVE REGULATION OF RNA SPLICING
|
6
|
2.23e-01
|
4.58e-01
|
0.42900
|
0.404000
|
-0.146000
|
8.77e-02
|
5.37e-01
|
GOBP CELL REDOX HOMEOSTASIS
|
6
|
3.22e-01
|
5.56e-01
|
0.42900
|
-0.343000
|
0.258000
|
1.47e-01
|
2.76e-01
|
GOBP CELL ADHESION MEDIATED BY INTEGRIN
|
6
|
2.29e-01
|
4.63e-01
|
0.42900
|
0.152000
|
-0.401000
|
5.19e-01
|
8.96e-02
|
GOBP REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT
|
22
|
1.28e-02
|
9.50e-02
|
0.42900
|
0.228000
|
-0.363000
|
6.62e-02
|
3.42e-03
|
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE
|
10
|
3.78e-02
|
1.72e-01
|
0.42900
|
0.050200
|
-0.426000
|
7.84e-01
|
2.01e-02
|
GOMF GROWTH FACTOR BINDING
|
13
|
9.56e-02
|
2.90e-01
|
0.42800
|
0.315000
|
-0.291000
|
5.07e-02
|
7.09e-02
|
GOBP REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY
|
5
|
8.94e-02
|
2.82e-01
|
0.42800
|
0.408000
|
0.130000
|
1.15e-01
|
6.15e-01
|
GOBP ERYTHROCYTE HOMEOSTASIS
|
15
|
3.62e-03
|
4.44e-02
|
0.42800
|
0.006590
|
0.428000
|
9.65e-01
|
4.32e-03
|
GOBP NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS
|
5
|
4.03e-01
|
6.25e-01
|
0.42800
|
-0.322000
|
0.282000
|
2.14e-01
|
2.77e-01
|
GOBP REGULATION OF DENDRITE DEVELOPMENT
|
11
|
4.00e-02
|
1.77e-01
|
0.42700
|
0.087500
|
-0.418000
|
6.17e-01
|
1.68e-02
|
GOMF PHOSPHORIC DIESTER HYDROLASE ACTIVITY
|
6
|
2.15e-01
|
4.50e-01
|
0.42700
|
0.134000
|
-0.406000
|
5.72e-01
|
8.62e-02
|
GOBP NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY
|
16
|
5.75e-02
|
2.17e-01
|
0.42700
|
0.305000
|
-0.299000
|
3.56e-02
|
3.99e-02
|
GOBP NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION
|
6
|
4.32e-02
|
1.86e-01
|
0.42700
|
0.379000
|
0.196000
|
1.09e-01
|
4.07e-01
|
GOBP REGULATION OF STEROID BIOSYNTHETIC PROCESS
|
10
|
1.31e-01
|
3.45e-01
|
0.42600
|
0.368000
|
-0.215000
|
4.46e-02
|
2.41e-01
|
GOCC OUTER MITOCHONDRIAL MEMBRANE PROTEIN COMPLEX
|
5
|
4.01e-01
|
6.23e-01
|
0.42600
|
-0.268000
|
0.331000
|
3.00e-01
|
2.01e-01
|
GOBP ACYL COA METABOLIC PROCESS
|
20
|
2.84e-02
|
1.47e-01
|
0.42600
|
-0.319000
|
0.282000
|
1.44e-02
|
3.01e-02
|
GOBP TETRAPYRROLE BIOSYNTHETIC PROCESS
|
7
|
5.72e-02
|
2.17e-01
|
0.42600
|
0.047700
|
0.423000
|
8.28e-01
|
5.33e-02
|
GOBP T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE
|
6
|
1.53e-01
|
3.74e-01
|
0.42500
|
0.421000
|
-0.061300
|
7.50e-02
|
7.95e-01
|
GOBP RESPONSE TO EPIDERMAL GROWTH FACTOR
|
7
|
2.53e-01
|
4.87e-01
|
0.42500
|
0.360000
|
-0.227000
|
1.01e-01
|
3.00e-01
|
GOBP POSITIVE REGULATION OF ENDOCYTOSIS
|
18
|
4.14e-02
|
1.80e-01
|
0.42500
|
0.312000
|
-0.289000
|
2.29e-02
|
3.53e-02
|
GOBP LEUKOCYTE PROLIFERATION
|
10
|
1.01e-02
|
8.42e-02
|
0.42500
|
0.410000
|
0.111000
|
2.53e-02
|
5.44e-01
|
GOBP REGULATION OF SYSTEM PROCESS
|
40
|
8.04e-04
|
1.62e-02
|
0.42300
|
0.334000
|
-0.260000
|
3.09e-04
|
5.06e-03
|
GOBP POSITIVE REGULATION OF CELL GROWTH
|
13
|
8.19e-02
|
2.68e-01
|
0.42300
|
0.228000
|
-0.356000
|
1.56e-01
|
2.69e-02
|
GOBP STEROL BIOSYNTHETIC PROCESS
|
9
|
1.82e-01
|
4.09e-01
|
0.42300
|
0.350000
|
-0.237000
|
6.97e-02
|
2.20e-01
|
GOCC EXTERNAL ENCAPSULATING STRUCTURE
|
20
|
5.61e-03
|
5.80e-02
|
0.42200
|
0.118000
|
-0.405000
|
3.66e-01
|
1.83e-03
|
GOCC A BAND
|
5
|
3.65e-01
|
5.91e-01
|
0.42100
|
0.207000
|
-0.367000
|
4.25e-01
|
1.56e-01
|
GOBP PROSTANOID METABOLIC PROCESS
|
9
|
1.99e-01
|
4.32e-01
|
0.42100
|
-0.332000
|
0.260000
|
8.62e-02
|
1.79e-01
|
GOBP PROTEIN AUTOPHOSPHORYLATION
|
11
|
1.47e-01
|
3.68e-01
|
0.42000
|
0.283000
|
-0.311000
|
1.06e-01
|
7.58e-02
|
GOBP REGULATION OF MEMBRANE PERMEABILITY
|
9
|
3.72e-02
|
1.70e-01
|
0.42000
|
0.009840
|
0.420000
|
9.59e-01
|
2.96e-02
|
GOMF ACYLGLYCEROL O ACYLTRANSFERASE ACTIVITY
|
5
|
3.71e-01
|
5.93e-01
|
0.42000
|
0.210000
|
-0.364000
|
4.18e-01
|
1.60e-01
|
GOMF N ACYLTRANSFERASE ACTIVITY
|
7
|
2.32e-02
|
1.32e-01
|
0.41900
|
0.278000
|
0.314000
|
2.04e-01
|
1.52e-01
|
GOMF SINGLE STRANDED DNA BINDING
|
7
|
2.94e-01
|
5.27e-01
|
0.41900
|
-0.317000
|
0.274000
|
1.47e-01
|
2.11e-01
|
GOBP ORGANIC ACID METABOLIC PROCESS
|
153
|
1.49e-12
|
2.02e-10
|
0.41900
|
-0.208000
|
0.364000
|
2.94e-05
|
1.79e-13
|
GOBP ALDEHYDE METABOLIC PROCESS
|
15
|
3.74e-02
|
1.70e-01
|
0.41900
|
-0.169000
|
0.383000
|
2.61e-01
|
1.06e-02
|
GOMF SMAD BINDING
|
11
|
1.50e-01
|
3.72e-01
|
0.41800
|
0.304000
|
-0.287000
|
8.19e-02
|
1.01e-01
|
GOCC CLATHRIN COATED PIT
|
7
|
2.99e-01
|
5.32e-01
|
0.41800
|
0.293000
|
-0.299000
|
1.81e-01
|
1.73e-01
|
GOBP STRIATED MUSCLE CELL PROLIFERATION
|
7
|
2.96e-01
|
5.30e-01
|
0.41800
|
0.277000
|
-0.314000
|
2.06e-01
|
1.52e-01
|
GOBP KIDNEY EPITHELIUM DEVELOPMENT
|
15
|
6.15e-02
|
2.24e-01
|
0.41800
|
0.349000
|
-0.230000
|
1.98e-02
|
1.26e-01
|
GOCC BASAL PART OF CELL
|
38
|
9.16e-04
|
1.72e-02
|
0.41800
|
0.226000
|
-0.351000
|
1.75e-02
|
2.17e-04
|
GOMF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
14
|
9.11e-02
|
2.84e-01
|
0.41700
|
0.283000
|
-0.306000
|
6.79e-02
|
4.84e-02
|
GOBP REGULATION OF AUTOPHAGY OF MITOCHONDRION
|
8
|
1.53e-01
|
3.74e-01
|
0.41700
|
-0.145000
|
0.391000
|
4.80e-01
|
5.61e-02
|
GOBP PROTEIN DEPOLYMERIZATION
|
9
|
1.62e-01
|
3.81e-01
|
0.41700
|
0.194000
|
-0.369000
|
3.14e-01
|
5.63e-02
|
GOBP REGULATION OF PROTEIN DEPOLYMERIZATION
|
9
|
1.62e-01
|
3.81e-01
|
0.41700
|
0.194000
|
-0.369000
|
3.14e-01
|
5.63e-02
|
GOBP AMYLOID BETA CLEARANCE
|
5
|
4.20e-01
|
6.39e-01
|
0.41700
|
0.270000
|
-0.317000
|
2.97e-01
|
2.20e-01
|
GOMF HISTONE BINDING
|
20
|
1.49e-02
|
1.04e-01
|
0.41600
|
0.176000
|
-0.377000
|
1.77e-01
|
3.77e-03
|
GOBP ENDOTHELIAL CELL DEVELOPMENT
|
6
|
1.54e-01
|
3.74e-01
|
0.41600
|
-0.413000
|
0.045000
|
8.03e-02
|
8.49e-01
|
GOCC PLASMA MEMBRANE REGION
|
111
|
8.65e-09
|
7.30e-07
|
0.41600
|
0.241000
|
-0.339000
|
2.67e-05
|
2.87e-09
|
GOBP POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION
|
31
|
1.14e-03
|
2.02e-02
|
0.41500
|
0.159000
|
-0.384000
|
1.29e-01
|
2.54e-04
|
GOBP XENOBIOTIC TRANSMEMBRANE TRANSPORT
|
5
|
2.57e-01
|
4.89e-01
|
0.41500
|
0.091800
|
-0.405000
|
7.23e-01
|
1.18e-01
|
GOBP REGULATION OF GLUCONEOGENESIS
|
10
|
1.23e-01
|
3.35e-01
|
0.41500
|
0.375000
|
-0.178000
|
4.09e-02
|
3.31e-01
|
GOBP REGULATION OF CANONICAL WNT SIGNALING PATHWAY
|
26
|
9.93e-03
|
8.38e-02
|
0.41400
|
0.238000
|
-0.339000
|
3.75e-02
|
3.01e-03
|
GOBP REGULATION OF BIOMINERAL TISSUE DEVELOPMENT
|
9
|
2.09e-01
|
4.43e-01
|
0.41400
|
0.255000
|
-0.326000
|
1.87e-01
|
9.16e-02
|
GOMF UBIQUITIN LIKE PROTEIN CONJUGATING ENZYME BINDING
|
5
|
3.45e-01
|
5.76e-01
|
0.41300
|
0.169000
|
-0.377000
|
5.13e-01
|
1.46e-01
|
GOCC TERTIARY GRANULE
|
16
|
5.46e-02
|
2.11e-01
|
0.41300
|
-0.346000
|
0.226000
|
1.73e-02
|
1.20e-01
|
GOBP NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT
|
11
|
1.53e-01
|
3.74e-01
|
0.41300
|
0.318000
|
-0.264000
|
6.92e-02
|
1.32e-01
|
GOCC I BAND
|
12
|
6.55e-02
|
2.33e-01
|
0.41300
|
0.146000
|
-0.386000
|
3.85e-01
|
2.11e-02
|
GOBP POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS
|
5
|
3.90e-01
|
6.12e-01
|
0.41200
|
0.354000
|
-0.212000
|
1.72e-01
|
4.12e-01
|
GOBP ATP BIOSYNTHETIC PROCESS
|
35
|
3.85e-07
|
2.36e-05
|
0.41200
|
0.101000
|
0.400000
|
3.09e-01
|
5.20e-05
|
GOBP RESPONSE TO CALCIUM ION
|
12
|
1.32e-01
|
3.45e-01
|
0.41200
|
0.315000
|
-0.266000
|
6.04e-02
|
1.12e-01
|
GOBP RESPONSE TO TOXIC SUBSTANCE
|
33
|
3.36e-03
|
4.30e-02
|
0.41200
|
-0.242000
|
0.333000
|
1.74e-02
|
1.06e-03
|
GOBP RESPONSE TO AXON INJURY
|
7
|
3.07e-01
|
5.41e-01
|
0.41100
|
-0.313000
|
0.266000
|
1.53e-01
|
2.24e-01
|
GOBP RENAL TUBULE DEVELOPMENT
|
10
|
1.34e-01
|
3.48e-01
|
0.41100
|
0.367000
|
-0.184000
|
4.51e-02
|
3.16e-01
|
GOBP PROTEIN TARGETING TO MITOCHONDRION
|
17
|
3.63e-02
|
1.67e-01
|
0.41000
|
-0.191000
|
0.363000
|
1.76e-01
|
1.00e-02
|
GOBP RECEPTOR LOCALIZATION TO SYNAPSE
|
7
|
1.71e-01
|
3.95e-01
|
0.41000
|
0.106000
|
-0.396000
|
6.29e-01
|
7.06e-02
|
GOBP POSITIVE REGULATION OF GROWTH
|
16
|
5.38e-02
|
2.09e-01
|
0.40900
|
0.214000
|
-0.349000
|
1.41e-01
|
1.63e-02
|
GOMF PEPTIDASE INHIBITOR ACTIVITY
|
12
|
1.39e-01
|
3.55e-01
|
0.40900
|
0.301000
|
-0.277000
|
7.28e-02
|
9.81e-02
|
GOBP RETINA DEVELOPMENT IN CAMERA TYPE EYE
|
11
|
1.58e-01
|
3.78e-01
|
0.40800
|
0.319000
|
-0.256000
|
6.86e-02
|
1.44e-01
|
GOBP NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS
|
20
|
2.49e-02
|
1.37e-01
|
0.40800
|
0.206000
|
-0.352000
|
1.14e-01
|
6.75e-03
|
GOCC ORGANELLAR RIBOSOME
|
13
|
1.19e-01
|
3.29e-01
|
0.40800
|
-0.298000
|
0.279000
|
6.45e-02
|
8.31e-02
|
GOBP AXON EXTENSION
|
10
|
1.96e-01
|
4.27e-01
|
0.40700
|
0.280000
|
-0.296000
|
1.27e-01
|
1.07e-01
|
GOMF MONOATOMIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
15
|
7.12e-02
|
2.44e-01
|
0.40700
|
0.340000
|
-0.223000
|
2.33e-02
|
1.37e-01
|
GOMF KINASE INHIBITOR ACTIVITY
|
8
|
1.30e-01
|
3.43e-01
|
0.40600
|
0.094600
|
-0.395000
|
6.44e-01
|
5.41e-02
|
GOBP CARBOHYDRATE BIOSYNTHETIC PROCESS
|
26
|
6.10e-03
|
6.15e-02
|
0.40600
|
0.365000
|
-0.177000
|
1.41e-03
|
1.22e-01
|
GOMF POTASSIUM CHANNEL ACTIVITY
|
8
|
2.02e-01
|
4.36e-01
|
0.40600
|
0.366000
|
-0.174000
|
7.39e-02
|
3.95e-01
|
GOBP TYPE I INTERFERON PRODUCTION
|
7
|
3.05e-01
|
5.39e-01
|
0.40500
|
-0.327000
|
0.239000
|
1.35e-01
|
2.75e-01
|
GOBP NEGATIVE REGULATION OF MAPK CASCADE
|
19
|
4.72e-02
|
1.95e-01
|
0.40500
|
0.275000
|
-0.298000
|
3.94e-02
|
2.58e-02
|
GOBP MODIFIED AMINO ACID TRANSPORT
|
7
|
2.98e-01
|
5.31e-01
|
0.40500
|
0.334000
|
-0.229000
|
1.27e-01
|
2.95e-01
|
GOBP REGULATED EXOCYTOSIS
|
10
|
1.24e-01
|
3.36e-01
|
0.40500
|
0.159000
|
-0.373000
|
3.87e-01
|
4.21e-02
|
GOCC MITOCHONDRIAL ENVELOPE
|
135
|
8.73e-14
|
1.69e-11
|
0.40500
|
-0.109000
|
0.390000
|
3.77e-02
|
7.41e-14
|
GOBP MYELOID CELL HOMEOSTASIS
|
17
|
3.73e-03
|
4.49e-02
|
0.40500
|
-0.000874
|
0.405000
|
9.95e-01
|
4.07e-03
|
GOBP REGULATION OF ATP BIOSYNTHETIC PROCESS
|
6
|
2.36e-01
|
4.69e-01
|
0.40500
|
0.389000
|
-0.113000
|
1.00e-01
|
6.33e-01
|
GOBP REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS
|
6
|
2.36e-01
|
4.69e-01
|
0.40500
|
0.389000
|
-0.113000
|
1.00e-01
|
6.33e-01
|
GOBP REGULATION OF GLUCOSE METABOLIC PROCESS
|
21
|
3.20e-02
|
1.58e-01
|
0.40500
|
0.317000
|
-0.252000
|
1.27e-02
|
4.75e-02
|
GOBP RECOMBINATIONAL REPAIR
|
11
|
1.60e-01
|
3.80e-01
|
0.40500
|
0.245000
|
-0.322000
|
1.61e-01
|
6.59e-02
|
GOMF PHOSPHOLIPASE ACTIVITY
|
11
|
1.32e-02
|
9.65e-02
|
0.40400
|
-0.076900
|
-0.397000
|
6.61e-01
|
2.32e-02
|
GOMF ATP DEPENDENT ACTIVITY ACTING ON DNA
|
10
|
1.27e-01
|
3.39e-01
|
0.40400
|
0.161000
|
-0.371000
|
3.81e-01
|
4.30e-02
|
GOBP ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE
|
6
|
4.99e-02
|
2.01e-01
|
0.40400
|
0.305000
|
0.266000
|
1.97e-01
|
2.61e-01
|
GOBP ANTIMICROBIAL HUMORAL RESPONSE
|
6
|
4.99e-02
|
2.01e-01
|
0.40400
|
0.305000
|
0.266000
|
1.97e-01
|
2.61e-01
|
GOBP MICROTUBULE POLYMERIZATION
|
6
|
4.97e-02
|
2.01e-01
|
0.40400
|
-0.291000
|
-0.281000
|
2.19e-01
|
2.35e-01
|
GOCC TELOMERASE HOLOENZYME COMPLEX
|
5
|
2.91e-01
|
5.25e-01
|
0.40400
|
-0.391000
|
0.103000
|
1.31e-01
|
6.91e-01
|
GOBP CARDIAC MUSCLE CELL PROLIFERATION
|
5
|
4.22e-01
|
6.39e-01
|
0.40400
|
0.226000
|
-0.334000
|
3.82e-01
|
1.97e-01
|
GOBP REGULATION OF EMBRYONIC DEVELOPMENT
|
7
|
1.08e-01
|
3.12e-01
|
0.40400
|
0.403000
|
-0.013800
|
6.54e-02
|
9.50e-01
|
GOBP REGULATION OF AXONOGENESIS
|
12
|
9.39e-02
|
2.88e-01
|
0.40300
|
0.173000
|
-0.364000
|
3.02e-01
|
2.98e-02
|
GOBP STRESS GRANULE ASSEMBLY
|
6
|
3.52e-01
|
5.82e-01
|
0.40300
|
-0.221000
|
0.337000
|
3.50e-01
|
1.54e-01
|
GOBP REGULATION OF RESPONSE TO WOUNDING
|
11
|
5.51e-02
|
2.12e-01
|
0.40300
|
0.077600
|
-0.395000
|
6.57e-01
|
2.39e-02
|
GOBP NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS
|
37
|
3.15e-07
|
1.98e-05
|
0.40200
|
0.102000
|
0.389000
|
2.88e-01
|
5.17e-05
|
GOBP POSITIVE REGULATION OF CYTOKINESIS
|
6
|
1.35e-01
|
3.49e-01
|
0.40200
|
-0.007090
|
-0.402000
|
9.76e-01
|
8.88e-02
|
GOBP NEGATIVE REGULATION OF CELL CELL ADHESION
|
10
|
9.85e-02
|
2.96e-01
|
0.40200
|
0.384000
|
-0.119000
|
3.62e-02
|
5.17e-01
|
GOBP POSITIVE REGULATION OF PROTEOLYSIS
|
18
|
5.30e-02
|
2.07e-01
|
0.40200
|
0.245000
|
-0.318000
|
7.37e-02
|
2.02e-02
|
GOBP MODIFIED AMINO ACID METABOLIC PROCESS
|
31
|
5.57e-03
|
5.80e-02
|
0.40100
|
-0.225000
|
0.332000
|
3.21e-02
|
1.55e-03
|
GOBP REGULATION OF NEURON PROJECTION DEVELOPMENT
|
41
|
2.01e-04
|
5.12e-03
|
0.40100
|
0.145000
|
-0.374000
|
1.14e-01
|
4.43e-05
|
GOBP PROTEIN FOLDING
|
25
|
5.55e-03
|
5.80e-02
|
0.40100
|
-0.372000
|
0.148000
|
1.40e-03
|
2.05e-01
|
GOBP LIPID HOMEOSTASIS
|
27
|
1.49e-02
|
1.04e-01
|
0.40000
|
0.289000
|
-0.277000
|
1.02e-02
|
1.35e-02
|
GOBP ESTABLISHMENT OF CELL POLARITY
|
12
|
1.52e-01
|
3.74e-01
|
0.40000
|
0.277000
|
-0.289000
|
9.81e-02
|
8.49e-02
|
GOBP CELLULAR RESPONSE TO OSMOTIC STRESS
|
10
|
1.74e-01
|
3.99e-01
|
0.40000
|
0.341000
|
-0.210000
|
6.31e-02
|
2.53e-01
|
GOBP FOREBRAIN GENERATION OF NEURONS
|
6
|
2.05e-01
|
4.38e-01
|
0.40000
|
-0.072800
|
0.393000
|
7.58e-01
|
9.62e-02
|
GOBP ZYMOGEN ACTIVATION
|
6
|
2.49e-01
|
4.84e-01
|
0.40000
|
0.115000
|
-0.383000
|
6.26e-01
|
1.05e-01
|
GOBP GASTRULATION
|
15
|
7.13e-02
|
2.44e-01
|
0.40000
|
0.205000
|
-0.343000
|
1.72e-01
|
2.22e-02
|
GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX
|
9
|
2.58e-02
|
1.39e-01
|
0.40000
|
0.104000
|
0.386000
|
5.90e-01
|
4.58e-02
|
GOBP LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE
|
11
|
1.51e-01
|
3.74e-01
|
0.39900
|
0.336000
|
-0.215000
|
5.45e-02
|
2.19e-01
|
GOMF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY
|
21
|
1.84e-02
|
1.16e-01
|
0.39900
|
0.174000
|
-0.359000
|
1.71e-01
|
4.71e-03
|
GOBP ORGANELLE TRANSPORT ALONG MICROTUBULE
|
7
|
2.53e-01
|
4.87e-01
|
0.39900
|
-0.362000
|
0.167000
|
9.79e-02
|
4.47e-01
|
GOBP POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY
|
11
|
1.77e-01
|
4.03e-01
|
0.39800
|
0.300000
|
-0.262000
|
8.58e-02
|
1.35e-01
|
GOBP POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE
|
12
|
1.46e-01
|
3.67e-01
|
0.39800
|
0.313000
|
-0.246000
|
6.16e-02
|
1.43e-01
|
GOCC 9PLUS2 MOTILE CILIUM
|
8
|
2.78e-01
|
5.09e-01
|
0.39800
|
-0.246000
|
0.312000
|
2.29e-01
|
1.27e-01
|
GOBP REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY
|
8
|
3.39e-02
|
1.61e-01
|
0.39800
|
0.132000
|
0.375000
|
5.19e-01
|
6.71e-02
|
GOMF INORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
23
|
2.71e-02
|
1.43e-01
|
0.39800
|
0.307000
|
-0.252000
|
1.14e-02
|
3.79e-02
|
GOMF SERINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY
|
5
|
4.13e-01
|
6.32e-01
|
0.39700
|
0.200000
|
-0.343000
|
4.39e-01
|
1.85e-01
|
GOBP RESPONSE TO COPPER ION
|
5
|
1.37e-01
|
3.51e-01
|
0.39700
|
0.098000
|
0.385000
|
7.05e-01
|
1.37e-01
|
GOBP CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE
|
12
|
6.53e-02
|
2.33e-01
|
0.39700
|
0.380000
|
-0.114000
|
2.33e-02
|
4.95e-01
|
GOBP REGULATION OF WOUND HEALING
|
7
|
8.33e-02
|
2.71e-01
|
0.39600
|
-0.045400
|
-0.394000
|
8.36e-01
|
7.21e-02
|
GOBP REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION
|
9
|
2.36e-01
|
4.69e-01
|
0.39600
|
0.239000
|
-0.316000
|
2.16e-01
|
1.02e-01
|
GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE
|
8
|
2.88e-01
|
5.20e-01
|
0.39600
|
0.258000
|
-0.300000
|
2.08e-01
|
1.43e-01
|
GOMF HEXOSYLTRANSFERASE ACTIVITY
|
13
|
3.51e-03
|
4.43e-02
|
0.39600
|
-0.363000
|
-0.158000
|
2.43e-02
|
3.26e-01
|
GOBP CARDIAC MUSCLE CELL DIFFERENTIATION
|
11
|
1.19e-01
|
3.29e-01
|
0.39500
|
0.163000
|
-0.360000
|
3.51e-01
|
3.94e-02
|
GOBP MONOSACCHARIDE BIOSYNTHETIC PROCESS
|
18
|
4.51e-03
|
5.09e-02
|
0.39500
|
0.395000
|
-0.017200
|
3.95e-03
|
9.01e-01
|
GOBP RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS
|
38
|
3.95e-07
|
2.37e-05
|
0.39500
|
0.098100
|
0.383000
|
3.03e-01
|
5.50e-05
|
GOBP REGULATION OF LEUKOCYTE PROLIFERATION
|
9
|
2.13e-02
|
1.26e-01
|
0.39500
|
0.367000
|
0.147000
|
5.77e-02
|
4.46e-01
|
GOBP IMPORT ACROSS PLASMA MEMBRANE
|
22
|
3.43e-02
|
1.62e-01
|
0.39500
|
0.298000
|
-0.259000
|
1.65e-02
|
3.70e-02
|
GOMF STEROL TRANSFER ACTIVITY
|
8
|
2.05e-01
|
4.38e-01
|
0.39500
|
0.363000
|
-0.155000
|
7.66e-02
|
4.48e-01
|
GOCC PLATELET ALPHA GRANULE
|
7
|
2.62e-01
|
4.96e-01
|
0.39500
|
0.166000
|
-0.358000
|
4.47e-01
|
1.02e-01
|
GOBP REGULATION OF EXOCYTOSIS
|
6
|
3.80e-01
|
6.00e-01
|
0.39500
|
0.232000
|
-0.319000
|
3.27e-01
|
1.77e-01
|
GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY
|
20
|
4.02e-02
|
1.77e-01
|
0.39400
|
0.322000
|
-0.228000
|
1.34e-02
|
7.95e-02
|
GOBP REGULATION OF OSSIFICATION
|
9
|
1.25e-01
|
3.37e-01
|
0.39400
|
0.106000
|
-0.380000
|
5.83e-01
|
4.92e-02
|
GOBP RNA EXPORT FROM NUCLEUS
|
8
|
1.67e-01
|
3.88e-01
|
0.39400
|
0.115000
|
-0.377000
|
5.74e-01
|
6.58e-02
|
GOBP DENDRITIC SPINE DEVELOPMENT
|
8
|
2.19e-01
|
4.54e-01
|
0.39400
|
0.167000
|
-0.357000
|
4.16e-01
|
8.17e-02
|
GOBP PROTEIN ACETYLATION
|
5
|
9.35e-02
|
2.88e-01
|
0.39400
|
0.295000
|
0.260000
|
2.54e-01
|
3.14e-01
|
GOBP PROTEIN ACYLATION
|
5
|
9.35e-02
|
2.88e-01
|
0.39400
|
0.295000
|
0.260000
|
2.54e-01
|
3.14e-01
|
GOBP SKELETAL SYSTEM MORPHOGENESIS
|
19
|
5.66e-02
|
2.16e-01
|
0.39300
|
0.274000
|
-0.283000
|
4.04e-02
|
3.42e-02
|
GOBP REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE
|
21
|
2.90e-02
|
1.50e-01
|
0.39300
|
0.336000
|
-0.204000
|
8.16e-03
|
1.08e-01
|
GOCC TERMINAL BOUTON
|
5
|
1.74e-01
|
3.99e-01
|
0.39200
|
0.390000
|
0.047100
|
1.32e-01
|
8.56e-01
|
GOBP ROOF OF MOUTH DEVELOPMENT
|
8
|
2.23e-01
|
4.59e-01
|
0.39200
|
0.168000
|
-0.354000
|
4.12e-01
|
8.36e-02
|
GOBP RESPONSE TO FOOD
|
5
|
3.62e-01
|
5.89e-01
|
0.39200
|
0.365000
|
-0.142000
|
1.58e-01
|
5.83e-01
|
GOBP ORGANIC ACID BIOSYNTHETIC PROCESS
|
55
|
2.26e-04
|
5.55e-03
|
0.39200
|
-0.233000
|
0.315000
|
3.42e-03
|
7.46e-05
|
GOBP PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY
|
6
|
3.96e-01
|
6.17e-01
|
0.39200
|
0.247000
|
-0.304000
|
2.97e-01
|
1.98e-01
|
GOBP NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION
|
5
|
3.59e-01
|
5.88e-01
|
0.39100
|
0.138000
|
-0.366000
|
5.93e-01
|
1.57e-01
|
GOBP REGULATION OF CELL MORPHOGENESIS
|
27
|
6.98e-03
|
6.68e-02
|
0.39100
|
0.168000
|
-0.353000
|
1.35e-01
|
1.64e-03
|
GOBP INTRACELLULAR LIPID TRANSPORT
|
6
|
3.10e-01
|
5.43e-01
|
0.39100
|
0.360000
|
-0.153000
|
1.28e-01
|
5.17e-01
|
GOBP TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY
|
20
|
2.64e-02
|
1.41e-01
|
0.39100
|
0.173000
|
-0.351000
|
1.85e-01
|
7.01e-03
|
GOBP MACROPHAGE ACTIVATION
|
5
|
1.06e-01
|
3.09e-01
|
0.39100
|
0.337000
|
0.198000
|
1.93e-01
|
4.44e-01
|
GOBP REGULATION OF MACROPHAGE ACTIVATION
|
5
|
1.06e-01
|
3.09e-01
|
0.39100
|
0.337000
|
0.198000
|
1.93e-01
|
4.44e-01
|
GOBP REGULATION OF CELL SIZE
|
18
|
5.90e-02
|
2.19e-01
|
0.39000
|
0.227000
|
-0.318000
|
9.82e-02
|
2.05e-02
|
GOBP REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION
|
6
|
6.14e-02
|
2.24e-01
|
0.39000
|
-0.295000
|
-0.255000
|
2.12e-01
|
2.81e-01
|
GOBP NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH
|
12
|
1.52e-01
|
3.74e-01
|
0.39000
|
0.316000
|
-0.228000
|
5.91e-02
|
1.74e-01
|
GOBP ERK1 AND ERK2 CASCADE
|
26
|
2.05e-02
|
1.24e-01
|
0.39000
|
0.297000
|
-0.253000
|
9.50e-03
|
2.71e-02
|
GOBP EXOCYTOSIS
|
18
|
4.43e-02
|
1.89e-01
|
0.39000
|
0.187000
|
-0.342000
|
1.73e-01
|
1.26e-02
|
GOBP CELLULAR RESPONSE TO NUTRIENT
|
11
|
1.81e-01
|
4.08e-01
|
0.39000
|
0.233000
|
-0.312000
|
1.83e-01
|
7.41e-02
|
GOCC MULTIVESICULAR BODY
|
12
|
6.00e-02
|
2.21e-01
|
0.38900
|
0.091100
|
-0.379000
|
5.87e-01
|
2.38e-02
|
GOBP RESPONSE TO ELECTRICAL STIMULUS
|
5
|
4.41e-01
|
6.56e-01
|
0.38900
|
-0.210000
|
0.328000
|
4.17e-01
|
2.06e-01
|
GOBP GENERATION OF PRECURSOR METABOLITES AND ENERGY
|
101
|
6.73e-13
|
1.01e-10
|
0.38900
|
-0.015200
|
0.389000
|
8.01e-01
|
6.28e-11
|
GOBP NEGATIVE REGULATION OF CELL ADHESION
|
18
|
6.54e-02
|
2.33e-01
|
0.38900
|
0.304000
|
-0.242000
|
2.66e-02
|
7.75e-02
|
GOBP HEART PROCESS
|
21
|
2.95e-02
|
1.51e-01
|
0.38900
|
0.195000
|
-0.336000
|
1.25e-01
|
8.13e-03
|
GOCC CELL LEADING EDGE
|
47
|
8.95e-04
|
1.71e-02
|
0.38900
|
0.238000
|
-0.307000
|
5.65e-03
|
3.35e-04
|
GOBP REGULATION OF STEROID METABOLIC PROCESS
|
12
|
1.35e-01
|
3.49e-01
|
0.38800
|
0.334000
|
-0.199000
|
4.63e-02
|
2.35e-01
|
GOBP DNA RECOMBINATION
|
13
|
1.29e-01
|
3.43e-01
|
0.38800
|
0.222000
|
-0.319000
|
1.68e-01
|
4.77e-02
|
GOBP CALCIUM ION TRANSMEMBRANE TRANSPORT
|
25
|
2.56e-02
|
1.39e-01
|
0.38800
|
0.272000
|
-0.278000
|
1.99e-02
|
1.74e-02
|
GOCC ENDOPLASMIC RETICULUM LUMEN
|
28
|
1.04e-02
|
8.49e-02
|
0.38800
|
0.203000
|
-0.331000
|
6.66e-02
|
2.67e-03
|
GOBP CORTICAL CYTOSKELETON ORGANIZATION
|
14
|
4.39e-02
|
1.88e-01
|
0.38800
|
0.104000
|
-0.374000
|
5.05e-01
|
1.59e-02
|
GOBP CARDIOCYTE DIFFERENTIATION
|
12
|
1.22e-01
|
3.34e-01
|
0.38800
|
0.179000
|
-0.344000
|
2.84e-01
|
4.02e-02
|
GOBP REGULATION OF NEUROGENESIS
|
29
|
5.45e-03
|
5.75e-02
|
0.38800
|
0.167000
|
-0.350000
|
1.24e-01
|
1.25e-03
|
GOBP PURINE NUCLEOTIDE BIOSYNTHETIC PROCESS
|
43
|
5.81e-07
|
3.34e-05
|
0.38700
|
0.046200
|
0.385000
|
6.07e-01
|
1.68e-05
|
GOMF ALCOHOL DEHYDROGENASE NADPPLUS ACTIVITY
|
5
|
4.41e-01
|
6.56e-01
|
0.38700
|
-0.328000
|
0.206000
|
2.05e-01
|
4.27e-01
|
GOBP RENAL SYSTEM PROCESS
|
21
|
1.95e-02
|
1.20e-01
|
0.38700
|
0.355000
|
-0.155000
|
5.18e-03
|
2.24e-01
|
GOMF UDP GLYCOSYLTRANSFERASE ACTIVITY
|
10
|
2.56e-02
|
1.39e-01
|
0.38700
|
-0.379000
|
-0.080900
|
3.89e-02
|
6.59e-01
|
GOBP CHLORIDE TRANSPORT
|
7
|
3.48e-01
|
5.79e-01
|
0.38600
|
0.242000
|
-0.301000
|
2.70e-01
|
1.69e-01
|
GOBP CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS
|
10
|
1.20e-02
|
9.14e-02
|
0.38600
|
0.325000
|
0.209000
|
7.62e-02
|
2.56e-01
|
GOBP POSITIVE REGULATION OF STEROL TRANSPORT
|
5
|
4.79e-01
|
6.84e-01
|
0.38600
|
0.285000
|
-0.260000
|
2.72e-01
|
3.15e-01
|
GOBP FEEDING BEHAVIOR
|
6
|
2.58e-01
|
4.90e-01
|
0.38500
|
0.373000
|
-0.096200
|
1.14e-01
|
6.84e-01
|
GOCC CLATHRIN COATED VESICLE MEMBRANE
|
11
|
2.00e-01
|
4.33e-01
|
0.38500
|
0.286000
|
-0.257000
|
1.02e-01
|
1.42e-01
|
GOCC SITE OF DNA DAMAGE
|
8
|
2.39e-01
|
4.71e-01
|
0.38500
|
0.167000
|
-0.347000
|
4.14e-01
|
9.07e-02
|
GOBP RESPONSE TO RETINOIC ACID
|
8
|
2.38e-01
|
4.71e-01
|
0.38400
|
0.347000
|
-0.166000
|
9.05e-02
|
4.19e-01
|
GOBP MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY
|
5
|
4.56e-01
|
6.69e-01
|
0.38400
|
0.319000
|
-0.214000
|
2.18e-01
|
4.09e-01
|
GOCC U12 TYPE SPLICEOSOMAL COMPLEX
|
5
|
3.70e-01
|
5.93e-01
|
0.38400
|
-0.134000
|
0.360000
|
6.06e-01
|
1.64e-01
|
GOBP CELLULAR RESPONSE TO ACID CHEMICAL
|
11
|
1.58e-01
|
3.78e-01
|
0.38400
|
0.336000
|
-0.187000
|
5.50e-02
|
2.86e-01
|
GOBP PROTEIN COMPLEX OLIGOMERIZATION
|
23
|
6.49e-03
|
6.40e-02
|
0.38400
|
-0.099900
|
0.371000
|
4.11e-01
|
2.26e-03
|
GOCC BASOLATERAL PLASMA MEMBRANE
|
33
|
7.69e-03
|
7.04e-02
|
0.38400
|
0.233000
|
-0.305000
|
2.20e-02
|
2.76e-03
|
GOBP NUCLEAR EXPORT
|
16
|
1.95e-02
|
1.20e-01
|
0.38400
|
0.064100
|
-0.378000
|
6.59e-01
|
9.19e-03
|
GOBP CELLULAR RESPONSE TO GLUCOCORTICOID STIMULUS
|
8
|
4.16e-02
|
1.81e-01
|
0.38300
|
0.359000
|
0.135000
|
7.98e-02
|
5.12e-01
|
GOMF CALCIUM ION BINDING
|
31
|
8.66e-03
|
7.63e-02
|
0.38300
|
0.214000
|
-0.318000
|
4.17e-02
|
2.44e-03
|
GOBP REGULATION OF BLOOD CIRCULATION
|
18
|
6.60e-02
|
2.34e-01
|
0.38300
|
0.224000
|
-0.311000
|
1.03e-01
|
2.34e-02
|
GOBP ACTION POTENTIAL
|
8
|
3.05e-01
|
5.39e-01
|
0.38100
|
0.231000
|
-0.303000
|
2.60e-01
|
1.39e-01
|
GOBP CELL PROJECTION MORPHOGENESIS
|
64
|
1.50e-04
|
4.12e-03
|
0.38100
|
0.254000
|
-0.284000
|
6.03e-04
|
1.27e-04
|
GOBP REGULATION OF CHONDROCYTE DIFFERENTIATION
|
6
|
3.46e-01
|
5.76e-01
|
0.38000
|
0.161000
|
-0.344000
|
4.96e-01
|
1.45e-01
|
GOBP NEGATIVE REGULATION OF HEMOPOIESIS
|
7
|
1.02e-01
|
3.02e-01
|
0.38000
|
-0.043700
|
-0.377000
|
8.42e-01
|
8.48e-02
|
GOBP POSITIVE REGULATION OF HYDROLASE ACTIVITY
|
9
|
2.72e-01
|
5.07e-01
|
0.38000
|
0.240000
|
-0.294000
|
2.14e-01
|
1.28e-01
|
GOMF POTASSIUM CHANNEL REGULATOR ACTIVITY
|
5
|
1.94e-01
|
4.25e-01
|
0.37900
|
0.375000
|
0.048700
|
1.47e-01
|
8.51e-01
|
GOBP RENAL TUBULE MORPHOGENESIS
|
5
|
3.93e-01
|
6.15e-01
|
0.37900
|
0.351000
|
-0.142000
|
1.75e-01
|
5.84e-01
|
GOBP ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY
|
7
|
3.71e-01
|
5.93e-01
|
0.37800
|
0.280000
|
-0.254000
|
2.01e-01
|
2.46e-01
|
GOBP ADENYLATE CYCLASE MODULATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY
|
7
|
3.71e-01
|
5.93e-01
|
0.37800
|
0.280000
|
-0.254000
|
2.01e-01
|
2.46e-01
|
GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY
|
7
|
3.71e-01
|
5.93e-01
|
0.37800
|
0.283000
|
-0.250000
|
1.96e-01
|
2.53e-01
|
GOCC AXONAL GROWTH CONE
|
5
|
1.24e-01
|
3.36e-01
|
0.37800
|
-0.187000
|
-0.328000
|
4.70e-01
|
2.05e-01
|
GOBP POSITIVE REGULATION OF NEUROGENESIS
|
20
|
1.81e-02
|
1.15e-01
|
0.37800
|
0.116000
|
-0.360000
|
3.74e-01
|
5.69e-03
|
GOBP REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS
|
10
|
2.06e-01
|
4.38e-01
|
0.37800
|
0.325000
|
-0.193000
|
7.66e-02
|
2.93e-01
|
GOCC CYTOSOLIC TRANSLATION PREINITIATION COMPLEX
|
6
|
4.26e-01
|
6.42e-01
|
0.37700
|
-0.244000
|
0.288000
|
3.02e-01
|
2.23e-01
|
GOBP CIRCULATORY SYSTEM PROCESS
|
61
|
2.64e-04
|
6.20e-03
|
0.37700
|
0.259000
|
-0.275000
|
6.35e-04
|
2.82e-04
|
GOBP ENDOTHELIAL CELL APOPTOTIC PROCESS
|
5
|
4.93e-01
|
6.91e-01
|
0.37700
|
0.249000
|
-0.283000
|
3.36e-01
|
2.74e-01
|
GOBP NAD METABOLIC PROCESS
|
9
|
8.83e-02
|
2.80e-01
|
0.37700
|
-0.022800
|
0.377000
|
9.06e-01
|
5.13e-02
|
GOBP ARTERY DEVELOPMENT
|
10
|
2.41e-01
|
4.74e-01
|
0.37700
|
0.239000
|
-0.292000
|
1.93e-01
|
1.12e-01
|
GOBP LIPID MODIFICATION
|
35
|
3.27e-03
|
4.25e-02
|
0.37700
|
-0.174000
|
0.335000
|
7.98e-02
|
7.16e-04
|
GOBP CIRCADIAN RHYTHM
|
23
|
5.69e-03
|
5.83e-02
|
0.37600
|
0.368000
|
-0.077700
|
2.42e-03
|
5.23e-01
|
GOBP REGULATION OF DENDRITE MORPHOGENESIS
|
10
|
9.65e-02
|
2.91e-01
|
0.37600
|
0.067900
|
-0.370000
|
7.11e-01
|
4.35e-02
|
GOBP REGULATION OF DEVELOPMENTAL GROWTH
|
31
|
1.21e-02
|
9.21e-02
|
0.37600
|
0.227000
|
-0.300000
|
3.09e-02
|
4.24e-03
|
GOMF RIBOSOME BINDING
|
14
|
1.34e-01
|
3.47e-01
|
0.37600
|
-0.299000
|
0.228000
|
5.42e-02
|
1.41e-01
|
GOBP REGULATION OF MONOATOMIC ION TRANSPORT
|
32
|
1.24e-02
|
9.35e-02
|
0.37600
|
0.256000
|
-0.275000
|
1.31e-02
|
7.78e-03
|
GOCC ACTIN FILAMENT
|
12
|
1.31e-01
|
3.45e-01
|
0.37500
|
0.164000
|
-0.338000
|
3.29e-01
|
4.38e-02
|
GOBP PROTEIN HOMOOLIGOMERIZATION
|
18
|
9.25e-03
|
7.94e-02
|
0.37500
|
-0.029500
|
0.374000
|
8.30e-01
|
6.33e-03
|
GOBP NUCLEOTIDE BIOSYNTHETIC PROCESS
|
44
|
6.54e-07
|
3.68e-05
|
0.37500
|
0.059600
|
0.370000
|
5.02e-01
|
2.80e-05
|
GOBP ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS
|
8
|
1.71e-01
|
3.95e-01
|
0.37500
|
0.366000
|
-0.083300
|
7.43e-02
|
6.84e-01
|
GOBP NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE
|
8
|
3.15e-01
|
5.50e-01
|
0.37500
|
0.224000
|
-0.301000
|
2.74e-01
|
1.42e-01
|
GOMF CHROMATIN PROTEIN ADAPTOR ACTIVITY
|
11
|
1.26e-01
|
3.38e-01
|
0.37500
|
0.131000
|
-0.351000
|
4.54e-01
|
4.46e-02
|
GOBP MALE SEX DIFFERENTIATION
|
14
|
1.41e-01
|
3.59e-01
|
0.37500
|
0.240000
|
-0.288000
|
1.22e-01
|
6.37e-02
|
GOBP SYNAPSE ASSEMBLY
|
16
|
8.98e-02
|
2.82e-01
|
0.37400
|
0.201000
|
-0.316000
|
1.66e-01
|
2.98e-02
|
GOCC PRESYNAPTIC ACTIVE ZONE
|
5
|
4.64e-01
|
6.72e-01
|
0.37400
|
0.196000
|
-0.319000
|
4.49e-01
|
2.18e-01
|
GOCC APICAL PART OF CELL
|
55
|
5.71e-04
|
1.22e-02
|
0.37400
|
0.290000
|
-0.237000
|
2.72e-04
|
2.92e-03
|
GOBP CELL SURFACE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY
|
31
|
9.26e-03
|
7.94e-02
|
0.37400
|
0.194000
|
-0.319000
|
6.43e-02
|
2.35e-03
|
GOCC GOLGI ASSOCIATED VESICLE
|
7
|
3.70e-01
|
5.93e-01
|
0.37400
|
-0.295000
|
0.229000
|
1.78e-01
|
2.95e-01
|
GOBP ENERGY HOMEOSTASIS
|
13
|
1.51e-02
|
1.05e-01
|
0.37400
|
0.370000
|
0.053600
|
2.16e-02
|
7.39e-01
|
GOBP ENDOCYTIC RECYCLING
|
9
|
5.97e-02
|
2.21e-01
|
0.37400
|
-0.040200
|
-0.371000
|
8.35e-01
|
5.45e-02
|
GOBP COLLAGEN METABOLIC PROCESS
|
7
|
3.00e-01
|
5.33e-01
|
0.37300
|
0.156000
|
-0.339000
|
4.76e-01
|
1.21e-01
|
GOBP POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION
|
8
|
1.96e-01
|
4.27e-01
|
0.37300
|
0.358000
|
-0.105000
|
8.03e-02
|
6.10e-01
|
GOBP ENDOTHELIAL CELL PROLIFERATION
|
14
|
1.36e-01
|
3.50e-01
|
0.37300
|
0.300000
|
-0.222000
|
5.33e-02
|
1.53e-01
|
GOBP TISSUE REMODELING
|
18
|
8.61e-02
|
2.77e-01
|
0.37300
|
0.255000
|
-0.273000
|
6.32e-02
|
4.69e-02
|
GOMF VITAMIN B6 BINDING
|
13
|
9.94e-02
|
2.98e-01
|
0.37300
|
-0.144000
|
0.344000
|
3.70e-01
|
3.26e-02
|
GOMF PHOSPHATIDYLINOSITOL BINDING
|
26
|
2.15e-02
|
1.26e-01
|
0.37300
|
0.202000
|
-0.313000
|
7.70e-02
|
6.17e-03
|
GOBP CELLULAR RESPONSE TO UNFOLDED PROTEIN
|
7
|
1.59e-01
|
3.79e-01
|
0.37300
|
0.023600
|
-0.372000
|
9.14e-01
|
8.91e-02
|
GOBP RESPONSE TO ESTROGEN
|
5
|
4.38e-01
|
6.53e-01
|
0.37300
|
0.168000
|
-0.333000
|
5.17e-01
|
1.99e-01
|
GOBP CELL SUBSTRATE JUNCTION ORGANIZATION
|
15
|
9.23e-02
|
2.86e-01
|
0.37200
|
0.177000
|
-0.327000
|
2.38e-01
|
2.91e-02
|
GOBP REGULATION OF CHEMOTAXIS
|
15
|
1.03e-01
|
3.03e-01
|
0.37200
|
0.193000
|
-0.318000
|
1.99e-01
|
3.38e-02
|
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS
|
5
|
4.51e-01
|
6.65e-01
|
0.37200
|
0.178000
|
-0.327000
|
4.92e-01
|
2.07e-01
|
GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION
|
21
|
2.14e-02
|
1.26e-01
|
0.37200
|
0.348000
|
-0.131000
|
6.16e-03
|
3.02e-01
|
GOMF MAGNESIUM ION BINDING
|
22
|
5.17e-02
|
2.04e-01
|
0.37200
|
-0.270000
|
0.256000
|
3.00e-02
|
3.96e-02
|
GOBP REGULATION OF RECEPTOR INTERNALIZATION
|
7
|
3.85e-01
|
6.06e-01
|
0.37100
|
0.251000
|
-0.274000
|
2.51e-01
|
2.12e-01
|
GOBP POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS
|
6
|
3.61e-01
|
5.89e-01
|
0.37100
|
0.156000
|
-0.337000
|
5.10e-01
|
1.54e-01
|
GOBP POSITIVE REGULATION OF HORMONE SECRETION
|
8
|
3.06e-01
|
5.40e-01
|
0.37100
|
0.312000
|
-0.202000
|
1.28e-01
|
3.25e-01
|
GOBP REGULATION OF CILIUM ASSEMBLY
|
11
|
9.49e-02
|
2.90e-01
|
0.37100
|
0.085200
|
-0.361000
|
6.26e-01
|
3.89e-02
|
GOBP ALDEHYDE BIOSYNTHETIC PROCESS
|
5
|
1.58e-01
|
3.78e-01
|
0.37100
|
0.350000
|
0.124000
|
1.77e-01
|
6.32e-01
|
GOBP POSITIVE REGULATION OF CHEMOTAXIS
|
9
|
1.50e-01
|
3.71e-01
|
0.37000
|
0.088900
|
-0.360000
|
6.46e-01
|
6.28e-02
|
GOBP REGULATION OF CYTOPLASMIC TRANSLATION
|
5
|
4.36e-01
|
6.52e-01
|
0.37000
|
-0.161000
|
0.334000
|
5.35e-01
|
1.97e-01
|
GOBP REGULATION OF SMOOTHENED SIGNALING PATHWAY
|
9
|
1.19e-01
|
3.29e-01
|
0.37000
|
0.053000
|
-0.366000
|
7.84e-01
|
5.79e-02
|
GOBP ACTOMYOSIN STRUCTURE ORGANIZATION
|
26
|
1.65e-02
|
1.09e-01
|
0.37000
|
0.172000
|
-0.328000
|
1.33e-01
|
4.17e-03
|
GOBP SYNAPTIC VESICLE EXOCYTOSIS
|
5
|
3.92e-01
|
6.14e-01
|
0.37000
|
0.124000
|
-0.348000
|
6.32e-01
|
1.78e-01
|
GOBP DEVELOPMENTAL PIGMENTATION
|
5
|
4.83e-01
|
6.86e-01
|
0.37000
|
0.206000
|
-0.307000
|
4.27e-01
|
2.35e-01
|
GOBP PIGMENT CELL DIFFERENTIATION
|
5
|
4.83e-01
|
6.86e-01
|
0.37000
|
0.206000
|
-0.307000
|
4.27e-01
|
2.35e-01
|
GOBP TISSUE REGENERATION
|
6
|
8.60e-02
|
2.76e-01
|
0.36900
|
-0.304000
|
-0.209000
|
1.98e-01
|
3.76e-01
|
GOBP REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT
|
6
|
3.56e-01
|
5.86e-01
|
0.36900
|
0.339000
|
-0.148000
|
1.52e-01
|
5.31e-01
|
GOBP STEM CELL DIFFERENTIATION
|
23
|
3.53e-02
|
1.64e-01
|
0.36900
|
0.200000
|
-0.311000
|
1.01e-01
|
1.05e-02
|
GOMF FATTY ACID BINDING
|
8
|
5.86e-02
|
2.19e-01
|
0.36900
|
0.109000
|
0.352000
|
5.96e-01
|
8.54e-02
|
GOBP REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION
|
5
|
4.83e-01
|
6.86e-01
|
0.36800
|
0.308000
|
-0.202000
|
2.34e-01
|
4.35e-01
|
GOBP ATP METABOLIC PROCESS
|
48
|
1.03e-07
|
6.79e-06
|
0.36800
|
0.093300
|
0.356000
|
2.73e-01
|
2.69e-05
|
GOBP INTRACELLULAR IRON ION HOMEOSTASIS
|
12
|
9.26e-02
|
2.87e-01
|
0.36800
|
-0.102000
|
0.353000
|
5.44e-01
|
3.48e-02
|
GOBP MULTICELLULAR ORGANISMAL LEVEL WATER HOMEOSTASIS
|
5
|
1.76e-01
|
4.03e-01
|
0.36700
|
0.353000
|
0.100000
|
1.72e-01
|
6.98e-01
|
GOBP REGULATION OF SYNAPSE ASSEMBLY
|
14
|
1.55e-01
|
3.74e-01
|
0.36700
|
0.240000
|
-0.277000
|
1.22e-01
|
7.42e-02
|
GOBP ACETYL COA METABOLIC PROCESS
|
7
|
3.71e-01
|
5.93e-01
|
0.36700
|
-0.207000
|
0.303000
|
3.44e-01
|
1.67e-01
|
GOBP MESENCHYMAL CELL DIFFERENTIATION
|
23
|
4.73e-02
|
1.95e-01
|
0.36700
|
0.237000
|
-0.280000
|
5.14e-02
|
2.13e-02
|
GOCC PROTEIN DNA COMPLEX
|
10
|
2.45e-01
|
4.81e-01
|
0.36600
|
-0.209000
|
0.301000
|
2.55e-01
|
1.01e-01
|
GOCC AXON CYTOPLASM
|
8
|
1.98e-01
|
4.30e-01
|
0.36600
|
-0.354000
|
0.092500
|
8.40e-02
|
6.52e-01
|
GOBP LONG CHAIN FATTY ACID METABOLIC PROCESS
|
21
|
4.23e-03
|
4.90e-02
|
0.36600
|
-0.010400
|
0.365000
|
9.35e-01
|
4.00e-03
|
GOBP POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT
|
21
|
2.47e-02
|
1.36e-01
|
0.36600
|
0.130000
|
-0.342000
|
3.06e-01
|
7.16e-03
|
GOBP REGULATION OF GTPASE ACTIVITY
|
13
|
1.47e-01
|
3.68e-01
|
0.36500
|
0.187000
|
-0.314000
|
2.45e-01
|
5.13e-02
|
GOBP NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY
|
5
|
4.76e-01
|
6.82e-01
|
0.36500
|
0.314000
|
-0.186000
|
2.25e-01
|
4.73e-01
|
GOBP REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS
|
14
|
8.93e-02
|
2.82e-01
|
0.36500
|
0.137000
|
-0.339000
|
3.78e-01
|
2.92e-02
|
GOBP MEMBRANE REPOLARIZATION
|
5
|
4.82e-01
|
6.86e-01
|
0.36500
|
0.192000
|
-0.310000
|
4.59e-01
|
2.30e-01
|
GOMF HISTONE READER ACTIVITY
|
10
|
1.82e-01
|
4.09e-01
|
0.36500
|
0.140000
|
-0.337000
|
4.45e-01
|
6.65e-02
|
GOBP LIPOSACCHARIDE METABOLIC PROCESS
|
9
|
2.59e-02
|
1.39e-01
|
0.36400
|
-0.264000
|
-0.251000
|
1.72e-01
|
1.94e-01
|
GOBP PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE
|
8
|
2.32e-01
|
4.66e-01
|
0.36400
|
0.344000
|
-0.119000
|
9.32e-02
|
5.61e-01
|
GOBP REGULATION OF OSTEOCLAST DIFFERENTIATION
|
5
|
4.66e-01
|
6.74e-01
|
0.36400
|
0.174000
|
-0.320000
|
5.01e-01
|
2.17e-01
|
GOMF TRANSCRIPTION COREGULATOR BINDING
|
15
|
1.41e-01
|
3.58e-01
|
0.36400
|
0.273000
|
-0.240000
|
6.84e-02
|
1.10e-01
|
GOBP BIOMINERAL TISSUE DEVELOPMENT
|
14
|
1.42e-01
|
3.61e-01
|
0.36400
|
0.204000
|
-0.301000
|
1.90e-01
|
5.22e-02
|
GOBP NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS
|
6
|
9.22e-02
|
2.86e-01
|
0.36400
|
0.298000
|
0.209000
|
2.08e-01
|
3.77e-01
|
GOBP TRIGLYCERIDE METABOLIC PROCESS
|
16
|
1.26e-01
|
3.38e-01
|
0.36400
|
0.248000
|
-0.266000
|
8.74e-02
|
6.77e-02
|
GOBP LIPID OXIDATION
|
30
|
1.83e-02
|
1.16e-01
|
0.36400
|
-0.218000
|
0.291000
|
4.07e-02
|
6.42e-03
|
GOBP FATTY ACID METABOLIC PROCESS
|
71
|
2.85e-05
|
1.04e-03
|
0.36300
|
-0.169000
|
0.322000
|
1.69e-02
|
4.75e-06
|
GOBP PROTEIN LOCALIZATION TO POSTSYNAPSE
|
6
|
3.59e-01
|
5.88e-01
|
0.36300
|
0.138000
|
-0.336000
|
5.59e-01
|
1.55e-01
|
GOBP UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS
|
13
|
1.54e-01
|
3.74e-01
|
0.36300
|
-0.310000
|
0.189000
|
5.44e-02
|
2.40e-01
|
GOMF SIGNALING RECEPTOR REGULATOR ACTIVITY
|
23
|
1.06e-02
|
8.50e-02
|
0.36300
|
0.351000
|
-0.090500
|
3.83e-03
|
4.57e-01
|
GOBP FATTY ACID BIOSYNTHETIC PROCESS
|
30
|
2.09e-02
|
1.26e-01
|
0.36200
|
-0.276000
|
0.234000
|
9.56e-03
|
2.82e-02
|
GOBP REGULATION OF MONONUCLEAR CELL MIGRATION
|
11
|
2.39e-01
|
4.71e-01
|
0.36200
|
0.274000
|
-0.237000
|
1.17e-01
|
1.76e-01
|
GOBP PEPTIDE METABOLIC PROCESS
|
7
|
9.29e-02
|
2.87e-01
|
0.36200
|
-0.347000
|
-0.103000
|
1.13e-01
|
6.38e-01
|
GOMF SIGNAL SEQUENCE BINDING
|
5
|
5.16e-01
|
7.07e-01
|
0.36200
|
-0.282000
|
0.227000
|
2.76e-01
|
3.81e-01
|
GOBP SENSORY ORGAN DEVELOPMENT
|
32
|
1.75e-02
|
1.12e-01
|
0.36200
|
0.256000
|
-0.256000
|
1.34e-02
|
1.33e-02
|
GOBP RRNA METABOLIC PROCESS
|
19
|
3.76e-03
|
4.49e-02
|
0.36200
|
0.042100
|
0.359000
|
7.53e-01
|
7.11e-03
|
GOBP SPINAL CORD DEVELOPMENT
|
5
|
5.18e-01
|
7.07e-01
|
0.36200
|
0.228000
|
-0.281000
|
3.79e-01
|
2.78e-01
|
GOBP FORMATION OF PRIMARY GERM LAYER
|
10
|
2.11e-01
|
4.44e-01
|
0.36100
|
0.160000
|
-0.324000
|
3.82e-01
|
7.75e-02
|
GOBP REGULATION OF AMIDE METABOLIC PROCESS
|
11
|
2.81e-02
|
1.47e-01
|
0.36100
|
0.351000
|
0.084300
|
4.47e-02
|
6.30e-01
|
GOCC EARLY ENDOSOME MEMBRANE
|
14
|
1.19e-01
|
3.29e-01
|
0.36000
|
0.165000
|
-0.320000
|
2.87e-01
|
3.92e-02
|
GOBP PEROXISOME ORGANIZATION
|
6
|
4.06e-01
|
6.26e-01
|
0.36000
|
0.317000
|
-0.171000
|
1.80e-01
|
4.71e-01
|
GOBP BONE RESORPTION
|
6
|
4.63e-01
|
6.71e-01
|
0.36000
|
0.240000
|
-0.268000
|
3.10e-01
|
2.56e-01
|
GOCC CORTICAL CYTOSKELETON
|
8
|
3.37e-01
|
5.75e-01
|
0.36000
|
0.296000
|
-0.204000
|
1.48e-01
|
3.19e-01
|
GOCC LEADING EDGE MEMBRANE
|
16
|
1.09e-01
|
3.13e-01
|
0.36000
|
0.195000
|
-0.302000
|
1.80e-01
|
3.74e-02
|
GOBP REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS
|
24
|
2.10e-02
|
1.26e-01
|
0.35900
|
0.144000
|
-0.329000
|
2.27e-01
|
5.62e-03
|
GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY
|
6
|
1.63e-01
|
3.82e-01
|
0.35900
|
0.056700
|
0.355000
|
8.11e-01
|
1.34e-01
|
GOBP NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS
|
51
|
1.27e-07
|
8.19e-06
|
0.35900
|
0.080600
|
0.350000
|
3.30e-01
|
2.15e-05
|
GOMF PRIMARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
37
|
3.99e-06
|
1.80e-04
|
0.35900
|
0.115000
|
0.340000
|
2.35e-01
|
4.08e-04
|
GOBP ORGANIC ACID TRANSMEMBRANE TRANSPORT
|
22
|
5.09e-02
|
2.03e-01
|
0.35900
|
0.199000
|
-0.298000
|
1.09e-01
|
1.63e-02
|
GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY
|
8
|
4.48e-02
|
1.90e-01
|
0.35800
|
0.218000
|
0.284000
|
2.88e-01
|
1.65e-01
|
GOMF ALCOHOL DEHYDROGENASE NAD P PLUS ACTIVITY
|
7
|
4.14e-01
|
6.32e-01
|
0.35800
|
-0.248000
|
0.258000
|
2.58e-01
|
2.39e-01
|
GOBP POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS
|
6
|
4.36e-01
|
6.52e-01
|
0.35700
|
0.302000
|
-0.191000
|
2.02e-01
|
4.18e-01
|
GOMF PENTOSYLTRANSFERASE ACTIVITY
|
5
|
4.83e-01
|
6.86e-01
|
0.35700
|
-0.174000
|
0.312000
|
5.01e-01
|
2.29e-01
|
GOBP RESPONSE TO ETHER
|
5
|
4.43e-01
|
6.57e-01
|
0.35700
|
0.329000
|
-0.139000
|
2.04e-01
|
5.92e-01
|
GOCC MICROVILLUS
|
13
|
1.04e-01
|
3.06e-01
|
0.35700
|
0.337000
|
-0.118000
|
3.65e-02
|
4.66e-01
|
GOMF HISTONE DEACETYLASE BINDING
|
13
|
1.39e-01
|
3.56e-01
|
0.35700
|
0.158000
|
-0.320000
|
3.26e-01
|
4.72e-02
|
GOCC CELL PROJECTION MEMBRANE
|
34
|
1.35e-02
|
9.82e-02
|
0.35700
|
0.219000
|
-0.282000
|
2.94e-02
|
5.01e-03
|
GOCC ENDOPLASMIC RETICULUM EXIT SITE
|
10
|
2.01e-01
|
4.36e-01
|
0.35600
|
0.141000
|
-0.327000
|
4.41e-01
|
7.46e-02
|
GOMF EXONUCLEASE ACTIVITY
|
6
|
2.35e-01
|
4.69e-01
|
0.35600
|
0.355000
|
-0.021000
|
1.33e-01
|
9.29e-01
|
GOBP REGULATION OF NERVOUS SYSTEM DEVELOPMENT
|
31
|
1.67e-02
|
1.09e-01
|
0.35600
|
0.199000
|
-0.295000
|
5.85e-02
|
4.90e-03
|
GOBP ACTIN FILAMENT BASED PROCESS
|
73
|
4.02e-05
|
1.39e-03
|
0.35600
|
0.170000
|
-0.312000
|
1.44e-02
|
6.89e-06
|
GOBP POSITIVE REGULATION OF MITOTIC CELL CYCLE
|
7
|
1.06e-01
|
3.10e-01
|
0.35600
|
0.089800
|
0.344000
|
6.82e-01
|
1.16e-01
|
GOCC CHROMOSOME TELOMERIC REGION
|
11
|
7.65e-02
|
2.56e-01
|
0.35500
|
0.028800
|
-0.354000
|
8.69e-01
|
4.28e-02
|
GOBP LEUKOCYTE CHEMOTAXIS
|
11
|
2.55e-01
|
4.87e-01
|
0.35500
|
0.260000
|
-0.242000
|
1.37e-01
|
1.66e-01
|
GOCC CAVEOLA
|
7
|
3.48e-01
|
5.79e-01
|
0.35500
|
0.318000
|
-0.158000
|
1.46e-01
|
4.70e-01
|
GOBP DEVELOPMENTAL GROWTH
|
70
|
2.24e-04
|
5.55e-03
|
0.35500
|
0.230000
|
-0.271000
|
1.22e-03
|
1.34e-04
|
GOBP ACTIN FILAMENT DEPOLYMERIZATION
|
6
|
3.71e-01
|
5.93e-01
|
0.35500
|
0.131000
|
-0.330000
|
5.80e-01
|
1.63e-01
|
GOBP REGULATION OF MUSCLE ADAPTATION
|
11
|
2.49e-01
|
4.84e-01
|
0.35500
|
0.275000
|
-0.224000
|
1.16e-01
|
2.01e-01
|
GOBP REGULATION OF MUSCLE HYPERTROPHY
|
11
|
2.49e-01
|
4.84e-01
|
0.35500
|
0.275000
|
-0.224000
|
1.16e-01
|
2.01e-01
|
GOBP CELLULAR RESPONSE TO KETONE
|
13
|
2.33e-02
|
1.32e-01
|
0.35500
|
0.351000
|
0.049000
|
2.91e-02
|
7.61e-01
|
GOMF SERINE HYDROLASE ACTIVITY
|
15
|
7.23e-02
|
2.46e-01
|
0.35500
|
0.112000
|
-0.337000
|
4.56e-01
|
2.49e-02
|
GOBP SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION
|
41
|
3.55e-03
|
4.44e-02
|
0.35400
|
0.178000
|
-0.307000
|
5.30e-02
|
8.08e-04
|
GOBP METALLO SULFUR CLUSTER ASSEMBLY
|
5
|
5.33e-01
|
7.18e-01
|
0.35400
|
-0.225000
|
0.273000
|
3.86e-01
|
2.91e-01
|
GOBP REGULATION OF LEUKOCYTE MIGRATION
|
13
|
1.52e-01
|
3.74e-01
|
0.35400
|
0.166000
|
-0.312000
|
3.04e-01
|
5.24e-02
|
GOMF NUCLEAR RETINOIC ACID RECEPTOR BINDING
|
5
|
5.11e-01
|
7.03e-01
|
0.35200
|
0.297000
|
-0.190000
|
2.52e-01
|
4.63e-01
|
GOBP REGULATION OF ACTIN FILAMENT BASED PROCESS
|
36
|
2.01e-03
|
2.95e-02
|
0.35200
|
0.107000
|
-0.335000
|
2.74e-01
|
5.88e-04
|
GOBP NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION
|
8
|
1.55e-01
|
3.74e-01
|
0.35200
|
0.351000
|
-0.022700
|
8.67e-02
|
9.12e-01
|
GOBP POSITIVE REGULATION OF INTRACELLULAR TRANSPORT
|
15
|
4.22e-02
|
1.83e-01
|
0.35100
|
0.052200
|
-0.348000
|
7.28e-01
|
2.05e-02
|
GOCC ACTIN BASED CELL PROJECTION
|
21
|
6.17e-02
|
2.25e-01
|
0.35100
|
0.297000
|
-0.188000
|
1.94e-02
|
1.40e-01
|
GOBP KIDNEY MORPHOGENESIS
|
9
|
3.27e-01
|
5.62e-01
|
0.35100
|
0.219000
|
-0.274000
|
2.58e-01
|
1.56e-01
|
GOBP CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION
|
52
|
1.67e-03
|
2.62e-02
|
0.35100
|
0.207000
|
-0.283000
|
1.12e-02
|
5.29e-04
|
GOCC COLLAGEN CONTAINING EXTRACELLULAR MATRIX
|
17
|
4.12e-02
|
1.80e-01
|
0.35000
|
0.083600
|
-0.340000
|
5.54e-01
|
1.59e-02
|
GOMF LIGASE ACTIVITY FORMING CARBON SULFUR BONDS
|
8
|
2.79e-01
|
5.11e-01
|
0.35000
|
-0.325000
|
0.131000
|
1.13e-01
|
5.24e-01
|
GOBP RESPONSE TO GROWTH FACTOR
|
57
|
1.10e-03
|
1.95e-02
|
0.35000
|
0.215000
|
-0.276000
|
6.02e-03
|
4.22e-04
|
GOBP TELENCEPHALON DEVELOPMENT
|
19
|
9.11e-02
|
2.84e-01
|
0.35000
|
0.203000
|
-0.285000
|
1.29e-01
|
3.29e-02
|
GOCC LAMELLIPODIUM
|
18
|
9.89e-02
|
2.97e-01
|
0.34900
|
0.194000
|
-0.290000
|
1.58e-01
|
3.42e-02
|
GOBP NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION
|
8
|
3.46e-01
|
5.76e-01
|
0.34800
|
0.297000
|
-0.182000
|
1.48e-01
|
3.74e-01
|
GOBP INTERMEDIATE FILAMENT BASED PROCESS
|
7
|
1.55e-01
|
3.74e-01
|
0.34800
|
-0.030200
|
-0.347000
|
8.90e-01
|
1.13e-01
|
GOMF MACROMOLECULAR CONFORMATION ISOMERASE ACTIVITY
|
16
|
3.40e-02
|
1.61e-01
|
0.34800
|
0.045000
|
-0.345000
|
7.57e-01
|
1.75e-02
|
GOBP CELL JUNCTION ASSEMBLY
|
43
|
6.21e-03
|
6.23e-02
|
0.34800
|
0.221000
|
-0.269000
|
1.37e-02
|
2.71e-03
|
GOBP PALLIUM DEVELOPMENT
|
15
|
1.17e-01
|
3.28e-01
|
0.34700
|
0.154000
|
-0.310000
|
3.04e-01
|
3.85e-02
|
GOBP PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS
|
51
|
6.86e-06
|
2.90e-04
|
0.34700
|
-0.004360
|
0.347000
|
9.58e-01
|
2.58e-05
|
GOCC MULTIVESICULAR BODY MEMBRANE
|
9
|
1.14e-01
|
3.21e-01
|
0.34600
|
0.001640
|
-0.346000
|
9.93e-01
|
7.30e-02
|
GOCC RUFFLE
|
25
|
5.28e-02
|
2.07e-01
|
0.34600
|
0.228000
|
-0.261000
|
5.11e-02
|
2.53e-02
|
GOCC SPECIFIC GRANULE MEMBRANE
|
7
|
3.72e-01
|
5.93e-01
|
0.34600
|
0.158000
|
-0.308000
|
4.72e-01
|
1.59e-01
|
GOMF ACID THIOL LIGASE ACTIVITY
|
6
|
4.34e-01
|
6.51e-01
|
0.34600
|
-0.306000
|
0.162000
|
1.96e-01
|
4.92e-01
|
GOMF RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING
|
51
|
2.91e-03
|
3.89e-02
|
0.34600
|
0.233000
|
-0.256000
|
4.70e-03
|
1.95e-03
|
GOBP NADH METABOLIC PROCESS
|
5
|
2.78e-01
|
5.10e-01
|
0.34600
|
0.019000
|
0.345000
|
9.42e-01
|
1.82e-01
|
GOBP NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS
|
21
|
8.08e-02
|
2.67e-01
|
0.34500
|
0.272000
|
-0.213000
|
3.23e-02
|
9.38e-02
|
GOMF PROTEIN SERINE THREONINE KINASE INHIBITOR ACTIVITY
|
6
|
2.71e-01
|
5.06e-01
|
0.34500
|
0.033500
|
-0.344000
|
8.87e-01
|
1.46e-01
|
GOBP HIPPOCAMPUS DEVELOPMENT
|
7
|
3.74e-01
|
5.95e-01
|
0.34500
|
0.158000
|
-0.307000
|
4.72e-01
|
1.61e-01
|
GOBP POSITIVE REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION
|
5
|
5.17e-01
|
7.07e-01
|
0.34500
|
-0.296000
|
0.178000
|
2.53e-01
|
4.92e-01
|
GOBP MITOCHONDRIAL TRANSPORT
|
25
|
1.81e-02
|
1.15e-01
|
0.34500
|
-0.116000
|
0.325000
|
3.19e-01
|
5.32e-03
|
GOBP REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS
|
66
|
1.13e-04
|
3.27e-03
|
0.34500
|
0.151000
|
-0.311000
|
3.93e-02
|
2.02e-05
|
GOCC RECYCLING ENDOSOME MEMBRANE
|
14
|
5.16e-02
|
2.04e-01
|
0.34500
|
0.039600
|
-0.343000
|
7.99e-01
|
2.72e-02
|
GOBP VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS
|
7
|
1.31e-01
|
3.45e-01
|
0.34500
|
-0.071100
|
-0.337000
|
7.46e-01
|
1.23e-01
|
GOBP MEMBRANE LIPID BIOSYNTHETIC PROCESS
|
9
|
6.65e-02
|
2.35e-01
|
0.34400
|
-0.333000
|
-0.089300
|
8.52e-02
|
6.44e-01
|
GOBP SPHINGOLIPID BIOSYNTHETIC PROCESS
|
9
|
6.65e-02
|
2.35e-01
|
0.34400
|
-0.333000
|
-0.089300
|
8.52e-02
|
6.44e-01
|
GOBP MEMBRANE BIOGENESIS
|
9
|
1.83e-01
|
4.11e-01
|
0.34400
|
0.072300
|
-0.336000
|
7.08e-01
|
8.18e-02
|
GOBP REGULATION OF WNT SIGNALING PATHWAY
|
32
|
2.08e-02
|
1.25e-01
|
0.34400
|
0.198000
|
-0.281000
|
5.51e-02
|
6.61e-03
|
GOMF UBIQUITIN LIKE PROTEIN READER ACTIVITY
|
6
|
4.94e-01
|
6.93e-01
|
0.34300
|
0.224000
|
-0.260000
|
3.43e-01
|
2.71e-01
|
GOCC CLATHRIN COATED VESICLE
|
19
|
1.12e-01
|
3.19e-01
|
0.34300
|
0.232000
|
-0.252000
|
8.17e-02
|
5.90e-02
|
GOBP REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY
|
23
|
5.06e-02
|
2.03e-01
|
0.34300
|
0.173000
|
-0.296000
|
1.55e-01
|
1.49e-02
|
GOBP CYTOPLASMIC TRANSLATIONAL INITIATION
|
7
|
3.41e-01
|
5.76e-01
|
0.34200
|
-0.318000
|
0.126000
|
1.46e-01
|
5.64e-01
|
GOMF KINASE ACTIVATOR ACTIVITY
|
13
|
2.24e-01
|
4.59e-01
|
0.34200
|
0.251000
|
-0.232000
|
1.19e-01
|
1.49e-01
|
GOMF LIPASE ACTIVITY
|
13
|
3.01e-02
|
1.53e-01
|
0.34200
|
-0.048000
|
-0.339000
|
7.66e-01
|
3.54e-02
|
GOBP REGULATION OF CELL PROJECTION ORGANIZATION
|
65
|
1.53e-04
|
4.14e-03
|
0.34200
|
0.150000
|
-0.308000
|
4.20e-02
|
2.79e-05
|
GOBP MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS
|
37
|
1.51e-02
|
1.05e-01
|
0.34200
|
-0.227000
|
0.256000
|
1.86e-02
|
7.96e-03
|
GOMF ATPASE REGULATOR ACTIVITY
|
11
|
2.49e-01
|
4.84e-01
|
0.34200
|
-0.182000
|
0.289000
|
2.97e-01
|
9.85e-02
|
GOMF SODIUM CHANNEL ACTIVITY
|
8
|
1.40e-01
|
3.57e-01
|
0.34100
|
0.341000
|
0.015200
|
9.63e-02
|
9.41e-01
|
GOBP RESPONSE TO TRANSFORMING GROWTH FACTOR BETA
|
28
|
2.59e-02
|
1.39e-01
|
0.34000
|
0.165000
|
-0.298000
|
1.36e-01
|
6.93e-03
|
GOBP NEUTRAL LIPID METABOLIC PROCESS
|
17
|
1.46e-01
|
3.67e-01
|
0.34000
|
0.250000
|
-0.231000
|
7.69e-02
|
1.02e-01
|
GOBP REGULATION OF SECRETION
|
34
|
6.44e-03
|
6.40e-02
|
0.34000
|
0.316000
|
-0.125000
|
1.65e-03
|
2.13e-01
|
GOBP RHYTHMIC PROCESS
|
29
|
8.67e-03
|
7.63e-02
|
0.33900
|
0.325000
|
-0.099100
|
2.74e-03
|
3.62e-01
|
GOBP ENERGY RESERVE METABOLIC PROCESS
|
14
|
8.47e-02
|
2.73e-01
|
0.33900
|
0.081500
|
-0.329000
|
6.00e-01
|
3.38e-02
|
GOBP GLUCAN METABOLIC PROCESS
|
14
|
8.47e-02
|
2.73e-01
|
0.33900
|
0.081500
|
-0.329000
|
6.00e-01
|
3.38e-02
|
GOMF NUCLEOBASE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY
|
6
|
3.39e-01
|
5.76e-01
|
0.33900
|
-0.076600
|
0.331000
|
7.46e-01
|
1.62e-01
|
GOMF CIS REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING
|
44
|
7.78e-03
|
7.10e-02
|
0.33900
|
0.246000
|
-0.234000
|
5.51e-03
|
8.32e-03
|
GOBP TRANSLATION
|
100
|
1.05e-08
|
8.59e-07
|
0.33900
|
-0.051900
|
0.335000
|
3.89e-01
|
2.28e-08
|
GOBP MYELOID CELL DEVELOPMENT
|
5
|
1.75e-01
|
4.01e-01
|
0.33900
|
0.208000
|
0.267000
|
4.21e-01
|
3.02e-01
|
GOBP REGULATION OF TRANS SYNAPTIC SIGNALING
|
34
|
2.34e-02
|
1.32e-01
|
0.33800
|
0.238000
|
-0.240000
|
1.76e-02
|
1.67e-02
|
GOBP KERATINOCYTE DIFFERENTIATION
|
8
|
3.24e-01
|
5.60e-01
|
0.33800
|
0.140000
|
-0.307000
|
4.94e-01
|
1.34e-01
|
GOBP REGULATION OF INTRACELLULAR TRANSPORT
|
26
|
1.25e-02
|
9.35e-02
|
0.33700
|
0.088000
|
-0.326000
|
4.42e-01
|
4.40e-03
|
GOBP REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR
|
15
|
1.88e-02
|
1.17e-01
|
0.33700
|
0.052300
|
0.333000
|
7.27e-01
|
2.63e-02
|
GOMF PHOSPHORIC ESTER HYDROLASE ACTIVITY
|
38
|
1.46e-02
|
1.03e-01
|
0.33700
|
0.216000
|
-0.259000
|
2.33e-02
|
6.47e-03
|
GOMF MOLECULAR SEQUESTERING ACTIVITY
|
5
|
5.64e-01
|
7.39e-01
|
0.33700
|
-0.212000
|
0.262000
|
4.13e-01
|
3.11e-01
|
GOMF GLYCOSYLTRANSFERASE ACTIVITY
|
19
|
7.14e-03
|
6.75e-02
|
0.33700
|
-0.334000
|
-0.047000
|
1.24e-02
|
7.25e-01
|
GOBP REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS
|
8
|
4.07e-01
|
6.26e-01
|
0.33700
|
0.254000
|
-0.221000
|
2.16e-01
|
2.80e-01
|
GOBP CELL MATRIX ADHESION
|
23
|
5.87e-02
|
2.19e-01
|
0.33700
|
0.175000
|
-0.288000
|
1.51e-01
|
1.79e-02
|
GOBP REGULATION OF SMALL MOLECULE METABOLIC PROCESS
|
42
|
3.84e-03
|
4.55e-02
|
0.33600
|
0.302000
|
-0.149000
|
8.54e-04
|
1.01e-01
|
GOBP INORGANIC ANION TRANSPORT
|
18
|
1.35e-01
|
3.49e-01
|
0.33600
|
0.224000
|
-0.251000
|
1.02e-01
|
6.72e-02
|
GOBP STEROID METABOLIC PROCESS
|
36
|
6.95e-03
|
6.68e-02
|
0.33600
|
0.307000
|
-0.138000
|
1.66e-03
|
1.59e-01
|
GOCC PML BODY
|
5
|
4.57e-01
|
6.69e-01
|
0.33600
|
0.109000
|
-0.318000
|
6.73e-01
|
2.19e-01
|
GOBP NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY
|
13
|
8.68e-02
|
2.78e-01
|
0.33600
|
0.057700
|
-0.331000
|
7.20e-01
|
3.97e-02
|
GOMF PROLINE RICH REGION BINDING
|
5
|
5.56e-01
|
7.34e-01
|
0.33600
|
0.196000
|
-0.273000
|
4.49e-01
|
2.92e-01
|
GOBP MONOCARBOXYLIC ACID METABOLIC PROCESS
|
106
|
4.67e-07
|
2.74e-05
|
0.33500
|
-0.123000
|
0.312000
|
3.64e-02
|
8.89e-08
|
GOBP VIRAL PROTEIN PROCESSING
|
6
|
2.03e-01
|
4.37e-01
|
0.33500
|
-0.331000
|
-0.056100
|
1.62e-01
|
8.12e-01
|
GOBP PROTEIN EXIT FROM ENDOPLASMIC RETICULUM
|
5
|
2.23e-01
|
4.59e-01
|
0.33500
|
-0.316000
|
-0.111000
|
2.23e-01
|
6.67e-01
|
GOBP RESPONSE TO FIBROBLAST GROWTH FACTOR
|
7
|
3.62e-01
|
5.89e-01
|
0.33500
|
0.126000
|
-0.310000
|
5.64e-01
|
1.57e-01
|
GOMF PROTEIN PHOSPHATASE BINDING
|
13
|
1.85e-01
|
4.12e-01
|
0.33400
|
-0.296000
|
0.155000
|
6.60e-02
|
3.34e-01
|
GOBP REGULATION OF OSTEOBLAST DIFFERENTIATION
|
16
|
1.50e-02
|
1.04e-01
|
0.33400
|
0.329000
|
0.055800
|
2.33e-02
|
7.01e-01
|
GOBP RESPONSE TO CHEMOKINE
|
5
|
5.64e-01
|
7.39e-01
|
0.33400
|
0.201000
|
-0.267000
|
4.38e-01
|
3.02e-01
|
GOBP REGULATION OF VIRAL LIFE CYCLE
|
6
|
4.85e-01
|
6.86e-01
|
0.33400
|
-0.179000
|
0.282000
|
4.49e-01
|
2.33e-01
|
GOCC NEURON SPINE
|
13
|
1.82e-01
|
4.09e-01
|
0.33400
|
0.152000
|
-0.297000
|
3.47e-01
|
6.47e-02
|
GOBP ORGANIC ANION TRANSPORT
|
46
|
7.44e-03
|
6.88e-02
|
0.33400
|
0.228000
|
-0.243000
|
8.46e-03
|
5.05e-03
|
GOBP REGULATION OF STEM CELL DIFFERENTIATION
|
7
|
2.97e-01
|
5.31e-01
|
0.33300
|
0.075500
|
-0.324000
|
7.30e-01
|
1.39e-01
|
GOBP NEGATIVE REGULATION OF SECRETION
|
12
|
2.36e-01
|
4.69e-01
|
0.33300
|
0.282000
|
-0.176000
|
9.19e-02
|
2.93e-01
|
GOBP REGULATION OF LIPID CATABOLIC PROCESS
|
6
|
5.13e-01
|
7.05e-01
|
0.33300
|
0.210000
|
-0.258000
|
3.74e-01
|
2.76e-01
|
GOBP NUCLEOTIDE EXCISION REPAIR
|
7
|
4.22e-01
|
6.39e-01
|
0.33300
|
-0.169000
|
0.287000
|
4.40e-01
|
1.91e-01
|
GOCC RIBONUCLEOPROTEIN COMPLEX
|
94
|
7.84e-09
|
7.06e-07
|
0.33300
|
-0.018900
|
0.332000
|
7.60e-01
|
7.17e-08
|
GOBP REGULATION OF ERBB SIGNALING PATHWAY
|
5
|
4.99e-01
|
6.96e-01
|
0.33300
|
0.304000
|
-0.135000
|
2.40e-01
|
6.03e-01
|
GOBP FATTY ACID TRANSPORT
|
16
|
1.70e-01
|
3.95e-01
|
0.33300
|
0.258000
|
-0.209000
|
7.54e-02
|
1.50e-01
|
GOBP TISSUE MIGRATION
|
12
|
2.66e-01
|
5.00e-01
|
0.33300
|
0.211000
|
-0.257000
|
2.07e-01
|
1.26e-01
|
GOBP AXON DEVELOPMENT
|
42
|
1.15e-02
|
8.95e-02
|
0.33200
|
0.245000
|
-0.225000
|
6.85e-03
|
1.32e-02
|
GOBP ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY
|
86
|
1.51e-04
|
4.13e-03
|
0.33200
|
0.238000
|
-0.232000
|
2.27e-04
|
3.15e-04
|
GOBP CEREBRAL CORTEX DEVELOPMENT
|
11
|
1.64e-01
|
3.83e-01
|
0.33200
|
0.086900
|
-0.320000
|
6.20e-01
|
6.70e-02
|
GOCC VESICLE COAT
|
7
|
3.72e-01
|
5.93e-01
|
0.33200
|
-0.306000
|
0.128000
|
1.62e-01
|
5.58e-01
|
GOCC 9PLUS0 NON MOTILE CILIUM
|
9
|
2.17e-01
|
4.53e-01
|
0.33200
|
0.078100
|
-0.322000
|
6.86e-01
|
9.54e-02
|
GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY
|
26
|
6.25e-02
|
2.27e-01
|
0.33100
|
0.240000
|
-0.228000
|
3.57e-02
|
4.64e-02
|
GOMF MONOOXYGENASE ACTIVITY
|
17
|
2.42e-02
|
1.35e-01
|
0.33100
|
-0.001840
|
0.331000
|
9.90e-01
|
1.89e-02
|
GOBP POSITIVE REGULATION OF VIRAL PROCESS
|
6
|
4.67e-01
|
6.75e-01
|
0.33100
|
-0.292000
|
0.157000
|
2.17e-01
|
5.08e-01
|
GOCC CALCIUM CHANNEL COMPLEX
|
5
|
5.78e-01
|
7.49e-01
|
0.33100
|
0.211000
|
-0.255000
|
4.16e-01
|
3.25e-01
|
GOBP XENOBIOTIC METABOLIC PROCESS
|
16
|
1.72e-01
|
3.96e-01
|
0.33000
|
-0.204000
|
0.260000
|
1.61e-01
|
7.32e-02
|
GOBP REGULATION OF PROTEIN POLYUBIQUITINATION
|
5
|
5.83e-01
|
7.52e-01
|
0.33000
|
0.241000
|
-0.226000
|
3.52e-01
|
3.83e-01
|
GOBP MESENCHYME DEVELOPMENT
|
32
|
3.31e-02
|
1.61e-01
|
0.33000
|
0.216000
|
-0.250000
|
3.63e-02
|
1.58e-02
|
GOBP REGULATION OF CELL ADHESION
|
59
|
2.25e-03
|
3.21e-02
|
0.33000
|
0.239000
|
-0.228000
|
1.89e-03
|
3.08e-03
|
GOMF DNA BINDING TRANSCRIPTION REPRESSOR ACTIVITY
|
12
|
2.76e-01
|
5.08e-01
|
0.33000
|
0.243000
|
-0.223000
|
1.46e-01
|
1.83e-01
|
GOCC NUCLEAR PORE
|
9
|
1.08e-01
|
3.11e-01
|
0.33000
|
-0.328000
|
-0.040700
|
9.00e-02
|
8.33e-01
|
GOBP REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY
|
7
|
4.47e-01
|
6.62e-01
|
0.33000
|
0.273000
|
-0.186000
|
2.13e-01
|
3.96e-01
|
GOBP PURINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT
|
5
|
5.82e-01
|
7.52e-01
|
0.33000
|
-0.250000
|
0.215000
|
3.34e-01
|
4.07e-01
|
GOBP NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT
|
6
|
5.22e-01
|
7.09e-01
|
0.33000
|
0.213000
|
-0.252000
|
3.68e-01
|
2.87e-01
|
GOBP NEGATIVE REGULATION OF STEM CELL POPULATION MAINTENANCE
|
5
|
2.11e-01
|
4.44e-01
|
0.32900
|
-0.150000
|
-0.293000
|
5.62e-01
|
2.58e-01
|
GOBP INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY
|
5
|
5.00e-01
|
6.96e-01
|
0.32900
|
0.303000
|
-0.128000
|
2.41e-01
|
6.21e-01
|
GOBP CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES
|
17
|
1.63e-01
|
3.83e-01
|
0.32900
|
-0.217000
|
0.247000
|
1.24e-01
|
7.97e-02
|
GOBP REGULATION OF VIRAL GENOME REPLICATION
|
5
|
5.31e-01
|
7.16e-01
|
0.32900
|
-0.292000
|
0.152000
|
2.60e-01
|
5.57e-01
|
GOBP CELL GROWTH
|
42
|
9.19e-03
|
7.94e-02
|
0.32800
|
0.273000
|
-0.183000
|
2.58e-03
|
4.39e-02
|
GOBP PIGMENTATION
|
7
|
4.59e-01
|
6.69e-01
|
0.32800
|
0.193000
|
-0.265000
|
3.78e-01
|
2.26e-01
|
GOCC FICOLIN 1 RICH GRANULE MEMBRANE
|
8
|
4.05e-01
|
6.26e-01
|
0.32800
|
-0.270000
|
0.186000
|
1.88e-01
|
3.63e-01
|
GOBP LEUKOCYTE CELL CELL ADHESION
|
27
|
2.97e-02
|
1.51e-01
|
0.32800
|
0.297000
|
-0.138000
|
8.09e-03
|
2.20e-01
|
GOMF SODIUM CHANNEL REGULATOR ACTIVITY
|
6
|
1.81e-01
|
4.09e-01
|
0.32800
|
0.311000
|
0.104000
|
1.89e-01
|
6.59e-01
|
GOBP DENDRITE MORPHOGENESIS
|
16
|
1.33e-01
|
3.47e-01
|
0.32800
|
0.149000
|
-0.292000
|
3.04e-01
|
4.47e-02
|
GOBP VITAMIN METABOLIC PROCESS
|
10
|
8.98e-02
|
2.82e-01
|
0.32700
|
0.325000
|
0.037100
|
7.63e-02
|
8.40e-01
|
GOBP NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION
|
14
|
7.07e-02
|
2.44e-01
|
0.32700
|
0.037900
|
-0.324000
|
8.07e-01
|
3.66e-02
|
GOBP MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION
|
7
|
1.02e-01
|
3.02e-01
|
0.32700
|
-0.229000
|
-0.232000
|
2.95e-01
|
2.89e-01
|
GOBP REGULATION OF BLOOD PRESSURE
|
28
|
2.18e-02
|
1.27e-01
|
0.32600
|
0.303000
|
-0.122000
|
6.07e-03
|
2.69e-01
|
GOBP NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY
|
6
|
4.57e-01
|
6.69e-01
|
0.32600
|
0.139000
|
-0.296000
|
5.58e-01
|
2.11e-01
|
GOBP CARDIAC SEPTUM MORPHOGENESIS
|
5
|
2.96e-01
|
5.30e-01
|
0.32600
|
-0.040800
|
-0.324000
|
8.75e-01
|
2.11e-01
|
GOBP NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION
|
17
|
8.32e-02
|
2.71e-01
|
0.32600
|
0.106000
|
-0.309000
|
4.52e-01
|
2.86e-02
|
GOBP GLUCOSE METABOLIC PROCESS
|
36
|
3.57e-03
|
4.44e-02
|
0.32600
|
0.315000
|
-0.085000
|
1.24e-03
|
3.84e-01
|
GOBP REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE
|
15
|
1.60e-01
|
3.80e-01
|
0.32600
|
0.287000
|
-0.154000
|
5.56e-02
|
3.06e-01
|
GOBP NAD BIOSYNTHETIC PROCESS
|
6
|
5.09e-01
|
7.03e-01
|
0.32600
|
-0.182000
|
0.270000
|
4.42e-01
|
2.53e-01
|
GOBP PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS
|
6
|
5.09e-01
|
7.03e-01
|
0.32600
|
-0.182000
|
0.270000
|
4.42e-01
|
2.53e-01
|
GOBP CELL SUBSTRATE ADHESION
|
33
|
1.87e-02
|
1.17e-01
|
0.32500
|
0.152000
|
-0.287000
|
1.36e-01
|
4.79e-03
|
GOBP ACUTE INFLAMMATORY RESPONSE
|
9
|
1.85e-01
|
4.12e-01
|
0.32500
|
0.323000
|
-0.037700
|
9.51e-02
|
8.45e-01
|
GOBP NUCLEOTIDE TRANSPORT
|
5
|
2.50e-01
|
4.84e-01
|
0.32400
|
0.100000
|
0.308000
|
6.98e-01
|
2.33e-01
|
GOBP PURINE NUCLEOTIDE TRANSPORT
|
5
|
2.50e-01
|
4.84e-01
|
0.32400
|
0.100000
|
0.308000
|
6.98e-01
|
2.33e-01
|
GOMF NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
5
|
2.50e-01
|
4.84e-01
|
0.32400
|
0.100000
|
0.308000
|
6.98e-01
|
2.33e-01
|
GOMF ORGANOPHOSPHATE ESTER TRANSMEMBRANE TRANSPORTER ACTIVITY
|
5
|
2.50e-01
|
4.84e-01
|
0.32400
|
0.100000
|
0.308000
|
6.98e-01
|
2.33e-01
|
GOMF PURINE NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
5
|
2.50e-01
|
4.84e-01
|
0.32400
|
0.100000
|
0.308000
|
6.98e-01
|
2.33e-01
|
GOBP FEMALE GAMETE GENERATION
|
6
|
1.48e-01
|
3.68e-01
|
0.32400
|
-0.257000
|
-0.198000
|
2.77e-01
|
4.03e-01
|
GOCC PROTEIN COMPLEX INVOLVED IN CELL ADHESION
|
5
|
3.54e-01
|
5.83e-01
|
0.32400
|
0.007520
|
-0.324000
|
9.77e-01
|
2.11e-01
|
GOMF CHROMATIN BINDING
|
59
|
2.68e-03
|
3.65e-02
|
0.32400
|
0.213000
|
-0.244000
|
5.61e-03
|
1.51e-03
|
GOBP REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY
|
6
|
5.10e-01
|
7.03e-01
|
0.32400
|
0.270000
|
-0.179000
|
2.53e-01
|
4.50e-01
|
GOBP NEGATIVE REGULATION OF MONOATOMIC ION TRANSPORT
|
13
|
2.52e-01
|
4.86e-01
|
0.32400
|
0.198000
|
-0.256000
|
2.18e-01
|
1.12e-01
|
GOMF PHOSPHATASE ACTIVITY
|
32
|
3.93e-02
|
1.76e-01
|
0.32400
|
0.229000
|
-0.228000
|
2.65e-02
|
2.73e-02
|
GOBP REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY
|
6
|
4.26e-01
|
6.43e-01
|
0.32400
|
-0.110000
|
0.304000
|
6.41e-01
|
1.98e-01
|
GOBP REGULATION OF POTASSIUM ION TRANSPORT
|
7
|
4.23e-01
|
6.40e-01
|
0.32300
|
0.287000
|
-0.148000
|
1.89e-01
|
4.99e-01
|
GOBP ORGANIC ACID TRANSPORT
|
40
|
1.74e-02
|
1.12e-01
|
0.32300
|
0.212000
|
-0.244000
|
2.24e-02
|
8.56e-03
|
GOMF MOLECULAR CARRIER ACTIVITY
|
8
|
4.30e-01
|
6.45e-01
|
0.32300
|
-0.200000
|
0.254000
|
3.29e-01
|
2.16e-01
|
GOBP REGULATION OF PROTEIN TARGETING
|
8
|
1.09e-01
|
3.13e-01
|
0.32300
|
0.105000
|
0.305000
|
6.10e-01
|
1.36e-01
|
GOBP PURINE NUCLEOTIDE CATABOLIC PROCESS
|
20
|
7.46e-02
|
2.51e-01
|
0.32300
|
0.296000
|
-0.130000
|
2.32e-02
|
3.19e-01
|
GOBP ENDODERM DEVELOPMENT
|
9
|
3.37e-01
|
5.75e-01
|
0.32300
|
0.151000
|
-0.285000
|
4.34e-01
|
1.40e-01
|
GOBP DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS
|
16
|
1.81e-01
|
4.08e-01
|
0.32300
|
0.190000
|
-0.261000
|
1.92e-01
|
7.26e-02
|
GOBP REGULATION OF DNA BIOSYNTHETIC PROCESS
|
11
|
2.34e-01
|
4.68e-01
|
0.32300
|
0.126000
|
-0.297000
|
4.71e-01
|
8.98e-02
|
GOBP AMIDE BIOSYNTHETIC PROCESS
|
16
|
9.41e-02
|
2.88e-01
|
0.32200
|
-0.308000
|
0.096000
|
3.43e-02
|
5.09e-01
|
GOMF ENDOPEPTIDASE REGULATOR ACTIVITY
|
16
|
1.36e-01
|
3.50e-01
|
0.32200
|
0.290000
|
-0.140000
|
4.60e-02
|
3.34e-01
|
GOBP NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS
|
6
|
5.40e-01
|
7.24e-01
|
0.32200
|
0.241000
|
-0.213000
|
3.08e-01
|
3.67e-01
|
GOBP CD4 POSITIVE ALPHA BETA T CELL ACTIVATION
|
7
|
4.06e-01
|
6.26e-01
|
0.32100
|
0.293000
|
-0.131000
|
1.81e-01
|
5.49e-01
|
GOMF PHOSPHATIDYLINOSITOL PHOSPHATE BINDING
|
14
|
1.93e-01
|
4.24e-01
|
0.32100
|
0.154000
|
-0.281000
|
3.21e-01
|
6.98e-02
|
GOBP RESCUE OF STALLED RIBOSOME
|
5
|
5.73e-01
|
7.45e-01
|
0.32100
|
0.172000
|
-0.271000
|
5.06e-01
|
2.96e-01
|
GOBP RIBOSOME DISASSEMBLY
|
5
|
5.73e-01
|
7.45e-01
|
0.32100
|
0.172000
|
-0.271000
|
5.06e-01
|
2.96e-01
|
GOBP NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS
|
88
|
1.77e-04
|
4.63e-03
|
0.32000
|
0.195000
|
-0.254000
|
2.25e-03
|
6.73e-05
|
GOBP REGULATION OF ORGAN GROWTH
|
8
|
4.37e-01
|
6.52e-01
|
0.32000
|
0.200000
|
-0.250000
|
3.30e-01
|
2.22e-01
|
GOCC TRANSPORTER COMPLEX
|
67
|
1.74e-09
|
1.80e-07
|
0.32000
|
0.208000
|
0.243000
|
4.19e-03
|
7.78e-04
|
GOBP PLASMA MEMBRANE ORGANIZATION
|
17
|
8.14e-02
|
2.68e-01
|
0.32000
|
0.091000
|
-0.306000
|
5.19e-01
|
2.98e-02
|
GOBP RESPONSE TO INTERLEUKIN 1
|
10
|
3.68e-01
|
5.92e-01
|
0.31900
|
0.222000
|
-0.229000
|
2.25e-01
|
2.12e-01
|
GOBP POSITIVE REGULATION OF DEVELOPMENTAL PROCESS
|
94
|
1.45e-04
|
4.03e-03
|
0.31900
|
0.214000
|
-0.236000
|
5.30e-04
|
1.34e-04
|
GOBP REGULATION OF REPRODUCTIVE PROCESS
|
9
|
3.02e-01
|
5.36e-01
|
0.31900
|
0.118000
|
-0.296000
|
5.43e-01
|
1.25e-01
|
GOBP CARDIAC CHAMBER MORPHOGENESIS
|
7
|
1.61e-01
|
3.80e-01
|
0.31900
|
-0.087800
|
-0.306000
|
6.89e-01
|
1.62e-01
|
GOBP POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT
|
11
|
8.35e-02
|
2.71e-01
|
0.31800
|
-0.032400
|
-0.317000
|
8.53e-01
|
7.02e-02
|
GOBP CALCIUM MEDIATED SIGNALING
|
15
|
1.87e-01
|
4.16e-01
|
0.31800
|
0.273000
|
-0.163000
|
6.85e-02
|
2.77e-01
|
GOCC SITE OF POLARIZED GROWTH
|
15
|
1.33e-01
|
3.47e-01
|
0.31800
|
0.113000
|
-0.298000
|
4.53e-01
|
4.73e-02
|
GOBP RECEPTOR INTERNALIZATION
|
11
|
3.36e-01
|
5.74e-01
|
0.31800
|
0.222000
|
-0.227000
|
2.04e-01
|
1.94e-01
|
GOBP MULTICELLULAR ORGANISMAL RESPONSE TO STRESS
|
10
|
2.87e-01
|
5.19e-01
|
0.31800
|
0.132000
|
-0.289000
|
4.73e-01
|
1.15e-01
|
GOBP NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION
|
14
|
1.95e-01
|
4.27e-01
|
0.31800
|
0.281000
|
-0.149000
|
7.07e-02
|
3.37e-01
|
GOBP ACTIN NUCLEATION
|
5
|
5.22e-01
|
7.09e-01
|
0.31700
|
0.121000
|
-0.293000
|
6.41e-01
|
2.57e-01
|
GOBP ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION
|
5
|
5.22e-01
|
7.09e-01
|
0.31700
|
0.121000
|
-0.293000
|
6.41e-01
|
2.57e-01
|
GOBP RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN
|
13
|
2.20e-02
|
1.27e-01
|
0.31700
|
-0.274000
|
-0.160000
|
8.90e-02
|
3.20e-01
|
GOBP TRNA METABOLIC PROCESS
|
7
|
2.00e-01
|
4.33e-01
|
0.31700
|
-0.314000
|
-0.041200
|
1.51e-01
|
8.51e-01
|
GOBP MUSCLE HYPERTROPHY
|
12
|
3.00e-01
|
5.33e-01
|
0.31700
|
0.244000
|
-0.202000
|
1.45e-01
|
2.28e-01
|
GOBP POSITIVE REGULATION OF MUSCLE HYPERTROPHY
|
6
|
4.16e-01
|
6.34e-01
|
0.31700
|
0.089700
|
-0.304000
|
7.05e-01
|
1.99e-01
|
GOBP POSITIVE REGULATION OF SECRETION
|
18
|
6.87e-02
|
2.41e-01
|
0.31600
|
0.305000
|
-0.081700
|
2.60e-02
|
5.52e-01
|
GOBP PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION
|
24
|
4.94e-02
|
2.01e-01
|
0.31600
|
0.290000
|
-0.124000
|
1.47e-02
|
2.99e-01
|
GOCC PLASMA MEMBRANE RAFT
|
8
|
4.25e-01
|
6.41e-01
|
0.31600
|
0.265000
|
-0.171000
|
1.96e-01
|
4.04e-01
|
GOMF SEQUENCE SPECIFIC DNA BINDING
|
74
|
7.70e-04
|
1.57e-02
|
0.31600
|
0.190000
|
-0.252000
|
6.03e-03
|
2.67e-04
|
GOBP MRNA TRANSCRIPTION
|
6
|
5.27e-01
|
7.14e-01
|
0.31500
|
0.172000
|
-0.264000
|
4.68e-01
|
2.64e-01
|
GOBP DENDRITE DEVELOPMENT
|
20
|
1.29e-01
|
3.43e-01
|
0.31500
|
0.182000
|
-0.257000
|
1.63e-01
|
4.84e-02
|
GOBP NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS
|
55
|
1.94e-05
|
7.60e-04
|
0.31500
|
0.005420
|
0.315000
|
9.46e-01
|
7.54e-05
|
GOMF L AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY
|
7
|
4.47e-01
|
6.61e-01
|
0.31500
|
0.278000
|
-0.147000
|
2.04e-01
|
5.01e-01
|
GOBP REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY
|
11
|
7.43e-02
|
2.50e-01
|
0.31500
|
0.309000
|
0.057300
|
7.70e-02
|
7.43e-01
|
GOMF MRNA 5 UTR BINDING
|
5
|
3.57e-01
|
5.87e-01
|
0.31400
|
0.314000
|
0.008500
|
2.25e-01
|
9.74e-01
|
GOBP SENSORY ORGAN MORPHOGENESIS
|
15
|
2.32e-01
|
4.66e-01
|
0.31400
|
0.206000
|
-0.237000
|
1.69e-01
|
1.15e-01
|
GOBP MITOCHONDRIAL MEMBRANE ORGANIZATION
|
19
|
3.78e-02
|
1.72e-01
|
0.31400
|
-0.039100
|
0.311000
|
7.70e-01
|
1.97e-02
|
GOMF MONOCARBOXYLIC ACID BINDING
|
12
|
3.40e-02
|
1.61e-01
|
0.31400
|
0.145000
|
0.278000
|
3.89e-01
|
9.65e-02
|
GOMF RRNA BINDING
|
8
|
1.84e-01
|
4.12e-01
|
0.31400
|
0.020100
|
0.313000
|
9.22e-01
|
1.27e-01
|
GOBP CELL ADHESION
|
100
|
1.09e-04
|
3.20e-03
|
0.31300
|
0.202000
|
-0.240000
|
7.90e-04
|
6.69e-05
|
GOBP REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING
|
6
|
2.54e-01
|
4.87e-01
|
0.31300
|
-0.046500
|
-0.310000
|
8.44e-01
|
1.90e-01
|
GOMF ORGANIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY
|
23
|
7.57e-02
|
2.53e-01
|
0.31300
|
0.147000
|
-0.276000
|
2.26e-01
|
2.31e-02
|
GOCC PLATELET ALPHA GRANULE LUMEN
|
6
|
4.58e-01
|
6.69e-01
|
0.31300
|
0.111000
|
-0.292000
|
6.37e-01
|
2.17e-01
|
GOBP REGULATION OF TRANSLATION
|
47
|
1.19e-02
|
9.14e-02
|
0.31200
|
-0.204000
|
0.236000
|
1.73e-02
|
5.90e-03
|
GOBP ADHERENS JUNCTION ORGANIZATION
|
5
|
2.24e-01
|
4.59e-01
|
0.31200
|
0.220000
|
0.222000
|
3.96e-01
|
3.91e-01
|
GOBP RESPONSE TO OSMOTIC STRESS
|
12
|
3.05e-01
|
5.39e-01
|
0.31200
|
0.248000
|
-0.190000
|
1.39e-01
|
2.58e-01
|
GOBP CLATHRIN DEPENDENT ENDOCYTOSIS
|
6
|
3.14e-01
|
5.48e-01
|
0.31200
|
0.006540
|
-0.312000
|
9.78e-01
|
1.87e-01
|
GOBP BONE MORPHOGENESIS
|
10
|
2.68e-01
|
5.03e-01
|
0.31200
|
0.107000
|
-0.293000
|
5.60e-01
|
1.10e-01
|
GOBP CEREBELLAR CORTEX DEVELOPMENT
|
6
|
5.13e-01
|
7.05e-01
|
0.31200
|
0.273000
|
-0.152000
|
2.49e-01
|
5.22e-01
|
GOBP EPITHELIAL CELL APOPTOTIC PROCESS
|
7
|
5.08e-01
|
7.02e-01
|
0.31200
|
0.235000
|
-0.205000
|
2.82e-01
|
3.50e-01
|
GOBP MRNA TRANSPORT
|
9
|
3.74e-01
|
5.95e-01
|
0.31200
|
0.155000
|
-0.270000
|
4.22e-01
|
1.62e-01
|
GOCC GOLGI LUMEN
|
6
|
4.05e-01
|
6.26e-01
|
0.31200
|
0.073300
|
-0.303000
|
7.57e-01
|
2.00e-01
|
GOMF LIPID TRANSFER ACTIVITY
|
11
|
3.37e-01
|
5.75e-01
|
0.31200
|
0.247000
|
-0.189000
|
1.57e-01
|
2.79e-01
|
GOCC SMOOTH ENDOPLASMIC RETICULUM
|
5
|
5.45e-01
|
7.27e-01
|
0.31100
|
-0.126000
|
0.284000
|
6.26e-01
|
2.72e-01
|
GOCC AZUROPHIL GRANULE MEMBRANE
|
6
|
4.91e-01
|
6.90e-01
|
0.31100
|
-0.282000
|
0.131000
|
2.33e-01
|
5.80e-01
|
GOMF UBIQUITIN SPECIFIC PROTEASE BINDING
|
5
|
4.61e-01
|
6.70e-01
|
0.31100
|
0.064400
|
-0.304000
|
8.04e-01
|
2.40e-01
|
GOBP RESPONSE TO CAMP
|
11
|
1.12e-01
|
3.19e-01
|
0.31000
|
0.310000
|
0.007610
|
7.60e-02
|
9.65e-01
|
GOBP CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN
|
9
|
1.11e-01
|
3.18e-01
|
0.31000
|
-0.079100
|
-0.300000
|
6.83e-01
|
1.20e-01
|
GOBP NEURON MIGRATION
|
13
|
2.23e-01
|
4.59e-01
|
0.31000
|
0.136000
|
-0.279000
|
3.98e-01
|
8.34e-02
|
GOBP STEROID BIOSYNTHETIC PROCESS
|
19
|
1.16e-01
|
3.25e-01
|
0.31000
|
0.277000
|
-0.140000
|
3.79e-02
|
2.96e-01
|
GOBP NON PROTEINOGENIC AMINO ACID METABOLIC PROCESS
|
13
|
2.07e-01
|
4.39e-01
|
0.31000
|
-0.123000
|
0.285000
|
4.47e-01
|
7.71e-02
|
GOCC CENTRIOLAR SATELLITE
|
14
|
2.40e-01
|
4.74e-01
|
0.31000
|
0.170000
|
-0.259000
|
2.72e-01
|
9.59e-02
|
GOBP NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION
|
6
|
3.64e-01
|
5.91e-01
|
0.30900
|
0.307000
|
-0.039200
|
1.95e-01
|
8.68e-01
|
GOBP DOUBLE STRAND BREAK REPAIR
|
17
|
1.94e-01
|
4.25e-01
|
0.30800
|
0.187000
|
-0.245000
|
1.84e-01
|
8.24e-02
|
GOBP INTERLEUKIN 1 PRODUCTION
|
7
|
5.11e-01
|
7.03e-01
|
0.30800
|
0.192000
|
-0.241000
|
3.80e-01
|
2.71e-01
|
GOBP MITOCHONDRION ORGANIZATION
|
55
|
5.70e-04
|
1.22e-02
|
0.30700
|
-0.082100
|
0.296000
|
3.03e-01
|
1.94e-04
|
GOBP HEPATICOBILIARY SYSTEM DEVELOPMENT
|
19
|
1.68e-01
|
3.89e-01
|
0.30700
|
0.238000
|
-0.194000
|
7.45e-02
|
1.46e-01
|
GOCC RECYCLING ENDOSOME
|
18
|
1.42e-02
|
1.01e-01
|
0.30700
|
-0.076900
|
-0.297000
|
5.75e-01
|
3.01e-02
|
GOBP REACTIVE OXYGEN SPECIES METABOLIC PROCESS
|
29
|
2.63e-02
|
1.41e-01
|
0.30700
|
-0.105000
|
0.288000
|
3.33e-01
|
7.85e-03
|
GOBP NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION
|
12
|
3.14e-01
|
5.48e-01
|
0.30700
|
-0.247000
|
0.182000
|
1.41e-01
|
2.77e-01
|
GOBP MONONUCLEAR CELL MIGRATION
|
15
|
2.46e-01
|
4.81e-01
|
0.30700
|
0.235000
|
-0.196000
|
1.17e-01
|
1.91e-01
|
GOBP REGULATION OF LIPID BIOSYNTHETIC PROCESS
|
18
|
9.58e-02
|
2.90e-01
|
0.30600
|
0.291000
|
-0.096900
|
3.40e-02
|
4.80e-01
|
GOBP NEGATIVE REGULATION OF DNA METABOLIC PROCESS
|
11
|
3.52e-01
|
5.82e-01
|
0.30600
|
0.188000
|
-0.242000
|
2.82e-01
|
1.67e-01
|
GOCC BLOOD MICROPARTICLE
|
9
|
4.08e-01
|
6.26e-01
|
0.30600
|
-0.255000
|
0.169000
|
1.87e-01
|
3.81e-01
|
GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN LINEAR AMIDES
|
9
|
3.13e-01
|
5.47e-01
|
0.30600
|
-0.099500
|
0.289000
|
6.07e-01
|
1.34e-01
|
GOBP AMYLOID BETA FORMATION
|
8
|
3.96e-01
|
6.18e-01
|
0.30600
|
0.278000
|
-0.127000
|
1.75e-01
|
5.36e-01
|
GOMF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY
|
42
|
2.05e-02
|
1.24e-01
|
0.30600
|
0.242000
|
-0.187000
|
7.63e-03
|
3.90e-02
|
GOBP REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT
|
94
|
3.07e-04
|
7.16e-03
|
0.30600
|
0.209000
|
-0.223000
|
7.54e-04
|
3.06e-04
|
GOCC PLASMA MEMBRANE SIGNALING RECEPTOR COMPLEX
|
12
|
3.10e-01
|
5.43e-01
|
0.30600
|
0.251000
|
-0.174000
|
1.34e-01
|
3.00e-01
|
GOBP AMINO ACID TRANSPORT
|
15
|
2.54e-01
|
4.87e-01
|
0.30500
|
0.209000
|
-0.223000
|
1.64e-01
|
1.38e-01
|
GOCC CYTOPLASMIC MICROTUBULE
|
7
|
2.90e-01
|
5.23e-01
|
0.30500
|
-0.018000
|
0.305000
|
9.35e-01
|
1.64e-01
|
GOBP MORPHOGENESIS OF A BRANCHING STRUCTURE
|
15
|
2.55e-01
|
4.87e-01
|
0.30500
|
0.207000
|
-0.224000
|
1.69e-01
|
1.36e-01
|
GOBP HOMOTYPIC CELL CELL ADHESION
|
10
|
4.03e-01
|
6.25e-01
|
0.30400
|
-0.212000
|
0.218000
|
2.48e-01
|
2.34e-01
|
GOBP ADRENERGIC RECEPTOR SIGNALING PATHWAY
|
5
|
5.22e-01
|
7.09e-01
|
0.30400
|
0.289000
|
-0.095100
|
2.65e-01
|
7.13e-01
|
GOBP TRANSITION METAL ION TRANSPORT
|
8
|
1.94e-01
|
4.25e-01
|
0.30300
|
0.031100
|
0.302000
|
8.79e-01
|
1.41e-01
|
GOBP NEGATIVE REGULATION OF AMIDE METABOLIC PROCESS
|
6
|
4.73e-01
|
6.79e-01
|
0.30300
|
0.285000
|
-0.103000
|
2.28e-01
|
6.63e-01
|
GOBP NEGATIVE REGULATION OF LOCOMOTION
|
23
|
1.17e-01
|
3.28e-01
|
0.30300
|
0.182000
|
-0.243000
|
1.35e-01
|
4.59e-02
|
GOBP RESPONSE TO ACTIVITY
|
8
|
1.12e-01
|
3.19e-01
|
0.30300
|
0.168000
|
0.252000
|
4.13e-01
|
2.18e-01
|
GOBP RESPONSE TO KETONE
|
25
|
4.71e-02
|
1.95e-01
|
0.30300
|
0.284000
|
-0.105000
|
1.48e-02
|
3.70e-01
|
GOBP NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS
|
5
|
4.35e-01
|
6.51e-01
|
0.30300
|
0.301000
|
-0.030400
|
2.45e-01
|
9.07e-01
|
GOBP NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS
|
5
|
4.35e-01
|
6.51e-01
|
0.30300
|
0.301000
|
-0.030400
|
2.45e-01
|
9.07e-01
|
GOMF ENZYME ACTIVATOR ACTIVITY
|
62
|
3.36e-03
|
4.30e-02
|
0.30300
|
0.174000
|
-0.248000
|
2.10e-02
|
9.74e-04
|
GOBP REGULATION OF MACROPHAGE MIGRATION
|
5
|
5.69e-01
|
7.42e-01
|
0.30300
|
0.275000
|
-0.127000
|
2.89e-01
|
6.23e-01
|
GOMF PHOSPHATASE REGULATOR ACTIVITY
|
14
|
2.18e-01
|
4.54e-01
|
0.30200
|
0.134000
|
-0.271000
|
3.88e-01
|
8.10e-02
|
GOBP CEREBRAL CORTEX CELL MIGRATION
|
7
|
4.86e-01
|
6.88e-01
|
0.30200
|
0.149000
|
-0.263000
|
4.95e-01
|
2.31e-01
|
GOBP FOREBRAIN CELL MIGRATION
|
7
|
4.86e-01
|
6.88e-01
|
0.30200
|
0.149000
|
-0.263000
|
4.95e-01
|
2.31e-01
|
GOBP SMALL MOLECULE METABOLIC PROCESS
|
256
|
6.28e-12
|
8.08e-10
|
0.30200
|
-0.102000
|
0.284000
|
1.18e-02
|
1.56e-12
|
GOMF HISTONE MODIFYING ACTIVITY
|
16
|
2.04e-01
|
4.38e-01
|
0.30200
|
0.157000
|
-0.258000
|
2.80e-01
|
7.62e-02
|
GOBP REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE
|
6
|
5.51e-01
|
7.32e-01
|
0.30100
|
-0.159000
|
0.256000
|
5.02e-01
|
2.79e-01
|
GOMF LIPID TRANSMEMBRANE TRANSPORTER ACTIVITY
|
8
|
1.59e-01
|
3.79e-01
|
0.30100
|
-0.291000
|
-0.077400
|
1.56e-01
|
7.06e-01
|
GOBP GENERATION OF NEURONS
|
128
|
2.39e-05
|
8.97e-04
|
0.30100
|
0.186000
|
-0.236000
|
5.59e-04
|
1.11e-05
|
GOBP SMOOTHENED SIGNALING PATHWAY
|
12
|
1.23e-01
|
3.35e-01
|
0.30000
|
0.011200
|
-0.300000
|
9.47e-01
|
7.34e-02
|
GOBP INTERLEUKIN 6 PRODUCTION
|
7
|
5.36e-01
|
7.20e-01
|
0.30000
|
0.201000
|
-0.223000
|
3.60e-01
|
3.08e-01
|
GOBP APOPTOTIC MITOCHONDRIAL CHANGES
|
14
|
1.55e-01
|
3.74e-01
|
0.30000
|
-0.079800
|
0.289000
|
6.07e-01
|
6.28e-02
|
GOBP MESONEPHROS DEVELOPMENT
|
7
|
4.68e-01
|
6.75e-01
|
0.29900
|
0.270000
|
-0.130000
|
2.18e-01
|
5.54e-01
|
GOMF STRUCTURAL MOLECULE ACTIVITY
|
72
|
1.30e-08
|
9.77e-07
|
0.29900
|
0.155000
|
0.256000
|
2.75e-02
|
2.58e-04
|
GOCC CELL BODY
|
42
|
2.44e-02
|
1.35e-01
|
0.29900
|
0.183000
|
-0.236000
|
4.35e-02
|
9.13e-03
|
GOBP PROGRAMMED NECROTIC CELL DEATH
|
5
|
6.42e-01
|
7.94e-01
|
0.29900
|
0.224000
|
-0.198000
|
3.87e-01
|
4.45e-01
|
GOBP NUCLEAR RECEPTOR MEDIATED CORTICOSTEROID SIGNALING PATHWAY
|
5
|
4.93e-01
|
6.92e-01
|
0.29900
|
-0.292000
|
0.064700
|
2.60e-01
|
8.03e-01
|
GOBP INTERLEUKIN 1 BETA PRODUCTION
|
5
|
3.96e-01
|
6.17e-01
|
0.29800
|
-0.008170
|
-0.298000
|
9.75e-01
|
2.49e-01
|
GOBP TUBE CLOSURE
|
7
|
5.39e-01
|
7.23e-01
|
0.29800
|
0.193000
|
-0.227000
|
3.78e-01
|
3.01e-01
|
GOBP SYNAPTIC SIGNALING
|
54
|
6.82e-03
|
6.61e-02
|
0.29700
|
0.159000
|
-0.251000
|
4.74e-02
|
1.76e-03
|
GOBP REGULATION OF NUCLEAR DIVISION
|
10
|
4.07e-01
|
6.26e-01
|
0.29700
|
0.181000
|
-0.236000
|
3.24e-01
|
1.99e-01
|
GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION
|
6
|
5.55e-01
|
7.34e-01
|
0.29700
|
-0.152000
|
0.255000
|
5.22e-01
|
2.80e-01
|
GOBP REGULATION OF INSULIN SECRETION
|
8
|
1.23e-01
|
3.34e-01
|
0.29700
|
0.164000
|
0.247000
|
4.24e-01
|
2.27e-01
|
GOBP MESODERM MORPHOGENESIS
|
5
|
4.89e-01
|
6.89e-01
|
0.29600
|
0.057500
|
-0.291000
|
8.24e-01
|
2.61e-01
|
GOMF PROTEIN TRANSPORTER ACTIVITY
|
6
|
4.78e-01
|
6.83e-01
|
0.29600
|
-0.281000
|
0.093500
|
2.34e-01
|
6.93e-01
|
GOBP TRNA PROCESSING
|
6
|
2.26e-01
|
4.61e-01
|
0.29600
|
-0.268000
|
-0.125000
|
2.56e-01
|
5.96e-01
|
GOBP REGULATION OF VASOCONSTRICTION
|
5
|
5.44e-01
|
7.25e-01
|
0.29600
|
0.280000
|
-0.095800
|
2.79e-01
|
7.12e-01
|
GOBP VASOCONSTRICTION
|
5
|
5.44e-01
|
7.25e-01
|
0.29600
|
0.280000
|
-0.095800
|
2.79e-01
|
7.12e-01
|
GOMF MOLECULAR CONDENSATE SCAFFOLD ACTIVITY
|
5
|
2.76e-01
|
5.08e-01
|
0.29600
|
0.255000
|
0.150000
|
3.24e-01
|
5.62e-01
|
GOCC RNA POLYMERASE II TRANSCRIPTION REGULATOR COMPLEX
|
20
|
1.76e-01
|
4.02e-01
|
0.29600
|
0.228000
|
-0.188000
|
7.96e-02
|
1.48e-01
|
GOBP RESPONSE TO ETHANOL
|
14
|
3.38e-02
|
1.61e-01
|
0.29600
|
0.117000
|
0.272000
|
4.53e-01
|
7.98e-02
|
GOBP NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION
|
59
|
3.46e-04
|
7.93e-03
|
0.29600
|
0.289000
|
-0.060800
|
1.67e-04
|
4.30e-01
|
GOBP REGULATION OF TRANSLATIONAL INITIATION
|
11
|
2.56e-01
|
4.87e-01
|
0.29600
|
-0.282000
|
0.089400
|
1.07e-01
|
6.09e-01
|
GOMF CHLORIDE CHANNEL ACTIVITY
|
5
|
5.04e-01
|
7.00e-01
|
0.29500
|
0.288000
|
-0.065000
|
2.67e-01
|
8.02e-01
|
GOBP REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION
|
17
|
1.36e-02
|
9.87e-02
|
0.29500
|
-0.255000
|
-0.149000
|
7.12e-02
|
2.92e-01
|
GOBP RNA MODIFICATION
|
10
|
3.91e-01
|
6.13e-01
|
0.29500
|
-0.249000
|
0.158000
|
1.75e-01
|
3.90e-01
|
GOBP NON PROTEINOGENIC AMINO ACID CATABOLIC PROCESS
|
6
|
2.71e-01
|
5.05e-01
|
0.29400
|
0.072000
|
0.285000
|
7.61e-01
|
2.27e-01
|
GOCC ORGANELLE ENVELOPE
|
183
|
1.76e-08
|
1.29e-06
|
0.29400
|
-0.110000
|
0.273000
|
1.70e-02
|
3.04e-09
|
GOBP ACTIN POLYMERIZATION OR DEPOLYMERIZATION
|
14
|
2.37e-01
|
4.70e-01
|
0.29400
|
0.130000
|
-0.263000
|
4.01e-01
|
8.97e-02
|
GOMF CELL CELL ADHESION MEDIATOR ACTIVITY
|
6
|
3.77e-01
|
5.98e-01
|
0.29400
|
0.019100
|
-0.293000
|
9.36e-01
|
2.15e-01
|
GOMF SECONDARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
31
|
4.96e-02
|
2.01e-01
|
0.29300
|
0.141000
|
-0.257000
|
1.81e-01
|
1.43e-02
|
GOBP REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS
|
13
|
2.38e-01
|
4.71e-01
|
0.29300
|
0.112000
|
-0.271000
|
4.89e-01
|
9.26e-02
|
GOBP REGULATION OF B CELL ACTIVATION
|
8
|
2.67e-01
|
5.03e-01
|
0.29300
|
0.293000
|
-0.013900
|
1.53e-01
|
9.46e-01
|
GOBP CELL FATE COMMITMENT
|
18
|
1.67e-01
|
3.88e-01
|
0.29300
|
0.135000
|
-0.260000
|
3.24e-01
|
5.83e-02
|
GOBP REGULATION OF LOCOMOTION
|
75
|
2.01e-03
|
2.95e-02
|
0.29300
|
0.179000
|
-0.232000
|
9.42e-03
|
7.35e-04
|
GOMF PROTEIN TYROSINE KINASE ACTIVITY
|
15
|
1.30e-01
|
3.44e-01
|
0.29200
|
0.061300
|
-0.286000
|
6.83e-01
|
5.66e-02
|
GOMF BASIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY
|
5
|
5.43e-01
|
7.25e-01
|
0.29200
|
0.086600
|
-0.279000
|
7.38e-01
|
2.82e-01
|
GOBP NUCLEOTIDE METABOLIC PROCESS
|
73
|
3.32e-08
|
2.36e-06
|
0.29200
|
0.139000
|
0.257000
|
4.63e-02
|
2.24e-04
|
GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION
|
6
|
5.33e-01
|
7.17e-01
|
0.29200
|
0.122000
|
-0.265000
|
6.06e-01
|
2.63e-01
|
GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR
|
8
|
3.54e-01
|
5.83e-01
|
0.29200
|
-0.071600
|
0.283000
|
7.27e-01
|
1.68e-01
|
GOBP FOCAL ADHESION ASSEMBLY
|
13
|
2.54e-01
|
4.87e-01
|
0.29200
|
0.119000
|
-0.266000
|
4.60e-01
|
9.85e-02
|
GOBP CELL SURFACE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY
|
55
|
1.05e-02
|
8.50e-02
|
0.29100
|
0.229000
|
-0.180000
|
4.03e-03
|
2.38e-02
|
GOCC ADHERENS JUNCTION
|
15
|
2.29e-01
|
4.63e-01
|
0.29100
|
0.135000
|
-0.258000
|
3.68e-01
|
8.61e-02
|
GOMF PHOSPHOLIPID BINDING
|
44
|
1.66e-02
|
1.09e-01
|
0.29100
|
0.143000
|
-0.253000
|
1.06e-01
|
4.27e-03
|
GOMF TRANSFERASE ACTIVITY TRANSFERRING ONE CARBON GROUPS
|
18
|
9.17e-02
|
2.86e-01
|
0.29100
|
-0.284000
|
0.063000
|
3.84e-02
|
6.46e-01
|
GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION
|
8
|
4.96e-01
|
6.95e-01
|
0.29100
|
-0.170000
|
0.236000
|
4.06e-01
|
2.50e-01
|
GOBP REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS
|
6
|
6.07e-01
|
7.70e-01
|
0.29100
|
0.209000
|
-0.202000
|
3.77e-01
|
3.93e-01
|
GOCC DENDRITIC TREE
|
46
|
1.08e-02
|
8.62e-02
|
0.29100
|
0.128000
|
-0.261000
|
1.41e-01
|
2.61e-03
|
GOBP TYPE B PANCREATIC CELL PROLIFERATION
|
5
|
2.76e-01
|
5.08e-01
|
0.29000
|
0.217000
|
0.192000
|
4.01e-01
|
4.57e-01
|
GOMF CELL ADHESION MEDIATOR ACTIVITY
|
7
|
4.87e-01
|
6.88e-01
|
0.29000
|
0.123000
|
-0.263000
|
5.74e-01
|
2.31e-01
|
GOMF PEPTIDASE REGULATOR ACTIVITY
|
17
|
1.92e-01
|
4.22e-01
|
0.29000
|
0.256000
|
-0.135000
|
6.90e-02
|
3.40e-01
|
GOCC ORGANELLE MEMBRANE CONTACT SITE
|
7
|
4.38e-01
|
6.53e-01
|
0.28900
|
0.090000
|
-0.275000
|
6.81e-01
|
2.09e-01
|
GOBP WNT SIGNALING PATHWAY
|
37
|
4.39e-02
|
1.88e-01
|
0.28900
|
0.170000
|
-0.234000
|
7.77e-02
|
1.53e-02
|
GOBP REGULATION OF CELLULAR COMPONENT SIZE
|
33
|
5.19e-02
|
2.05e-01
|
0.28900
|
0.151000
|
-0.246000
|
1.40e-01
|
1.57e-02
|
GOBP NEURAL TUBE FORMATION
|
8
|
4.79e-01
|
6.84e-01
|
0.28900
|
0.148000
|
-0.248000
|
4.70e-01
|
2.27e-01
|
GOBP REGULATION OF CELL CELL ADHESION
|
30
|
3.45e-02
|
1.62e-01
|
0.28900
|
0.272000
|
-0.095900
|
1.08e-02
|
3.69e-01
|
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR
|
8
|
1.31e-01
|
3.44e-01
|
0.28800
|
0.208000
|
0.200000
|
3.10e-01
|
3.30e-01
|
GOBP LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY
|
8
|
2.20e-01
|
4.55e-01
|
0.28800
|
0.286000
|
0.036200
|
1.63e-01
|
8.60e-01
|
GOBP NEUROGENESIS
|
143
|
8.10e-06
|
3.31e-04
|
0.28800
|
0.149000
|
-0.246000
|
3.58e-03
|
1.48e-06
|
GOBP REGULATION OF MYELOID CELL DIFFERENTIATION
|
14
|
1.19e-01
|
3.29e-01
|
0.28800
|
0.287000
|
-0.025300
|
6.45e-02
|
8.71e-01
|
GOBP CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION
|
15
|
2.80e-01
|
5.11e-01
|
0.28700
|
0.232000
|
-0.169000
|
1.22e-01
|
2.60e-01
|
GOBP NEGATIVE REGULATION OF REPRODUCTIVE PROCESS
|
5
|
2.98e-01
|
5.31e-01
|
0.28700
|
-0.247000
|
-0.146000
|
3.40e-01
|
5.72e-01
|
GOCC PHAGOCYTIC VESICLE MEMBRANE
|
8
|
5.14e-01
|
7.06e-01
|
0.28600
|
-0.176000
|
0.226000
|
3.91e-01
|
2.70e-01
|
GOBP THIOESTER BIOSYNTHETIC PROCESS
|
7
|
5.56e-01
|
7.34e-01
|
0.28600
|
-0.172000
|
0.229000
|
4.33e-01
|
2.96e-01
|
GOBP RIBONUCLEOPROTEIN COMPLEX BIOGENESIS
|
44
|
9.25e-04
|
1.72e-02
|
0.28600
|
-0.003570
|
0.286000
|
9.68e-01
|
1.25e-03
|
GOMF METAL CLUSTER BINDING
|
15
|
2.83e-01
|
5.15e-01
|
0.28600
|
-0.167000
|
0.232000
|
2.67e-01
|
1.22e-01
|
GOBP REGULATION OF CELL JUNCTION ASSEMBLY
|
26
|
1.23e-01
|
3.35e-01
|
0.28600
|
0.182000
|
-0.220000
|
1.11e-01
|
5.51e-02
|
GOMF HSP70 PROTEIN BINDING
|
6
|
3.21e-01
|
5.55e-01
|
0.28500
|
-0.282000
|
-0.043100
|
2.33e-01
|
8.56e-01
|
GOCC SITE OF DOUBLE STRAND BREAK
|
5
|
5.52e-01
|
7.32e-01
|
0.28500
|
0.079700
|
-0.274000
|
7.58e-01
|
2.91e-01
|
GOBP SKELETAL SYSTEM DEVELOPMENT
|
42
|
3.64e-02
|
1.67e-01
|
0.28400
|
0.181000
|
-0.219000
|
4.62e-02
|
1.55e-02
|
GOBP POSITIVE REGULATION OF MAPK CASCADE
|
31
|
5.75e-02
|
2.17e-01
|
0.28400
|
0.251000
|
-0.132000
|
1.68e-02
|
2.08e-01
|
GOBP CORTICAL MICROTUBULE ORGANIZATION
|
5
|
5.25e-01
|
7.12e-01
|
0.28400
|
0.058500
|
-0.277000
|
8.21e-01
|
2.84e-01
|
GOBP INNER MITOCHONDRIAL MEMBRANE ORGANIZATION
|
8
|
3.69e-01
|
5.93e-01
|
0.28400
|
-0.065700
|
0.276000
|
7.49e-01
|
1.78e-01
|
GOBP CELL JUNCTION ORGANIZATION
|
79
|
2.70e-03
|
3.67e-02
|
0.28300
|
0.207000
|
-0.194000
|
2.06e-03
|
3.87e-03
|
GOBP MICROTUBULE BASED TRANSPORT
|
17
|
3.19e-02
|
1.58e-01
|
0.28300
|
-0.274000
|
-0.073500
|
5.24e-02
|
6.03e-01
|
GOBP POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS
|
10
|
4.30e-01
|
6.45e-01
|
0.28300
|
0.234000
|
-0.159000
|
2.02e-01
|
3.86e-01
|
GOBP REGULATION OF KETONE METABOLIC PROCESS
|
16
|
2.18e-01
|
4.53e-01
|
0.28300
|
0.254000
|
-0.125000
|
8.09e-02
|
3.91e-01
|
GOBP GLYCOSYLATION
|
17
|
3.56e-02
|
1.65e-01
|
0.28200
|
-0.275000
|
-0.063400
|
5.10e-02
|
6.53e-01
|
GOBP ENDOSOMAL TRANSPORT
|
30
|
2.72e-02
|
1.43e-01
|
0.28200
|
0.068500
|
-0.274000
|
5.21e-01
|
1.02e-02
|
GOBP NEGATIVE REGULATION OF MOLECULAR FUNCTION
|
28
|
1.13e-01
|
3.20e-01
|
0.28200
|
0.184000
|
-0.214000
|
9.51e-02
|
5.29e-02
|
GOBP NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION
|
6
|
6.11e-01
|
7.70e-01
|
0.28200
|
0.167000
|
-0.228000
|
4.81e-01
|
3.36e-01
|
GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS
|
6
|
4.21e-01
|
6.39e-01
|
0.28200
|
0.028100
|
-0.280000
|
9.06e-01
|
2.36e-01
|
GOBP METANEPHRIC EPITHELIUM DEVELOPMENT
|
5
|
5.51e-01
|
7.32e-01
|
0.28200
|
0.272000
|
-0.073200
|
2.94e-01
|
7.77e-01
|
GOBP METANEPHRIC TUBULE DEVELOPMENT
|
5
|
5.51e-01
|
7.32e-01
|
0.28200
|
0.272000
|
-0.073200
|
2.94e-01
|
7.77e-01
|
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR
|
16
|
2.11e-02
|
1.26e-01
|
0.28200
|
0.193000
|
0.205000
|
1.83e-01
|
1.60e-01
|
GOBP NEURON RECOGNITION
|
6
|
5.99e-01
|
7.66e-01
|
0.28100
|
0.237000
|
-0.152000
|
3.17e-01
|
5.19e-01
|
GOCC EUKARYOTIC 48S PREINITIATION COMPLEX
|
5
|
6.77e-01
|
8.14e-01
|
0.28100
|
-0.196000
|
0.202000
|
4.49e-01
|
4.36e-01
|
GOCC EXTRINSIC COMPONENT OF PLASMA MEMBRANE
|
10
|
4.60e-01
|
6.70e-01
|
0.28100
|
-0.202000
|
0.195000
|
2.71e-01
|
2.87e-01
|
GOBP RESPIRATORY SYSTEM DEVELOPMENT
|
20
|
2.15e-01
|
4.50e-01
|
0.28100
|
0.200000
|
-0.198000
|
1.25e-01
|
1.29e-01
|
GOBP LOCOMOTION
|
80
|
2.50e-03
|
3.50e-02
|
0.28000
|
0.175000
|
-0.219000
|
8.58e-03
|
1.04e-03
|
GOBP BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE
|
11
|
3.26e-01
|
5.62e-01
|
0.28000
|
0.105000
|
-0.260000
|
5.49e-01
|
1.38e-01
|
GOBP RESPONSE TO FATTY ACID
|
10
|
1.01e-01
|
3.00e-01
|
0.28000
|
0.241000
|
0.143000
|
1.89e-01
|
4.37e-01
|
GOCC CILIARY BASAL BODY
|
18
|
1.20e-01
|
3.30e-01
|
0.28000
|
0.070400
|
-0.271000
|
6.08e-01
|
4.82e-02
|
GOCC SARCOPLASMIC RETICULUM
|
9
|
2.94e-01
|
5.27e-01
|
0.28000
|
0.037700
|
-0.277000
|
8.45e-01
|
1.52e-01
|
GOBP CELLULAR RESPONSE TO TYPE II INTERFERON
|
8
|
5.36e-01
|
7.20e-01
|
0.27900
|
-0.180000
|
0.214000
|
3.79e-01
|
2.97e-01
|
GOBP EMBRYO IMPLANTATION
|
11
|
3.41e-01
|
5.76e-01
|
0.27900
|
0.112000
|
-0.256000
|
5.21e-01
|
1.44e-01
|
GOBP CELL MORPHOGENESIS
|
90
|
9.03e-04
|
1.71e-02
|
0.27900
|
0.154000
|
-0.233000
|
1.49e-02
|
2.24e-04
|
GOBP REGULATION OF PEPTIDE TRANSPORT
|
9
|
1.26e-01
|
3.38e-01
|
0.27900
|
0.150000
|
0.235000
|
4.38e-01
|
2.24e-01
|
GOBP TAXIS
|
23
|
1.63e-01
|
3.83e-01
|
0.27800
|
0.165000
|
-0.224000
|
1.74e-01
|
6.54e-02
|
GOMF COPPER ION BINDING
|
5
|
6.79e-01
|
8.14e-01
|
0.27800
|
-0.179000
|
0.213000
|
4.89e-01
|
4.11e-01
|
GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR
|
10
|
3.87e-01
|
6.08e-01
|
0.27800
|
0.253000
|
-0.116000
|
1.69e-01
|
5.26e-01
|
GOBP REGULATION OF BONE MINERALIZATION
|
6
|
6.07e-01
|
7.70e-01
|
0.27800
|
0.151000
|
-0.234000
|
5.24e-01
|
3.23e-01
|
GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II
|
95
|
1.19e-03
|
2.09e-02
|
0.27800
|
0.196000
|
-0.197000
|
1.46e-03
|
1.38e-03
|
GOBP REGULATION OF CELL SUBSTRATE ADHESION
|
21
|
7.06e-02
|
2.44e-01
|
0.27800
|
0.050400
|
-0.273000
|
6.92e-01
|
3.15e-02
|
GOBP MYOBLAST DIFFERENTIATION
|
8
|
4.36e-01
|
6.52e-01
|
0.27800
|
-0.096400
|
0.260000
|
6.38e-01
|
2.04e-01
|
GOBP ORGANELLE MEMBRANE FUSION
|
10
|
1.49e-01
|
3.70e-01
|
0.27800
|
-0.271000
|
-0.062100
|
1.40e-01
|
7.35e-01
|
GOMF PROTEASE BINDING
|
12
|
2.62e-01
|
4.96e-01
|
0.27800
|
0.266000
|
-0.079400
|
1.12e-01
|
6.36e-01
|
GOBP BONE MINERALIZATION
|
7
|
5.22e-01
|
7.09e-01
|
0.27700
|
0.121000
|
-0.250000
|
5.81e-01
|
2.54e-01
|
GOBP FOREBRAIN DEVELOPMENT
|
25
|
1.48e-01
|
3.68e-01
|
0.27700
|
0.173000
|
-0.216000
|
1.38e-01
|
6.37e-02
|
GOBP MONOCARBOXYLIC ACID TRANSPORT
|
23
|
1.79e-01
|
4.06e-01
|
0.27700
|
0.199000
|
-0.193000
|
1.01e-01
|
1.13e-01
|
GOBP REGULATION OF PHOSPHOLIPID METABOLIC PROCESS
|
6
|
5.28e-01
|
7.14e-01
|
0.27700
|
-0.089700
|
0.262000
|
7.05e-01
|
2.67e-01
|
GOBP POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS
|
12
|
4.03e-01
|
6.25e-01
|
0.27700
|
0.184000
|
-0.207000
|
2.71e-01
|
2.18e-01
|
GOBP PROTEIN LOCALIZATION TO CELL PERIPHERY
|
40
|
4.86e-02
|
2.00e-01
|
0.27700
|
0.172000
|
-0.217000
|
6.46e-02
|
1.92e-02
|
GOBP REGULATION OF SYNAPTIC PLASTICITY
|
19
|
2.39e-01
|
4.72e-01
|
0.27600
|
0.209000
|
-0.180000
|
1.17e-01
|
1.77e-01
|
GOBP FIBROBLAST PROLIFERATION
|
12
|
2.83e-01
|
5.15e-01
|
0.27600
|
-0.090000
|
0.261000
|
5.91e-01
|
1.19e-01
|
GOBP REGULATION OF CELL SHAPE
|
15
|
1.32e-01
|
3.45e-01
|
0.27600
|
0.032500
|
-0.274000
|
8.29e-01
|
6.76e-02
|
GOBP REGULATION OF CELLULAR RESPONSE TO HYPOXIA
|
5
|
4.61e-01
|
6.70e-01
|
0.27600
|
-0.276000
|
-0.001630
|
2.87e-01
|
9.95e-01
|
GOBP OSTEOBLAST DIFFERENTIATION
|
25
|
6.88e-03
|
6.64e-02
|
0.27600
|
0.261000
|
0.088200
|
2.51e-02
|
4.50e-01
|
GOBP GLYCOPROTEIN METABOLIC PROCESS
|
30
|
2.83e-02
|
1.47e-01
|
0.27500
|
-0.269000
|
0.058200
|
1.16e-02
|
5.86e-01
|
GOMF ACETYLGLUCOSAMINYLTRANSFERASE ACTIVITY
|
6
|
2.53e-01
|
4.87e-01
|
0.27500
|
-0.219000
|
-0.167000
|
3.54e-01
|
4.81e-01
|
GOBP REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I
|
5
|
6.66e-01
|
8.07e-01
|
0.27500
|
0.149000
|
-0.231000
|
5.66e-01
|
3.72e-01
|
GOBP TRANSCRIPTION BY RNA POLYMERASE I
|
5
|
6.66e-01
|
8.07e-01
|
0.27500
|
0.149000
|
-0.231000
|
5.66e-01
|
3.72e-01
|
GOBP REGULATION OF POSTSYNAPSE ORGANIZATION
|
14
|
3.10e-01
|
5.43e-01
|
0.27500
|
0.139000
|
-0.237000
|
3.70e-01
|
1.27e-01
|
GOCC MONOATOMIC ION CHANNEL COMPLEX
|
26
|
1.36e-01
|
3.50e-01
|
0.27500
|
0.222000
|
-0.162000
|
5.26e-02
|
1.58e-01
|
GOBP VIRION ASSEMBLY
|
9
|
3.27e-01
|
5.62e-01
|
0.27400
|
0.049700
|
-0.270000
|
7.97e-01
|
1.63e-01
|
GOBP PHOSPHATE ION TRANSPORT
|
6
|
5.00e-01
|
6.96e-01
|
0.27400
|
0.266000
|
-0.066000
|
2.61e-01
|
7.80e-01
|
GOBP PLASMA MEMBRANE REPAIR
|
6
|
2.88e-01
|
5.20e-01
|
0.27400
|
-0.106000
|
-0.253000
|
6.54e-01
|
2.85e-01
|
GOBP GLUCAN BIOSYNTHETIC PROCESS
|
5
|
6.75e-01
|
8.12e-01
|
0.27400
|
0.157000
|
-0.225000
|
5.45e-01
|
3.86e-01
|
GOBP RIBOSE PHOSPHATE METABOLIC PROCESS
|
60
|
2.96e-06
|
1.38e-04
|
0.27400
|
0.139000
|
0.236000
|
6.89e-02
|
2.00e-03
|
GOCC ORGANELLE ENVELOPE LUMEN
|
12
|
3.39e-01
|
5.76e-01
|
0.27400
|
-0.119000
|
0.247000
|
4.78e-01
|
1.41e-01
|
GOCC EUCHROMATIN
|
5
|
3.75e-01
|
5.96e-01
|
0.27400
|
0.261000
|
0.082700
|
3.14e-01
|
7.50e-01
|
GOBP GLOMERULUS DEVELOPMENT
|
9
|
4.67e-01
|
6.74e-01
|
0.27400
|
0.134000
|
-0.238000
|
4.87e-01
|
2.18e-01
|
GOCC MICROTUBULE ASSOCIATED COMPLEX
|
5
|
6.38e-01
|
7.92e-01
|
0.27300
|
-0.245000
|
0.120000
|
3.43e-01
|
6.43e-01
|
GOBP POSITIVE REGULATION OF CELL SUBSTRATE ADHESION
|
9
|
2.34e-01
|
4.68e-01
|
0.27300
|
-0.019900
|
-0.272000
|
9.18e-01
|
1.59e-01
|
GOMF TRANSPORTER ACTIVATOR ACTIVITY
|
5
|
5.57e-01
|
7.35e-01
|
0.27200
|
-0.266000
|
0.060500
|
3.05e-01
|
8.15e-01
|
GOBP REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS
|
17
|
2.86e-01
|
5.18e-01
|
0.27200
|
0.209000
|
-0.175000
|
1.39e-01
|
2.14e-01
|
GOBP IMMUNE EFFECTOR PROCESS
|
26
|
2.47e-02
|
1.36e-01
|
0.27200
|
0.272000
|
-0.010300
|
1.73e-02
|
9.28e-01
|
GOBP POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION
|
6
|
4.89e-01
|
6.89e-01
|
0.27200
|
0.267000
|
-0.055300
|
2.60e-01
|
8.15e-01
|
GOBP REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS
|
14
|
3.61e-01
|
5.89e-01
|
0.27200
|
0.184000
|
-0.200000
|
2.36e-01
|
1.97e-01
|
GOBP PYRUVATE METABOLIC PROCESS
|
20
|
2.23e-02
|
1.28e-01
|
0.27200
|
0.260000
|
0.078300
|
4.54e-02
|
5.48e-01
|
GOBP POSITIVE REGULATION OF PROTEIN POLYMERIZATION
|
8
|
1.90e-01
|
4.20e-01
|
0.27200
|
-0.114000
|
-0.247000
|
5.77e-01
|
2.29e-01
|
GOBP REGULATION OF INTRACELLULAR PROTEIN TRANSPORT
|
16
|
8.17e-02
|
2.68e-01
|
0.27200
|
-0.014600
|
-0.271000
|
9.20e-01
|
6.19e-02
|
GOMF LIGASE ACTIVITY
|
23
|
1.52e-01
|
3.74e-01
|
0.27200
|
-0.136000
|
0.235000
|
2.63e-01
|
5.30e-02
|
GOBP NEGATIVE REGULATION OF CATALYTIC ACTIVITY
|
19
|
2.56e-01
|
4.87e-01
|
0.27100
|
0.189000
|
-0.195000
|
1.57e-01
|
1.45e-01
|
GOBP CARDIAC MUSCLE TISSUE DEVELOPMENT
|
20
|
9.38e-02
|
2.88e-01
|
0.27100
|
0.053100
|
-0.266000
|
6.84e-01
|
4.10e-02
|
GOBP TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION
|
10
|
3.34e-01
|
5.72e-01
|
0.27100
|
0.262000
|
-0.071000
|
1.54e-01
|
6.99e-01
|
GOBP REGULATION OF CELL MATRIX ADHESION
|
15
|
2.21e-01
|
4.58e-01
|
0.27100
|
0.089000
|
-0.256000
|
5.53e-01
|
8.81e-02
|
GOBP REGULATION OF KINASE ACTIVITY
|
24
|
1.28e-01
|
3.42e-01
|
0.27100
|
0.123000
|
-0.241000
|
3.02e-01
|
4.27e-02
|
GOBP REGULATION OF CALCIUM MEDIATED SIGNALING
|
7
|
3.52e-01
|
5.82e-01
|
0.27100
|
0.271000
|
0.001640
|
2.16e-01
|
9.94e-01
|
GOBP CARDIAC SEPTUM DEVELOPMENT
|
9
|
3.64e-01
|
5.91e-01
|
0.27100
|
0.065000
|
-0.263000
|
7.37e-01
|
1.74e-01
|
GOCC NURD COMPLEX
|
5
|
3.69e-01
|
5.93e-01
|
0.27000
|
-0.251000
|
-0.098700
|
3.32e-01
|
7.03e-01
|
GOBP POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING
|
5
|
3.44e-01
|
5.76e-01
|
0.26900
|
-0.138000
|
-0.231000
|
5.93e-01
|
3.72e-01
|
GOBP TYPE II INTERFERON PRODUCTION
|
8
|
3.49e-01
|
5.79e-01
|
0.26900
|
0.268000
|
-0.026400
|
1.91e-01
|
8.97e-01
|
GOBP REGULATION OF ORGANIC ACID TRANSPORT
|
8
|
4.57e-01
|
6.69e-01
|
0.26900
|
0.253000
|
-0.091400
|
2.18e-01
|
6.56e-01
|
GOCC TRANS GOLGI NETWORK
|
21
|
3.06e-02
|
1.54e-01
|
0.26800
|
-0.039800
|
-0.266000
|
7.54e-01
|
3.67e-02
|
GOMF 2 OXOGLUTARATE DEPENDENT DIOXYGENASE ACTIVITY
|
5
|
6.01e-01
|
7.67e-01
|
0.26800
|
0.083300
|
-0.255000
|
7.48e-01
|
3.24e-01
|
GOBP NEURAL PRECURSOR CELL PROLIFERATION
|
14
|
3.62e-01
|
5.89e-01
|
0.26800
|
0.211000
|
-0.166000
|
1.74e-01
|
2.85e-01
|
GOBP REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION
|
5
|
6.97e-01
|
8.26e-01
|
0.26800
|
-0.171000
|
0.207000
|
5.09e-01
|
4.24e-01
|
GOBP SMOOTH MUSCLE CELL DIFFERENTIATION
|
5
|
6.97e-01
|
8.26e-01
|
0.26800
|
-0.171000
|
0.207000
|
5.09e-01
|
4.24e-01
|
GOBP CELL PROJECTION ORGANIZATION
|
130
|
2.26e-04
|
5.55e-03
|
0.26800
|
0.178000
|
-0.201000
|
8.86e-04
|
1.71e-04
|
GOBP RESPONSE TO CORTICOSTEROID
|
18
|
8.10e-02
|
2.67e-01
|
0.26800
|
0.268000
|
-0.008440
|
5.06e-02
|
9.51e-01
|
GOMF TRANSCRIPTION REGULATOR ACTIVITY
|
95
|
1.48e-03
|
2.47e-02
|
0.26800
|
0.214000
|
-0.161000
|
5.09e-04
|
8.86e-03
|
GOMF TRANSCRIPTION COACTIVATOR ACTIVITY
|
29
|
7.00e-02
|
2.44e-01
|
0.26800
|
0.248000
|
-0.101000
|
2.21e-02
|
3.53e-01
|
GOCC P BODY
|
11
|
2.17e-01
|
4.53e-01
|
0.26800
|
-0.010600
|
0.268000
|
9.52e-01
|
1.26e-01
|
GOBP TIGHT JUNCTION ASSEMBLY
|
5
|
5.30e-01
|
7.15e-01
|
0.26800
|
-0.032400
|
0.266000
|
9.01e-01
|
3.05e-01
|
GOBP ERAD PATHWAY
|
13
|
6.07e-02
|
2.23e-01
|
0.26700
|
-0.211000
|
-0.164000
|
1.90e-01
|
3.08e-01
|
GOBP INFLAMMATORY RESPONSE
|
51
|
1.20e-02
|
9.14e-02
|
0.26700
|
0.245000
|
-0.108000
|
3.03e-03
|
1.93e-01
|
GOBP MULTICELLULAR ORGANISMAL LEVEL IRON ION HOMEOSTASIS
|
5
|
3.41e-01
|
5.76e-01
|
0.26700
|
0.158000
|
0.215000
|
5.41e-01
|
4.06e-01
|
GOCC BRUSH BORDER MEMBRANE
|
11
|
4.05e-01
|
6.26e-01
|
0.26700
|
0.235000
|
-0.127000
|
1.79e-01
|
4.69e-01
|
GOBP IMPORT INTO CELL
|
74
|
5.74e-03
|
5.83e-02
|
0.26700
|
0.158000
|
-0.215000
|
2.21e-02
|
1.88e-03
|
GOBP ICOSANOID BIOSYNTHETIC PROCESS
|
6
|
2.93e-01
|
5.26e-01
|
0.26700
|
0.123000
|
0.237000
|
6.02e-01
|
3.17e-01
|
GOBP RESPONSE TO GAMMA RADIATION
|
6
|
6.24e-01
|
7.81e-01
|
0.26700
|
-0.229000
|
0.138000
|
3.34e-01
|
5.61e-01
|
GOBP RESPONSE TO ACID CHEMICAL
|
15
|
3.45e-01
|
5.76e-01
|
0.26700
|
0.169000
|
-0.206000
|
2.59e-01
|
1.69e-01
|
GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY
|
19
|
2.55e-01
|
4.87e-01
|
0.26700
|
-0.163000
|
0.211000
|
2.23e-01
|
1.13e-01
|
GOBP REGULATION OF CENTROSOME CYCLE
|
6
|
2.71e-01
|
5.05e-01
|
0.26700
|
-0.187000
|
-0.190000
|
4.30e-01
|
4.21e-01
|
GOBP REGULATION OF CENTROSOME DUPLICATION
|
6
|
2.71e-01
|
5.05e-01
|
0.26700
|
-0.187000
|
-0.190000
|
4.30e-01
|
4.21e-01
|
GOBP NEGATIVE REGULATION OF BLOOD PRESSURE
|
6
|
5.38e-01
|
7.23e-01
|
0.26700
|
0.255000
|
-0.076600
|
2.80e-01
|
7.46e-01
|
GOBP EMBRYONIC EPITHELIAL TUBE FORMATION
|
9
|
4.08e-01
|
6.26e-01
|
0.26600
|
0.083100
|
-0.253000
|
6.67e-01
|
1.90e-01
|
GOBP NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC
|
12
|
3.53e-01
|
5.82e-01
|
0.26600
|
0.112000
|
-0.242000
|
5.04e-01
|
1.49e-01
|
GOBP REGULATION OF VIRAL PROCESS
|
9
|
4.61e-01
|
6.70e-01
|
0.26600
|
-0.114000
|
0.240000
|
5.54e-01
|
2.14e-01
|
GOBP PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS
|
8
|
2.98e-01
|
5.31e-01
|
0.26600
|
0.015400
|
0.266000
|
9.40e-01
|
1.95e-01
|
GOBP AXONAL TRANSPORT
|
8
|
2.49e-01
|
4.84e-01
|
0.26600
|
-0.260000
|
-0.057300
|
2.05e-01
|
7.80e-01
|
GOBP MYELOID LEUKOCYTE MIGRATION
|
14
|
3.62e-01
|
5.89e-01
|
0.26600
|
0.215000
|
-0.157000
|
1.67e-01
|
3.13e-01
|
GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE
|
18
|
2.76e-01
|
5.08e-01
|
0.26600
|
0.212000
|
-0.160000
|
1.22e-01
|
2.43e-01
|
GOBP PHOSPHORYLATION
|
71
|
8.37e-03
|
7.51e-02
|
0.26600
|
0.206000
|
-0.168000
|
3.58e-03
|
1.71e-02
|
GOBP RESPONSE TO MINERALOCORTICOID
|
5
|
6.01e-01
|
7.67e-01
|
0.26600
|
0.254000
|
-0.077800
|
3.27e-01
|
7.64e-01
|
GOBP PLATELET ACTIVATION
|
13
|
3.08e-01
|
5.41e-01
|
0.26500
|
-0.101000
|
0.246000
|
5.32e-01
|
1.27e-01
|
GOBP ORGANOPHOSPHATE BIOSYNTHETIC PROCESS
|
86
|
3.60e-05
|
1.27e-03
|
0.26500
|
-0.029000
|
0.264000
|
6.54e-01
|
4.27e-05
|
GOMF HEAT SHOCK PROTEIN BINDING
|
13
|
2.05e-01
|
4.38e-01
|
0.26500
|
-0.263000
|
0.035900
|
1.03e-01
|
8.24e-01
|
GOBP REGULATION OF PHOSPHORYLATION
|
38
|
5.22e-02
|
2.05e-01
|
0.26500
|
0.130000
|
-0.231000
|
1.71e-01
|
1.53e-02
|
GOBP EMBRYONIC PLACENTA MORPHOGENESIS
|
5
|
6.39e-01
|
7.93e-01
|
0.26500
|
-0.244000
|
0.104000
|
3.46e-01
|
6.88e-01
|
GOBP AMIDE METABOLIC PROCESS
|
65
|
1.35e-02
|
9.86e-02
|
0.26500
|
-0.180000
|
0.194000
|
1.43e-02
|
8.30e-03
|
GOBP CARBOHYDRATE DERIVATIVE TRANSPORT
|
7
|
4.24e-01
|
6.40e-01
|
0.26500
|
0.262000
|
-0.034600
|
2.31e-01
|
8.74e-01
|
GOBP MIDBRAIN DEVELOPMENT
|
12
|
4.37e-01
|
6.52e-01
|
0.26400
|
-0.198000
|
0.176000
|
2.38e-01
|
2.95e-01
|
GOMF ENZYME REGULATOR ACTIVITY
|
117
|
4.72e-04
|
1.03e-02
|
0.26400
|
0.159000
|
-0.211000
|
4.60e-03
|
1.64e-04
|
GOCC RECEPTOR COMPLEX
|
21
|
2.32e-01
|
4.66e-01
|
0.26400
|
0.166000
|
-0.206000
|
1.93e-01
|
1.06e-01
|
GOCC SMALL NUCLEAR RIBONUCLEOPROTEIN COMPLEX
|
8
|
5.05e-01
|
7.00e-01
|
0.26400
|
0.239000
|
-0.111000
|
2.43e-01
|
5.87e-01
|
GOCC SM LIKE PROTEIN FAMILY COMPLEX
|
8
|
5.05e-01
|
7.00e-01
|
0.26400
|
0.239000
|
-0.111000
|
2.43e-01
|
5.87e-01
|
GOBP CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS
|
10
|
3.19e-01
|
5.53e-01
|
0.26400
|
0.048600
|
-0.259000
|
7.91e-01
|
1.58e-01
|
GOBP RNA 3 END PROCESSING
|
5
|
6.92e-01
|
8.23e-01
|
0.26400
|
-0.219000
|
0.147000
|
3.99e-01
|
5.69e-01
|
GOBP LATE ENDOSOME TO LYSOSOME TRANSPORT
|
5
|
3.45e-01
|
5.76e-01
|
0.26400
|
-0.193000
|
-0.179000
|
4.56e-01
|
4.88e-01
|
GOBP LATE ENDOSOME TO VACUOLE TRANSPORT
|
5
|
3.45e-01
|
5.76e-01
|
0.26400
|
-0.193000
|
-0.179000
|
4.56e-01
|
4.88e-01
|
GOBP MITOTIC METAPHASE CHROMOSOME ALIGNMENT
|
5
|
3.45e-01
|
5.76e-01
|
0.26400
|
-0.193000
|
-0.179000
|
4.56e-01
|
4.88e-01
|
GOBP MULTIVESICULAR BODY SORTING PATHWAY
|
5
|
3.45e-01
|
5.76e-01
|
0.26400
|
-0.193000
|
-0.179000
|
4.56e-01
|
4.88e-01
|
GOBP NON LYTIC VIRAL RELEASE
|
5
|
3.45e-01
|
5.76e-01
|
0.26400
|
-0.193000
|
-0.179000
|
4.56e-01
|
4.88e-01
|
GOBP NUCLEAR MEMBRANE REASSEMBLY
|
5
|
3.45e-01
|
5.76e-01
|
0.26400
|
-0.193000
|
-0.179000
|
4.56e-01
|
4.88e-01
|
GOBP REGULATION OF MITOTIC SPINDLE ASSEMBLY
|
5
|
3.45e-01
|
5.76e-01
|
0.26400
|
-0.193000
|
-0.179000
|
4.56e-01
|
4.88e-01
|
GOBP REGULATION OF SPINDLE ASSEMBLY
|
5
|
3.45e-01
|
5.76e-01
|
0.26400
|
-0.193000
|
-0.179000
|
4.56e-01
|
4.88e-01
|
GOBP REGULATION OF SPINDLE ORGANIZATION
|
5
|
3.45e-01
|
5.76e-01
|
0.26400
|
-0.193000
|
-0.179000
|
4.56e-01
|
4.88e-01
|
GOCC AMPHISOME
|
5
|
3.45e-01
|
5.76e-01
|
0.26400
|
-0.193000
|
-0.179000
|
4.56e-01
|
4.88e-01
|
GOCC ESCRT COMPLEX
|
5
|
3.45e-01
|
5.76e-01
|
0.26400
|
-0.193000
|
-0.179000
|
4.56e-01
|
4.88e-01
|
GOCC KINETOCHORE MICROTUBULE
|
5
|
3.45e-01
|
5.76e-01
|
0.26400
|
-0.193000
|
-0.179000
|
4.56e-01
|
4.88e-01
|
GOMF HISTONE H3 METHYLTRANSFERASE ACTIVITY
|
5
|
6.85e-01
|
8.18e-01
|
0.26400
|
0.224000
|
-0.140000
|
3.88e-01
|
5.90e-01
|
GOMF LYSINE N METHYLTRANSFERASE ACTIVITY
|
5
|
6.85e-01
|
8.18e-01
|
0.26400
|
0.224000
|
-0.140000
|
3.88e-01
|
5.90e-01
|
GOBP NEPHRON DEVELOPMENT
|
17
|
3.17e-01
|
5.51e-01
|
0.26300
|
0.186000
|
-0.187000
|
1.88e-01
|
1.86e-01
|
GOBP POSITIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS
|
9
|
4.90e-01
|
6.90e-01
|
0.26300
|
0.127000
|
-0.231000
|
5.13e-01
|
2.33e-01
|
GOCC SOMATODENDRITIC COMPARTMENT
|
64
|
1.13e-02
|
8.85e-02
|
0.26300
|
0.147000
|
-0.218000
|
4.74e-02
|
3.23e-03
|
GOBP NEUROTRANSMITTER SECRETION
|
8
|
3.58e-01
|
5.88e-01
|
0.26300
|
0.020900
|
-0.262000
|
9.19e-01
|
2.01e-01
|
GOBP DEFENSE RESPONSE TO BACTERIUM
|
11
|
9.96e-02
|
2.98e-01
|
0.26300
|
0.200000
|
0.171000
|
2.54e-01
|
3.30e-01
|
GOBP REGULATION OF MRNA SPLICING VIA SPLICEOSOME
|
14
|
9.51e-02
|
2.90e-01
|
0.26300
|
0.257000
|
0.055100
|
9.81e-02
|
7.23e-01
|
GOMF NUCLEIC ACID CONFORMATION ISOMERASE ACTIVITY
|
11
|
2.08e-01
|
4.42e-01
|
0.26200
|
-0.007020
|
-0.262000
|
9.68e-01
|
1.34e-01
|
GOBP REGULATION OF CELL GROWTH
|
34
|
6.28e-02
|
2.28e-01
|
0.26200
|
0.236000
|
-0.113000
|
1.87e-02
|
2.59e-01
|
GOBP PROTEOGLYCAN BIOSYNTHETIC PROCESS
|
5
|
4.06e-01
|
6.26e-01
|
0.26200
|
-0.080400
|
-0.249000
|
7.56e-01
|
3.36e-01
|
GOBP GROWTH
|
85
|
4.52e-03
|
5.09e-02
|
0.26100
|
0.194000
|
-0.176000
|
2.82e-03
|
6.81e-03
|
GOBP REGULATION OF LIPID METABOLIC PROCESS
|
39
|
4.55e-02
|
1.92e-01
|
0.26100
|
0.234000
|
-0.117000
|
1.29e-02
|
2.14e-01
|
GOBP SEQUESTERING OF CALCIUM ION
|
9
|
3.62e-01
|
5.89e-01
|
0.26100
|
0.046000
|
-0.257000
|
8.12e-01
|
1.84e-01
|
GOBP POSITIVE REGULATION OF RNA METABOLIC PROCESS
|
159
|
7.06e-05
|
2.30e-03
|
0.26100
|
0.201000
|
-0.167000
|
4.12e-05
|
6.73e-04
|
GOBP RESPONSE TO COLD
|
8
|
5.42e-01
|
7.25e-01
|
0.26100
|
0.226000
|
-0.129000
|
2.69e-01
|
5.28e-01
|
GOBP REGULATION OF EPITHELIAL CELL MIGRATION
|
9
|
5.43e-01
|
7.25e-01
|
0.26100
|
0.200000
|
-0.167000
|
3.01e-01
|
3.87e-01
|
GOBP POSITIVE REGULATION OF CELL DIFFERENTIATION
|
62
|
1.88e-02
|
1.18e-01
|
0.26100
|
0.189000
|
-0.180000
|
1.22e-02
|
1.68e-02
|
GOBP UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY
|
6
|
3.13e-01
|
5.47e-01
|
0.26000
|
-0.116000
|
-0.233000
|
6.23e-01
|
3.24e-01
|
GOBP VIRAL BUDDING
|
6
|
3.13e-01
|
5.47e-01
|
0.26000
|
-0.116000
|
-0.233000
|
6.23e-01
|
3.24e-01
|
GOBP CELLULAR RESPONSE TO FATTY ACID
|
7
|
2.59e-01
|
4.91e-01
|
0.26000
|
0.233000
|
0.116000
|
2.87e-01
|
5.98e-01
|
GOBP VASCULAR PROCESS IN CIRCULATORY SYSTEM
|
29
|
1.25e-01
|
3.36e-01
|
0.26000
|
0.141000
|
-0.219000
|
1.96e-01
|
4.35e-02
|
GOBP MITOTIC DNA INTEGRITY CHECKPOINT SIGNALING
|
6
|
6.45e-01
|
7.96e-01
|
0.26000
|
0.140000
|
-0.219000
|
5.55e-01
|
3.54e-01
|
GOBP STEROL TRANSPORT
|
18
|
1.71e-01
|
3.95e-01
|
0.26000
|
0.249000
|
-0.072200
|
6.89e-02
|
5.99e-01
|
GOMF GROWTH FACTOR RECEPTOR BINDING
|
5
|
3.80e-01
|
6.00e-01
|
0.25900
|
-0.230000
|
-0.120000
|
3.75e-01
|
6.42e-01
|
GOBP GLYCOPROTEIN BIOSYNTHETIC PROCESS
|
21
|
4.02e-02
|
1.77e-01
|
0.25900
|
-0.257000
|
-0.035000
|
4.32e-02
|
7.83e-01
|
GOBP POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS
|
31
|
1.05e-01
|
3.08e-01
|
0.25900
|
0.222000
|
-0.134000
|
3.47e-02
|
2.01e-01
|
GOMF UBIQUITIN BINDING
|
11
|
2.74e-01
|
5.08e-01
|
0.25900
|
0.033100
|
-0.257000
|
8.50e-01
|
1.42e-01
|
GOCC PRECATALYTIC SPLICEOSOME
|
6
|
2.94e-01
|
5.27e-01
|
0.25900
|
0.200000
|
0.164000
|
3.97e-01
|
4.88e-01
|
GOBP NEGATIVE REGULATION OF CELL DEVELOPMENT
|
18
|
1.62e-01
|
3.81e-01
|
0.25900
|
0.064300
|
-0.251000
|
6.39e-01
|
6.75e-02
|
GOCC AZUROPHIL GRANULE LUMEN
|
15
|
2.26e-01
|
4.61e-01
|
0.25900
|
-0.249000
|
0.068800
|
9.65e-02
|
6.47e-01
|
GOBP VERY LONG CHAIN FATTY ACID METABOLIC PROCESS
|
6
|
6.51e-01
|
7.97e-01
|
0.25900
|
0.216000
|
-0.142000
|
3.61e-01
|
5.47e-01
|
GOBP CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT
|
19
|
3.24e-02
|
1.59e-01
|
0.25800
|
-0.240000
|
-0.095000
|
7.23e-02
|
4.77e-01
|
GOCC MOTILE CILIUM
|
14
|
3.62e-01
|
5.89e-01
|
0.25800
|
-0.220000
|
0.135000
|
1.57e-01
|
3.85e-01
|
GOBP REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY
|
15
|
2.24e-01
|
4.59e-01
|
0.25800
|
0.066200
|
-0.249000
|
6.59e-01
|
9.67e-02
|
GOBP REGULATION OF MICROTUBULE BASED PROCESS
|
22
|
1.23e-02
|
9.31e-02
|
0.25800
|
-0.198000
|
-0.165000
|
1.11e-01
|
1.85e-01
|
GOBP RETINOIC ACID RECEPTOR SIGNALING PATHWAY
|
6
|
5.54e-01
|
7.33e-01
|
0.25700
|
0.069000
|
-0.248000
|
7.71e-01
|
2.94e-01
|
GOCC PROTEIN KINASE COMPLEX
|
13
|
4.06e-01
|
6.26e-01
|
0.25700
|
0.146000
|
-0.212000
|
3.64e-01
|
1.88e-01
|
GOBP RESPONSE TO REACTIVE OXYGEN SPECIES
|
23
|
2.27e-01
|
4.61e-01
|
0.25700
|
-0.176000
|
0.188000
|
1.48e-01
|
1.22e-01
|
GOBP NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION
|
17
|
3.29e-01
|
5.65e-01
|
0.25700
|
0.196000
|
-0.166000
|
1.64e-01
|
2.39e-01
|
GOBP NUCLEAR ENVELOPE ORGANIZATION
|
7
|
2.55e-01
|
4.87e-01
|
0.25700
|
-0.217000
|
-0.138000
|
3.23e-01
|
5.29e-01
|
GOBP RESPONSE TO HYDROGEN PEROXIDE
|
11
|
4.60e-01
|
6.70e-01
|
0.25700
|
-0.140000
|
0.215000
|
4.24e-01
|
2.19e-01
|
GOCC NEURON PROJECTION TERMINUS
|
9
|
1.78e-01
|
4.05e-01
|
0.25700
|
0.223000
|
0.126000
|
2.48e-01
|
5.14e-01
|
GOBP REGULATION OF PROTEIN POLYMERIZATION
|
14
|
6.04e-02
|
2.22e-01
|
0.25700
|
-0.183000
|
-0.179000
|
2.38e-01
|
2.48e-01
|
GOBP REGULATION OF STEM CELL POPULATION MAINTENANCE
|
8
|
3.08e-01
|
5.41e-01
|
0.25700
|
-0.255000
|
-0.026800
|
2.13e-01
|
8.96e-01
|
GOBP TUBE FORMATION
|
13
|
2.79e-01
|
5.11e-01
|
0.25600
|
0.066500
|
-0.247000
|
6.80e-01
|
1.24e-01
|
GOCC ACTIN CYTOSKELETON
|
42
|
5.40e-02
|
2.10e-01
|
0.25600
|
0.135000
|
-0.217000
|
1.37e-01
|
1.65e-02
|
GOCC NON MOTILE CILIUM
|
12
|
2.68e-01
|
5.03e-01
|
0.25600
|
0.042200
|
-0.252000
|
8.01e-01
|
1.32e-01
|
GOBP AMEBOIDAL TYPE CELL MIGRATION
|
21
|
2.63e-01
|
4.97e-01
|
0.25600
|
0.182000
|
-0.179000
|
1.51e-01
|
1.59e-01
|
GOBP REGULATION OF MITOCHONDRION ORGANIZATION
|
11
|
1.79e-01
|
4.06e-01
|
0.25500
|
0.047900
|
0.251000
|
7.84e-01
|
1.52e-01
|
GOBP NEURON CELLULAR HOMEOSTASIS
|
8
|
5.58e-01
|
7.35e-01
|
0.25500
|
0.128000
|
-0.221000
|
5.32e-01
|
2.82e-01
|
GOBP RESPONSE TO STARVATION
|
28
|
1.45e-01
|
3.65e-01
|
0.25500
|
0.214000
|
-0.138000
|
5.21e-02
|
2.12e-01
|
GOMF PEPTIDASE ACTIVATOR ACTIVITY
|
5
|
3.78e-01
|
5.99e-01
|
0.25500
|
0.146000
|
0.208000
|
5.73e-01
|
4.21e-01
|
GOBP GLYCOPROTEIN CATABOLIC PROCESS
|
6
|
6.78e-01
|
8.14e-01
|
0.25500
|
-0.195000
|
0.164000
|
4.11e-01
|
4.88e-01
|
GOBP LABYRINTHINE LAYER DEVELOPMENT
|
8
|
4.62e-01
|
6.70e-01
|
0.25500
|
-0.245000
|
0.067200
|
2.31e-01
|
7.43e-01
|
GOBP PHOSPHATIDYLGLYCEROL METABOLIC PROCESS
|
6
|
5.51e-01
|
7.32e-01
|
0.25400
|
0.060800
|
-0.247000
|
7.97e-01
|
2.97e-01
|
GOCC LYSOSOMAL LUMEN
|
14
|
1.27e-01
|
3.40e-01
|
0.25400
|
-0.034000
|
-0.252000
|
8.27e-01
|
1.05e-01
|
GOBP POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY
|
5
|
6.92e-01
|
8.23e-01
|
0.25400
|
-0.123000
|
0.222000
|
6.34e-01
|
3.91e-01
|
GOBP POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS
|
36
|
6.35e-02
|
2.29e-01
|
0.25400
|
0.109000
|
-0.229000
|
2.66e-01
|
1.90e-02
|
GOMF CYTOSKELETAL PROTEIN BINDING
|
88
|
5.38e-03
|
5.74e-02
|
0.25300
|
0.172000
|
-0.186000
|
7.15e-03
|
3.53e-03
|
GOBP ENDOCYTOSIS
|
54
|
2.55e-02
|
1.39e-01
|
0.25300
|
0.131000
|
-0.216000
|
1.03e-01
|
7.05e-03
|
GOMF FLAVIN ADENINE DINUCLEOTIDE BINDING
|
14
|
1.32e-01
|
3.45e-01
|
0.25300
|
-0.251000
|
-0.030600
|
1.06e-01
|
8.44e-01
|
GOBP BILE ACID BIOSYNTHETIC PROCESS
|
7
|
3.36e-01
|
5.74e-01
|
0.25300
|
0.052100
|
0.247000
|
8.12e-01
|
2.59e-01
|
GOBP BILE ACID METABOLIC PROCESS
|
7
|
3.36e-01
|
5.74e-01
|
0.25300
|
0.052100
|
0.247000
|
8.12e-01
|
2.59e-01
|
GOBP HEART MORPHOGENESIS
|
19
|
2.06e-01
|
4.39e-01
|
0.25200
|
0.092200
|
-0.235000
|
4.90e-01
|
7.84e-02
|
GOBP METANEPHROS DEVELOPMENT
|
7
|
4.50e-01
|
6.65e-01
|
0.25200
|
0.251000
|
-0.028100
|
2.52e-01
|
8.98e-01
|
GOMF MONOATOMIC CATION CHANNEL ACTIVITY
|
29
|
1.21e-01
|
3.32e-01
|
0.25200
|
0.223000
|
-0.117000
|
3.97e-02
|
2.81e-01
|
GOBP PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS
|
5
|
7.22e-01
|
8.44e-01
|
0.25200
|
-0.202000
|
0.150000
|
4.36e-01
|
5.62e-01
|
GOBP PHOSPHATIDYLINOSITOL PHOSPHATE BIOSYNTHETIC PROCESS
|
5
|
7.22e-01
|
8.44e-01
|
0.25200
|
-0.202000
|
0.150000
|
4.36e-01
|
5.62e-01
|
GOBP REGULATION OF ACTIN FILAMENT LENGTH
|
10
|
4.97e-01
|
6.95e-01
|
0.25100
|
0.129000
|
-0.216000
|
4.82e-01
|
2.39e-01
|
GOBP REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY
|
7
|
5.26e-01
|
7.14e-01
|
0.25100
|
0.072000
|
-0.241000
|
7.42e-01
|
2.72e-01
|
GOBP REGULATION OF MUSCLE SYSTEM PROCESS
|
21
|
2.75e-01
|
5.08e-01
|
0.25100
|
0.180000
|
-0.176000
|
1.57e-01
|
1.67e-01
|
GOBP LEUKOCYTE MIGRATION
|
23
|
1.70e-01
|
3.94e-01
|
0.25100
|
0.104000
|
-0.228000
|
3.91e-01
|
6.02e-02
|
GOBP POSITIVE REGULATION OF TRANSPORT
|
72
|
9.98e-03
|
8.40e-02
|
0.25100
|
0.210000
|
-0.138000
|
2.76e-03
|
4.90e-02
|
GOMF S ADENOSYLMETHIONINE DEPENDENT METHYLTRANSFERASE ACTIVITY
|
13
|
8.77e-02
|
2.79e-01
|
0.25100
|
-0.140000
|
-0.208000
|
3.83e-01
|
1.97e-01
|
GOMF UBIQUITIN LIKE PROTEIN CONJUGATING ENZYME ACTIVITY
|
7
|
4.09e-01
|
6.26e-01
|
0.25100
|
-0.251000
|
-0.001640
|
2.52e-01
|
9.94e-01
|
GOBP VIRAL GENOME REPLICATION
|
11
|
4.88e-01
|
6.89e-01
|
0.25000
|
-0.205000
|
0.144000
|
2.42e-01
|
4.11e-01
|
GOBP NEUROMUSCULAR PROCESS
|
17
|
4.02e-02
|
1.77e-01
|
0.25000
|
-0.189000
|
-0.163000
|
1.79e-01
|
2.48e-01
|
GOBP HETEROCHROMATIN FORMATION
|
11
|
4.42e-01
|
6.56e-01
|
0.25000
|
0.111000
|
-0.224000
|
5.25e-01
|
2.01e-01
|
GOBP INTERFERON MEDIATED SIGNALING PATHWAY
|
5
|
7.19e-01
|
8.43e-01
|
0.25000
|
-0.140000
|
0.207000
|
5.88e-01
|
4.25e-01
|
GOBP CELL CELL SIGNALING
|
85
|
7.06e-03
|
6.71e-02
|
0.24900
|
0.161000
|
-0.190000
|
1.30e-02
|
3.36e-03
|
GOBP EXPORT ACROSS PLASMA MEMBRANE
|
9
|
5.66e-01
|
7.41e-01
|
0.24900
|
0.149000
|
-0.199000
|
4.41e-01
|
3.04e-01
|
GOBP CELLULAR RESPONSE TO HORMONE STIMULUS
|
70
|
2.95e-03
|
3.91e-02
|
0.24800
|
0.236000
|
-0.075800
|
8.66e-04
|
2.87e-01
|
GOBP METHYLATION
|
14
|
1.78e-01
|
4.05e-01
|
0.24800
|
-0.248000
|
0.001180
|
1.10e-01
|
9.94e-01
|
GOBP RESPONSE TO BACTERIUM
|
44
|
4.33e-03
|
5.00e-02
|
0.24800
|
0.006100
|
0.248000
|
9.45e-01
|
5.20e-03
|
GOBP AMINO ACID TRANSMEMBRANE TRANSPORT
|
12
|
4.57e-01
|
6.69e-01
|
0.24800
|
0.136000
|
-0.207000
|
4.18e-01
|
2.17e-01
|
GOBP ANIMAL ORGAN MORPHOGENESIS
|
74
|
1.45e-02
|
1.03e-01
|
0.24800
|
0.172000
|
-0.178000
|
1.30e-02
|
1.01e-02
|
GOBP POSITIVE REGULATION OF PROTEIN TRANSPORT
|
24
|
2.16e-01
|
4.51e-01
|
0.24800
|
0.139000
|
-0.205000
|
2.43e-01
|
8.55e-02
|
GOBP EPITHELIAL TO MESENCHYMAL TRANSITION
|
16
|
3.34e-01
|
5.72e-01
|
0.24700
|
0.123000
|
-0.215000
|
3.98e-01
|
1.40e-01
|
GOBP SKIN EPIDERMIS DEVELOPMENT
|
9
|
5.46e-01
|
7.28e-01
|
0.24700
|
-0.212000
|
0.128000
|
2.74e-01
|
5.10e-01
|
GOMF RNA NUCLEASE ACTIVITY
|
7
|
6.36e-01
|
7.91e-01
|
0.24700
|
0.205000
|
-0.138000
|
3.50e-01
|
5.28e-01
|
GOCC AZUROPHIL GRANULE
|
22
|
1.47e-01
|
3.67e-01
|
0.24700
|
-0.236000
|
0.071400
|
5.71e-02
|
5.66e-01
|
GOBP REPRODUCTIVE SYSTEM DEVELOPMENT
|
24
|
1.96e-01
|
4.27e-01
|
0.24700
|
0.122000
|
-0.215000
|
3.07e-01
|
7.13e-02
|
GOBP PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM
|
14
|
4.26e-01
|
6.43e-01
|
0.24700
|
-0.155000
|
0.192000
|
3.18e-01
|
2.17e-01
|
GOBP B CELL ACTIVATION
|
18
|
2.28e-01
|
4.61e-01
|
0.24700
|
0.232000
|
-0.082900
|
9.04e-02
|
5.46e-01
|
GOMF ORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
28
|
1.91e-01
|
4.22e-01
|
0.24600
|
0.164000
|
-0.184000
|
1.38e-01
|
9.57e-02
|
GOBP MONOSACCHARIDE METABOLIC PROCESS
|
43
|
2.35e-02
|
1.32e-01
|
0.24600
|
0.237000
|
-0.066900
|
8.16e-03
|
4.56e-01
|
GOBP VITAMIN TRANSPORT
|
6
|
6.31e-01
|
7.86e-01
|
0.24600
|
0.097300
|
-0.226000
|
6.81e-01
|
3.39e-01
|
GOBP REGULATION OF VASCULATURE DEVELOPMENT
|
20
|
3.07e-01
|
5.41e-01
|
0.24600
|
0.167000
|
-0.181000
|
2.00e-01
|
1.66e-01
|
GOBP REGULATION OF PROTEIN IMPORT INTO NUCLEUS
|
7
|
5.16e-01
|
7.07e-01
|
0.24600
|
-0.239000
|
0.055200
|
2.74e-01
|
8.01e-01
|
GOBP AXO DENDRITIC TRANSPORT
|
10
|
1.65e-01
|
3.85e-01
|
0.24600
|
-0.202000
|
-0.140000
|
2.71e-01
|
4.46e-01
|
GOBP NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS
|
100
|
5.71e-06
|
2.45e-04
|
0.24600
|
0.014900
|
0.245000
|
8.05e-01
|
4.52e-05
|
GOBP B CELL DIFFERENTIATION
|
11
|
5.22e-01
|
7.09e-01
|
0.24600
|
0.170000
|
-0.177000
|
3.30e-01
|
3.13e-01
|
GOBP REGULATION OF STEROL TRANSPORT
|
10
|
4.03e-01
|
6.25e-01
|
0.24600
|
0.237000
|
-0.062700
|
1.96e-01
|
7.33e-01
|
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION
|
45
|
7.24e-02
|
2.46e-01
|
0.24500
|
0.187000
|
-0.159000
|
3.26e-02
|
7.07e-02
|
GOBP POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION
|
85
|
3.29e-03
|
4.26e-02
|
0.24500
|
0.110000
|
-0.219000
|
9.00e-02
|
7.21e-04
|
GOBP NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS
|
30
|
1.74e-01
|
3.99e-01
|
0.24500
|
0.165000
|
-0.181000
|
1.21e-01
|
9.00e-02
|
GOBP CELLULAR RESPONSE TO ENDOGENOUS STIMULUS
|
110
|
1.61e-03
|
2.58e-02
|
0.24500
|
0.203000
|
-0.137000
|
4.21e-04
|
1.77e-02
|
GOBP STEM CELL DIVISION
|
7
|
4.86e-01
|
6.88e-01
|
0.24500
|
0.036200
|
-0.242000
|
8.69e-01
|
2.69e-01
|
GOBP EPITHELIAL TUBE MORPHOGENESIS
|
23
|
2.18e-01
|
4.53e-01
|
0.24500
|
0.123000
|
-0.212000
|
3.12e-01
|
8.16e-02
|
GOMF PROMOTER SPECIFIC CHROMATIN BINDING
|
7
|
4.84e-01
|
6.86e-01
|
0.24500
|
0.034100
|
-0.242000
|
8.76e-01
|
2.69e-01
|
GOMF FAD BINDING
|
6
|
4.44e-01
|
6.59e-01
|
0.24400
|
-0.243000
|
-0.028900
|
3.05e-01
|
9.03e-01
|
GOBP RESPONSE TO ENDOPLASMIC RETICULUM STRESS
|
26
|
9.44e-03
|
8.04e-02
|
0.24400
|
-0.186000
|
-0.158000
|
1.04e-01
|
1.67e-01
|
GOBP ORGANIC HYDROXY COMPOUND TRANSPORT
|
33
|
1.19e-01
|
3.29e-01
|
0.24400
|
0.209000
|
-0.126000
|
4.02e-02
|
2.18e-01
|
GOCC EARLY ENDOSOME
|
27
|
2.08e-01
|
4.41e-01
|
0.24400
|
0.160000
|
-0.184000
|
1.55e-01
|
1.01e-01
|
GOBP POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS
|
28
|
1.84e-01
|
4.11e-01
|
0.24300
|
0.141000
|
-0.198000
|
2.02e-01
|
7.28e-02
|
GOMF ISOMERASE ACTIVITY
|
37
|
1.64e-02
|
1.09e-01
|
0.24300
|
-0.242000
|
0.010900
|
1.19e-02
|
9.10e-01
|
GOBP REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS
|
16
|
2.23e-01
|
4.59e-01
|
0.24300
|
-0.049700
|
0.237000
|
7.32e-01
|
1.02e-01
|
GOMF PHOSPHATE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
5
|
4.07e-01
|
6.26e-01
|
0.24200
|
0.163000
|
0.180000
|
5.30e-01
|
4.88e-01
|
GOBP MUSCLE ADAPTATION
|
12
|
4.56e-01
|
6.69e-01
|
0.24200
|
0.209000
|
-0.121000
|
2.12e-01
|
4.70e-01
|
GOBP CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN
|
21
|
2.46e-02
|
1.36e-01
|
0.24200
|
0.156000
|
0.184000
|
2.19e-01
|
1.47e-01
|
GOBP STRIATED MUSCLE CONTRACTION
|
11
|
3.99e-01
|
6.20e-01
|
0.24100
|
0.069900
|
-0.231000
|
6.89e-01
|
1.88e-01
|
GOBP AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS
|
9
|
5.83e-01
|
7.52e-01
|
0.24100
|
0.195000
|
-0.141000
|
3.13e-01
|
4.64e-01
|
GOBP AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS
|
9
|
5.83e-01
|
7.52e-01
|
0.24100
|
0.195000
|
-0.141000
|
3.13e-01
|
4.64e-01
|
GOCC TERTIARY GRANULE MEMBRANE
|
5
|
4.52e-01
|
6.65e-01
|
0.24100
|
-0.224000
|
-0.089500
|
3.88e-01
|
7.30e-01
|
GOBP CELL SURFACE RECEPTOR SIGNALING PATHWAY VIA JAK STAT
|
10
|
5.54e-01
|
7.33e-01
|
0.24100
|
0.192000
|
-0.145000
|
2.95e-01
|
4.28e-01
|
GOBP CELL SURFACE RECEPTOR SIGNALING PATHWAY VIA STAT
|
10
|
5.54e-01
|
7.33e-01
|
0.24100
|
0.192000
|
-0.145000
|
2.95e-01
|
4.28e-01
|
GOBP CARBOHYDRATE HOMEOSTASIS
|
25
|
3.52e-02
|
1.64e-01
|
0.24000
|
0.237000
|
0.038400
|
4.21e-02
|
7.42e-01
|
GOBP SUPRAMOLECULAR FIBER ORGANIZATION
|
65
|
1.03e-02
|
8.49e-02
|
0.24000
|
0.093500
|
-0.221000
|
2.04e-01
|
2.63e-03
|
GOMF RNA POLYMERASE II SPECIFIC DNA BINDING TRANSCRIPTION FACTOR BINDING
|
38
|
9.53e-02
|
2.90e-01
|
0.24000
|
0.125000
|
-0.205000
|
1.91e-01
|
3.11e-02
|
GOCC U2 TYPE CATALYTIC STEP 2 SPLICEOSOME
|
5
|
4.61e-01
|
6.70e-01
|
0.24000
|
0.082000
|
0.225000
|
7.51e-01
|
3.84e-01
|
GOBP REGULATION OF CELL DIVISION
|
15
|
2.11e-01
|
4.44e-01
|
0.24000
|
-0.239000
|
0.023800
|
1.12e-01
|
8.74e-01
|
GOBP REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION
|
11
|
4.39e-01
|
6.53e-01
|
0.24000
|
0.089000
|
-0.223000
|
6.11e-01
|
2.03e-01
|
GOBP NUCLEAR RECEPTOR MEDIATED SIGNALING PATHWAY
|
30
|
1.86e-01
|
4.14e-01
|
0.24000
|
0.157000
|
-0.181000
|
1.42e-01
|
8.96e-02
|
GOMF CLATHRIN BINDING
|
5
|
7.48e-01
|
8.61e-01
|
0.24000
|
0.149000
|
-0.188000
|
5.65e-01
|
4.69e-01
|
GOBP NEURON DEVELOPMENT
|
99
|
5.37e-03
|
5.74e-02
|
0.23900
|
0.158000
|
-0.180000
|
8.83e-03
|
2.98e-03
|
GOMF FIBROBLAST GROWTH FACTOR BINDING
|
5
|
7.33e-01
|
8.53e-01
|
0.23900
|
0.202000
|
-0.127000
|
4.35e-01
|
6.23e-01
|
GOBP MEMBRANE FUSION
|
13
|
1.34e-01
|
3.47e-01
|
0.23900
|
-0.223000
|
-0.086100
|
1.66e-01
|
5.93e-01
|
GOBP FATTY ACID DERIVATIVE METABOLIC PROCESS
|
16
|
4.06e-01
|
6.26e-01
|
0.23900
|
-0.180000
|
0.157000
|
2.15e-01
|
2.80e-01
|
GOBP EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS
|
5
|
5.43e-01
|
7.25e-01
|
0.23900
|
-0.013400
|
-0.239000
|
9.59e-01
|
3.57e-01
|
GOBP PROTEIN LOCALIZATION TO NUCLEUS
|
22
|
2.92e-01
|
5.26e-01
|
0.23900
|
-0.180000
|
0.157000
|
1.48e-01
|
2.08e-01
|
GOBP RESPONSE TO NUTRIENT
|
31
|
1.54e-01
|
3.74e-01
|
0.23800
|
0.201000
|
-0.128000
|
5.58e-02
|
2.22e-01
|
GOBP MODIFICATION OF POSTSYNAPTIC STRUCTURE
|
7
|
6.25e-01
|
7.82e-01
|
0.23800
|
-0.212000
|
0.108000
|
3.32e-01
|
6.22e-01
|
GOBP POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY
|
9
|
5.42e-01
|
7.25e-01
|
0.23800
|
0.104000
|
-0.214000
|
5.89e-01
|
2.68e-01
|
GOBP LUNG ALVEOLUS DEVELOPMENT
|
10
|
4.63e-01
|
6.71e-01
|
0.23800
|
0.079700
|
-0.224000
|
6.64e-01
|
2.22e-01
|
GOBP REGULATION OF T CELL ACTIVATION
|
21
|
2.98e-02
|
1.51e-01
|
0.23800
|
0.196000
|
0.135000
|
1.24e-01
|
2.88e-01
|
GOCC SARCOPLASM
|
12
|
2.31e-01
|
4.65e-01
|
0.23800
|
-0.017100
|
-0.237000
|
9.19e-01
|
1.57e-01
|
GOBP BEHAVIOR
|
54
|
3.50e-02
|
1.64e-01
|
0.23700
|
0.208000
|
-0.115000
|
9.66e-03
|
1.53e-01
|
GOBP P38MAPK CASCADE
|
6
|
6.44e-01
|
7.95e-01
|
0.23700
|
0.220000
|
-0.088900
|
3.52e-01
|
7.07e-01
|
GOBP CYTOKINETIC PROCESS
|
10
|
1.92e-01
|
4.22e-01
|
0.23700
|
-0.203000
|
-0.122000
|
2.67e-01
|
5.05e-01
|
GOBP MITOTIC CYTOKINETIC PROCESS
|
10
|
1.92e-01
|
4.22e-01
|
0.23700
|
-0.203000
|
-0.122000
|
2.67e-01
|
5.05e-01
|
GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION
|
8
|
6.41e-01
|
7.94e-01
|
0.23700
|
0.177000
|
-0.158000
|
3.88e-01
|
4.41e-01
|
GOCC FIBRILLAR CENTER
|
16
|
3.72e-01
|
5.93e-01
|
0.23700
|
0.122000
|
-0.204000
|
4.03e-01
|
1.62e-01
|
GOBP REGULATION OF CELL PROJECTION ASSEMBLY
|
22
|
1.11e-01
|
3.17e-01
|
0.23700
|
0.025500
|
-0.236000
|
8.37e-01
|
5.78e-02
|
GOBP NEGATIVE REGULATION OF BMP SIGNALING PATHWAY
|
5
|
5.39e-01
|
7.23e-01
|
0.23700
|
-0.019900
|
-0.236000
|
9.39e-01
|
3.62e-01
|
GOBP PHENOL CONTAINING COMPOUND METABOLIC PROCESS
|
10
|
2.26e-01
|
4.61e-01
|
0.23700
|
-0.224000
|
-0.076600
|
2.22e-01
|
6.76e-01
|
GOBP REGULATION OF INFLAMMATORY RESPONSE
|
24
|
1.23e-01
|
3.35e-01
|
0.23700
|
0.231000
|
-0.052000
|
5.23e-02
|
6.62e-01
|
GOMF LIPID BINDING
|
78
|
1.58e-02
|
1.07e-01
|
0.23700
|
0.183000
|
-0.150000
|
6.72e-03
|
2.60e-02
|
GOBP RAC PROTEIN SIGNAL TRANSDUCTION
|
6
|
6.12e-01
|
7.70e-01
|
0.23700
|
0.227000
|
-0.066500
|
3.37e-01
|
7.79e-01
|
GOMF TRANSCRIPTION FACTOR BINDING
|
56
|
5.11e-02
|
2.03e-01
|
0.23600
|
0.160000
|
-0.174000
|
4.32e-02
|
2.72e-02
|
GOBP NUCLEAR MEMBRANE ORGANIZATION
|
6
|
3.71e-01
|
5.93e-01
|
0.23600
|
-0.200000
|
-0.126000
|
3.98e-01
|
5.94e-01
|
GOCC SPINDLE MICROTUBULE
|
6
|
3.71e-01
|
5.93e-01
|
0.23600
|
-0.200000
|
-0.126000
|
3.98e-01
|
5.94e-01
|
GOBP CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS
|
70
|
7.40e-04
|
1.53e-02
|
0.23600
|
-0.009850
|
0.236000
|
8.90e-01
|
8.80e-04
|
GOBP PURINE CONTAINING COMPOUND METABOLIC PROCESS
|
95
|
2.06e-05
|
7.85e-04
|
0.23600
|
0.017700
|
0.236000
|
7.75e-01
|
1.30e-04
|
GOMF UBIQUITIN LIKE PROTEIN BINDING
|
13
|
2.29e-01
|
4.63e-01
|
0.23600
|
-0.002280
|
-0.236000
|
9.89e-01
|
1.43e-01
|
GOBP CELLULAR RESPONSE TO XENOBIOTIC STIMULUS
|
19
|
2.79e-01
|
5.11e-01
|
0.23600
|
-0.101000
|
0.213000
|
4.49e-01
|
1.11e-01
|
GOBP POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION
|
16
|
3.81e-01
|
6.01e-01
|
0.23600
|
0.124000
|
-0.201000
|
3.93e-01
|
1.68e-01
|
GOBP RESPONSE TO OXYGEN LEVELS
|
39
|
7.12e-02
|
2.44e-01
|
0.23600
|
-0.096000
|
0.215000
|
3.07e-01
|
2.19e-02
|
GOBP PHOSPHATIDYLCHOLINE METABOLIC PROCESS
|
8
|
2.59e-01
|
4.91e-01
|
0.23600
|
-0.151000
|
-0.181000
|
4.62e-01
|
3.77e-01
|
GOBP LIPID DROPLET ORGANIZATION
|
6
|
4.23e-01
|
6.40e-01
|
0.23500
|
-0.067000
|
-0.226000
|
7.77e-01
|
3.40e-01
|
GOCC SUPRAMOLECULAR POLYMER
|
60
|
1.16e-02
|
9.01e-02
|
0.23500
|
0.074700
|
-0.223000
|
3.29e-01
|
3.47e-03
|
GOBP EPITHELIAL CELL MORPHOGENESIS
|
8
|
2.76e-01
|
5.08e-01
|
0.23500
|
-0.117000
|
-0.204000
|
5.70e-01
|
3.19e-01
|
GOBP CELL MOTILITY
|
123
|
1.36e-03
|
2.30e-02
|
0.23500
|
0.130000
|
-0.196000
|
1.80e-02
|
3.44e-04
|
GOBP EXPORT FROM CELL
|
68
|
1.67e-02
|
1.09e-01
|
0.23500
|
0.114000
|
-0.206000
|
1.14e-01
|
4.26e-03
|
GOBP SECRETION
|
73
|
1.91e-02
|
1.19e-01
|
0.23500
|
0.138000
|
-0.190000
|
4.77e-02
|
6.30e-03
|
GOBP REGULATION OF ACTIN FILAMENT ORGANIZATION
|
27
|
9.09e-02
|
2.84e-01
|
0.23500
|
0.044400
|
-0.231000
|
6.93e-01
|
4.02e-02
|
GOBP PROTEIN LOCALIZATION TO EXTRACELLULAR REGION
|
34
|
7.23e-02
|
2.46e-01
|
0.23400
|
0.069200
|
-0.224000
|
4.91e-01
|
2.57e-02
|
GOBP HORMONE MEDIATED SIGNALING PATHWAY
|
29
|
2.11e-01
|
4.44e-01
|
0.23400
|
0.152000
|
-0.178000
|
1.62e-01
|
1.01e-01
|
GOBP ACTIN FILAMENT BUNDLE ORGANIZATION
|
22
|
1.86e-01
|
4.14e-01
|
0.23400
|
0.071700
|
-0.223000
|
5.64e-01
|
7.33e-02
|
GOBP REGULATION OF PHOSPHORUS METABOLIC PROCESS
|
62
|
3.56e-02
|
1.65e-01
|
0.23400
|
0.188000
|
-0.139000
|
1.25e-02
|
6.47e-02
|
GOCC ROUGH ENDOPLASMIC RETICULUM MEMBRANE
|
6
|
6.00e-01
|
7.66e-01
|
0.23300
|
-0.052900
|
0.227000
|
8.23e-01
|
3.36e-01
|
GOBP ACTIN FILAMENT POLYMERIZATION
|
12
|
4.04e-01
|
6.25e-01
|
0.23300
|
0.074000
|
-0.221000
|
6.59e-01
|
1.87e-01
|
GOBP POSITIVE REGULATION OF CELL ADHESION
|
31
|
1.94e-01
|
4.25e-01
|
0.23300
|
0.176000
|
-0.152000
|
9.31e-02
|
1.48e-01
|
GOCC TRANSCRIPTION REPRESSOR COMPLEX
|
5
|
7.66e-01
|
8.70e-01
|
0.23300
|
-0.167000
|
0.162000
|
5.20e-01
|
5.31e-01
|
GOMF ORGANIC ACID BINDING
|
21
|
5.46e-02
|
2.11e-01
|
0.23300
|
0.065600
|
0.223000
|
6.06e-01
|
7.90e-02
|
GOBP LIPID LOCALIZATION
|
61
|
4.30e-02
|
1.86e-01
|
0.23300
|
0.152000
|
-0.176000
|
4.49e-02
|
2.02e-02
|
GOBP REGULATION OF TELOMERE MAINTENANCE
|
8
|
4.22e-01
|
6.40e-01
|
0.23200
|
0.002870
|
-0.232000
|
9.89e-01
|
2.57e-01
|
GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS
|
13
|
3.25e-01
|
5.60e-01
|
0.23200
|
0.227000
|
-0.046900
|
1.58e-01
|
7.71e-01
|
GOCC CONTRACTILE MUSCLE FIBER
|
17
|
1.33e-01
|
3.47e-01
|
0.23200
|
-0.022100
|
-0.231000
|
8.76e-01
|
1.02e-01
|
GOBP POSITIVE REGULATION OF CELL DIVISION
|
10
|
2.04e-01
|
4.38e-01
|
0.23200
|
-0.196000
|
-0.125000
|
2.86e-01
|
4.97e-01
|
GOBP RESPONSE TO ORGANOPHOSPHORUS
|
16
|
2.44e-01
|
4.80e-01
|
0.23200
|
0.228000
|
-0.042300
|
1.17e-01
|
7.71e-01
|
GOMF PEPTIDE BINDING
|
26
|
1.33e-01
|
3.46e-01
|
0.23200
|
0.223000
|
-0.064600
|
5.17e-02
|
5.73e-01
|
GOBP VESICLE MEDIATED TRANSPORT
|
117
|
1.22e-04
|
3.50e-03
|
0.23200
|
0.052100
|
-0.226000
|
3.54e-01
|
5.53e-05
|
GOCC CELL DIVISION SITE
|
6
|
5.75e-01
|
7.47e-01
|
0.23100
|
0.034100
|
-0.229000
|
8.85e-01
|
3.33e-01
|
GOBP POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT
|
5
|
7.58e-01
|
8.65e-01
|
0.23100
|
-0.187000
|
0.136000
|
4.70e-01
|
6.00e-01
|
GOBP PIGMENT BIOSYNTHETIC PROCESS
|
8
|
2.75e-01
|
5.08e-01
|
0.23100
|
0.183000
|
0.141000
|
3.73e-01
|
4.90e-01
|
GOBP PEPTIDYL LYSINE MODIFICATION
|
11
|
2.26e-01
|
4.61e-01
|
0.23100
|
0.060000
|
0.223000
|
7.32e-01
|
2.02e-01
|
GOBP REGULATION OF FIBROBLAST PROLIFERATION
|
8
|
4.90e-01
|
6.90e-01
|
0.23100
|
-0.039300
|
0.227000
|
8.48e-01
|
2.67e-01
|
GOCC PLASMA MEMBRANE PROTEIN COMPLEX
|
33
|
1.48e-01
|
3.69e-01
|
0.23000
|
0.198000
|
-0.117000
|
5.17e-02
|
2.49e-01
|
GOBP ADAPTIVE IMMUNE RESPONSE
|
14
|
1.77e-01
|
4.03e-01
|
0.23000
|
0.227000
|
0.036800
|
1.43e-01
|
8.13e-01
|
GOBP EPITHELIAL CELL DIFFERENTIATION
|
51
|
7.14e-02
|
2.44e-01
|
0.23000
|
0.141000
|
-0.181000
|
8.71e-02
|
2.82e-02
|
GOBP REGULATION OF CELL DEVELOPMENT
|
57
|
4.41e-02
|
1.88e-01
|
0.22900
|
0.122000
|
-0.194000
|
1.18e-01
|
1.33e-02
|
GOCC CHROMATIN
|
101
|
6.44e-03
|
6.40e-02
|
0.22900
|
0.137000
|
-0.184000
|
2.25e-02
|
2.16e-03
|
GOBP RESPONSE TO ALCOHOL
|
35
|
4.55e-03
|
5.09e-02
|
0.22900
|
0.188000
|
0.131000
|
5.82e-02
|
1.85e-01
|
GOBP NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT
|
10
|
3.97e-01
|
6.18e-01
|
0.22900
|
0.028400
|
-0.227000
|
8.77e-01
|
2.15e-01
|
GOBP ACTIN FILAMENT ORGANIZATION
|
41
|
3.86e-02
|
1.75e-01
|
0.22900
|
0.052600
|
-0.223000
|
5.67e-01
|
1.52e-02
|
GOBP LYSOSOMAL TRANSPORT
|
13
|
2.47e-01
|
4.83e-01
|
0.22800
|
-0.005440
|
-0.228000
|
9.73e-01
|
1.56e-01
|
GOBP ORGANELLE FUSION
|
14
|
1.30e-01
|
3.44e-01
|
0.22800
|
-0.207000
|
-0.095300
|
1.82e-01
|
5.40e-01
|
GOMF ENDOPEPTIDASE ACTIVITY
|
34
|
1.72e-01
|
3.97e-01
|
0.22800
|
0.140000
|
-0.180000
|
1.63e-01
|
7.33e-02
|
GOMF ATPASE COUPLED MONOATOMIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
5
|
6.42e-01
|
7.94e-01
|
0.22800
|
0.225000
|
-0.035600
|
3.85e-01
|
8.91e-01
|
GOBP CELL CELL ADHESION
|
57
|
5.56e-02
|
2.13e-01
|
0.22800
|
0.180000
|
-0.140000
|
2.17e-02
|
7.35e-02
|
GOBP MULTIVESICULAR BODY ORGANIZATION
|
5
|
4.53e-01
|
6.67e-01
|
0.22700
|
-0.169000
|
-0.152000
|
5.15e-01
|
5.56e-01
|
GOBP REGULATION OF MUSCLE CONTRACTION
|
11
|
5.59e-01
|
7.36e-01
|
0.22700
|
0.136000
|
-0.182000
|
4.37e-01
|
2.98e-01
|
GOBP CELLULAR RESPONSE TO INSULIN STIMULUS
|
30
|
5.88e-02
|
2.19e-01
|
0.22700
|
0.226000
|
-0.017000
|
3.40e-02
|
8.74e-01
|
GOBP PROTEIN LOCALIZATION TO CELL JUNCTION
|
11
|
2.66e-01
|
5.00e-01
|
0.22700
|
-0.035800
|
-0.224000
|
8.38e-01
|
2.00e-01
|
GOBP CARDIAC CHAMBER DEVELOPMENT
|
13
|
2.17e-01
|
4.53e-01
|
0.22600
|
-0.031100
|
-0.224000
|
8.47e-01
|
1.64e-01
|
GOBP FAT CELL DIFFERENTIATION
|
19
|
2.69e-01
|
5.05e-01
|
0.22600
|
0.213000
|
-0.076200
|
1.11e-01
|
5.68e-01
|
GOCC COPII COATED ER TO GOLGI TRANSPORT VESICLE
|
9
|
5.36e-01
|
7.20e-01
|
0.22600
|
-0.076500
|
0.213000
|
6.92e-01
|
2.71e-01
|
GOBP ENSHEATHMENT OF NEURONS
|
11
|
3.59e-01
|
5.88e-01
|
0.22600
|
-0.225000
|
0.020700
|
1.99e-01
|
9.06e-01
|
GOMF ATPASE BINDING
|
13
|
3.17e-01
|
5.51e-01
|
0.22600
|
0.224000
|
-0.030400
|
1.65e-01
|
8.51e-01
|
GOCC CIS GOLGI NETWORK
|
26
|
2.58e-01
|
4.90e-01
|
0.22500
|
0.184000
|
-0.130000
|
1.08e-01
|
2.55e-01
|
GOBP REGULATION OF CELL DIFFERENTIATION
|
118
|
4.60e-03
|
5.13e-02
|
0.22500
|
0.163000
|
-0.155000
|
3.52e-03
|
5.40e-03
|
GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION
|
6
|
5.13e-01
|
7.05e-01
|
0.22500
|
0.019100
|
0.224000
|
9.36e-01
|
3.43e-01
|
GOBP POSITIVE REGULATION OF TRANSLATION
|
15
|
3.17e-01
|
5.51e-01
|
0.22500
|
-0.218000
|
0.055700
|
1.47e-01
|
7.11e-01
|
GOBP COGNITION
|
31
|
1.21e-01
|
3.32e-01
|
0.22500
|
0.212000
|
-0.074200
|
4.35e-02
|
4.80e-01
|
GOCC CYTOPLASMIC STRESS GRANULE
|
19
|
2.28e-01
|
4.62e-01
|
0.22500
|
-0.219000
|
0.052000
|
1.02e-01
|
6.97e-01
|
GOBP INTRACELLULAR GLUCOSE HOMEOSTASIS
|
15
|
2.36e-01
|
4.69e-01
|
0.22500
|
0.224000
|
-0.011100
|
1.35e-01
|
9.41e-01
|
GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR
|
8
|
6.57e-01
|
8.03e-01
|
0.22500
|
0.183000
|
-0.130000
|
3.72e-01
|
5.25e-01
|
GOCC AXON
|
49
|
6.41e-02
|
2.30e-01
|
0.22400
|
0.107000
|
-0.197000
|
2.04e-01
|
1.91e-02
|
GOBP POST TRANSCRIPTIONAL REGULATION OF GENE EXPRESSION
|
59
|
5.50e-02
|
2.12e-01
|
0.22400
|
-0.137000
|
0.178000
|
7.61e-02
|
2.10e-02
|
GOBP NEGATIVE REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT
|
9
|
4.45e-01
|
6.59e-01
|
0.22400
|
0.024600
|
-0.223000
|
8.99e-01
|
2.49e-01
|
GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN
|
6
|
5.60e-01
|
7.37e-01
|
0.22400
|
-0.010600
|
0.224000
|
9.64e-01
|
3.44e-01
|
GOBP NEGATIVE REGULATION OF CELL GROWTH
|
14
|
4.88e-01
|
6.89e-01
|
0.22400
|
0.180000
|
-0.133000
|
2.47e-01
|
3.90e-01
|
GOBP NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION
|
70
|
2.86e-02
|
1.48e-01
|
0.22400
|
0.123000
|
-0.187000
|
8.40e-02
|
8.53e-03
|
GOCC CENTRIOLE
|
9
|
3.98e-01
|
6.20e-01
|
0.22400
|
-0.223000
|
-0.003100
|
2.48e-01
|
9.87e-01
|
GOBP RESPONSE TO IONIZING RADIATION
|
10
|
5.87e-01
|
7.56e-01
|
0.22300
|
-0.187000
|
0.122000
|
3.08e-01
|
5.05e-01
|
GOBP MONOATOMIC CATION TRANSPORT
|
110
|
2.04e-05
|
7.85e-04
|
0.22300
|
0.223000
|
0.012400
|
1.09e-04
|
8.29e-01
|
GOBP LOCOMOTORY BEHAVIOR
|
18
|
3.49e-01
|
5.79e-01
|
0.22300
|
0.101000
|
-0.199000
|
4.63e-01
|
1.47e-01
|
GOBP PROTEIN TARGETING TO MEMBRANE
|
10
|
5.92e-01
|
7.60e-01
|
0.22300
|
-0.125000
|
0.185000
|
4.95e-01
|
3.14e-01
|
GOBP REGULATION OF CELLULAR COMPONENT BIOGENESIS
|
90
|
1.09e-03
|
1.94e-02
|
0.22300
|
0.042800
|
-0.219000
|
4.99e-01
|
5.31e-04
|
GOCC TRANS GOLGI NETWORK MEMBRANE
|
9
|
5.37e-01
|
7.21e-01
|
0.22300
|
0.071200
|
-0.211000
|
7.13e-01
|
2.75e-01
|
GOBP REGULATION OF GROWTH
|
48
|
9.04e-02
|
2.84e-01
|
0.22300
|
0.182000
|
-0.129000
|
3.24e-02
|
1.30e-01
|
GOBP MULTICELLULAR ORGANISMAL LEVEL CHEMICAL HOMEOSTASIS
|
14
|
1.22e-01
|
3.34e-01
|
0.22200
|
0.168000
|
0.146000
|
2.81e-01
|
3.46e-01
|
GOBP ALCOHOL BIOSYNTHETIC PROCESS
|
19
|
1.75e-01
|
4.01e-01
|
0.22200
|
0.222000
|
-0.015800
|
9.68e-02
|
9.06e-01
|
GOBP REGULATION OF CYTOSKELETON ORGANIZATION
|
49
|
5.40e-03
|
5.74e-02
|
0.22200
|
-0.022000
|
-0.221000
|
7.94e-01
|
8.56e-03
|
GOCC NUCLEAR SPECK
|
47
|
5.50e-02
|
2.12e-01
|
0.22200
|
0.205000
|
-0.084800
|
1.67e-02
|
3.24e-01
|
GOBP MAPK CASCADE
|
59
|
5.21e-02
|
2.05e-01
|
0.22200
|
0.184000
|
-0.123000
|
1.67e-02
|
1.11e-01
|
GOBP NEGATIVE REGULATION OF ENDOCYTOSIS
|
5
|
5.47e-01
|
7.29e-01
|
0.22100
|
0.047400
|
0.216000
|
8.55e-01
|
4.03e-01
|
GOMF STEROL BINDING
|
11
|
4.91e-01
|
6.91e-01
|
0.22100
|
0.206000
|
-0.080200
|
2.38e-01
|
6.47e-01
|
GOBP GOLGI VESICLE TRANSPORT
|
37
|
3.43e-02
|
1.62e-01
|
0.22100
|
0.012100
|
-0.221000
|
9.00e-01
|
2.20e-02
|
GOBP BODY FLUID SECRETION
|
7
|
6.81e-01
|
8.15e-01
|
0.22100
|
0.191000
|
-0.110000
|
3.82e-01
|
6.14e-01
|
GOBP GLYCOSYL COMPOUND METABOLIC PROCESS
|
6
|
6.58e-01
|
8.03e-01
|
0.22100
|
-0.211000
|
0.066100
|
3.73e-01
|
7.80e-01
|
GOBP POSTSYNAPSE ORGANIZATION
|
24
|
3.17e-01
|
5.51e-01
|
0.22100
|
0.144000
|
-0.167000
|
2.26e-01
|
1.60e-01
|
GOCC CHROMOSOMAL REGION
|
31
|
6.90e-02
|
2.41e-01
|
0.22100
|
0.023000
|
-0.219000
|
8.26e-01
|
3.68e-02
|
GOBP REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS
|
12
|
5.19e-01
|
7.09e-01
|
0.22000
|
-0.191000
|
0.109000
|
2.53e-01
|
5.15e-01
|
GOBP PROTEIN LOCALIZATION TO PLASMA MEMBRANE
|
34
|
1.99e-01
|
4.32e-01
|
0.22000
|
0.142000
|
-0.169000
|
1.59e-01
|
9.27e-02
|
GOMF GDP BINDING
|
25
|
2.93e-01
|
5.26e-01
|
0.22000
|
0.131000
|
-0.177000
|
2.62e-01
|
1.30e-01
|
GOCC HISTONE METHYLTRANSFERASE COMPLEX
|
5
|
5.62e-01
|
7.37e-01
|
0.22000
|
-0.038200
|
-0.217000
|
8.83e-01
|
4.03e-01
|
GOBP MEMBRANE DEPOLARIZATION
|
7
|
3.65e-01
|
5.91e-01
|
0.22000
|
0.182000
|
0.123000
|
4.05e-01
|
5.76e-01
|
GOCC POSTSYNAPSE
|
72
|
3.42e-02
|
1.62e-01
|
0.22000
|
0.132000
|
-0.175000
|
5.94e-02
|
1.24e-02
|
GOMF CIS TRANS ISOMERASE ACTIVITY
|
7
|
3.67e-01
|
5.92e-01
|
0.22000
|
-0.184000
|
-0.120000
|
4.01e-01
|
5.83e-01
|
GOBP NEGATIVE REGULATION OF TRANSPORT
|
34
|
1.88e-01
|
4.17e-01
|
0.21900
|
0.180000
|
-0.126000
|
7.39e-02
|
2.10e-01
|
GOBP REGULATION OF FATTY ACID METABOLIC PROCESS
|
11
|
5.46e-01
|
7.28e-01
|
0.21900
|
0.192000
|
-0.105000
|
2.72e-01
|
5.48e-01
|
GOBP CALCIUM ION HOMEOSTASIS
|
21
|
1.49e-01
|
3.70e-01
|
0.21900
|
0.012000
|
-0.219000
|
9.25e-01
|
8.54e-02
|
GOBP ENDOCHONDRAL BONE MORPHOGENESIS
|
7
|
7.07e-01
|
8.35e-01
|
0.21900
|
0.129000
|
-0.177000
|
5.57e-01
|
4.18e-01
|
GOCC U2 TYPE SPLICEOSOMAL COMPLEX
|
11
|
3.94e-01
|
6.15e-01
|
0.21900
|
0.217000
|
-0.026400
|
2.14e-01
|
8.80e-01
|
GOBP NEGATIVE REGULATION OF PROTEIN POLYMERIZATION
|
6
|
6.10e-01
|
7.70e-01
|
0.21900
|
-0.217000
|
0.032000
|
3.60e-01
|
8.92e-01
|
GOBP CELL CYCLE G2 M PHASE TRANSITION
|
8
|
6.72e-01
|
8.10e-01
|
0.21900
|
-0.127000
|
0.178000
|
5.36e-01
|
3.85e-01
|
GOMF KINASE REGULATOR ACTIVITY
|
23
|
3.21e-01
|
5.55e-01
|
0.21900
|
0.125000
|
-0.179000
|
3.04e-01
|
1.40e-01
|
GOBP REGULATION OF MRNA PROCESSING
|
15
|
1.24e-01
|
3.36e-01
|
0.21800
|
0.188000
|
0.111000
|
2.11e-01
|
4.58e-01
|
GOBP AMINOGLYCAN METABOLIC PROCESS
|
6
|
6.09e-01
|
7.70e-01
|
0.21800
|
0.030300
|
-0.216000
|
8.98e-01
|
3.61e-01
|
GOBP GLYCOSAMINOGLYCAN METABOLIC PROCESS
|
6
|
6.09e-01
|
7.70e-01
|
0.21800
|
0.030300
|
-0.216000
|
8.98e-01
|
3.61e-01
|
GOBP NEGATIVE REGULATION OF RESPONSE TO STIMULUS
|
131
|
2.62e-03
|
3.62e-02
|
0.21800
|
0.122000
|
-0.180000
|
2.17e-02
|
7.08e-04
|
GOBP REGULATION OF CYTOKINESIS
|
8
|
3.82e-01
|
6.02e-01
|
0.21800
|
-0.055500
|
-0.211000
|
7.87e-01
|
3.03e-01
|
GOBP REGULATION OF MYOBLAST DIFFERENTIATION
|
7
|
4.77e-01
|
6.82e-01
|
0.21800
|
0.021700
|
0.217000
|
9.21e-01
|
3.22e-01
|
GOMF CARBOHYDRATE BINDING
|
16
|
1.20e-01
|
3.30e-01
|
0.21800
|
-0.197000
|
-0.092300
|
1.75e-01
|
5.25e-01
|
GOBP PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS
|
27
|
2.15e-02
|
1.26e-01
|
0.21800
|
0.140000
|
0.167000
|
2.13e-01
|
1.38e-01
|
GOBP CELLULAR COMPONENT DISASSEMBLY
|
46
|
4.64e-02
|
1.94e-01
|
0.21700
|
0.061800
|
-0.208000
|
4.77e-01
|
1.63e-02
|
GOMF STRUCTURAL CONSTITUENT OF CYTOSKELETON
|
12
|
5.74e-01
|
7.46e-01
|
0.21700
|
0.153000
|
-0.155000
|
3.63e-01
|
3.56e-01
|
GOCC NUCLEOLUS
|
87
|
2.13e-02
|
1.26e-01
|
0.21600
|
0.169000
|
-0.135000
|
8.41e-03
|
3.59e-02
|
GOBP REGULATION OF TRANSPORT
|
130
|
2.94e-03
|
3.91e-02
|
0.21600
|
0.180000
|
-0.119000
|
7.69e-04
|
2.59e-02
|
GOBP HOMEOSTASIS OF NUMBER OF CELLS
|
25
|
3.23e-02
|
1.59e-01
|
0.21600
|
0.122000
|
0.178000
|
2.97e-01
|
1.27e-01
|
GOBP MICROTUBULE ORGANIZING CENTER ORGANIZATION
|
12
|
1.82e-01
|
4.09e-01
|
0.21600
|
-0.152000
|
-0.153000
|
3.64e-01
|
3.61e-01
|
GOCC MEMBRANE COAT
|
10
|
6.13e-01
|
7.70e-01
|
0.21600
|
-0.178000
|
0.122000
|
3.32e-01
|
5.07e-01
|
GOBP AUTOPHAGOSOME MATURATION
|
10
|
2.45e-01
|
4.81e-01
|
0.21600
|
-0.168000
|
-0.134000
|
3.58e-01
|
4.64e-01
|
GOBP VESICLE BUDDING FROM MEMBRANE
|
15
|
5.06e-01
|
7.00e-01
|
0.21500
|
-0.146000
|
0.158000
|
3.29e-01
|
2.93e-01
|
GOCC ROUGH ENDOPLASMIC RETICULUM
|
10
|
2.55e-01
|
4.87e-01
|
0.21500
|
0.116000
|
0.181000
|
5.28e-01
|
3.24e-01
|
GOBP MITOTIC NUCLEAR DIVISION
|
22
|
2.32e-01
|
4.66e-01
|
0.21400
|
0.060100
|
-0.206000
|
6.29e-01
|
9.76e-02
|
GOBP MONOATOMIC CATION TRANSMEMBRANE TRANSPORT
|
89
|
8.41e-05
|
2.64e-03
|
0.21400
|
0.210000
|
0.044400
|
9.48e-04
|
4.86e-01
|
GOBP CELLULAR RESPONSE TO BIOTIC STIMULUS
|
22
|
4.79e-02
|
1.97e-01
|
0.21400
|
0.135000
|
0.167000
|
2.78e-01
|
1.80e-01
|
GOBP MEMBRANE FISSION
|
5
|
5.15e-01
|
7.07e-01
|
0.21400
|
-0.101000
|
-0.189000
|
6.96e-01
|
4.65e-01
|
GOMF PROTEIN MEMBRANE ADAPTOR ACTIVITY
|
8
|
3.86e-01
|
6.07e-01
|
0.21400
|
-0.205000
|
-0.061800
|
3.17e-01
|
7.63e-01
|
GOMF MONOATOMIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
76
|
1.02e-04
|
3.06e-03
|
0.21400
|
0.197000
|
0.084900
|
4.00e-03
|
2.15e-01
|
GOBP GRANULOCYTE MIGRATION
|
5
|
6.79e-01
|
8.14e-01
|
0.21400
|
0.034300
|
-0.211000
|
8.95e-01
|
4.15e-01
|
GOBP NEUTROPHIL MIGRATION
|
5
|
6.79e-01
|
8.14e-01
|
0.21400
|
0.034300
|
-0.211000
|
8.95e-01
|
4.15e-01
|
GOMF ENZYME SUBSTRATE ADAPTOR ACTIVITY
|
6
|
7.49e-01
|
8.61e-01
|
0.21300
|
-0.120000
|
0.177000
|
6.12e-01
|
4.55e-01
|
GOBP TRANSLATIONAL INITIATION
|
17
|
4.30e-01
|
6.46e-01
|
0.21300
|
-0.182000
|
0.111000
|
1.97e-01
|
4.31e-01
|
GOBP MORPHOGENESIS OF EMBRYONIC EPITHELIUM
|
12
|
4.77e-01
|
6.82e-01
|
0.21300
|
0.071600
|
-0.201000
|
6.69e-01
|
2.31e-01
|
GOBP REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION
|
36
|
5.05e-02
|
2.03e-01
|
0.21300
|
0.015600
|
-0.212000
|
8.74e-01
|
2.97e-02
|
GOBP ORGANELLE DISASSEMBLY
|
10
|
5.42e-01
|
7.25e-01
|
0.21300
|
0.072500
|
-0.200000
|
6.93e-01
|
2.75e-01
|
GOBP SPHINGOLIPID METABOLIC PROCESS
|
17
|
1.83e-01
|
4.11e-01
|
0.21300
|
-0.212000
|
-0.020500
|
1.33e-01
|
8.85e-01
|
GOBP CYTOSKELETON ORGANIZATION
|
120
|
4.48e-04
|
9.84e-03
|
0.21200
|
0.048400
|
-0.207000
|
3.84e-01
|
1.88e-04
|
GOBP PROTEIN POLYMERIZATION
|
23
|
1.12e-01
|
3.19e-01
|
0.21200
|
-0.011600
|
-0.212000
|
9.24e-01
|
8.12e-02
|
GOBP RESPONSE TO PURINE CONTAINING COMPOUND
|
16
|
2.34e-01
|
4.68e-01
|
0.21200
|
0.212000
|
0.000515
|
1.44e-01
|
9.97e-01
|
GOMF DNA BINDING TRANSCRIPTION FACTOR BINDING
|
47
|
1.33e-01
|
3.47e-01
|
0.21200
|
0.148000
|
-0.152000
|
8.58e-02
|
7.61e-02
|
GOBP STEROID HORMONE RECEPTOR SIGNALING PATHWAY
|
22
|
3.46e-01
|
5.76e-01
|
0.21200
|
0.113000
|
-0.179000
|
3.63e-01
|
1.49e-01
|
GOBP XENOBIOTIC TRANSPORT
|
10
|
4.63e-01
|
6.71e-01
|
0.21200
|
-0.210000
|
0.031000
|
2.53e-01
|
8.66e-01
|
GOBP CELLULAR RESPONSE TO ALCOHOL
|
15
|
1.30e-01
|
3.43e-01
|
0.21200
|
0.153000
|
0.147000
|
3.09e-01
|
3.29e-01
|
GOBP RESPONSE TO INSULIN
|
35
|
5.62e-02
|
2.15e-01
|
0.21100
|
0.211000
|
-0.014500
|
3.31e-02
|
8.84e-01
|
GOBP EPITHELIAL CELL PROLIFERATION
|
43
|
1.24e-01
|
3.35e-01
|
0.21100
|
0.183000
|
-0.106000
|
4.14e-02
|
2.38e-01
|
GOBP DETECTION OF STIMULUS
|
7
|
7.35e-01
|
8.53e-01
|
0.21100
|
-0.151000
|
0.148000
|
4.91e-01
|
4.99e-01
|
GOBP STRESS FIBER ASSEMBLY
|
16
|
2.01e-01
|
4.36e-01
|
0.21100
|
-0.024800
|
-0.210000
|
8.64e-01
|
1.49e-01
|
GOCC NEURON PROJECTION
|
87
|
1.03e-02
|
8.46e-02
|
0.21100
|
0.084500
|
-0.193000
|
1.88e-01
|
2.57e-03
|
GOBP NEUROTRANSMITTER TRANSPORT
|
13
|
3.59e-01
|
5.88e-01
|
0.21100
|
0.024700
|
-0.210000
|
8.78e-01
|
1.93e-01
|
GOBP REGULATION OF ENDOCYTOSIS
|
30
|
2.50e-01
|
4.84e-01
|
0.21100
|
0.175000
|
-0.118000
|
1.02e-01
|
2.67e-01
|
GOBP SPROUTING ANGIOGENESIS
|
5
|
5.32e-01
|
7.16e-01
|
0.21100
|
0.092800
|
0.189000
|
7.20e-01
|
4.65e-01
|
GOBP EPIDERMAL CELL DIFFERENTIATION
|
12
|
3.94e-01
|
6.15e-01
|
0.21100
|
0.027100
|
-0.209000
|
8.72e-01
|
2.12e-01
|
GOBP MACROMOLECULE METHYLATION
|
5
|
8.03e-01
|
8.85e-01
|
0.21100
|
-0.157000
|
0.141000
|
5.46e-01
|
5.87e-01
|
GOBP PROTEIN INSERTION INTO MEMBRANE
|
5
|
7.64e-01
|
8.70e-01
|
0.21000
|
-0.190000
|
0.090800
|
4.63e-01
|
7.26e-01
|
GOBP REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY
|
13
|
5.17e-01
|
7.07e-01
|
0.21000
|
0.100000
|
-0.185000
|
5.34e-01
|
2.51e-01
|
GOBP AMYLOID BETA METABOLIC PROCESS
|
9
|
6.12e-01
|
7.70e-01
|
0.21000
|
0.191000
|
-0.087600
|
3.22e-01
|
6.50e-01
|
GOBP REGULATION OF DEFENSE RESPONSE TO VIRUS
|
6
|
5.15e-01
|
7.07e-01
|
0.21000
|
-0.204000
|
-0.049600
|
3.87e-01
|
8.34e-01
|
GOCC INTERCELLULAR BRIDGE
|
7
|
6.07e-01
|
7.70e-01
|
0.21000
|
-0.206000
|
0.042600
|
3.47e-01
|
8.46e-01
|
GOBP ENDOCRINE PROCESS
|
10
|
2.62e-01
|
4.95e-01
|
0.21000
|
-0.134000
|
-0.162000
|
4.66e-01
|
3.76e-01
|
GOBP CELL CHEMOTAXIS
|
13
|
5.33e-01
|
7.17e-01
|
0.21000
|
0.109000
|
-0.180000
|
4.99e-01
|
2.64e-01
|
GOBP NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT
|
10
|
6.47e-01
|
7.96e-01
|
0.21000
|
0.139000
|
-0.157000
|
4.47e-01
|
3.92e-01
|
GOCC GLUTAMATERGIC SYNAPSE
|
58
|
5.53e-02
|
2.12e-01
|
0.21000
|
0.095800
|
-0.187000
|
2.18e-01
|
1.61e-02
|
GOBP REGULATION OF CELL CYCLE G2 M PHASE TRANSITION
|
6
|
7.63e-01
|
8.69e-01
|
0.21000
|
-0.128000
|
0.167000
|
5.90e-01
|
4.81e-01
|
GOBP CATECHOLAMINE TRANSPORT
|
7
|
7.38e-01
|
8.54e-01
|
0.21000
|
-0.145000
|
0.152000
|
5.07e-01
|
4.89e-01
|
GOBP MONOAMINE TRANSPORT
|
7
|
7.38e-01
|
8.54e-01
|
0.21000
|
-0.145000
|
0.152000
|
5.07e-01
|
4.89e-01
|
GOBP NEGATIVE REGULATION OF AUTOPHAGY
|
16
|
3.03e-01
|
5.37e-01
|
0.21000
|
0.032400
|
-0.207000
|
8.24e-01
|
1.54e-01
|
GOCC MEMBRANE PROTEIN COMPLEX
|
143
|
3.62e-05
|
1.27e-03
|
0.21000
|
-0.020800
|
0.209000
|
6.85e-01
|
4.65e-05
|
GOCC PIGMENT GRANULE
|
17
|
3.18e-01
|
5.52e-01
|
0.21000
|
-0.204000
|
0.049200
|
1.49e-01
|
7.27e-01
|
GOBP RETICULOPHAGY
|
6
|
5.20e-01
|
7.09e-01
|
0.20900
|
-0.047700
|
-0.204000
|
8.40e-01
|
3.89e-01
|
GOBP OLEFINIC COMPOUND METABOLIC PROCESS
|
26
|
8.87e-02
|
2.81e-01
|
0.20900
|
0.013700
|
0.209000
|
9.05e-01
|
6.80e-02
|
GOBP REGULATION OF PROTEIN MODIFICATION PROCESS
|
60
|
3.36e-02
|
1.61e-01
|
0.20900
|
0.072600
|
-0.196000
|
3.43e-01
|
1.02e-02
|
GOBP BASIC AMINO ACID TRANSPORT
|
6
|
7.46e-01
|
8.60e-01
|
0.20900
|
0.180000
|
-0.106000
|
4.45e-01
|
6.54e-01
|
GOBP NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY
|
17
|
3.66e-01
|
5.91e-01
|
0.20900
|
-0.070700
|
0.197000
|
6.17e-01
|
1.63e-01
|
GOBP CYTOSKELETON DEPENDENT CYTOKINESIS
|
20
|
2.60e-01
|
4.92e-01
|
0.20900
|
0.048200
|
-0.204000
|
7.11e-01
|
1.18e-01
|
GOBP MITOTIC CYTOKINESIS
|
20
|
2.60e-01
|
4.92e-01
|
0.20900
|
0.048200
|
-0.204000
|
7.11e-01
|
1.18e-01
|
GOBP NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS
|
75
|
4.56e-02
|
1.92e-01
|
0.20900
|
0.159000
|
-0.136000
|
2.11e-02
|
4.81e-02
|
GOBP RESPONSE TO MOLECULE OF BACTERIAL ORIGIN
|
33
|
2.85e-02
|
1.48e-01
|
0.20900
|
0.052000
|
0.202000
|
6.10e-01
|
4.72e-02
|
GOBP REGULATION OF ANATOMICAL STRUCTURE SIZE
|
46
|
9.34e-02
|
2.88e-01
|
0.20900
|
0.088600
|
-0.189000
|
3.08e-01
|
2.96e-02
|
GOMF ACTIN MONOMER BINDING
|
5
|
7.87e-01
|
8.77e-01
|
0.20800
|
0.108000
|
-0.178000
|
6.76e-01
|
4.92e-01
|
GOBP POSITIVE REGULATION OF CHROMOSOME ORGANIZATION
|
5
|
7.03e-01
|
8.31e-01
|
0.20800
|
-0.204000
|
0.040800
|
4.30e-01
|
8.75e-01
|
GOBP EXOCRINE SYSTEM DEVELOPMENT
|
5
|
7.60e-01
|
8.65e-01
|
0.20800
|
0.191000
|
-0.082700
|
4.60e-01
|
7.50e-01
|
GOMF C ACYLTRANSFERASE ACTIVITY
|
6
|
6.48e-01
|
7.96e-01
|
0.20800
|
-0.035400
|
0.205000
|
8.81e-01
|
3.86e-01
|
GOBP SOMATIC STEM CELL POPULATION MAINTENANCE
|
7
|
6.70e-01
|
8.10e-01
|
0.20800
|
0.074400
|
-0.194000
|
7.34e-01
|
3.76e-01
|
GOBP MUSCLE CELL MIGRATION
|
8
|
3.64e-01
|
5.91e-01
|
0.20800
|
-0.178000
|
-0.107000
|
3.85e-01
|
6.02e-01
|
GOBP SECONDARY ALCOHOL METABOLIC PROCESS
|
21
|
2.22e-01
|
4.58e-01
|
0.20700
|
0.205000
|
-0.033800
|
1.08e-01
|
7.90e-01
|
GOMF MOLECULAR FUNCTION ACTIVATOR ACTIVITY
|
90
|
2.83e-02
|
1.47e-01
|
0.20700
|
0.138000
|
-0.154000
|
2.95e-02
|
1.45e-02
|
GOBP SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR
|
27
|
3.10e-02
|
1.55e-01
|
0.20700
|
0.138000
|
0.154000
|
2.19e-01
|
1.72e-01
|
GOCC POLYMERIC CYTOSKELETAL FIBER
|
43
|
5.08e-02
|
2.03e-01
|
0.20700
|
0.035300
|
-0.203000
|
6.94e-01
|
2.32e-02
|
GOBP PROTEIN STABILIZATION
|
24
|
3.06e-01
|
5.41e-01
|
0.20600
|
-0.094800
|
0.183000
|
4.26e-01
|
1.24e-01
|
GOBP DOPAMINE TRANSPORT
|
5
|
5.28e-01
|
7.14e-01
|
0.20600
|
-0.167000
|
-0.120000
|
5.18e-01
|
6.42e-01
|
GOBP SPINDLE ORGANIZATION
|
13
|
1.88e-01
|
4.17e-01
|
0.20600
|
-0.139000
|
-0.151000
|
3.88e-01
|
3.48e-01
|
GOBP CELLULAR RESPONSE TO STEROID HORMONE STIMULUS
|
33
|
1.32e-01
|
3.45e-01
|
0.20500
|
0.198000
|
-0.054700
|
5.23e-02
|
5.92e-01
|
GOBP RESPONSE TO TUMOR NECROSIS FACTOR
|
22
|
2.44e-01
|
4.80e-01
|
0.20500
|
0.199000
|
-0.048700
|
1.09e-01
|
6.95e-01
|
GOBP NUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS
|
15
|
2.74e-01
|
5.08e-01
|
0.20500
|
0.205000
|
0.004500
|
1.72e-01
|
9.76e-01
|
GOBP NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS
|
15
|
2.74e-01
|
5.08e-01
|
0.20500
|
0.205000
|
0.004500
|
1.72e-01
|
9.76e-01
|
GOBP POSITIVE REGULATION OF NEURON DIFFERENTIATION
|
7
|
5.80e-01
|
7.51e-01
|
0.20500
|
0.204000
|
-0.016800
|
3.51e-01
|
9.39e-01
|
GOBP REGULATION OF NITRIC OXIDE METABOLIC PROCESS
|
10
|
6.61e-01
|
8.04e-01
|
0.20500
|
-0.151000
|
0.138000
|
4.10e-01
|
4.50e-01
|
GOBP CHROMOSOME LOCALIZATION
|
8
|
3.81e-01
|
6.01e-01
|
0.20500
|
-0.096200
|
-0.181000
|
6.39e-01
|
3.78e-01
|
GOBP MIDBODY ABSCISSION
|
6
|
4.64e-01
|
6.72e-01
|
0.20500
|
-0.138000
|
-0.151000
|
5.59e-01
|
5.23e-01
|
GOBP PHOSPHOLIPID TRANSPORT
|
11
|
4.14e-01
|
6.32e-01
|
0.20500
|
0.009700
|
-0.204000
|
9.56e-01
|
2.43e-01
|
GOBP MUSCLE CELL DEVELOPMENT
|
13
|
4.36e-01
|
6.52e-01
|
0.20500
|
0.049500
|
-0.199000
|
7.59e-01
|
2.18e-01
|
GOBP POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT
|
7
|
4.20e-01
|
6.39e-01
|
0.20500
|
-0.173000
|
-0.110000
|
4.31e-01
|
6.16e-01
|
GOCC MITOTIC SPINDLE
|
17
|
4.99e-01
|
6.96e-01
|
0.20500
|
0.140000
|
-0.149000
|
3.22e-01
|
2.90e-01
|
GOCC ENDOCYTIC VESICLE LUMEN
|
5
|
5.77e-01
|
7.48e-01
|
0.20400
|
-0.194000
|
-0.063100
|
4.53e-01
|
8.08e-01
|
GOBP PROTEIN TARGETING
|
39
|
1.91e-01
|
4.22e-01
|
0.20400
|
-0.118000
|
0.167000
|
2.08e-01
|
7.61e-02
|
GOBP INNER EAR MORPHOGENESIS
|
5
|
5.28e-01
|
7.14e-01
|
0.20400
|
-0.139000
|
-0.150000
|
5.92e-01
|
5.63e-01
|
GOBP CERAMIDE BIOSYNTHETIC PROCESS
|
5
|
6.30e-01
|
7.86e-01
|
0.20400
|
-0.203000
|
-0.019300
|
4.32e-01
|
9.41e-01
|
GOBP REGULATION OF FAT CELL DIFFERENTIATION
|
14
|
3.67e-01
|
5.92e-01
|
0.20400
|
0.202000
|
-0.029200
|
1.93e-01
|
8.51e-01
|
GOMF CHROMATIN DNA BINDING
|
19
|
4.52e-01
|
6.65e-01
|
0.20400
|
0.125000
|
-0.161000
|
3.49e-01
|
2.28e-01
|
GOBP CELLULAR RESPONSE TO LIPID
|
72
|
4.10e-03
|
4.80e-02
|
0.20400
|
0.204000
|
-0.008470
|
3.67e-03
|
9.04e-01
|
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE
|
45
|
1.66e-01
|
3.87e-01
|
0.20400
|
-0.134000
|
0.153000
|
1.27e-01
|
8.05e-02
|
GOBP EXCRETION
|
6
|
6.86e-01
|
8.18e-01
|
0.20400
|
0.051000
|
-0.197000
|
8.29e-01
|
4.05e-01
|
GOBP CENTROSOME DUPLICATION
|
7
|
4.14e-01
|
6.32e-01
|
0.20300
|
-0.131000
|
-0.156000
|
5.50e-01
|
4.77e-01
|
GOBP REGULATION OF MODIFICATION OF POSTSYNAPTIC STRUCTURE
|
6
|
5.92e-01
|
7.60e-01
|
0.20300
|
-0.203000
|
-0.008990
|
3.91e-01
|
9.70e-01
|
GOBP REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE
|
6
|
5.92e-01
|
7.60e-01
|
0.20300
|
-0.203000
|
-0.008990
|
3.91e-01
|
9.70e-01
|
GOCC CATALYTIC COMPLEX
|
197
|
1.67e-04
|
4.43e-03
|
0.20300
|
-0.081700
|
0.186000
|
6.88e-02
|
3.24e-05
|
GOCC MICROTUBULE ORGANIZING CENTER
|
61
|
7.41e-02
|
2.50e-01
|
0.20300
|
0.109000
|
-0.171000
|
1.51e-01
|
2.39e-02
|
GOBP REGULATION OF ORGANELLE ASSEMBLY
|
26
|
8.70e-02
|
2.78e-01
|
0.20300
|
-0.029200
|
-0.201000
|
7.99e-01
|
7.97e-02
|
GOCC CELL SURFACE
|
59
|
5.49e-02
|
2.12e-01
|
0.20300
|
0.082400
|
-0.185000
|
2.85e-01
|
1.63e-02
|
GOBP RESPONSE TO ENDOGENOUS STIMULUS
|
133
|
7.20e-03
|
6.76e-02
|
0.20200
|
0.157000
|
-0.128000
|
3.01e-03
|
1.61e-02
|
GOBP MONOATOMIC ION TRANSMEMBRANE TRANSPORT
|
101
|
2.06e-04
|
5.20e-03
|
0.20200
|
0.201000
|
0.018600
|
7.68e-04
|
7.57e-01
|
GOBP NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION
|
6
|
5.77e-01
|
7.48e-01
|
0.20200
|
0.201000
|
0.021500
|
3.95e-01
|
9.27e-01
|
GOMF NUCLEAR RECEPTOR BINDING
|
24
|
3.43e-01
|
5.76e-01
|
0.20200
|
0.104000
|
-0.173000
|
3.83e-01
|
1.45e-01
|
GOBP REGENERATION
|
15
|
2.97e-01
|
5.31e-01
|
0.20200
|
0.003020
|
-0.202000
|
9.84e-01
|
1.78e-01
|
GOCC SWI SNF SUPERFAMILY TYPE COMPLEX
|
12
|
2.81e-01
|
5.12e-01
|
0.20200
|
-0.059800
|
-0.193000
|
7.21e-01
|
2.50e-01
|
GOBP POSITIVE REGULATION OF VASCULATURE DEVELOPMENT
|
12
|
6.13e-01
|
7.70e-01
|
0.20200
|
0.157000
|
-0.126000
|
3.49e-01
|
4.51e-01
|
GOCC NEURON PROJECTION CYTOPLASM
|
12
|
2.50e-01
|
4.84e-01
|
0.20200
|
-0.180000
|
-0.090400
|
2.82e-01
|
5.90e-01
|
GOBP REGULATION OF PROTEIN SECRETION
|
16
|
3.47e-01
|
5.77e-01
|
0.20200
|
0.198000
|
-0.037600
|
1.73e-01
|
7.96e-01
|
GOBP REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS
|
7
|
7.43e-01
|
8.58e-01
|
0.20200
|
-0.165000
|
0.116000
|
4.52e-01
|
5.97e-01
|
GOBP REGULATION OF CATALYTIC ACTIVITY
|
53
|
1.14e-01
|
3.21e-01
|
0.20100
|
0.115000
|
-0.165000
|
1.56e-01
|
4.14e-02
|
GOCC CENTROSOME
|
50
|
1.13e-01
|
3.21e-01
|
0.20100
|
0.102000
|
-0.173000
|
2.20e-01
|
3.76e-02
|
GOBP PROTEIN EXPORT FROM NUCLEUS
|
6
|
4.75e-01
|
6.82e-01
|
0.20100
|
-0.139000
|
-0.145000
|
5.56e-01
|
5.39e-01
|
GOMF ALCOHOL BINDING
|
11
|
6.09e-01
|
7.70e-01
|
0.20100
|
0.102000
|
-0.174000
|
5.62e-01
|
3.21e-01
|
GOBP REGULATION OF MEMBRANE POTENTIAL
|
30
|
2.26e-01
|
4.61e-01
|
0.20100
|
0.184000
|
-0.081800
|
8.53e-02
|
4.44e-01
|
GOCC GOLGI APPARATUS SUBCOMPARTMENT
|
46
|
3.71e-02
|
1.70e-01
|
0.20100
|
0.018700
|
-0.200000
|
8.29e-01
|
2.11e-02
|
GOBP GLIAL CELL MIGRATION
|
7
|
6.11e-01
|
7.70e-01
|
0.20100
|
0.026700
|
-0.199000
|
9.03e-01
|
3.64e-01
|
GOBP TISSUE HOMEOSTASIS
|
22
|
4.07e-01
|
6.26e-01
|
0.20100
|
0.120000
|
-0.161000
|
3.34e-01
|
1.95e-01
|
GOBP RNA SPLICING VIA TRANSESTERIFICATION REACTIONS
|
32
|
1.79e-01
|
4.06e-01
|
0.20100
|
0.189000
|
-0.067600
|
6.80e-02
|
5.14e-01
|
GOBP POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION
|
18
|
2.98e-01
|
5.31e-01
|
0.20000
|
0.032800
|
-0.198000
|
8.11e-01
|
1.49e-01
|
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM
|
6
|
7.80e-01
|
8.75e-01
|
0.20000
|
-0.161000
|
0.120000
|
4.96e-01
|
6.13e-01
|
GOBP POSITIVE REGULATION OF MRNA CATABOLIC PROCESS
|
13
|
3.12e-01
|
5.46e-01
|
0.20000
|
0.021500
|
0.199000
|
8.94e-01
|
2.16e-01
|
GOMF GLUTAMATE RECEPTOR BINDING
|
6
|
6.63e-01
|
8.06e-01
|
0.20000
|
-0.030800
|
0.198000
|
8.96e-01
|
4.03e-01
|
GOBP NEGATIVE REGULATION OF SIGNALING
|
121
|
9.06e-03
|
7.87e-02
|
0.20000
|
0.111000
|
-0.167000
|
4.56e-02
|
2.51e-03
|
GOCC MICROBODY MEMBRANE
|
11
|
2.80e-01
|
5.11e-01
|
0.20000
|
-0.176000
|
-0.096000
|
3.15e-01
|
5.83e-01
|
GOBP REGULATION OF VESICLE MEDIATED TRANSPORT
|
38
|
2.27e-01
|
4.61e-01
|
0.20000
|
0.128000
|
-0.154000
|
1.78e-01
|
1.07e-01
|
GOBP REGULATION OF LYMPHOCYTE ACTIVATION
|
30
|
4.91e-02
|
2.01e-01
|
0.20000
|
0.193000
|
0.053300
|
7.09e-02
|
6.18e-01
|
GOBP POLYOL METABOLIC PROCESS
|
15
|
1.80e-01
|
4.08e-01
|
0.20000
|
0.093300
|
0.177000
|
5.34e-01
|
2.39e-01
|
GOMF ACETYLTRANSFERASE ACTIVITY
|
10
|
3.01e-01
|
5.34e-01
|
0.20000
|
0.120000
|
0.160000
|
5.15e-01
|
3.83e-01
|
GOBP REGULATION OF HYDROLASE ACTIVITY
|
19
|
4.33e-01
|
6.50e-01
|
0.20000
|
0.101000
|
-0.172000
|
4.49e-01
|
1.97e-01
|
GOBP EPITHELIAL CELL DEVELOPMENT
|
17
|
1.51e-01
|
3.74e-01
|
0.20000
|
-0.182000
|
-0.083000
|
1.98e-01
|
5.57e-01
|
GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II
|
90
|
3.51e-02
|
1.64e-01
|
0.20000
|
0.128000
|
-0.153000
|
4.31e-02
|
1.54e-02
|
GOBP IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY
|
20
|
2.57e-01
|
4.90e-01
|
0.19900
|
0.197000
|
-0.028900
|
1.30e-01
|
8.24e-01
|
GOMF IONOTROPIC GLUTAMATE RECEPTOR BINDING
|
5
|
7.95e-01
|
8.81e-01
|
0.19900
|
-0.175000
|
0.094400
|
4.98e-01
|
7.15e-01
|
GOCC MIDBODY
|
22
|
1.45e-01
|
3.64e-01
|
0.19900
|
-0.198000
|
-0.021400
|
1.11e-01
|
8.63e-01
|
GOBP PANCREAS DEVELOPMENT
|
9
|
3.40e-01
|
5.76e-01
|
0.19900
|
-0.125000
|
-0.155000
|
5.18e-01
|
4.23e-01
|
GOBP NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS
|
18
|
4.73e-01
|
6.79e-01
|
0.19900
|
0.111000
|
-0.165000
|
4.19e-01
|
2.29e-01
|
GOBP AUTOPHAGY OF MITOCHONDRION
|
17
|
5.00e-01
|
6.96e-01
|
0.19900
|
-0.116000
|
0.162000
|
4.12e-01
|
2.52e-01
|
GOBP MRNA METABOLIC PROCESS
|
72
|
6.90e-02
|
2.41e-01
|
0.19900
|
0.149000
|
-0.132000
|
3.39e-02
|
6.05e-02
|
GOBP POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION
|
17
|
3.65e-01
|
5.91e-01
|
0.19900
|
0.192000
|
-0.049800
|
1.73e-01
|
7.24e-01
|
GOBP RESPONSE TO ALKALOID
|
8
|
4.74e-01
|
6.80e-01
|
0.19800
|
0.034000
|
0.196000
|
8.68e-01
|
3.40e-01
|
GOCC CAJAL BODY
|
10
|
6.79e-01
|
8.14e-01
|
0.19800
|
-0.145000
|
0.135000
|
4.29e-01
|
4.61e-01
|
GOBP CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS
|
35
|
1.07e-01
|
3.10e-01
|
0.19800
|
0.195000
|
-0.034500
|
4.88e-02
|
7.28e-01
|
GOMF G PROTEIN COUPLED RECEPTOR BINDING
|
12
|
6.30e-01
|
7.86e-01
|
0.19800
|
0.133000
|
-0.146000
|
4.27e-01
|
3.83e-01
|
GOBP NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION
|
9
|
7.08e-01
|
8.36e-01
|
0.19800
|
0.142000
|
-0.137000
|
4.61e-01
|
4.79e-01
|
GOBP ALPHA BETA T CELL DIFFERENTIATION
|
7
|
6.71e-01
|
8.10e-01
|
0.19800
|
0.190000
|
-0.055600
|
3.87e-01
|
7.99e-01
|
GOBP METAPHASE CHROMOSOME ALIGNMENT
|
7
|
4.68e-01
|
6.75e-01
|
0.19700
|
-0.078600
|
-0.181000
|
7.20e-01
|
4.08e-01
|
GOBP POSITIVE REGULATION OF LEUKOCYTE MIGRATION
|
8
|
6.94e-01
|
8.24e-01
|
0.19700
|
0.090900
|
-0.175000
|
6.57e-01
|
3.93e-01
|
GOBP POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION
|
8
|
6.94e-01
|
8.24e-01
|
0.19700
|
0.090900
|
-0.175000
|
6.57e-01
|
3.93e-01
|
GOCC CATION CHANNEL COMPLEX
|
17
|
2.86e-01
|
5.18e-01
|
0.19700
|
0.197000
|
-0.011100
|
1.62e-01
|
9.37e-01
|
GOBP NEGATIVE REGULATION OF GROWTH
|
20
|
3.81e-01
|
6.01e-01
|
0.19700
|
0.180000
|
-0.080100
|
1.66e-01
|
5.39e-01
|
GOBP RESPONSE TO NICOTINE
|
5
|
5.57e-01
|
7.34e-01
|
0.19700
|
0.160000
|
0.116000
|
5.37e-01
|
6.55e-01
|
GOBP CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS
|
16
|
3.48e-01
|
5.78e-01
|
0.19700
|
0.195000
|
-0.029700
|
1.80e-01
|
8.38e-01
|
GOBP T CELL DIFFERENTIATION
|
16
|
1.73e-01
|
3.98e-01
|
0.19700
|
0.087200
|
0.177000
|
5.49e-01
|
2.24e-01
|
GOBP CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM
|
21
|
9.07e-02
|
2.84e-01
|
0.19700
|
-0.108000
|
-0.165000
|
3.94e-01
|
1.95e-01
|
GOBP NEGATIVE REGULATION OF GENE EXPRESSION
|
94
|
3.39e-02
|
1.61e-01
|
0.19700
|
0.150000
|
-0.128000
|
1.57e-02
|
3.86e-02
|
GOCC MITOCHONDRIAL SMALL RIBOSOMAL SUBUNIT
|
5
|
7.76e-01
|
8.74e-01
|
0.19700
|
-0.183000
|
0.073200
|
4.81e-01
|
7.77e-01
|
GOCC SCHAFFER COLLATERAL CA1 SYNAPSE
|
10
|
6.43e-01
|
7.95e-01
|
0.19700
|
0.172000
|
-0.095000
|
3.48e-01
|
6.05e-01
|
GOBP ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT
|
19
|
1.34e-01
|
3.48e-01
|
0.19700
|
-0.181000
|
-0.075800
|
1.74e-01
|
5.71e-01
|
GOBP REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY
|
16
|
2.93e-01
|
5.26e-01
|
0.19700
|
0.001850
|
-0.197000
|
9.90e-01
|
1.76e-01
|
GOBP CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS
|
34
|
1.94e-01
|
4.25e-01
|
0.19600
|
0.181000
|
-0.076500
|
7.18e-02
|
4.46e-01
|
GOBP NUCLEAR TRANSPORT
|
29
|
9.42e-02
|
2.88e-01
|
0.19600
|
-0.012500
|
-0.196000
|
9.09e-01
|
7.12e-02
|
GOBP NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY
|
16
|
4.24e-01
|
6.41e-01
|
0.19600
|
-0.186000
|
0.061400
|
2.00e-01
|
6.73e-01
|
GOBP SMOOTH MUSCLE CELL MIGRATION
|
7
|
4.80e-01
|
6.84e-01
|
0.19500
|
-0.180000
|
-0.074800
|
4.11e-01
|
7.33e-01
|
GOCC HISTONE DEACETYLASE COMPLEX
|
16
|
3.40e-01
|
5.76e-01
|
0.19500
|
0.022100
|
-0.194000
|
8.79e-01
|
1.83e-01
|
GOBP REGULATION OF RESPONSE TO EXTERNAL STIMULUS
|
78
|
4.89e-02
|
2.00e-01
|
0.19500
|
0.105000
|
-0.164000
|
1.21e-01
|
1.50e-02
|
GOBP REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS
|
10
|
4.51e-01
|
6.65e-01
|
0.19500
|
0.195000
|
0.007880
|
2.89e-01
|
9.66e-01
|
GOMF DICARBOXYLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY
|
6
|
5.07e-01
|
7.01e-01
|
0.19400
|
-0.111000
|
-0.159000
|
6.38e-01
|
5.00e-01
|
GOBP CHROMATIN ORGANIZATION
|
74
|
2.94e-02
|
1.51e-01
|
0.19400
|
0.068700
|
-0.182000
|
3.22e-01
|
8.70e-03
|
GOBP REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS
|
6
|
5.01e-01
|
6.97e-01
|
0.19400
|
0.143000
|
0.131000
|
5.46e-01
|
5.79e-01
|
GOBP REGULATION OF BMP SIGNALING PATHWAY
|
6
|
5.19e-01
|
7.09e-01
|
0.19400
|
-0.094800
|
-0.169000
|
6.88e-01
|
4.75e-01
|
GOBP T CELL ACTIVATION
|
31
|
3.21e-02
|
1.58e-01
|
0.19400
|
0.156000
|
0.115000
|
1.37e-01
|
2.76e-01
|
GOCC GOLGI CIS CISTERNA
|
17
|
4.90e-01
|
6.90e-01
|
0.19400
|
0.168000
|
-0.095700
|
2.33e-01
|
4.98e-01
|
GOBP ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS
|
81
|
3.60e-02
|
1.66e-01
|
0.19400
|
0.090500
|
-0.171000
|
1.73e-01
|
9.91e-03
|
GOBP NEGATIVE REGULATION OF RNA METABOLIC PROCESS
|
124
|
1.58e-02
|
1.07e-01
|
0.19400
|
0.140000
|
-0.134000
|
1.07e-02
|
1.42e-02
|
GOMF MODIFICATION DEPENDENT PROTEIN BINDING
|
12
|
5.59e-01
|
7.35e-01
|
0.19300
|
0.072000
|
-0.179000
|
6.67e-01
|
2.84e-01
|
GOBP REGULATION OF PROTEIN MATURATION
|
5
|
5.69e-01
|
7.42e-01
|
0.19300
|
-0.152000
|
-0.118000
|
5.56e-01
|
6.48e-01
|
GOCC AUTOPHAGOSOME MEMBRANE
|
13
|
2.52e-01
|
4.87e-01
|
0.19300
|
-0.087900
|
-0.172000
|
5.85e-01
|
2.87e-01
|
GOBP HEART DEVELOPMENT
|
45
|
1.02e-01
|
3.03e-01
|
0.19300
|
0.059800
|
-0.183000
|
4.96e-01
|
3.69e-02
|
GOBP CYTOPLASMIC MICROTUBULE ORGANIZATION
|
8
|
6.78e-01
|
8.14e-01
|
0.19200
|
0.070200
|
-0.179000
|
7.32e-01
|
3.83e-01
|
GOBP MODULATION BY HOST OF VIRAL PROCESS
|
6
|
7.97e-01
|
8.82e-01
|
0.19200
|
0.153000
|
-0.116000
|
5.16e-01
|
6.25e-01
|
GOBP INTRACELLULAR PH REDUCTION
|
7
|
6.69e-01
|
8.09e-01
|
0.19200
|
-0.187000
|
0.044200
|
3.94e-01
|
8.40e-01
|
GOBP DICARBOXYLIC ACID TRANSPORT
|
9
|
3.92e-01
|
6.14e-01
|
0.19100
|
-0.172000
|
-0.084500
|
3.74e-01
|
6.62e-01
|
GOCC NEURON TO NEURON SYNAPSE
|
40
|
2.29e-01
|
4.63e-01
|
0.19100
|
0.155000
|
-0.112000
|
9.55e-02
|
2.28e-01
|
GOCC HETEROCHROMATIN
|
6
|
7.19e-01
|
8.43e-01
|
0.19100
|
0.048800
|
-0.185000
|
8.37e-01
|
4.35e-01
|
GOCC LIPID DROPLET
|
16
|
1.90e-01
|
4.21e-01
|
0.19100
|
-0.169000
|
-0.088100
|
2.45e-01
|
5.45e-01
|
GOBP VIRAL TRANSCRIPTION
|
5
|
6.41e-01
|
7.94e-01
|
0.19100
|
0.186000
|
0.040200
|
4.72e-01
|
8.77e-01
|
GOBP STEROID HORMONE BIOSYNTHETIC PROCESS
|
6
|
5.76e-01
|
7.47e-01
|
0.19000
|
0.184000
|
0.049100
|
4.37e-01
|
8.36e-01
|
GOBP DIENCEPHALON DEVELOPMENT
|
5
|
7.95e-01
|
8.81e-01
|
0.19000
|
0.175000
|
-0.075200
|
5.00e-01
|
7.72e-01
|
GOBP MONOATOMIC ION TRANSPORT
|
126
|
1.05e-04
|
3.13e-03
|
0.19000
|
0.189000
|
0.017900
|
4.85e-04
|
7.42e-01
|
GOBP ORGANOPHOSPHATE METABOLIC PROCESS
|
139
|
2.72e-05
|
1.01e-03
|
0.19000
|
0.028700
|
0.188000
|
5.82e-01
|
2.97e-04
|
GOBP ODONTOGENESIS OF DENTIN CONTAINING TOOTH
|
5
|
6.61e-01
|
8.04e-01
|
0.19000
|
0.188000
|
0.024800
|
4.67e-01
|
9.24e-01
|
GOBP METENCEPHALON DEVELOPMENT
|
12
|
2.69e-01
|
5.05e-01
|
0.19000
|
0.139000
|
0.129000
|
4.07e-01
|
4.42e-01
|
GOBP RNA SPLICING
|
52
|
1.58e-01
|
3.79e-01
|
0.18900
|
0.151000
|
-0.114000
|
6.45e-02
|
1.64e-01
|
GOCC ATPASE COMPLEX
|
14
|
3.49e-01
|
5.79e-01
|
0.18900
|
-0.008000
|
-0.189000
|
9.59e-01
|
2.23e-01
|
GOMF CYCLIN BINDING
|
5
|
6.12e-01
|
7.70e-01
|
0.18900
|
0.175000
|
0.070600
|
4.98e-01
|
7.85e-01
|
GOBP RESPONSE TO LIPID
|
104
|
1.21e-03
|
2.10e-02
|
0.18900
|
0.189000
|
-0.005930
|
1.40e-03
|
9.20e-01
|
GOBP POSITIVE REGULATION OF MRNA METABOLIC PROCESS
|
18
|
1.55e-01
|
3.74e-01
|
0.18900
|
0.163000
|
0.096100
|
2.36e-01
|
4.84e-01
|
GOBP TOLL LIKE RECEPTOR SIGNALING PATHWAY
|
5
|
7.58e-01
|
8.65e-01
|
0.18800
|
-0.183000
|
0.043500
|
4.79e-01
|
8.67e-01
|
GOBP REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT
|
7
|
7.83e-01
|
8.75e-01
|
0.18800
|
0.128000
|
-0.138000
|
5.59e-01
|
5.30e-01
|
GOBP REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT
|
7
|
7.83e-01
|
8.75e-01
|
0.18800
|
0.128000
|
-0.138000
|
5.59e-01
|
5.30e-01
|
GOBP REGULATION OF TRANSFERASE ACTIVITY
|
30
|
2.99e-01
|
5.32e-01
|
0.18800
|
0.088600
|
-0.166000
|
4.07e-01
|
1.20e-01
|
GOBP CYTOKINESIS
|
23
|
2.83e-01
|
5.15e-01
|
0.18800
|
0.041900
|
-0.183000
|
7.31e-01
|
1.32e-01
|
GOBP NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS
|
8
|
7.14e-01
|
8.38e-01
|
0.18800
|
0.168000
|
-0.083700
|
4.12e-01
|
6.83e-01
|
GOBP VASCULOGENESIS
|
5
|
6.59e-01
|
8.03e-01
|
0.18800
|
0.185000
|
0.031000
|
4.74e-01
|
9.05e-01
|
GOBP MAMMARY GLAND DEVELOPMENT
|
11
|
5.53e-01
|
7.33e-01
|
0.18800
|
0.182000
|
-0.045500
|
2.98e-01
|
7.95e-01
|
GOBP LYTIC VACUOLE ORGANIZATION
|
14
|
3.62e-01
|
5.89e-01
|
0.18800
|
-0.188000
|
-0.004530
|
2.27e-01
|
9.77e-01
|
GOBP CELL CELL JUNCTION ORGANIZATION
|
23
|
1.91e-01
|
4.22e-01
|
0.18800
|
0.188000
|
0.004180
|
1.23e-01
|
9.73e-01
|
GOBP NEUROMUSCULAR PROCESS CONTROLLING BALANCE
|
8
|
4.82e-01
|
6.86e-01
|
0.18800
|
-0.054100
|
-0.180000
|
7.92e-01
|
3.80e-01
|
GOMF CARBOXYLIC ESTER HYDROLASE ACTIVITY
|
14
|
4.18e-01
|
6.37e-01
|
0.18800
|
-0.186000
|
0.022200
|
2.30e-01
|
8.86e-01
|
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN
|
23
|
2.60e-01
|
4.92e-01
|
0.18700
|
-0.030500
|
0.185000
|
8.02e-01
|
1.28e-01
|
GOBP REGULATION OF CELL ACTIVATION
|
39
|
4.71e-02
|
1.95e-01
|
0.18700
|
0.186000
|
0.024300
|
4.80e-02
|
7.96e-01
|
GOBP PROTEIN MATURATION
|
52
|
1.26e-01
|
3.38e-01
|
0.18700
|
-0.167000
|
0.085500
|
4.18e-02
|
2.96e-01
|
GOBP RESPONSE TO TEMPERATURE STIMULUS
|
19
|
2.41e-01
|
4.75e-01
|
0.18700
|
-0.187000
|
-0.012400
|
1.62e-01
|
9.26e-01
|
GOBP INSULIN RECEPTOR SIGNALING PATHWAY
|
19
|
2.37e-01
|
4.70e-01
|
0.18700
|
0.186000
|
0.014900
|
1.63e-01
|
9.11e-01
|
GOMF TRANSCRIPTION COREGULATOR ACTIVITY
|
52
|
1.61e-01
|
3.80e-01
|
0.18700
|
0.153000
|
-0.107000
|
6.17e-02
|
1.92e-01
|
GOBP APICAL JUNCTION ASSEMBLY
|
5
|
7.82e-01
|
8.75e-01
|
0.18700
|
-0.057500
|
0.177000
|
8.24e-01
|
4.93e-01
|
GOBP SEX DIFFERENTIATION
|
20
|
4.45e-01
|
6.60e-01
|
0.18600
|
0.085600
|
-0.166000
|
5.11e-01
|
2.03e-01
|
GOMF MONOATOMIC ION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
84
|
4.08e-04
|
9.18e-03
|
0.18600
|
0.168000
|
0.081500
|
1.01e-02
|
2.12e-01
|
GOBP STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE
|
8
|
6.97e-01
|
8.26e-01
|
0.18600
|
-0.069600
|
0.173000
|
7.34e-01
|
3.99e-01
|
GOBP CELLULAR RESPONSE TO CALCIUM ION
|
7
|
7.28e-01
|
8.48e-01
|
0.18600
|
0.173000
|
-0.068700
|
4.30e-01
|
7.54e-01
|
GOCC GOLGI STACK
|
27
|
2.25e-01
|
4.59e-01
|
0.18600
|
0.036500
|
-0.183000
|
7.46e-01
|
1.04e-01
|
GOCC VACUOLAR MEMBRANE
|
50
|
1.86e-01
|
4.14e-01
|
0.18600
|
0.117000
|
-0.145000
|
1.62e-01
|
8.27e-02
|
GOCC GOLGI CISTERNA
|
23
|
3.41e-01
|
5.76e-01
|
0.18600
|
0.061800
|
-0.175000
|
6.11e-01
|
1.49e-01
|
GOBP CENTRAL NERVOUS SYSTEM DEVELOPMENT
|
77
|
8.40e-02
|
2.72e-01
|
0.18600
|
0.126000
|
-0.136000
|
6.37e-02
|
4.46e-02
|
GOBP REGULATION OF MACROAUTOPHAGY
|
21
|
4.91e-01
|
6.90e-01
|
0.18600
|
-0.121000
|
0.140000
|
3.40e-01
|
2.69e-01
|
GOBP RUFFLE ORGANIZATION
|
6
|
8.07e-01
|
8.87e-01
|
0.18500
|
0.108000
|
-0.151000
|
6.49e-01
|
5.23e-01
|
GOBP REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION
|
14
|
2.54e-01
|
4.87e-01
|
0.18500
|
-0.084900
|
-0.165000
|
5.85e-01
|
2.89e-01
|
GOBP REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS
|
11
|
6.66e-01
|
8.07e-01
|
0.18500
|
0.099400
|
-0.156000
|
5.70e-01
|
3.72e-01
|
GOBP RESPONSE TO HYDROPEROXIDE
|
7
|
6.42e-01
|
7.94e-01
|
0.18500
|
-0.184000
|
0.015200
|
4.00e-01
|
9.45e-01
|
GOBP FEAR RESPONSE
|
6
|
5.53e-01
|
7.33e-01
|
0.18500
|
-0.086700
|
-0.164000
|
7.14e-01
|
4.89e-01
|
GOBP MONOATOMIC ANION TRANSPORT
|
16
|
5.73e-01
|
7.45e-01
|
0.18500
|
0.111000
|
-0.148000
|
4.47e-01
|
3.09e-01
|
GOBP POSITIVE REGULATION OF CATABOLIC PROCESS
|
62
|
1.14e-01
|
3.21e-01
|
0.18500
|
0.155000
|
-0.100000
|
3.95e-02
|
1.82e-01
|
GOBP MUSCLE ORGAN DEVELOPMENT
|
26
|
4.05e-01
|
6.26e-01
|
0.18500
|
0.108000
|
-0.149000
|
3.44e-01
|
1.92e-01
|
GOBP VACUOLAR TRANSPORT
|
15
|
4.04e-01
|
6.25e-01
|
0.18400
|
0.020900
|
-0.183000
|
8.89e-01
|
2.22e-01
|
GOBP POSITIVE REGULATION OF CELL DEVELOPMENT
|
32
|
2.71e-01
|
5.06e-01
|
0.18400
|
0.078200
|
-0.167000
|
4.50e-01
|
1.07e-01
|
GOBP FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS
|
12
|
3.24e-01
|
5.60e-01
|
0.18400
|
-0.169000
|
-0.073500
|
3.14e-01
|
6.61e-01
|
GOMF PROTEIN FOLDING CHAPERONE BINDING
|
18
|
4.97e-01
|
6.95e-01
|
0.18400
|
-0.162000
|
0.086600
|
2.37e-01
|
5.28e-01
|
GOBP PROTEIN CONTAINING COMPLEX DISASSEMBLY
|
30
|
9.38e-02
|
2.88e-01
|
0.18400
|
-0.031800
|
-0.181000
|
7.66e-01
|
8.98e-02
|
GOBP REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY
|
18
|
4.37e-01
|
6.52e-01
|
0.18400
|
0.174000
|
-0.060600
|
2.06e-01
|
6.59e-01
|
GOBP REGULATION OF MULTICELLULAR ORGANISM GROWTH
|
5
|
8.42e-01
|
9.09e-01
|
0.18400
|
-0.112000
|
0.145000
|
6.64e-01
|
5.75e-01
|
GOBP POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION
|
5
|
8.16e-01
|
8.93e-01
|
0.18300
|
0.165000
|
-0.080100
|
5.24e-01
|
7.57e-01
|
GOBP RENAL SYSTEM DEVELOPMENT
|
36
|
2.49e-01
|
4.84e-01
|
0.18300
|
0.163000
|
-0.084100
|
9.53e-02
|
3.90e-01
|
GOBP RESPONSE TO TYPE II INTERFERON
|
11
|
6.96e-01
|
8.25e-01
|
0.18300
|
-0.126000
|
0.133000
|
4.73e-01
|
4.46e-01
|
GOBP VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT
|
5
|
6.01e-01
|
7.67e-01
|
0.18300
|
-0.145000
|
-0.112000
|
5.76e-01
|
6.65e-01
|
GOBP MEMBRANE LIPID METABOLIC PROCESS
|
19
|
1.64e-01
|
3.83e-01
|
0.18300
|
-0.163000
|
-0.084000
|
2.23e-01
|
5.29e-01
|
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS
|
8
|
5.82e-01
|
7.52e-01
|
0.18300
|
-0.183000
|
0.000205
|
3.72e-01
|
9.99e-01
|
GOBP VACUOLAR ACIDIFICATION
|
6
|
6.40e-01
|
7.94e-01
|
0.18300
|
-0.182000
|
-0.017700
|
4.41e-01
|
9.40e-01
|
GOBP ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY
|
7
|
6.47e-01
|
7.96e-01
|
0.18300
|
-0.182000
|
0.014000
|
4.06e-01
|
9.49e-01
|
GOBP MOLTING CYCLE
|
7
|
7.50e-01
|
8.61e-01
|
0.18300
|
-0.076000
|
0.166000
|
7.29e-01
|
4.49e-01
|
GOBP MOLTING CYCLE PROCESS
|
7
|
7.50e-01
|
8.61e-01
|
0.18300
|
-0.076000
|
0.166000
|
7.29e-01
|
4.49e-01
|
GOBP CONSTITUTIVE HETEROCHROMATIN FORMATION
|
6
|
7.70e-01
|
8.71e-01
|
0.18200
|
0.066800
|
-0.170000
|
7.78e-01
|
4.73e-01
|
GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE
|
17
|
3.29e-01
|
5.65e-01
|
0.18200
|
0.182000
|
-0.002430
|
1.98e-01
|
9.86e-01
|
GOMF CATALYTIC ACTIVITY ACTING ON RNA
|
21
|
4.55e-01
|
6.69e-01
|
0.18200
|
-0.159000
|
0.087000
|
2.10e-01
|
4.94e-01
|
GOBP MITOCHONDRION LOCALIZATION
|
5
|
6.38e-01
|
7.92e-01
|
0.18200
|
-0.065700
|
-0.169000
|
8.00e-01
|
5.13e-01
|
GOMF PDZ DOMAIN BINDING
|
10
|
5.72e-01
|
7.44e-01
|
0.18200
|
0.179000
|
-0.028400
|
3.28e-01
|
8.77e-01
|
GOBP TETRAPYRROLE METABOLIC PROCESS
|
9
|
4.08e-01
|
6.26e-01
|
0.18100
|
0.112000
|
0.142000
|
5.61e-01
|
4.61e-01
|
GOBP POSITIVE REGULATION OF PROTEIN SECRETION
|
10
|
6.08e-01
|
7.70e-01
|
0.18100
|
0.176000
|
-0.045800
|
3.39e-01
|
8.03e-01
|
GOBP SMALL MOLECULE BIOSYNTHETIC PROCESS
|
92
|
8.07e-03
|
7.29e-02
|
0.18100
|
-0.026600
|
0.179000
|
6.71e-01
|
4.27e-03
|
GOBP REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY
|
31
|
3.37e-01
|
5.75e-01
|
0.18100
|
0.094200
|
-0.154000
|
3.70e-01
|
1.43e-01
|
GOBP NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS
|
139
|
1.64e-02
|
1.09e-01
|
0.18100
|
0.142000
|
-0.111000
|
6.25e-03
|
3.23e-02
|
GOBP SPLICEOSOMAL COMPLEX ASSEMBLY
|
11
|
6.75e-01
|
8.12e-01
|
0.18000
|
0.154000
|
-0.093400
|
3.78e-01
|
5.93e-01
|
GOBP RESPONSE TO UV
|
15
|
6.10e-01
|
7.70e-01
|
0.18000
|
-0.109000
|
0.144000
|
4.69e-01
|
3.38e-01
|
GOBP REGULATION OF MEIOTIC CELL CYCLE
|
5
|
7.82e-01
|
8.75e-01
|
0.18000
|
0.045100
|
-0.174000
|
8.62e-01
|
5.01e-01
|
GOCC CLUSTER OF ACTIN BASED CELL PROJECTIONS
|
20
|
3.65e-01
|
5.91e-01
|
0.18000
|
0.175000
|
-0.039500
|
1.78e-01
|
7.62e-01
|
GOBP CELL RECOGNITION
|
10
|
4.62e-01
|
6.71e-01
|
0.17900
|
0.176000
|
0.033800
|
3.37e-01
|
8.54e-01
|
GOBP REGULATION OF MOLECULAR FUNCTION
|
82
|
8.73e-02
|
2.78e-01
|
0.17900
|
0.126000
|
-0.128000
|
5.69e-02
|
5.27e-02
|
GOCC MEMBRANE MICRODOMAIN
|
18
|
2.24e-01
|
4.59e-01
|
0.17900
|
0.171000
|
0.053500
|
2.13e-01
|
6.97e-01
|
GOBP LYMPHOCYTE DIFFERENTIATION
|
26
|
2.37e-01
|
4.70e-01
|
0.17900
|
0.177000
|
-0.022800
|
1.21e-01
|
8.42e-01
|
GOBP MUSCLE CELL APOPTOTIC PROCESS
|
10
|
6.18e-01
|
7.75e-01
|
0.17900
|
-0.173000
|
0.045600
|
3.46e-01
|
8.04e-01
|
GOBP AMINO ACID IMPORT ACROSS PLASMA MEMBRANE
|
7
|
5.20e-01
|
7.09e-01
|
0.17900
|
-0.154000
|
-0.091000
|
4.83e-01
|
6.78e-01
|
GOBP RESPONSE TO STEROID HORMONE
|
46
|
1.76e-01
|
4.02e-01
|
0.17800
|
0.162000
|
-0.075700
|
6.26e-02
|
3.84e-01
|
GOBP EXTRINSIC APOPTOTIC SIGNALING PATHWAY
|
15
|
6.25e-01
|
7.82e-01
|
0.17800
|
0.134000
|
-0.118000
|
3.74e-01
|
4.31e-01
|
GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY
|
13
|
6.68e-01
|
8.09e-01
|
0.17800
|
0.127000
|
-0.125000
|
4.31e-01
|
4.38e-01
|
GOBP POSITIVE REGULATION OF LOCOMOTION
|
41
|
2.87e-01
|
5.20e-01
|
0.17800
|
0.130000
|
-0.121000
|
1.55e-01
|
1.87e-01
|
GOMF RIBONUCLEOPROTEIN COMPLEX BINDING
|
22
|
5.09e-01
|
7.02e-01
|
0.17700
|
-0.117000
|
0.133000
|
3.45e-01
|
2.86e-01
|
GOBP MODULATION OF PROCESS OF ANOTHER ORGANISM
|
12
|
4.97e-01
|
6.95e-01
|
0.17700
|
0.177000
|
-0.013300
|
2.92e-01
|
9.37e-01
|
GOCC TRANSCRIPTION REGULATOR COMPLEX
|
39
|
2.64e-01
|
4.98e-01
|
0.17700
|
0.088500
|
-0.153000
|
3.47e-01
|
1.04e-01
|
GOCC POSTSYNAPTIC SPECIALIZATION
|
36
|
3.39e-01
|
5.76e-01
|
0.17600
|
0.131000
|
-0.118000
|
1.81e-01
|
2.25e-01
|
GOBP PROTEIN DNA COMPLEX ORGANIZATION
|
9
|
5.96e-01
|
7.64e-01
|
0.17600
|
-0.014600
|
0.176000
|
9.40e-01
|
3.63e-01
|
GOBP POSITIVE REGULATION OF BINDING
|
9
|
5.06e-01
|
7.00e-01
|
0.17600
|
-0.172000
|
-0.036200
|
3.72e-01
|
8.51e-01
|
GOMF XENOBIOTIC TRANSMEMBRANE TRANSPORTER ACTIVITY
|
9
|
4.54e-01
|
6.67e-01
|
0.17600
|
-0.159000
|
-0.076700
|
4.12e-01
|
6.92e-01
|
GOBP NEGATIVE REGULATION OF CELL DIFFERENTIATION
|
51
|
1.18e-01
|
3.28e-01
|
0.17600
|
0.167000
|
-0.054800
|
4.32e-02
|
5.07e-01
|
GOBP POSITIVE REGULATION OF ORGANELLE ASSEMBLY
|
6
|
6.12e-01
|
7.70e-01
|
0.17600
|
-0.167000
|
-0.056100
|
4.81e-01
|
8.12e-01
|
GOBP NEGATIVE REGULATION OF MRNA CATABOLIC PROCESS
|
13
|
3.07e-01
|
5.41e-01
|
0.17600
|
0.148000
|
0.094100
|
3.57e-01
|
5.59e-01
|
GOMF GTPASE ACTIVITY
|
61
|
9.72e-02
|
2.93e-01
|
0.17600
|
0.066400
|
-0.163000
|
3.82e-01
|
3.21e-02
|
GOCC OUTER MEMBRANE
|
33
|
3.68e-01
|
5.92e-01
|
0.17500
|
-0.110000
|
0.136000
|
2.79e-01
|
1.81e-01
|
GOMF N METHYLTRANSFERASE ACTIVITY
|
9
|
4.92e-01
|
6.91e-01
|
0.17500
|
-0.049000
|
-0.168000
|
8.00e-01
|
3.85e-01
|
GOBP MULTICELLULAR ORGANISM GROWTH
|
21
|
1.88e-01
|
4.17e-01
|
0.17500
|
0.166000
|
0.054300
|
1.91e-01
|
6.69e-01
|
GOBP OSSIFICATION
|
38
|
7.28e-02
|
2.47e-01
|
0.17500
|
0.173000
|
0.024700
|
6.90e-02
|
7.95e-01
|
GOBP HEAD DEVELOPMENT
|
63
|
1.44e-01
|
3.64e-01
|
0.17400
|
0.097700
|
-0.144000
|
1.91e-01
|
5.33e-02
|
GOCC SECRETORY GRANULE MEMBRANE
|
29
|
3.40e-01
|
5.76e-01
|
0.17400
|
0.071200
|
-0.159000
|
5.12e-01
|
1.43e-01
|
GOBP LYMPHOCYTE ACTIVATION
|
50
|
3.89e-02
|
1.76e-01
|
0.17400
|
0.174000
|
0.016000
|
3.74e-02
|
8.48e-01
|
GOBP VENTRICULAR SEPTUM DEVELOPMENT
|
7
|
8.00e-01
|
8.84e-01
|
0.17400
|
0.099100
|
-0.143000
|
6.51e-01
|
5.13e-01
|
GOMF MOLECULAR FUNCTION INHIBITOR ACTIVITY
|
54
|
1.69e-01
|
3.92e-01
|
0.17400
|
0.086300
|
-0.151000
|
2.83e-01
|
5.99e-02
|
GOBP REGULATION OF PROTEIN TRANSPORT
|
38
|
2.98e-01
|
5.31e-01
|
0.17400
|
0.094100
|
-0.146000
|
3.23e-01
|
1.24e-01
|
GOBP POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY
|
6
|
6.60e-01
|
8.03e-01
|
0.17400
|
0.022600
|
0.173000
|
9.24e-01
|
4.66e-01
|
GOBP VASODILATION
|
7
|
8.13e-01
|
8.92e-01
|
0.17300
|
0.120000
|
-0.125000
|
5.83e-01
|
5.69e-01
|
GOMF HORMONE BINDING
|
9
|
6.69e-01
|
8.09e-01
|
0.17300
|
-0.046100
|
0.167000
|
8.12e-01
|
3.87e-01
|
GOBP RNA TEMPLATED DNA BIOSYNTHETIC PROCESS
|
9
|
5.67e-01
|
7.41e-01
|
0.17300
|
-0.173000
|
-0.006740
|
3.70e-01
|
9.72e-01
|
GOBP TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING
|
9
|
5.67e-01
|
7.41e-01
|
0.17300
|
-0.173000
|
-0.006740
|
3.70e-01
|
9.72e-01
|
GOBP POSITIVE REGULATION OF CELL CYCLE PROCESS
|
16
|
4.50e-01
|
6.65e-01
|
0.17200
|
0.027200
|
-0.170000
|
8.52e-01
|
2.43e-01
|
GOBP INTRACELLULAR RECEPTOR SIGNALING PATHWAY
|
46
|
2.74e-01
|
5.08e-01
|
0.17200
|
0.125000
|
-0.118000
|
1.51e-01
|
1.73e-01
|
GOBP LINOLEIC ACID METABOLIC PROCESS
|
6
|
6.15e-01
|
7.72e-01
|
0.17100
|
0.065100
|
0.159000
|
7.83e-01
|
5.02e-01
|
GOCC SPECIFIC GRANULE
|
12
|
6.74e-01
|
8.12e-01
|
0.17100
|
0.085300
|
-0.149000
|
6.11e-01
|
3.75e-01
|
GOMF N ACETYLTRANSFERASE ACTIVITY
|
5
|
6.46e-01
|
7.96e-01
|
0.17100
|
0.142000
|
0.095100
|
5.82e-01
|
7.13e-01
|
GOMF PROTEIN N ACETYLTRANSFERASE ACTIVITY
|
5
|
6.46e-01
|
7.96e-01
|
0.17100
|
0.142000
|
0.095100
|
5.82e-01
|
7.13e-01
|
GOBP MITOTIC SPINDLE ORGANIZATION
|
12
|
3.53e-01
|
5.83e-01
|
0.17100
|
-0.093000
|
-0.144000
|
5.79e-01
|
3.91e-01
|
GOBP REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION
|
6
|
8.17e-01
|
8.93e-01
|
0.17100
|
0.150000
|
-0.081800
|
5.25e-01
|
7.30e-01
|
GOBP RESPONSE TO HORMONE
|
94
|
2.29e-02
|
1.30e-01
|
0.17100
|
0.165000
|
-0.047000
|
7.88e-03
|
4.49e-01
|
GOBP PROTEOGLYCAN METABOLIC PROCESS
|
8
|
4.97e-01
|
6.95e-01
|
0.17100
|
-0.140000
|
-0.098100
|
4.95e-01
|
6.32e-01
|
GOBP REGULATION OF EPITHELIAL CELL PROLIFERATION
|
35
|
3.38e-01
|
5.76e-01
|
0.17100
|
0.145000
|
-0.090700
|
1.44e-01
|
3.60e-01
|
GOBP MITOTIC SPINDLE ASSEMBLY
|
10
|
4.14e-01
|
6.32e-01
|
0.17000
|
-0.113000
|
-0.127000
|
5.37e-01
|
4.88e-01
|
GOBP SPINDLE ASSEMBLY
|
10
|
4.14e-01
|
6.32e-01
|
0.17000
|
-0.113000
|
-0.127000
|
5.37e-01
|
4.88e-01
|
GOBP GLAND DEVELOPMENT
|
44
|
2.55e-01
|
4.87e-01
|
0.17000
|
0.146000
|
-0.087700
|
1.00e-01
|
3.23e-01
|
GOBP JNK CASCADE
|
17
|
4.27e-01
|
6.43e-01
|
0.17000
|
-0.169000
|
0.023000
|
2.32e-01
|
8.71e-01
|
GOBP HEART VALVE DEVELOPMENT
|
6
|
7.45e-01
|
8.59e-01
|
0.17000
|
0.027000
|
-0.168000
|
9.09e-01
|
4.78e-01
|
GOBP MAMMARY GLAND EPITHELIUM DEVELOPMENT
|
6
|
7.70e-01
|
8.71e-01
|
0.17000
|
0.164000
|
-0.043100
|
4.88e-01
|
8.56e-01
|
GOCC VACUOLAR LUMEN
|
23
|
2.05e-01
|
4.38e-01
|
0.17000
|
-0.166000
|
-0.034100
|
1.72e-01
|
7.79e-01
|
GOBP POSTREPLICATION REPAIR
|
7
|
6.35e-01
|
7.90e-01
|
0.16900
|
-0.168000
|
-0.020100
|
4.43e-01
|
9.27e-01
|
GOBP NEGATIVE REGULATION OF MRNA METABOLIC PROCESS
|
14
|
2.99e-01
|
5.32e-01
|
0.16900
|
0.105000
|
0.132000
|
4.98e-01
|
3.94e-01
|
GOBP RESPONSE TO BMP
|
12
|
6.27e-01
|
7.84e-01
|
0.16900
|
0.056100
|
-0.159000
|
7.38e-01
|
3.42e-01
|
GOBP POSITIVE REGULATION OF GENE EXPRESSION
|
87
|
8.65e-02
|
2.77e-01
|
0.16800
|
0.140000
|
-0.094100
|
2.96e-02
|
1.43e-01
|
GOBP REGULATION OF HORMONE SECRETION
|
14
|
4.46e-01
|
6.61e-01
|
0.16800
|
0.168000
|
0.002000
|
2.78e-01
|
9.90e-01
|
GOBP REGULATION OF ORGANELLE ORGANIZATION
|
102
|
5.36e-03
|
5.74e-02
|
0.16800
|
0.005480
|
-0.168000
|
9.27e-01
|
4.79e-03
|
GOBP MRNA PROCESSING
|
47
|
2.78e-01
|
5.10e-01
|
0.16800
|
0.127000
|
-0.111000
|
1.40e-01
|
1.97e-01
|
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY
|
35
|
1.54e-01
|
3.74e-01
|
0.16800
|
-0.006960
|
0.168000
|
9.44e-01
|
8.99e-02
|
GOBP REGULATION OF APOPTOTIC SIGNALING PATHWAY
|
32
|
2.83e-01
|
5.15e-01
|
0.16800
|
-0.050600
|
0.160000
|
6.25e-01
|
1.21e-01
|
GOBP NERVOUS SYSTEM PROCESS
|
75
|
1.38e-01
|
3.54e-01
|
0.16800
|
0.113000
|
-0.124000
|
9.94e-02
|
7.15e-02
|
GOBP POSITIVE REGULATION OF TOR SIGNALING
|
10
|
7.53e-01
|
8.64e-01
|
0.16800
|
0.105000
|
-0.131000
|
5.66e-01
|
4.76e-01
|
GOCC ENDOSOME MEMBRANE
|
59
|
5.80e-02
|
2.17e-01
|
0.16800
|
0.018900
|
-0.167000
|
8.07e-01
|
3.06e-02
|
GOBP MITOPHAGY
|
15
|
6.05e-01
|
7.70e-01
|
0.16800
|
-0.074000
|
0.150000
|
6.22e-01
|
3.17e-01
|
GOCC ENDOSOME
|
95
|
1.37e-02
|
9.87e-02
|
0.16700
|
0.023400
|
-0.166000
|
7.04e-01
|
7.18e-03
|
GOCC LUMENAL SIDE OF MEMBRANE
|
7
|
8.21e-01
|
8.96e-01
|
0.16700
|
-0.132000
|
0.102000
|
5.48e-01
|
6.40e-01
|
GOMF MONOATOMIC ANION CHANNEL ACTIVITY
|
7
|
5.63e-01
|
7.38e-01
|
0.16700
|
0.088800
|
0.141000
|
6.85e-01
|
5.20e-01
|
GOBP GLYCEROLIPID METABOLIC PROCESS
|
40
|
2.76e-01
|
5.08e-01
|
0.16700
|
0.074400
|
-0.149000
|
4.23e-01
|
1.08e-01
|
GOBP NEGATIVE REGULATION OF RNA CATABOLIC PROCESS
|
14
|
3.07e-01
|
5.41e-01
|
0.16700
|
0.114000
|
0.121000
|
4.62e-01
|
4.35e-01
|
GOMF PROTEIN HOMODIMERIZATION ACTIVITY
|
71
|
1.18e-01
|
3.28e-01
|
0.16700
|
-0.146000
|
0.080400
|
3.89e-02
|
2.55e-01
|
GOBP INTRACELLULAR TRANSPORT
|
137
|
1.96e-04
|
5.04e-03
|
0.16600
|
-0.041700
|
-0.160000
|
4.26e-01
|
2.17e-03
|
GOMF NEUROTRANSMITTER RECEPTOR ACTIVITY
|
6
|
7.76e-01
|
8.74e-01
|
0.16600
|
0.161000
|
-0.039500
|
4.97e-01
|
8.67e-01
|
GOBP DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS
|
9
|
7.84e-01
|
8.75e-01
|
0.16600
|
0.111000
|
-0.123000
|
5.65e-01
|
5.26e-01
|
GOBP FEMALE SEX DIFFERENTIATION
|
9
|
7.84e-01
|
8.75e-01
|
0.16600
|
0.111000
|
-0.123000
|
5.65e-01
|
5.26e-01
|
GOMF SULFUR COMPOUND BINDING
|
27
|
1.43e-01
|
3.63e-01
|
0.16600
|
-0.054500
|
-0.156000
|
6.28e-01
|
1.64e-01
|
GOBP MESODERM DEVELOPMENT
|
9
|
7.72e-01
|
8.72e-01
|
0.16600
|
0.094000
|
-0.136000
|
6.27e-01
|
4.81e-01
|
GOMF GTPASE BINDING
|
40
|
1.38e-01
|
3.53e-01
|
0.16500
|
0.013000
|
-0.165000
|
8.88e-01
|
7.57e-02
|
GOBP OSTEOCLAST DIFFERENTIATION
|
7
|
6.50e-01
|
7.97e-01
|
0.16500
|
-0.018200
|
-0.164000
|
9.34e-01
|
4.53e-01
|
GOBP REGULATION OF CELL POPULATION PROLIFERATION
|
130
|
4.68e-03
|
5.20e-02
|
0.16500
|
0.163000
|
-0.028200
|
2.33e-03
|
5.99e-01
|
GOBP TRANSEPITHELIAL TRANSPORT
|
5
|
7.74e-01
|
8.73e-01
|
0.16500
|
0.011100
|
-0.165000
|
9.66e-01
|
5.25e-01
|
GOBP SYMBIONT ENTRY INTO HOST
|
13
|
6.74e-01
|
8.12e-01
|
0.16500
|
0.143000
|
-0.082700
|
3.76e-01
|
6.08e-01
|
GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY
|
9
|
6.64e-01
|
8.06e-01
|
0.16500
|
-0.162000
|
0.027500
|
4.01e-01
|
8.87e-01
|
GOMF UBIQUITIN LIKE PROTEIN LIGASE BINDING
|
49
|
2.78e-01
|
5.09e-01
|
0.16400
|
-0.126000
|
0.105000
|
1.33e-01
|
2.12e-01
|
GOBP NEGATIVE REGULATION OF NUCLEAR DIVISION
|
5
|
7.80e-01
|
8.75e-01
|
0.16400
|
0.164000
|
-0.014700
|
5.27e-01
|
9.55e-01
|
GOBP VESICLE CARGO LOADING
|
12
|
5.31e-01
|
7.16e-01
|
0.16400
|
0.004790
|
-0.164000
|
9.77e-01
|
3.27e-01
|
GOBP REGULATION OF BINDING
|
13
|
3.45e-01
|
5.76e-01
|
0.16400
|
-0.108000
|
-0.123000
|
5.02e-01
|
4.43e-01
|
GOBP NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS
|
15
|
6.47e-01
|
7.96e-01
|
0.16400
|
0.139000
|
-0.087000
|
3.55e-01
|
5.62e-01
|
GOBP NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY
|
7
|
6.60e-01
|
8.03e-01
|
0.16400
|
-0.015200
|
-0.163000
|
9.45e-01
|
4.56e-01
|
GOCC MICROTUBULE CYTOSKELETON
|
109
|
3.62e-02
|
1.67e-01
|
0.16400
|
0.068300
|
-0.149000
|
2.39e-01
|
1.01e-02
|
GOBP REGULATION OF SMOOTH MUSCLE CONTRACTION
|
5
|
7.35e-01
|
8.53e-01
|
0.16400
|
0.021200
|
0.162000
|
9.35e-01
|
5.31e-01
|
GOBP NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS
|
9
|
5.62e-01
|
7.37e-01
|
0.16400
|
0.161000
|
0.030100
|
4.05e-01
|
8.76e-01
|
GOBP TIGHT JUNCTION ORGANIZATION
|
7
|
6.37e-01
|
7.92e-01
|
0.16300
|
0.160000
|
0.031600
|
4.65e-01
|
8.85e-01
|
GOMF CYTOKINE RECEPTOR BINDING
|
8
|
6.57e-01
|
8.03e-01
|
0.16300
|
-0.003380
|
0.163000
|
9.87e-01
|
4.26e-01
|
GOBP SYNAPSE ORGANIZATION
|
49
|
2.83e-01
|
5.15e-01
|
0.16300
|
0.103000
|
-0.126000
|
2.22e-01
|
1.34e-01
|
GOCC PRESYNAPSE
|
45
|
2.82e-01
|
5.14e-01
|
0.16300
|
0.085400
|
-0.139000
|
3.31e-01
|
1.14e-01
|
GOCC CONDENSED CHROMOSOME CENTROMERIC REGION
|
14
|
5.77e-01
|
7.48e-01
|
0.16200
|
-0.157000
|
0.042200
|
3.13e-01
|
7.86e-01
|
GOBP EAR DEVELOPMENT
|
12
|
7.34e-01
|
8.53e-01
|
0.16200
|
0.116000
|
-0.113000
|
4.88e-01
|
4.99e-01
|
GOCC CILIUM
|
44
|
9.09e-02
|
2.84e-01
|
0.16200
|
-0.008710
|
-0.162000
|
9.22e-01
|
6.77e-02
|
GOBP NEGATIVE REGULATION OF ORGANELLE ORGANIZATION
|
30
|
3.78e-01
|
5.99e-01
|
0.16200
|
0.064600
|
-0.148000
|
5.45e-01
|
1.65e-01
|
GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION
|
8
|
7.56e-01
|
8.65e-01
|
0.16200
|
0.151000
|
-0.056900
|
4.60e-01
|
7.81e-01
|
GOBP PROTEASOMAL PROTEIN CATABOLIC PROCESS
|
61
|
1.42e-01
|
3.61e-01
|
0.16100
|
-0.149000
|
0.062400
|
4.96e-02
|
4.11e-01
|
GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL
|
8
|
6.07e-01
|
7.70e-01
|
0.16100
|
-0.159000
|
-0.029900
|
4.39e-01
|
8.84e-01
|
GOBP INTRACELLULAR PROTEIN TRANSPORT
|
63
|
5.88e-02
|
2.19e-01
|
0.16100
|
-0.161000
|
0.016800
|
3.16e-02
|
8.22e-01
|
GOCC VESICLE LUMEN
|
36
|
2.70e-01
|
5.05e-01
|
0.16100
|
-0.154000
|
0.048200
|
1.15e-01
|
6.22e-01
|
GOBP CHROMATIN REMODELING
|
52
|
9.60e-02
|
2.91e-01
|
0.16100
|
0.017500
|
-0.160000
|
8.31e-01
|
5.02e-02
|
GOCC SYNAPTIC VESICLE MEMBRANE
|
10
|
6.50e-01
|
7.97e-01
|
0.16100
|
0.028100
|
-0.159000
|
8.78e-01
|
3.87e-01
|
GOBP ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY
|
20
|
3.50e-01
|
5.79e-01
|
0.16000
|
-0.003140
|
-0.160000
|
9.81e-01
|
2.18e-01
|
GOBP POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS
|
110
|
6.28e-02
|
2.28e-01
|
0.16000
|
0.088700
|
-0.134000
|
1.25e-01
|
2.05e-02
|
GOBP U2 TYPE PRESPLICEOSOME ASSEMBLY
|
6
|
7.70e-01
|
8.71e-01
|
0.16000
|
0.158000
|
-0.025300
|
5.03e-01
|
9.15e-01
|
GOCC U2 SNRNP
|
6
|
7.70e-01
|
8.71e-01
|
0.16000
|
0.158000
|
-0.025300
|
5.03e-01
|
9.15e-01
|
GOMF SCAFFOLD PROTEIN BINDING
|
6
|
6.27e-01
|
7.84e-01
|
0.16000
|
-0.123000
|
-0.102000
|
6.02e-01
|
6.67e-01
|
GOBP CELLULAR RESPONSE TO ABIOTIC STIMULUS
|
27
|
5.11e-01
|
7.03e-01
|
0.16000
|
0.105000
|
-0.120000
|
3.51e-01
|
2.85e-01
|
GOCC NUCLEAR BODY
|
84
|
1.30e-01
|
3.43e-01
|
0.16000
|
0.126000
|
-0.097400
|
5.27e-02
|
1.36e-01
|
GOBP IMPORT INTO NUCLEUS
|
13
|
6.24e-01
|
7.81e-01
|
0.15900
|
-0.152000
|
0.047100
|
3.44e-01
|
7.70e-01
|
GOBP DNA TEMPLATED TRANSCRIPTION ELONGATION
|
5
|
8.60e-01
|
9.22e-01
|
0.15900
|
-0.142000
|
0.070600
|
5.83e-01
|
7.85e-01
|
GOBP POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION
|
17
|
4.72e-01
|
6.79e-01
|
0.15900
|
0.019700
|
-0.157000
|
8.89e-01
|
2.64e-01
|
GOCC BRUSH BORDER
|
18
|
5.18e-01
|
7.08e-01
|
0.15800
|
0.152000
|
-0.043900
|
2.67e-01
|
7.49e-01
|
GOBP PRESYNAPTIC ENDOCYTOSIS
|
10
|
5.24e-01
|
7.11e-01
|
0.15800
|
-0.151000
|
-0.045600
|
4.09e-01
|
8.04e-01
|
GOBP REGULATION OF MRNA METABOLIC PROCESS
|
30
|
1.35e-01
|
3.49e-01
|
0.15800
|
0.148000
|
0.056800
|
1.67e-01
|
5.95e-01
|
GOBP ASSOCIATIVE LEARNING
|
7
|
8.00e-01
|
8.84e-01
|
0.15800
|
0.145000
|
-0.061700
|
5.07e-01
|
7.78e-01
|
GOBP PROTEIN K11 LINKED UBIQUITINATION
|
6
|
8.59e-01
|
9.20e-01
|
0.15800
|
-0.125000
|
0.096200
|
5.97e-01
|
6.84e-01
|
GOBP POSITIVE REGULATION OF IMMUNE RESPONSE
|
46
|
4.87e-02
|
2.00e-01
|
0.15800
|
0.147000
|
0.057600
|
9.11e-02
|
5.07e-01
|
GOBP PROTEIN CONTAINING COMPLEX LOCALIZATION
|
19
|
2.46e-01
|
4.81e-01
|
0.15800
|
-0.091700
|
-0.128000
|
4.93e-01
|
3.37e-01
|
GOBP LOCALIZATION WITHIN MEMBRANE
|
64
|
2.15e-01
|
4.51e-01
|
0.15700
|
0.096500
|
-0.124000
|
1.93e-01
|
9.38e-02
|
GOBP TRANSMEMBRANE TRANSPORT
|
149
|
1.12e-02
|
8.85e-02
|
0.15700
|
0.148000
|
-0.052000
|
3.23e-03
|
3.03e-01
|
GOBP REGULATION OF DNA REPAIR
|
16
|
5.31e-01
|
7.16e-01
|
0.15700
|
-0.030900
|
0.154000
|
8.32e-01
|
2.90e-01
|
GOBP MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS
|
14
|
4.20e-01
|
6.39e-01
|
0.15700
|
-0.040200
|
-0.152000
|
7.96e-01
|
3.29e-01
|
GOMF CATALYTIC ACTIVITY ACTING ON DNA
|
16
|
6.59e-01
|
8.03e-01
|
0.15600
|
0.084700
|
-0.131000
|
5.60e-01
|
3.67e-01
|
GOBP NUCLEUS ORGANIZATION
|
13
|
4.38e-01
|
6.53e-01
|
0.15600
|
-0.149000
|
-0.046700
|
3.55e-01
|
7.72e-01
|
GOBP NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY
|
6
|
7.58e-01
|
8.65e-01
|
0.15600
|
-0.008990
|
0.156000
|
9.70e-01
|
5.11e-01
|
GOBP MAINTENANCE OF LOCATION
|
20
|
5.48e-01
|
7.29e-01
|
0.15600
|
0.063100
|
-0.142000
|
6.28e-01
|
2.74e-01
|
GOCC VESICLE MEMBRANE
|
107
|
1.08e-02
|
8.66e-02
|
0.15600
|
0.009600
|
-0.155000
|
8.70e-01
|
7.77e-03
|
GOBP CELL FATE SPECIFICATION
|
8
|
5.92e-01
|
7.60e-01
|
0.15600
|
-0.054700
|
-0.146000
|
7.90e-01
|
4.77e-01
|
GOBP MITOTIC CELL CYCLE PROCESS
|
61
|
1.52e-01
|
3.74e-01
|
0.15600
|
0.055100
|
-0.146000
|
4.68e-01
|
5.50e-02
|
GOCC AUTOPHAGOSOME
|
18
|
4.13e-01
|
6.32e-01
|
0.15600
|
-0.002200
|
-0.156000
|
9.87e-01
|
2.57e-01
|
GOBP VIRAL RELEASE FROM HOST CELL
|
8
|
5.98e-01
|
7.65e-01
|
0.15500
|
-0.147000
|
-0.050600
|
4.73e-01
|
8.05e-01
|
GOMF KINASE ACTIVITY
|
77
|
1.78e-01
|
4.05e-01
|
0.15500
|
0.114000
|
-0.106000
|
9.49e-02
|
1.20e-01
|
GOBP REGULATION OF CHROMOSOME SEGREGATION
|
7
|
6.71e-01
|
8.10e-01
|
0.15500
|
0.026900
|
0.153000
|
9.02e-01
|
4.86e-01
|
GOBP REGULATION OF SISTER CHROMATID SEGREGATION
|
7
|
6.71e-01
|
8.10e-01
|
0.15500
|
0.026900
|
0.153000
|
9.02e-01
|
4.86e-01
|
GOBP REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT
|
13
|
5.27e-01
|
7.14e-01
|
0.15500
|
-0.002780
|
-0.155000
|
9.86e-01
|
3.36e-01
|
GOCC CELL CELL JUNCTION
|
41
|
2.26e-01
|
4.61e-01
|
0.15500
|
0.035100
|
-0.150000
|
7.02e-01
|
1.01e-01
|
GOBP POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION
|
16
|
3.79e-01
|
6.00e-01
|
0.15400
|
0.149000
|
0.041700
|
3.07e-01
|
7.74e-01
|
GOMF SINGLE STRANDED RNA BINDING
|
6
|
8.30e-01
|
9.02e-01
|
0.15400
|
0.057500
|
-0.143000
|
8.08e-01
|
5.45e-01
|
GOBP POSITIVE REGULATION OF CATALYTIC ACTIVITY
|
26
|
5.05e-01
|
7.00e-01
|
0.15400
|
0.077100
|
-0.134000
|
5.01e-01
|
2.44e-01
|
GOBP LIMBIC SYSTEM DEVELOPMENT
|
10
|
6.74e-01
|
8.12e-01
|
0.15400
|
0.026900
|
-0.152000
|
8.83e-01
|
4.08e-01
|
GOBP REGULATION OF PROTEIN BINDING
|
6
|
6.47e-01
|
7.96e-01
|
0.15400
|
-0.106000
|
-0.112000
|
6.54e-01
|
6.37e-01
|
GOBP SENSORY PERCEPTION OF MECHANICAL STIMULUS
|
14
|
7.09e-01
|
8.36e-01
|
0.15400
|
0.088800
|
-0.126000
|
5.68e-01
|
4.19e-01
|
GOBP SPERMATID DIFFERENTIATION
|
12
|
4.24e-01
|
6.40e-01
|
0.15300
|
-0.115000
|
-0.102000
|
4.93e-01
|
5.44e-01
|
GOBP CHEMICAL HOMEOSTASIS
|
114
|
3.46e-02
|
1.62e-01
|
0.15300
|
0.145000
|
-0.050800
|
1.08e-02
|
3.71e-01
|
GOBP RNA LOCALIZATION
|
17
|
4.48e-01
|
6.62e-01
|
0.15300
|
-0.153000
|
-0.001650
|
2.79e-01
|
9.91e-01
|
GOBP REGULATION OF AUTOPHAGOSOME ASSEMBLY
|
5
|
7.00e-01
|
8.29e-01
|
0.15300
|
-0.107000
|
-0.108000
|
6.79e-01
|
6.75e-01
|
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE
|
13
|
4.18e-01
|
6.36e-01
|
0.15200
|
0.074100
|
0.133000
|
6.45e-01
|
4.08e-01
|
GOBP PHOSPHOLIPID BIOSYNTHETIC PROCESS
|
24
|
4.95e-01
|
6.94e-01
|
0.15200
|
-0.140000
|
0.059200
|
2.39e-01
|
6.19e-01
|
GOBP FACE DEVELOPMENT
|
8
|
8.31e-01
|
9.02e-01
|
0.15200
|
0.116000
|
-0.098100
|
5.70e-01
|
6.32e-01
|
GOBP MONONUCLEAR CELL DIFFERENTIATION
|
32
|
4.79e-01
|
6.84e-01
|
0.15200
|
0.120000
|
-0.093700
|
2.47e-01
|
3.65e-01
|
GOBP VACUOLE ORGANIZATION
|
28
|
1.55e-01
|
3.74e-01
|
0.15200
|
-0.131000
|
-0.076800
|
2.35e-01
|
4.87e-01
|
GOBP MITOTIC CELL CYCLE CHECKPOINT SIGNALING
|
10
|
7.79e-01
|
8.75e-01
|
0.15200
|
0.129000
|
-0.080900
|
4.83e-01
|
6.59e-01
|
GOBP CELL SURFACE PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY
|
6
|
7.37e-01
|
8.53e-01
|
0.15200
|
-0.151000
|
-0.013600
|
5.22e-01
|
9.54e-01
|
GOBP CELL SURFACE TOLL LIKE RECEPTOR SIGNALING PATHWAY
|
6
|
7.37e-01
|
8.53e-01
|
0.15200
|
-0.151000
|
-0.013600
|
5.22e-01
|
9.54e-01
|
GOBP EMBRYONIC ORGAN MORPHOGENESIS
|
12
|
6.47e-01
|
7.96e-01
|
0.15200
|
0.032900
|
-0.148000
|
8.45e-01
|
3.77e-01
|
GOBP C21 STEROID HORMONE BIOSYNTHETIC PROCESS
|
5
|
7.65e-01
|
8.70e-01
|
0.15200
|
0.022500
|
0.150000
|
9.31e-01
|
5.62e-01
|
GOBP C21 STEROID HORMONE METABOLIC PROCESS
|
5
|
7.65e-01
|
8.70e-01
|
0.15200
|
0.022500
|
0.150000
|
9.31e-01
|
5.62e-01
|
GOMF PASSIVE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
37
|
3.69e-01
|
5.93e-01
|
0.15200
|
0.136000
|
-0.066900
|
1.58e-01
|
4.88e-01
|
GOBP ORGANIC CATION TRANSPORT
|
17
|
6.81e-01
|
8.15e-01
|
0.15200
|
-0.114000
|
0.100000
|
4.20e-01
|
4.78e-01
|
GOBP EPIGENETIC REGULATION OF GENE EXPRESSION
|
20
|
3.92e-01
|
6.14e-01
|
0.15100
|
-0.002980
|
-0.151000
|
9.82e-01
|
2.45e-01
|
GOBP NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS
|
29
|
4.27e-01
|
6.43e-01
|
0.15100
|
0.056300
|
-0.141000
|
6.04e-01
|
1.96e-01
|
GOBP CARBOHYDRATE DERIVATIVE METABOLIC PROCESS
|
111
|
3.06e-03
|
4.00e-02
|
0.15100
|
0.034600
|
0.147000
|
5.47e-01
|
1.04e-02
|
GOBP MEIOTIC CELL CYCLE
|
13
|
6.94e-01
|
8.24e-01
|
0.15100
|
0.062800
|
-0.138000
|
6.97e-01
|
3.93e-01
|
GOBP CELLULAR RESPONSE TO IONIZING RADIATION
|
6
|
7.94e-01
|
8.81e-01
|
0.15000
|
0.023400
|
-0.149000
|
9.21e-01
|
5.30e-01
|
GOBP REGULATION OF CELLULAR SENESCENCE
|
6
|
6.68e-01
|
8.09e-01
|
0.15000
|
0.083700
|
0.125000
|
7.24e-01
|
5.98e-01
|
GOBP RESPONSE TO NUTRIENT LEVELS
|
72
|
1.29e-01
|
3.43e-01
|
0.15000
|
0.140000
|
-0.052800
|
4.58e-02
|
4.52e-01
|
GOMF PROTEIN KINASE ACTIVITY
|
68
|
2.26e-01
|
4.61e-01
|
0.15000
|
0.120000
|
-0.089500
|
9.60e-02
|
2.15e-01
|
GOMF UBIQUITIN LIKE PROTEIN PEPTIDASE ACTIVITY
|
8
|
6.03e-01
|
7.68e-01
|
0.14900
|
0.065900
|
0.134000
|
7.48e-01
|
5.14e-01
|
GOBP PROTEIN PROCESSING
|
18
|
6.13e-01
|
7.70e-01
|
0.14900
|
0.062400
|
-0.136000
|
6.49e-01
|
3.23e-01
|
GOBP POSITIVE REGULATION OF SIGNALING
|
145
|
3.94e-02
|
1.76e-01
|
0.14900
|
0.130000
|
-0.073700
|
1.11e-02
|
1.49e-01
|
GOBP POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY
|
7
|
7.44e-01
|
8.58e-01
|
0.14900
|
0.008530
|
-0.149000
|
9.69e-01
|
4.97e-01
|
GOBP SYNAPTIC VESICLE RECYCLING
|
12
|
4.81e-01
|
6.86e-01
|
0.14900
|
-0.138000
|
-0.057200
|
4.12e-01
|
7.33e-01
|
GOBP ALPHA BETA T CELL ACTIVATION
|
10
|
5.98e-01
|
7.65e-01
|
0.14900
|
0.147000
|
0.021800
|
4.22e-01
|
9.05e-01
|
GOBP PEPTIDYL AMINO ACID MODIFICATION
|
34
|
3.79e-01
|
6.00e-01
|
0.14900
|
0.139000
|
-0.054400
|
1.68e-01
|
5.88e-01
|
GOBP PROSTAGLANDIN TRANSPORT
|
5
|
7.21e-01
|
8.44e-01
|
0.14800
|
0.124000
|
0.081000
|
6.32e-01
|
7.54e-01
|
GOBP NEGATIVE REGULATION OF CANONICAL NF KAPPAB SIGNAL TRANSDUCTION
|
11
|
5.81e-01
|
7.52e-01
|
0.14800
|
0.147000
|
0.016600
|
4.00e-01
|
9.25e-01
|
GOBP CARBOHYDRATE METABOLIC PROCESS
|
68
|
2.04e-01
|
4.38e-01
|
0.14800
|
0.128000
|
-0.074200
|
7.53e-02
|
3.04e-01
|
GOMF PROTEIN CONTAINING COMPLEX BINDING
|
126
|
7.30e-02
|
2.47e-01
|
0.14800
|
0.084600
|
-0.122000
|
1.20e-01
|
2.52e-02
|
GOBP REGULATION OF ACTIN FILAMENT POLYMERIZATION
|
8
|
7.79e-01
|
8.75e-01
|
0.14800
|
0.044300
|
-0.141000
|
8.29e-01
|
4.91e-01
|
GOBP EPITHELIUM DEVELOPMENT
|
87
|
1.72e-01
|
3.96e-01
|
0.14800
|
0.099100
|
-0.110000
|
1.23e-01
|
8.74e-02
|
GOMF ACYLTRANSFERASE ACTIVITY TRANSFERRING GROUPS OTHER THAN AMINO ACYL GROUPS
|
25
|
2.74e-01
|
5.08e-01
|
0.14800
|
0.145000
|
0.027600
|
2.13e-01
|
8.13e-01
|
GOBP POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS
|
7
|
6.58e-01
|
8.03e-01
|
0.14800
|
-0.054500
|
-0.137000
|
8.04e-01
|
5.30e-01
|
GOBP TUBE DEVELOPMENT
|
92
|
1.59e-01
|
3.79e-01
|
0.14800
|
0.104000
|
-0.105000
|
9.80e-02
|
9.23e-02
|
GOCC INTRACELLULAR PROTEIN CONTAINING COMPLEX
|
71
|
2.19e-01
|
4.54e-01
|
0.14800
|
-0.119000
|
0.086900
|
9.07e-02
|
2.18e-01
|
GOMF CHOLESTEROL BINDING
|
9
|
8.22e-01
|
8.96e-01
|
0.14700
|
0.093400
|
-0.114000
|
6.29e-01
|
5.55e-01
|
GOBP MULTICELLULAR ORGANISMAL LEVEL HOMEOSTASIS
|
76
|
1.06e-02
|
8.50e-02
|
0.14700
|
0.128000
|
0.073200
|
6.17e-02
|
2.85e-01
|
GOBP RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE
|
7
|
7.75e-01
|
8.73e-01
|
0.14700
|
-0.024300
|
0.145000
|
9.12e-01
|
5.07e-01
|
GOBP POLYOL BIOSYNTHETIC PROCESS
|
7
|
6.29e-01
|
7.85e-01
|
0.14700
|
0.106000
|
0.102000
|
6.28e-01
|
6.41e-01
|
GOBP REGULATION OF CELLULAR LOCALIZATION
|
91
|
1.52e-01
|
3.74e-01
|
0.14700
|
0.118000
|
-0.088400
|
6.15e-02
|
1.60e-01
|
GOBP MACROPHAGE MIGRATION
|
6
|
7.91e-01
|
8.80e-01
|
0.14700
|
0.146000
|
-0.015000
|
5.37e-01
|
9.49e-01
|
GOBP NEGATIVE REGULATION OF TRANSLATION
|
24
|
5.58e-01
|
7.35e-01
|
0.14700
|
-0.070700
|
0.129000
|
5.53e-01
|
2.80e-01
|
GOCC GOLGI CISTERNA MEMBRANE
|
20
|
6.48e-01
|
7.96e-01
|
0.14700
|
0.089400
|
-0.116000
|
4.93e-01
|
3.72e-01
|
GOBP CELLULAR RESPONSE TO STARVATION
|
21
|
5.79e-01
|
7.49e-01
|
0.14600
|
0.133000
|
-0.061600
|
2.96e-01
|
6.28e-01
|
GOMF HISTONE METHYLTRANSFERASE ACTIVITY
|
6
|
8.45e-01
|
9.11e-01
|
0.14600
|
0.136000
|
-0.053100
|
5.65e-01
|
8.22e-01
|
GOBP LEARNING
|
11
|
7.94e-01
|
8.81e-01
|
0.14600
|
0.107000
|
-0.099000
|
5.40e-01
|
5.72e-01
|
GOBP POSITIVE REGULATION OF ORGANIC ACID TRANSPORT
|
6
|
7.85e-01
|
8.76e-01
|
0.14500
|
0.145000
|
-0.008040
|
5.39e-01
|
9.73e-01
|
GOBP CELL PROJECTION ASSEMBLY
|
44
|
2.31e-01
|
4.65e-01
|
0.14500
|
0.028100
|
-0.143000
|
7.51e-01
|
1.08e-01
|
GOBP TUBE MORPHOGENESIS
|
64
|
2.77e-01
|
5.09e-01
|
0.14500
|
0.094200
|
-0.111000
|
2.04e-01
|
1.36e-01
|
GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY
|
11
|
7.97e-01
|
8.82e-01
|
0.14500
|
0.105000
|
-0.099600
|
5.48e-01
|
5.69e-01
|
GOBP INORGANIC ION HOMEOSTASIS
|
53
|
2.91e-01
|
5.25e-01
|
0.14500
|
0.127000
|
-0.068600
|
1.16e-01
|
3.98e-01
|
GOBP PYRIDINE CONTAINING COMPOUND CATABOLIC PROCESS
|
16
|
4.77e-01
|
6.82e-01
|
0.14500
|
0.144000
|
0.014700
|
3.23e-01
|
9.19e-01
|
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS
|
9
|
7.74e-01
|
8.73e-01
|
0.14400
|
-0.048600
|
0.136000
|
8.01e-01
|
4.82e-01
|
GOMF HYDROLASE ACTIVITY ACTING ON ACID ANHYDRIDES
|
93
|
9.51e-02
|
2.90e-01
|
0.14400
|
0.054000
|
-0.134000
|
3.86e-01
|
3.14e-02
|
GOBP REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY
|
32
|
1.49e-01
|
3.70e-01
|
0.14400
|
-0.071700
|
-0.125000
|
4.88e-01
|
2.26e-01
|
GOBP REGULATION OF ADAPTIVE IMMUNE RESPONSE
|
5
|
8.75e-01
|
9.30e-01
|
0.14400
|
0.133000
|
-0.055900
|
6.08e-01
|
8.29e-01
|
GOMF DIOXYGENASE ACTIVITY
|
9
|
5.81e-01
|
7.51e-01
|
0.14400
|
-0.124000
|
-0.073200
|
5.22e-01
|
7.05e-01
|
GOBP IMMUNE SYSTEM DEVELOPMENT
|
12
|
7.52e-01
|
8.64e-01
|
0.14300
|
0.126000
|
-0.067800
|
4.51e-01
|
6.86e-01
|
GOBP CARDIAC VENTRICLE DEVELOPMENT
|
11
|
5.83e-01
|
7.52e-01
|
0.14300
|
-0.026600
|
-0.141000
|
8.79e-01
|
4.21e-01
|
GOBP BILE ACID AND BILE SALT TRANSPORT
|
5
|
7.34e-01
|
8.53e-01
|
0.14300
|
-0.086300
|
-0.114000
|
7.39e-01
|
6.60e-01
|
GOBP NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS
|
29
|
3.59e-01
|
5.88e-01
|
0.14300
|
0.142000
|
-0.018200
|
1.91e-01
|
8.67e-01
|
GOBP AUTOPHAGOSOME ORGANIZATION
|
15
|
5.05e-01
|
7.00e-01
|
0.14300
|
-0.142000
|
-0.015600
|
3.44e-01
|
9.17e-01
|
GOBP CELLULAR RESPONSE TO NITROGEN COMPOUND
|
62
|
5.80e-02
|
2.17e-01
|
0.14300
|
0.141000
|
0.023300
|
6.13e-02
|
7.57e-01
|
GOBP PIGMENT METABOLIC PROCESS
|
9
|
6.35e-01
|
7.90e-01
|
0.14300
|
0.139000
|
0.032600
|
4.72e-01
|
8.66e-01
|
GOBP RESPONSE TO VITAMIN
|
16
|
4.09e-01
|
6.26e-01
|
0.14300
|
0.131000
|
0.055800
|
3.66e-01
|
7.01e-01
|
GOBP ENDOMEMBRANE SYSTEM ORGANIZATION
|
69
|
1.61e-01
|
3.80e-01
|
0.14300
|
0.047600
|
-0.135000
|
5.06e-01
|
6.01e-02
|
GOCC TIGHT JUNCTION
|
14
|
6.82e-01
|
8.16e-01
|
0.14300
|
0.134000
|
-0.049300
|
3.89e-01
|
7.51e-01
|
GOBP POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY
|
12
|
7.88e-01
|
8.77e-01
|
0.14200
|
-0.104000
|
0.097400
|
5.36e-01
|
5.61e-01
|
GOBP ESTABLISHMENT OF ORGANELLE LOCALIZATION
|
28
|
2.17e-01
|
4.53e-01
|
0.14200
|
-0.053500
|
-0.132000
|
6.28e-01
|
2.33e-01
|
GOCC DISTAL AXON
|
22
|
6.49e-01
|
7.97e-01
|
0.14200
|
0.097200
|
-0.103000
|
4.34e-01
|
4.05e-01
|
GOCC CHROMOSOME CENTROMERIC REGION
|
20
|
5.00e-01
|
6.96e-01
|
0.14200
|
0.019400
|
-0.141000
|
8.81e-01
|
2.80e-01
|
GOCC RIBONUCLEOPROTEIN GRANULE
|
38
|
4.72e-01
|
6.79e-01
|
0.14100
|
-0.111000
|
0.086900
|
2.42e-01
|
3.61e-01
|
GOBP CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND
|
127
|
3.74e-03
|
4.49e-02
|
0.14100
|
0.138000
|
0.029900
|
1.10e-02
|
5.81e-01
|
GOBP LIPID CATABOLIC PROCESS
|
52
|
2.71e-01
|
5.06e-01
|
0.14100
|
-0.051500
|
0.131000
|
5.29e-01
|
1.09e-01
|
GOBP MYOFIBRIL ASSEMBLY
|
5
|
7.96e-01
|
8.81e-01
|
0.14100
|
-0.019600
|
-0.139000
|
9.40e-01
|
5.91e-01
|
GOCC GOLGI MEMBRANE
|
54
|
7.18e-02
|
2.45e-01
|
0.14000
|
-0.135000
|
-0.038500
|
9.30e-02
|
6.32e-01
|
GOBP POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY
|
15
|
4.92e-01
|
6.91e-01
|
0.14000
|
-0.027600
|
-0.137000
|
8.54e-01
|
3.60e-01
|
GOCC EXTERNAL SIDE OF PLASMA MEMBRANE
|
14
|
7.59e-01
|
8.65e-01
|
0.14000
|
0.110000
|
-0.086800
|
4.80e-01
|
5.76e-01
|
GOBP ISOPRENOID METABOLIC PROCESS
|
16
|
6.81e-01
|
8.15e-01
|
0.14000
|
-0.127000
|
0.058400
|
3.82e-01
|
6.88e-01
|
GOMF ENZYME INHIBITOR ACTIVITY
|
38
|
3.93e-01
|
6.15e-01
|
0.14000
|
0.053400
|
-0.129000
|
5.75e-01
|
1.75e-01
|
GOBP GLIAL CELL DIFFERENTIATION
|
16
|
3.91e-01
|
6.13e-01
|
0.13900
|
-0.108000
|
-0.088600
|
4.59e-01
|
5.42e-01
|
GOBP ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME
|
10
|
8.27e-01
|
9.00e-01
|
0.13900
|
0.099300
|
-0.097800
|
5.89e-01
|
5.94e-01
|
GOMF MODIFIED AMINO ACID BINDING
|
11
|
6.44e-01
|
7.96e-01
|
0.13900
|
-0.003960
|
-0.139000
|
9.82e-01
|
4.28e-01
|
GOBP PURINE CONTAINING COMPOUND CATABOLIC PROCESS
|
26
|
4.82e-01
|
6.86e-01
|
0.13900
|
0.134000
|
-0.037300
|
2.43e-01
|
7.44e-01
|
GOCC INCLUSION BODY
|
9
|
8.42e-01
|
9.09e-01
|
0.13900
|
0.105000
|
-0.091100
|
5.89e-01
|
6.38e-01
|
GOBP REGULATION OF CELL FATE SPECIFICATION
|
5
|
7.48e-01
|
8.61e-01
|
0.13800
|
-0.085000
|
-0.109000
|
7.43e-01
|
6.73e-01
|
GOCC LATE ENDOSOME
|
27
|
6.03e-01
|
7.68e-01
|
0.13800
|
0.105000
|
-0.089400
|
3.49e-01
|
4.27e-01
|
GOCC NUCLEAR MEMBRANE
|
32
|
1.61e-01
|
3.80e-01
|
0.13800
|
-0.098800
|
-0.096300
|
3.40e-01
|
3.52e-01
|
GOBP REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III
|
5
|
7.84e-01
|
8.75e-01
|
0.13800
|
-0.036600
|
-0.133000
|
8.88e-01
|
6.08e-01
|
GOBP TRANSCRIPTION BY RNA POLYMERASE III
|
5
|
7.84e-01
|
8.75e-01
|
0.13800
|
-0.036600
|
-0.133000
|
8.88e-01
|
6.08e-01
|
GOBP GOLGI ORGANIZATION
|
30
|
5.56e-01
|
7.34e-01
|
0.13700
|
0.077300
|
-0.114000
|
4.69e-01
|
2.88e-01
|
GOCC TRANSPORT VESICLE
|
30
|
5.70e-01
|
7.43e-01
|
0.13700
|
-0.108000
|
0.085100
|
3.13e-01
|
4.25e-01
|
GOBP NEURAL TUBE DEVELOPMENT
|
11
|
7.55e-01
|
8.65e-01
|
0.13700
|
0.046700
|
-0.129000
|
7.90e-01
|
4.61e-01
|
GOBP ORGANELLE FISSION
|
36
|
3.40e-01
|
5.76e-01
|
0.13700
|
0.026200
|
-0.135000
|
7.89e-01
|
1.68e-01
|
GOMF TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS
|
91
|
2.04e-01
|
4.38e-01
|
0.13700
|
0.088800
|
-0.104000
|
1.58e-01
|
9.73e-02
|
GOBP NEGATIVE REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS
|
10
|
5.70e-01
|
7.43e-01
|
0.13700
|
0.111000
|
0.080200
|
5.46e-01
|
6.62e-01
|
GOMF POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING
|
6
|
8.95e-01
|
9.43e-01
|
0.13700
|
0.098900
|
-0.094300
|
6.76e-01
|
6.90e-01
|
GOBP STEM CELL PROLIFERATION
|
5
|
8.55e-01
|
9.18e-01
|
0.13700
|
-0.023200
|
0.135000
|
9.29e-01
|
6.03e-01
|
GOBP MODIFIED AMINO ACID CATABOLIC PROCESS
|
5
|
8.67e-01
|
9.25e-01
|
0.13600
|
-0.033300
|
0.132000
|
8.98e-01
|
6.09e-01
|
GOBP MODIFICATION OF SYNAPTIC STRUCTURE
|
8
|
8.63e-01
|
9.24e-01
|
0.13600
|
-0.089900
|
0.102000
|
6.61e-01
|
6.18e-01
|
GOMF ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY
|
69
|
2.70e-02
|
1.43e-01
|
0.13600
|
0.114000
|
0.074800
|
1.12e-01
|
2.96e-01
|
GOBP GLIOGENESIS
|
25
|
2.76e-01
|
5.08e-01
|
0.13600
|
-0.058100
|
-0.123000
|
6.19e-01
|
2.92e-01
|
GOBP POSITIVE REGULATION OF ORGANELLE ORGANIZATION
|
35
|
4.15e-01
|
6.33e-01
|
0.13600
|
0.043700
|
-0.129000
|
6.59e-01
|
1.94e-01
|
GOBP REGULATION OF SYNAPTIC VESICLE RECYCLING
|
8
|
7.77e-01
|
8.74e-01
|
0.13600
|
-0.134000
|
0.020900
|
5.12e-01
|
9.19e-01
|
GOBP HORMONE METABOLIC PROCESS
|
22
|
6.64e-01
|
8.06e-01
|
0.13600
|
0.082200
|
-0.108000
|
5.09e-01
|
3.84e-01
|
GOBP ORGANOPHOSPHATE ESTER TRANSPORT
|
17
|
7.36e-01
|
8.53e-01
|
0.13600
|
0.091300
|
-0.100000
|
5.18e-01
|
4.77e-01
|
GOBP RESPONSE TO ESTRADIOL
|
16
|
7.29e-01
|
8.49e-01
|
0.13600
|
0.114000
|
-0.073000
|
4.31e-01
|
6.16e-01
|
GOBP REGULATION OF RESPONSE TO CYTOKINE STIMULUS
|
17
|
7.35e-01
|
8.53e-01
|
0.13600
|
0.101000
|
-0.090400
|
4.73e-01
|
5.22e-01
|
GOBP VISUAL BEHAVIOR
|
5
|
8.01e-01
|
8.84e-01
|
0.13500
|
-0.133000
|
-0.025800
|
6.08e-01
|
9.21e-01
|
GOBP EMBRYONIC MORPHOGENESIS
|
39
|
3.95e-01
|
6.17e-01
|
0.13500
|
0.048100
|
-0.127000
|
6.09e-01
|
1.78e-01
|
GOCC H4 HISTONE ACETYLTRANSFERASE COMPLEX
|
6
|
8.05e-01
|
8.87e-01
|
0.13500
|
-0.002730
|
0.135000
|
9.91e-01
|
5.68e-01
|
GOBP NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS
|
12
|
5.20e-01
|
7.09e-01
|
0.13500
|
0.111000
|
0.076700
|
5.07e-01
|
6.47e-01
|
GOBP PROTEIN LOCALIZATION TO VACUOLE
|
11
|
8.02e-01
|
8.84e-01
|
0.13500
|
0.070200
|
-0.116000
|
6.89e-01
|
5.09e-01
|
GOMF PROTEIN SERINE KINASE ACTIVITY
|
32
|
3.51e-01
|
5.81e-01
|
0.13500
|
0.135000
|
-0.012500
|
1.94e-01
|
9.04e-01
|
GOCC GOLGI APPARATUS
|
148
|
1.74e-02
|
1.12e-01
|
0.13500
|
0.021300
|
-0.133000
|
6.75e-01
|
8.50e-03
|
GOBP APOPTOTIC SIGNALING PATHWAY
|
57
|
7.48e-02
|
2.51e-01
|
0.13500
|
0.040000
|
0.129000
|
6.10e-01
|
1.01e-01
|
GOBP MEMBRANE DOCKING
|
9
|
8.31e-01
|
9.02e-01
|
0.13500
|
-0.118000
|
0.065600
|
5.43e-01
|
7.35e-01
|
GOBP AMINE TRANSPORT
|
8
|
6.42e-01
|
7.94e-01
|
0.13500
|
-0.097900
|
-0.092500
|
6.33e-01
|
6.52e-01
|
GOBP ANDROGEN RECEPTOR SIGNALING PATHWAY
|
9
|
6.12e-01
|
7.70e-01
|
0.13500
|
0.107000
|
0.081200
|
5.79e-01
|
6.74e-01
|
GOBP MICROTUBULE CYTOSKELETON ORGANIZATION
|
45
|
9.56e-02
|
2.90e-01
|
0.13400
|
-0.112000
|
-0.073900
|
2.01e-01
|
3.99e-01
|
GOMF PROTEIN METHYLTRANSFERASE ACTIVITY
|
11
|
7.08e-01
|
8.36e-01
|
0.13400
|
0.017900
|
-0.133000
|
9.18e-01
|
4.47e-01
|
GOBP HEMATOPOIETIC OR LYMPHOID ORGAN DEVELOPMENT
|
11
|
7.13e-01
|
8.38e-01
|
0.13400
|
0.132000
|
-0.019700
|
4.49e-01
|
9.10e-01
|
GOBP SUBSTRATE ADHESION DEPENDENT CELL SPREADING
|
11
|
7.56e-01
|
8.65e-01
|
0.13400
|
0.040200
|
-0.128000
|
8.18e-01
|
4.66e-01
|
GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION
|
5
|
8.81e-01
|
9.33e-01
|
0.13400
|
0.127000
|
-0.041200
|
6.24e-01
|
8.74e-01
|
GOCC PHAGOCYTIC VESICLE
|
13
|
7.95e-01
|
8.81e-01
|
0.13400
|
-0.087700
|
0.101000
|
5.86e-01
|
5.32e-01
|
GOMF VITAMIN BINDING
|
25
|
3.81e-01
|
6.01e-01
|
0.13300
|
0.011700
|
0.133000
|
9.20e-01
|
2.55e-01
|
GOBP ORGANOPHOSPHATE CATABOLIC PROCESS
|
33
|
5.00e-01
|
6.96e-01
|
0.13300
|
0.120000
|
-0.057300
|
2.40e-01
|
5.74e-01
|
GOBP CILIUM ORGANIZATION
|
30
|
4.27e-01
|
6.43e-01
|
0.13300
|
0.024900
|
-0.130000
|
8.16e-01
|
2.22e-01
|
GOCC MICROTUBULE
|
29
|
2.73e-01
|
5.08e-01
|
0.13300
|
-0.037800
|
-0.127000
|
7.28e-01
|
2.41e-01
|
GOBP DNA BIOSYNTHETIC PROCESS
|
18
|
4.48e-01
|
6.62e-01
|
0.13300
|
-0.036000
|
-0.128000
|
7.93e-01
|
3.52e-01
|
GOBP PROTEASOME MEDIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS
|
47
|
4.55e-01
|
6.68e-01
|
0.13200
|
-0.097300
|
0.089900
|
2.57e-01
|
2.96e-01
|
GOBP REGULATION OF PROTEOLYSIS
|
38
|
4.69e-01
|
6.76e-01
|
0.13200
|
0.061100
|
-0.117000
|
5.21e-01
|
2.18e-01
|
GOBP BLASTOCYST DEVELOPMENT
|
9
|
7.83e-01
|
8.75e-01
|
0.13200
|
0.030200
|
-0.129000
|
8.76e-01
|
5.06e-01
|
GOCC ENDOPLASMIC RETICULUM GOLGI INTERMEDIATE COMPARTMENT
|
17
|
6.01e-01
|
7.67e-01
|
0.13100
|
0.017500
|
-0.130000
|
9.01e-01
|
3.56e-01
|
GOMF SOLUTE INORGANIC ANION ANTIPORTER ACTIVITY
|
5
|
8.56e-01
|
9.19e-01
|
0.13100
|
0.130000
|
-0.014100
|
6.15e-01
|
9.57e-01
|
GOBP POSITIVE REGULATION OF PEPTIDE SECRETION
|
5
|
7.80e-01
|
8.75e-01
|
0.13100
|
0.116000
|
0.061800
|
6.55e-01
|
8.12e-01
|
GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION
|
30
|
5.92e-01
|
7.60e-01
|
0.13100
|
0.106000
|
-0.076600
|
3.19e-01
|
4.73e-01
|
GOBP BONE DEVELOPMENT
|
19
|
4.99e-01
|
6.96e-01
|
0.13100
|
-0.008180
|
-0.131000
|
9.51e-01
|
3.28e-01
|
GOMF NUCLEASE ACTIVITY
|
13
|
5.10e-01
|
7.03e-01
|
0.13000
|
0.092200
|
0.092200
|
5.67e-01
|
5.67e-01
|
GOCC NUCLEAR OUTER MEMBRANE ENDOPLASMIC RETICULUM MEMBRANE NETWORK
|
133
|
9.40e-03
|
8.04e-02
|
0.13000
|
-0.129000
|
-0.017400
|
1.48e-02
|
7.43e-01
|
GOCC RUFFLE MEMBRANE
|
11
|
8.33e-01
|
9.03e-01
|
0.13000
|
0.091800
|
-0.092300
|
6.00e-01
|
5.98e-01
|
GOBP ENDOSOME ORGANIZATION
|
10
|
6.15e-01
|
7.72e-01
|
0.13000
|
-0.114000
|
-0.061600
|
5.33e-01
|
7.37e-01
|
GOBP NEGATIVE REGULATION OF HORMONE SECRETION
|
5
|
8.36e-01
|
9.05e-01
|
0.13000
|
0.129000
|
0.006860
|
6.17e-01
|
9.79e-01
|
GOBP CRISTAE FORMATION
|
5
|
8.69e-01
|
9.26e-01
|
0.12900
|
-0.020600
|
0.127000
|
9.37e-01
|
6.24e-01
|
GOCC ACROSOMAL VESICLE
|
5
|
7.76e-01
|
8.74e-01
|
0.12900
|
-0.085600
|
-0.096100
|
7.41e-01
|
7.11e-01
|
GOMF CELL ADHESION MOLECULE BINDING
|
70
|
3.08e-01
|
5.41e-01
|
0.12900
|
0.070300
|
-0.108000
|
3.23e-01
|
1.30e-01
|
GOBP MICROTUBULE BASED PROCESS
|
66
|
4.41e-02
|
1.88e-01
|
0.12800
|
-0.104000
|
-0.074900
|
1.53e-01
|
3.05e-01
|
GOBP POSITIVE REGULATION OF PROGRAMMED CELL DEATH
|
40
|
2.54e-01
|
4.87e-01
|
0.12800
|
0.128000
|
0.007300
|
1.68e-01
|
9.37e-01
|
GOMF NUCLEAR GLUCOCORTICOID RECEPTOR BINDING
|
5
|
8.12e-01
|
8.92e-01
|
0.12800
|
-0.032700
|
-0.124000
|
9.00e-01
|
6.32e-01
|
GOCC PERINUCLEAR REGION OF CYTOPLASM
|
68
|
1.48e-01
|
3.69e-01
|
0.12800
|
-0.127000
|
0.013700
|
7.73e-02
|
8.49e-01
|
GOBP MYELOID CELL DIFFERENTIATION
|
31
|
2.22e-01
|
4.58e-01
|
0.12800
|
0.101000
|
0.078200
|
3.35e-01
|
4.57e-01
|
GOMF LNCRNA BINDING
|
8
|
6.79e-01
|
8.14e-01
|
0.12800
|
-0.068800
|
-0.108000
|
7.37e-01
|
5.99e-01
|
GOBP NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION
|
67
|
3.57e-01
|
5.86e-01
|
0.12800
|
0.095400
|
-0.085000
|
1.89e-01
|
2.42e-01
|
GOBP ENDOTHELIAL CELL DIFFERENTIATION
|
9
|
6.50e-01
|
7.97e-01
|
0.12800
|
-0.109000
|
-0.066300
|
5.73e-01
|
7.32e-01
|
GOCC EXTRINSIC COMPONENT OF ORGANELLE MEMBRANE
|
5
|
8.05e-01
|
8.87e-01
|
0.12800
|
-0.121000
|
-0.041500
|
6.41e-01
|
8.73e-01
|
GOBP POSITIVE REGULATION OF CELL ACTIVATION
|
23
|
3.26e-01
|
5.62e-01
|
0.12700
|
0.081000
|
0.098300
|
5.05e-01
|
4.19e-01
|
GOBP ORGANELLE LOCALIZATION
|
39
|
1.81e-01
|
4.09e-01
|
0.12700
|
-0.050400
|
-0.117000
|
5.92e-01
|
2.14e-01
|
GOBP NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS
|
68
|
3.50e-01
|
5.80e-01
|
0.12700
|
0.098400
|
-0.080500
|
1.72e-01
|
2.64e-01
|
GOBP DEFENSE RESPONSE TO SYMBIONT
|
66
|
2.86e-01
|
5.18e-01
|
0.12700
|
-0.053100
|
0.116000
|
4.68e-01
|
1.14e-01
|
GOBP REGULATION OF CHROMOSOME ORGANIZATION
|
17
|
7.23e-01
|
8.44e-01
|
0.12700
|
0.056800
|
-0.114000
|
6.87e-01
|
4.21e-01
|
GOBP PLACENTA DEVELOPMENT
|
21
|
4.67e-01
|
6.75e-01
|
0.12700
|
-0.015600
|
-0.126000
|
9.02e-01
|
3.22e-01
|
GOBP NUCLEOTIDE SUGAR METABOLIC PROCESS
|
5
|
9.24e-01
|
9.62e-01
|
0.12700
|
-0.088200
|
0.091200
|
7.33e-01
|
7.25e-01
|
GOBP CELLULAR RESPONSE TO CAMP
|
7
|
7.14e-01
|
8.38e-01
|
0.12700
|
0.072900
|
0.104000
|
7.39e-01
|
6.36e-01
|
GOBP DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION
|
56
|
2.83e-01
|
5.15e-01
|
0.12700
|
0.035800
|
-0.122000
|
6.51e-01
|
1.24e-01
|
GOBP MORPHOGENESIS OF AN EPITHELIAL SHEET
|
7
|
8.95e-01
|
9.43e-01
|
0.12700
|
0.092800
|
-0.086300
|
6.72e-01
|
6.94e-01
|
GOMF P53 BINDING
|
6
|
7.54e-01
|
8.64e-01
|
0.12700
|
-0.108000
|
-0.065400
|
6.46e-01
|
7.82e-01
|
GOBP RESPONSE TO PEPTIDE HORMONE
|
48
|
1.56e-01
|
3.74e-01
|
0.12600
|
0.123000
|
0.030700
|
1.50e-01
|
7.18e-01
|
GOBP REGULATION OF CELL FATE COMMITMENT
|
6
|
7.68e-01
|
8.71e-01
|
0.12600
|
-0.048500
|
-0.117000
|
8.37e-01
|
6.22e-01
|
GOMF NUCLEOSOMAL DNA BINDING
|
8
|
8.48e-01
|
9.12e-01
|
0.12600
|
-0.117000
|
0.047600
|
5.68e-01
|
8.16e-01
|
GOBP POSITIVE REGULATION OF MUSCLE CONTRACTION
|
5
|
7.99e-01
|
8.84e-01
|
0.12600
|
0.113000
|
0.055200
|
6.63e-01
|
8.31e-01
|
GOCC SPINDLE
|
38
|
4.70e-01
|
6.77e-01
|
0.12500
|
0.046300
|
-0.116000
|
6.27e-01
|
2.23e-01
|
GOBP POSITIVE REGULATION OF MACROAUTOPHAGY
|
11
|
7.78e-01
|
8.75e-01
|
0.12500
|
-0.034300
|
0.120000
|
8.44e-01
|
4.93e-01
|
GOBP POSITIVE REGULATION OF HEMOPOIESIS
|
13
|
7.10e-01
|
8.36e-01
|
0.12500
|
-0.019000
|
0.123000
|
9.06e-01
|
4.45e-01
|
GOBP KETONE METABOLIC PROCESS
|
30
|
3.17e-01
|
5.51e-01
|
0.12500
|
0.030500
|
0.121000
|
7.75e-01
|
2.58e-01
|
GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION
|
24
|
6.97e-01
|
8.26e-01
|
0.12400
|
-0.083100
|
0.092400
|
4.86e-01
|
4.38e-01
|
GOBP RESPONSE TO MECHANICAL STIMULUS
|
11
|
7.94e-01
|
8.81e-01
|
0.12400
|
0.117000
|
-0.041500
|
5.04e-01
|
8.13e-01
|
GOMF MRNA BINDING
|
50
|
3.72e-01
|
5.93e-01
|
0.12400
|
-0.043900
|
0.116000
|
5.99e-01
|
1.65e-01
|
GOBP ANTIGEN PROCESSING AND PRESENTATION
|
8
|
6.88e-01
|
8.20e-01
|
0.12400
|
0.081900
|
0.093000
|
6.90e-01
|
6.50e-01
|
GOBP CELLULAR RESPONSE TO HYDROGEN PEROXIDE
|
6
|
7.57e-01
|
8.65e-01
|
0.12400
|
0.077100
|
0.096800
|
7.44e-01
|
6.82e-01
|
GOBP BIOLOGICAL PROCESS INVOLVED IN INTERACTION WITH HOST
|
22
|
7.13e-01
|
8.38e-01
|
0.12400
|
0.075200
|
-0.098100
|
5.45e-01
|
4.30e-01
|
GOBP POSITIVE REGULATION OF FAT CELL DIFFERENTIATION
|
8
|
8.17e-01
|
8.93e-01
|
0.12300
|
0.121000
|
-0.021300
|
5.54e-01
|
9.17e-01
|
GOBP MRNA CATABOLIC PROCESS
|
25
|
6.04e-01
|
7.69e-01
|
0.12300
|
0.116000
|
-0.042200
|
3.22e-01
|
7.18e-01
|
GOBP REGULATION OF PROTEIN CATABOLIC PROCESS
|
46
|
4.82e-01
|
6.86e-01
|
0.12300
|
0.065100
|
-0.104000
|
4.54e-01
|
2.31e-01
|
GOBP RESPONSE TO OXYGEN CONTAINING COMPOUND
|
170
|
8.61e-03
|
7.63e-02
|
0.12300
|
0.122000
|
0.006990
|
1.02e-02
|
8.84e-01
|
GOBP CERAMIDE METABOLIC PROCESS
|
9
|
8.41e-01
|
9.09e-01
|
0.12200
|
-0.113000
|
0.046800
|
5.59e-01
|
8.09e-01
|
GOMF ATP HYDROLYSIS ACTIVITY
|
25
|
3.30e-01
|
5.66e-01
|
0.12200
|
-0.072200
|
-0.098600
|
5.36e-01
|
3.98e-01
|
GOBP DNA INTEGRITY CHECKPOINT SIGNALING
|
9
|
8.75e-01
|
9.30e-01
|
0.12200
|
0.079600
|
-0.092700
|
6.81e-01
|
6.32e-01
|
GOBP PROTEIN RNA COMPLEX ORGANIZATION
|
25
|
4.52e-01
|
6.65e-01
|
0.12200
|
0.008240
|
0.122000
|
9.44e-01
|
2.97e-01
|
GOMF MYOSIN BINDING
|
5
|
9.28e-01
|
9.64e-01
|
0.12200
|
-0.077100
|
0.094400
|
7.66e-01
|
7.15e-01
|
GOBP HIPPO SIGNALING
|
6
|
8.36e-01
|
9.05e-01
|
0.12200
|
0.000273
|
-0.122000
|
9.99e-01
|
6.06e-01
|
GOBP ANATOMICAL STRUCTURE MATURATION
|
8
|
7.56e-01
|
8.65e-01
|
0.12200
|
0.120000
|
0.019900
|
5.58e-01
|
9.23e-01
|
GOBP REGULATION OF IMMUNE RESPONSE
|
55
|
1.49e-01
|
3.70e-01
|
0.12200
|
0.119000
|
0.024100
|
1.34e-01
|
7.63e-01
|
GOBP ICOSANOID TRANSPORT
|
8
|
8.80e-01
|
9.33e-01
|
0.12200
|
0.103000
|
-0.065400
|
6.16e-01
|
7.50e-01
|
GOBP REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS
|
20
|
7.23e-01
|
8.44e-01
|
0.12200
|
0.062600
|
-0.104000
|
6.31e-01
|
4.23e-01
|
GOMF TELOMERASE RNA BINDING
|
5
|
8.61e-01
|
9.22e-01
|
0.12100
|
-0.121000
|
-0.000327
|
6.40e-01
|
9.99e-01
|
GOBP POSITIVE REGULATION OF CELL CELL ADHESION
|
18
|
5.62e-01
|
7.37e-01
|
0.12100
|
0.120000
|
0.011300
|
3.81e-01
|
9.34e-01
|
GOBP IN UTERO EMBRYONIC DEVELOPMENT
|
37
|
4.74e-01
|
6.80e-01
|
0.12000
|
-0.115000
|
0.036100
|
2.34e-01
|
7.08e-01
|
GOBP REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS
|
24
|
6.90e-01
|
8.21e-01
|
0.12000
|
0.102000
|
-0.064200
|
3.93e-01
|
5.90e-01
|
GOMF 4 IRON 4 SULFUR CLUSTER BINDING
|
9
|
7.71e-01
|
8.71e-01
|
0.12000
|
0.120000
|
-0.000729
|
5.34e-01
|
9.97e-01
|
GOBP TRABECULA MORPHOGENESIS
|
6
|
7.81e-01
|
8.75e-01
|
0.12000
|
-0.107000
|
-0.054100
|
6.50e-01
|
8.19e-01
|
GOBP RNA PROCESSING
|
78
|
2.03e-01
|
4.37e-01
|
0.12000
|
0.116000
|
-0.030300
|
8.64e-02
|
6.54e-01
|
GOBP POSITIVE REGULATION OF STRESS FIBER ASSEMBLY
|
6
|
8.43e-01
|
9.10e-01
|
0.12000
|
0.002180
|
-0.120000
|
9.93e-01
|
6.13e-01
|
GOMF TRANSPORTER ACTIVITY
|
133
|
3.26e-02
|
1.60e-01
|
0.11900
|
0.119000
|
-0.000631
|
2.44e-02
|
9.91e-01
|
GOBP SIGNAL RELEASE
|
34
|
6.12e-01
|
7.70e-01
|
0.11900
|
0.068300
|
-0.097300
|
4.97e-01
|
3.33e-01
|
GOBP PROCESS UTILIZING AUTOPHAGIC MECHANISM
|
78
|
8.69e-02
|
2.78e-01
|
0.11800
|
-0.020300
|
-0.117000
|
7.64e-01
|
8.45e-02
|
GOCC CYTOPLASMIC REGION
|
19
|
6.11e-01
|
7.70e-01
|
0.11800
|
-0.118000
|
0.008440
|
3.77e-01
|
9.50e-01
|
GOBP TOR SIGNALING
|
21
|
7.28e-01
|
8.48e-01
|
0.11800
|
0.101000
|
-0.062000
|
4.29e-01
|
6.26e-01
|
GOBP REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE
|
6
|
8.66e-01
|
9.24e-01
|
0.11800
|
0.017200
|
-0.117000
|
9.42e-01
|
6.21e-01
|
GOBP REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING
|
6
|
8.66e-01
|
9.24e-01
|
0.11800
|
0.017200
|
-0.117000
|
9.42e-01
|
6.21e-01
|
GOBP REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION
|
24
|
7.25e-01
|
8.45e-01
|
0.11700
|
-0.078900
|
0.086900
|
5.08e-01
|
4.66e-01
|
GOBP MAINTENANCE OF PROTEIN LOCATION
|
7
|
7.54e-01
|
8.64e-01
|
0.11700
|
0.061000
|
0.100000
|
7.81e-01
|
6.48e-01
|
GOBP NUCLEOBASE CONTAINING COMPOUND CATABOLIC PROCESS
|
58
|
2.10e-01
|
4.43e-01
|
0.11700
|
0.117000
|
0.001330
|
1.31e-01
|
9.86e-01
|
GOCC SUPRAMOLECULAR COMPLEX
|
97
|
1.04e-01
|
3.07e-01
|
0.11700
|
0.010500
|
-0.117000
|
8.64e-01
|
5.65e-02
|
GOBP CANONICAL NF KAPPAB SIGNAL TRANSDUCTION
|
34
|
5.91e-01
|
7.60e-01
|
0.11700
|
-0.054800
|
0.103000
|
5.86e-01
|
3.05e-01
|
GOBP PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS
|
84
|
2.09e-01
|
4.42e-01
|
0.11700
|
-0.112000
|
0.032900
|
8.63e-02
|
6.15e-01
|
GOBP L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT
|
10
|
7.56e-01
|
8.65e-01
|
0.11700
|
-0.002790
|
-0.116000
|
9.88e-01
|
5.26e-01
|
GOBP INNATE IMMUNE RESPONSE ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY
|
8
|
7.68e-01
|
8.71e-01
|
0.11600
|
-0.114000
|
-0.024200
|
5.79e-01
|
9.06e-01
|
GOBP WATER SOLUBLE VITAMIN METABOLIC PROCESS
|
5
|
9.19e-01
|
9.60e-01
|
0.11600
|
-0.106000
|
0.045800
|
6.82e-01
|
8.60e-01
|
GOBP CELLULAR RESPONSE TO NUTRIENT LEVELS
|
34
|
6.45e-01
|
7.96e-01
|
0.11500
|
0.085700
|
-0.077500
|
3.94e-01
|
4.41e-01
|
GOBP MACROAUTOPHAGY
|
48
|
2.10e-01
|
4.43e-01
|
0.11500
|
-0.112000
|
-0.028900
|
1.89e-01
|
7.34e-01
|
GOBP POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION
|
96
|
1.00e-01
|
2.99e-01
|
0.11500
|
0.115000
|
-0.004560
|
6.04e-02
|
9.41e-01
|
GOCC COATED VESICLE
|
29
|
6.85e-01
|
8.18e-01
|
0.11500
|
0.074200
|
-0.088300
|
4.94e-01
|
4.16e-01
|
GOBP ALCOHOL METABOLIC PROCESS
|
46
|
1.64e-01
|
3.84e-01
|
0.11500
|
0.078700
|
0.084100
|
3.65e-01
|
3.33e-01
|
GOBP LIPID METABOLIC PROCESS
|
160
|
1.39e-01
|
3.54e-01
|
0.11500
|
-0.063800
|
0.095800
|
1.93e-01
|
5.02e-02
|
GOBP NEGATIVE REGULATION OF JNK CASCADE
|
8
|
8.51e-01
|
9.13e-01
|
0.11500
|
0.028300
|
-0.112000
|
8.90e-01
|
5.86e-01
|
GOBP PROTEOLYSIS
|
126
|
8.64e-02
|
2.77e-01
|
0.11500
|
-0.113000
|
0.022400
|
3.77e-02
|
6.80e-01
|
GOBP REGULATION OF PROTEIN STABILITY
|
40
|
5.57e-01
|
7.34e-01
|
0.11500
|
-0.055600
|
0.100000
|
5.49e-01
|
2.79e-01
|
GOBP NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION
|
7
|
7.59e-01
|
8.65e-01
|
0.11500
|
-0.065900
|
-0.094000
|
7.63e-01
|
6.68e-01
|
GOBP MICROTUBULE BASED MOVEMENT
|
30
|
3.80e-01
|
6.00e-01
|
0.11500
|
-0.112000
|
-0.027000
|
2.96e-01
|
8.00e-01
|
GOMF PROTEIN DIMERIZATION ACTIVITY
|
101
|
2.54e-01
|
4.87e-01
|
0.11500
|
-0.099100
|
0.057400
|
9.86e-02
|
3.39e-01
|
GOBP INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS
|
7
|
8.65e-01
|
9.24e-01
|
0.11500
|
-0.025000
|
0.112000
|
9.09e-01
|
6.10e-01
|
GOMF TAU PROTEIN BINDING
|
11
|
8.39e-01
|
9.08e-01
|
0.11400
|
-0.103000
|
0.047600
|
5.54e-01
|
7.86e-01
|
GOMF TRANSCRIPTION COREPRESSOR ACTIVITY
|
27
|
6.69e-01
|
8.09e-01
|
0.11400
|
0.101000
|
-0.052800
|
3.70e-01
|
6.39e-01
|
GOBP CELL ACTIVATION
|
73
|
7.91e-02
|
2.63e-01
|
0.11400
|
0.103000
|
0.049400
|
1.41e-01
|
4.79e-01
|
GOBP PROTEIN LOCALIZATION TO ORGANELLE
|
88
|
2.89e-01
|
5.22e-01
|
0.11300
|
-0.101000
|
0.052200
|
1.15e-01
|
4.14e-01
|
GOBP CELL CYCLE
|
114
|
2.02e-01
|
4.36e-01
|
0.11300
|
0.050100
|
-0.102000
|
3.78e-01
|
7.35e-02
|
GOBP NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS
|
9
|
8.19e-01
|
8.94e-01
|
0.11300
|
0.112000
|
-0.015500
|
5.62e-01
|
9.36e-01
|
GOBP NEGATIVE REGULATION OF CATABOLIC PROCESS
|
47
|
5.02e-01
|
6.97e-01
|
0.11300
|
0.101000
|
-0.050700
|
2.40e-01
|
5.55e-01
|
GOBP IMMUNE RESPONSE REGULATING SIGNALING PATHWAY
|
33
|
3.17e-01
|
5.51e-01
|
0.11300
|
0.103000
|
0.045800
|
3.11e-01
|
6.53e-01
|
GOBP CELL CYCLE PROCESS
|
86
|
1.44e-01
|
3.64e-01
|
0.11300
|
0.006960
|
-0.112000
|
9.14e-01
|
8.16e-02
|
GOBP POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION
|
10
|
6.88e-01
|
8.20e-01
|
0.11200
|
0.094700
|
0.060700
|
6.06e-01
|
7.41e-01
|
GOBP GLYCEROPHOSPHOLIPID BIOSYNTHETIC PROCESS
|
14
|
8.35e-01
|
9.04e-01
|
0.11200
|
-0.090400
|
0.066300
|
5.61e-01
|
6.69e-01
|
GOCC ORGANELLE SUBCOMPARTMENT
|
170
|
3.93e-03
|
4.64e-02
|
0.11200
|
-0.093000
|
-0.062600
|
5.13e-02
|
1.90e-01
|
GOBP PROTEIN TRANSPORT
|
135
|
2.28e-02
|
1.30e-01
|
0.11200
|
-0.026500
|
-0.109000
|
6.15e-01
|
3.93e-02
|
GOBP REGULATION OF RNA SPLICING
|
23
|
4.72e-01
|
6.79e-01
|
0.11200
|
0.106000
|
0.035800
|
3.84e-01
|
7.69e-01
|
GOBP INDOLE CONTAINING COMPOUND METABOLIC PROCESS
|
5
|
9.13e-01
|
9.57e-01
|
0.11100
|
-0.031400
|
0.107000
|
9.04e-01
|
6.80e-01
|
GOBP PEPTIDYL SERINE MODIFICATION
|
10
|
8.71e-01
|
9.28e-01
|
0.11100
|
0.055900
|
-0.096000
|
7.60e-01
|
6.01e-01
|
GOBP POSITIVE REGULATION OF TRANSFERASE ACTIVITY
|
14
|
8.40e-01
|
9.09e-01
|
0.11100
|
-0.087900
|
0.067300
|
5.71e-01
|
6.65e-01
|
GOBP REGULATION OF HEMOPOIESIS
|
29
|
5.88e-01
|
7.57e-01
|
0.11100
|
0.107000
|
-0.027200
|
3.24e-01
|
8.02e-01
|
GOBP NEGATIVE REGULATION OF DEFENSE RESPONSE
|
21
|
5.67e-01
|
7.41e-01
|
0.11100
|
0.110000
|
0.011700
|
3.88e-01
|
9.26e-01
|
GOBP NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS
|
7
|
9.02e-01
|
9.47e-01
|
0.11000
|
-0.099600
|
0.047700
|
6.49e-01
|
8.28e-01
|
GOCC CYTOPLASMIC SIDE OF MEMBRANE
|
20
|
7.50e-01
|
8.62e-01
|
0.11000
|
-0.098700
|
0.049300
|
4.49e-01
|
7.05e-01
|
GOBP ENDOTHELIUM DEVELOPMENT
|
11
|
7.09e-01
|
8.36e-01
|
0.11000
|
-0.106000
|
-0.030600
|
5.45e-01
|
8.61e-01
|
GOBP MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS
|
68
|
3.99e-01
|
6.20e-01
|
0.11000
|
-0.097800
|
0.050700
|
1.75e-01
|
4.82e-01
|
GOBP CELLULAR RESPONSE TO OXYGEN LEVELS
|
20
|
6.90e-01
|
8.21e-01
|
0.11000
|
-0.025200
|
0.107000
|
8.46e-01
|
4.12e-01
|
GOMF TRANSPORTER REGULATOR ACTIVITY
|
14
|
8.45e-01
|
9.11e-01
|
0.11000
|
-0.069700
|
0.084800
|
6.54e-01
|
5.85e-01
|
GOBP ODONTOGENESIS
|
10
|
7.71e-01
|
8.71e-01
|
0.11000
|
0.109000
|
0.007880
|
5.51e-01
|
9.66e-01
|
GOMF PROTEIN TYROSINE KINASE BINDING
|
10
|
8.84e-01
|
9.36e-01
|
0.11000
|
0.066000
|
-0.087600
|
7.19e-01
|
6.33e-01
|
GOMF SNARE BINDING
|
9
|
8.82e-01
|
9.33e-01
|
0.10900
|
0.097100
|
-0.050600
|
6.16e-01
|
7.93e-01
|
GOBP THYMUS DEVELOPMENT
|
8
|
8.97e-01
|
9.44e-01
|
0.10900
|
-0.054100
|
0.095200
|
7.92e-01
|
6.42e-01
|
GOBP CIRCULATORY SYSTEM DEVELOPMENT
|
89
|
3.13e-01
|
5.47e-01
|
0.10900
|
0.049600
|
-0.096900
|
4.35e-01
|
1.27e-01
|
GOCC METHYLTRANSFERASE COMPLEX
|
9
|
7.47e-01
|
8.61e-01
|
0.10800
|
-0.099100
|
-0.043200
|
6.08e-01
|
8.23e-01
|
GOCC CONDENSED CHROMOSOME
|
16
|
5.85e-01
|
7.53e-01
|
0.10800
|
-0.094600
|
-0.052100
|
5.15e-01
|
7.20e-01
|
GOCC APICAL JUNCTION COMPLEX
|
19
|
6.09e-01
|
7.70e-01
|
0.10800
|
0.107000
|
0.013500
|
4.24e-01
|
9.20e-01
|
GOBP MAINTENANCE OF CELL NUMBER
|
16
|
6.54e-01
|
7.99e-01
|
0.10700
|
-0.015600
|
-0.106000
|
9.15e-01
|
4.65e-01
|
GOBP REGULATION OF JNK CASCADE
|
14
|
6.59e-01
|
8.03e-01
|
0.10700
|
-0.102000
|
-0.031700
|
5.10e-01
|
8.38e-01
|
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE
|
7
|
8.73e-01
|
9.29e-01
|
0.10700
|
0.016800
|
-0.105000
|
9.39e-01
|
6.30e-01
|
GOBP PROTEIN TARGETING TO VACUOLE
|
7
|
8.73e-01
|
9.29e-01
|
0.10700
|
0.016800
|
-0.105000
|
9.39e-01
|
6.30e-01
|
GOBP PHOSPHORUS METABOLIC PROCESS
|
211
|
3.59e-03
|
4.44e-02
|
0.10700
|
0.096900
|
0.044400
|
2.64e-02
|
3.10e-01
|
GOBP L AMINO ACID TRANSPORT
|
11
|
8.09e-01
|
8.89e-01
|
0.10600
|
0.016400
|
-0.105000
|
9.25e-01
|
5.48e-01
|
GOBP RESPONSE TO VIRUS
|
29
|
5.95e-01
|
7.63e-01
|
0.10600
|
-0.104000
|
0.020500
|
3.39e-01
|
8.50e-01
|
GOMF SNORNA BINDING
|
5
|
8.67e-01
|
9.25e-01
|
0.10600
|
-0.102000
|
-0.027900
|
6.93e-01
|
9.14e-01
|
GOBP DNA REPLICATION
|
9
|
8.02e-01
|
8.84e-01
|
0.10600
|
-0.008740
|
-0.105000
|
9.64e-01
|
5.85e-01
|
GOBP SENSORY PERCEPTION
|
26
|
6.98e-01
|
8.27e-01
|
0.10600
|
0.042600
|
-0.096700
|
7.10e-01
|
3.98e-01
|
GOMF TUBULIN BINDING
|
22
|
6.59e-01
|
8.03e-01
|
0.10600
|
0.015500
|
-0.105000
|
9.01e-01
|
4.00e-01
|
GOBP HOMEOSTATIC PROCESS
|
169
|
2.95e-02
|
1.51e-01
|
0.10600
|
0.105000
|
0.006560
|
2.75e-02
|
8.91e-01
|
GOCC FLEMMING BODY
|
5
|
9.44e-01
|
9.72e-01
|
0.10600
|
0.061800
|
-0.085600
|
8.12e-01
|
7.41e-01
|
GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT
|
5
|
9.43e-01
|
9.72e-01
|
0.10600
|
-0.086300
|
0.060800
|
7.39e-01
|
8.14e-01
|
GOBP REGULATION OF ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME
|
7
|
8.81e-01
|
9.33e-01
|
0.10500
|
0.103000
|
-0.019900
|
6.37e-01
|
9.28e-01
|
GOBP DEFENSE RESPONSE TO VIRUS
|
15
|
8.17e-01
|
8.93e-01
|
0.10500
|
-0.044700
|
0.095200
|
7.66e-01
|
5.26e-01
|
GOBP CELL CELL JUNCTION ASSEMBLY
|
14
|
6.31e-01
|
7.86e-01
|
0.10500
|
0.061000
|
0.085500
|
6.94e-01
|
5.82e-01
|
GOBP POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS
|
67
|
1.19e-01
|
3.29e-01
|
0.10500
|
0.079800
|
0.067700
|
2.72e-01
|
3.51e-01
|
GOMF KINASE BINDING
|
64
|
5.17e-01
|
7.07e-01
|
0.10500
|
0.077400
|
-0.070400
|
2.97e-01
|
3.43e-01
|
GOBP MUSCLE CELL PROLIFERATION
|
22
|
7.01e-01
|
8.29e-01
|
0.10400
|
0.027300
|
-0.101000
|
8.26e-01
|
4.18e-01
|
GOMF LIPID TRANSPORTER ACTIVITY
|
23
|
6.15e-01
|
7.72e-01
|
0.10400
|
0.002670
|
-0.104000
|
9.83e-01
|
3.91e-01
|
GOBP ENDOCRINE SYSTEM DEVELOPMENT
|
10
|
7.20e-01
|
8.44e-01
|
0.10400
|
-0.065800
|
-0.080900
|
7.20e-01
|
6.59e-01
|
GOBP ENDOSOME TO LYSOSOME TRANSPORT
|
8
|
7.77e-01
|
8.74e-01
|
0.10400
|
-0.091200
|
-0.050500
|
6.56e-01
|
8.06e-01
|
GOBP REGULATION OF CELL CYCLE
|
80
|
4.21e-01
|
6.39e-01
|
0.10400
|
0.058000
|
-0.086500
|
3.85e-01
|
1.95e-01
|
GOCC ACETYLTRANSFERASE COMPLEX
|
10
|
8.48e-01
|
9.12e-01
|
0.10400
|
-0.024800
|
0.101000
|
8.93e-01
|
5.83e-01
|
GOBP MEIOTIC CELL CYCLE PROCESS
|
9
|
7.66e-01
|
8.70e-01
|
0.10400
|
-0.095800
|
-0.039700
|
6.20e-01
|
8.37e-01
|
GOBP REGULATION OF CELL CYCLE PHASE TRANSITION
|
28
|
7.47e-01
|
8.61e-01
|
0.10400
|
-0.071800
|
0.074800
|
5.16e-01
|
4.98e-01
|
GOBP POSITIVE REGULATION OF PHOSPHORYLATION
|
22
|
7.92e-01
|
8.80e-01
|
0.10300
|
0.063900
|
-0.080700
|
6.07e-01
|
5.16e-01
|
GOMF MRNA 3 UTR BINDING
|
15
|
6.51e-01
|
7.97e-01
|
0.10300
|
0.037500
|
0.095800
|
8.03e-01
|
5.24e-01
|
GOBP TISSUE MORPHOGENESIS
|
45
|
4.89e-01
|
6.89e-01
|
0.10300
|
0.023700
|
-0.099900
|
7.87e-01
|
2.55e-01
|
GOBP MITOTIC CELL CYCLE
|
69
|
4.97e-01
|
6.95e-01
|
0.10300
|
0.063500
|
-0.080700
|
3.75e-01
|
2.60e-01
|
GOBP DNA DAMAGE RESPONSE
|
75
|
4.65e-01
|
6.72e-01
|
0.10300
|
0.061200
|
-0.082300
|
3.74e-01
|
2.32e-01
|
GOBP MUSCLE TISSUE DEVELOPMENT
|
33
|
4.59e-01
|
6.70e-01
|
0.10200
|
-0.013600
|
-0.102000
|
8.94e-01
|
3.19e-01
|
GOMF LIPOPROTEIN PARTICLE RECEPTOR BINDING
|
7
|
8.77e-01
|
9.30e-01
|
0.10200
|
0.011000
|
-0.102000
|
9.60e-01
|
6.42e-01
|
GOMF LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR BINDING
|
7
|
8.77e-01
|
9.30e-01
|
0.10200
|
0.011000
|
-0.102000
|
9.60e-01
|
6.42e-01
|
GOBP CELLULAR RESPONSE TO RADIATION
|
13
|
8.15e-01
|
8.93e-01
|
0.10200
|
0.025600
|
-0.098900
|
8.74e-01
|
5.39e-01
|
GOBP HINDBRAIN DEVELOPMENT
|
16
|
7.12e-01
|
8.38e-01
|
0.10200
|
0.102000
|
0.002470
|
4.85e-01
|
9.86e-01
|
GOBP REGULATION OF BODY FLUID LEVELS
|
30
|
5.93e-01
|
7.61e-01
|
0.10200
|
0.101000
|
-0.014900
|
3.47e-01
|
8.89e-01
|
GOBP REGULATION OF IMMUNE SYSTEM PROCESS
|
97
|
3.25e-01
|
5.60e-01
|
0.10100
|
0.091500
|
-0.043700
|
1.34e-01
|
4.75e-01
|
GOBP RESPONSE TO OXIDATIVE STRESS
|
45
|
5.17e-01
|
7.07e-01
|
0.10100
|
-0.028100
|
0.097500
|
7.49e-01
|
2.67e-01
|
GOBP VIRAL GENE EXPRESSION
|
15
|
6.29e-01
|
7.85e-01
|
0.10100
|
-0.077800
|
-0.064800
|
6.05e-01
|
6.66e-01
|
GOBP HEMOPOIESIS
|
65
|
3.61e-01
|
5.89e-01
|
0.10100
|
0.098900
|
-0.020400
|
1.79e-01
|
7.82e-01
|
GOBP ERBB SIGNALING PATHWAY
|
14
|
8.01e-01
|
8.84e-01
|
0.10100
|
0.021900
|
-0.098200
|
8.88e-01
|
5.27e-01
|
GOCC CELL SUBSTRATE JUNCTION
|
60
|
3.60e-01
|
5.89e-01
|
0.10100
|
-0.012700
|
0.099700
|
8.69e-01
|
1.92e-01
|
GOBP REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY
|
12
|
7.80e-01
|
8.75e-01
|
0.10000
|
-0.002050
|
-0.100000
|
9.90e-01
|
5.49e-01
|
GOCC VACUOLE
|
85
|
2.68e-01
|
5.03e-01
|
0.10000
|
0.018400
|
-0.098500
|
7.77e-01
|
1.29e-01
|
GOBP POST EMBRYONIC DEVELOPMENT
|
13
|
7.24e-01
|
8.44e-01
|
0.10000
|
0.097400
|
0.023400
|
5.45e-01
|
8.85e-01
|
GOBP POSITIVE REGULATION OF KINASE ACTIVITY
|
12
|
8.89e-01
|
9.39e-01
|
0.10000
|
-0.072200
|
0.069400
|
6.67e-01
|
6.79e-01
|
GOBP NITROGEN COMPOUND TRANSPORT
|
177
|
3.96e-02
|
1.77e-01
|
0.10000
|
-0.004590
|
-0.099900
|
9.22e-01
|
3.33e-02
|
GOCC NUCLEAR ENVELOPE
|
52
|
2.18e-01
|
4.54e-01
|
0.09970
|
-0.073600
|
-0.067200
|
3.68e-01
|
4.12e-01
|
GOCC SPLICEOSOMAL COMPLEX
|
20
|
7.13e-01
|
8.38e-01
|
0.09970
|
0.098600
|
-0.014700
|
4.49e-01
|
9.10e-01
|
GOBP RESPONSE TO METAL ION
|
36
|
5.06e-01
|
7.00e-01
|
0.09930
|
0.099300
|
-0.002650
|
3.10e-01
|
9.78e-01
|
GOBP POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS
|
31
|
6.34e-01
|
7.89e-01
|
0.09930
|
0.024700
|
-0.096200
|
8.15e-01
|
3.60e-01
|
GOBP MONOATOMIC ION HOMEOSTASIS
|
59
|
4.59e-01
|
6.70e-01
|
0.09910
|
0.094100
|
-0.031200
|
2.22e-01
|
6.86e-01
|
GOBP TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY
|
14
|
8.62e-01
|
9.22e-01
|
0.09860
|
0.084200
|
-0.051300
|
5.88e-01
|
7.41e-01
|
GOBP TELOMERE ORGANIZATION
|
12
|
7.09e-01
|
8.36e-01
|
0.09860
|
-0.052900
|
-0.083300
|
7.53e-01
|
6.19e-01
|
GOMF GUANYL NUCLEOTIDE BINDING
|
51
|
4.58e-01
|
6.69e-01
|
0.09850
|
-0.096700
|
0.018700
|
2.42e-01
|
8.21e-01
|
GOBP MEMBRANELESS ORGANELLE ASSEMBLY
|
34
|
3.76e-01
|
5.97e-01
|
0.09850
|
0.077000
|
0.061400
|
4.43e-01
|
5.41e-01
|
GOBP CELLULAR RESPONSE TO METAL ION
|
20
|
5.61e-01
|
7.37e-01
|
0.09830
|
0.078600
|
0.059100
|
5.46e-01
|
6.50e-01
|
GOBP POSITIVE REGULATION OF CANONICAL NF KAPPAB SIGNAL TRANSDUCTION
|
20
|
8.16e-01
|
8.93e-01
|
0.09790
|
-0.081800
|
0.053700
|
5.30e-01
|
6.80e-01
|
GOBP NEGATIVE REGULATION OF CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY
|
7
|
8.16e-01
|
8.93e-01
|
0.09770
|
-0.064500
|
-0.073400
|
7.68e-01
|
7.38e-01
|
GOBP POSITIVE REGULATION OF CELL CYCLE
|
23
|
7.09e-01
|
8.36e-01
|
0.09770
|
0.020800
|
-0.095500
|
8.64e-01
|
4.33e-01
|
GOMF PROTEIN SERINE THREONINE KINASE ACTIVITY
|
50
|
5.66e-01
|
7.40e-01
|
0.09750
|
0.088900
|
-0.040000
|
2.87e-01
|
6.31e-01
|
GOBP SKELETAL MUSCLE ORGAN DEVELOPMENT
|
9
|
7.74e-01
|
8.73e-01
|
0.09740
|
-0.078700
|
-0.057400
|
6.84e-01
|
7.67e-01
|
GOBP CHEMOKINE PRODUCTION
|
7
|
9.27e-01
|
9.64e-01
|
0.09700
|
0.045600
|
-0.085600
|
8.35e-01
|
6.96e-01
|
GOBP PROTEIN DESTABILIZATION
|
8
|
8.65e-01
|
9.24e-01
|
0.09670
|
0.096600
|
-0.004100
|
6.37e-01
|
9.84e-01
|
GOBP MUSCLE STRUCTURE DEVELOPMENT
|
57
|
5.57e-01
|
7.34e-01
|
0.09660
|
0.046400
|
-0.084800
|
5.54e-01
|
2.79e-01
|
GOBP OLIGODENDROCYTE DIFFERENTIATION
|
7
|
9.15e-01
|
9.58e-01
|
0.09610
|
-0.090700
|
0.031600
|
6.79e-01
|
8.85e-01
|
GOBP NEGATIVE REGULATION OF MITOTIC CELL CYCLE
|
17
|
8.09e-01
|
8.89e-01
|
0.09590
|
0.032200
|
-0.090400
|
8.19e-01
|
5.22e-01
|
GOBP APOPTOTIC PROCESS
|
168
|
3.54e-02
|
1.64e-01
|
0.09540
|
0.092600
|
0.023200
|
5.36e-02
|
6.28e-01
|
GOBP DEFENSE RESPONSE TO OTHER ORGANISM
|
73
|
4.77e-01
|
6.82e-01
|
0.09540
|
-0.043600
|
0.084800
|
5.32e-01
|
2.24e-01
|
GOMF QUATERNARY AMMONIUM GROUP BINDING
|
5
|
8.73e-01
|
9.29e-01
|
0.09500
|
0.076100
|
0.056900
|
7.69e-01
|
8.26e-01
|
GOMF NUCLEOTIDYLTRANSFERASE ACTIVITY
|
12
|
7.23e-01
|
8.44e-01
|
0.09490
|
-0.056300
|
-0.076400
|
7.37e-01
|
6.49e-01
|
GOBP VESICLE MEDIATED TRANSPORT IN SYNAPSE
|
24
|
5.28e-01
|
7.14e-01
|
0.09490
|
-0.077300
|
-0.055000
|
5.16e-01
|
6.44e-01
|
GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION
|
45
|
6.49e-01
|
7.97e-01
|
0.09460
|
0.081200
|
-0.048600
|
3.55e-01
|
5.79e-01
|
GOBP POSITIVE REGULATION OF DNA RECOMBINATION
|
6
|
9.49e-01
|
9.74e-01
|
0.09430
|
0.069500
|
-0.063800
|
7.69e-01
|
7.87e-01
|
GOBP REGULATION OF DNA RECOMBINATION
|
6
|
9.49e-01
|
9.74e-01
|
0.09430
|
0.069500
|
-0.063800
|
7.69e-01
|
7.87e-01
|
GOBP MULTICELLULAR ORGANISMAL REPRODUCTIVE PROCESS
|
45
|
4.27e-01
|
6.43e-01
|
0.09430
|
-0.007770
|
-0.094000
|
9.29e-01
|
2.84e-01
|
GOCC CYTOPLASMIC SIDE OF PLASMA MEMBRANE
|
16
|
7.75e-01
|
8.73e-01
|
0.09430
|
-0.093800
|
0.009790
|
5.19e-01
|
9.46e-01
|
GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR
|
9
|
7.91e-01
|
8.80e-01
|
0.09420
|
-0.049000
|
-0.080500
|
8.00e-01
|
6.77e-01
|
GOBP BLOOD VESSEL MORPHOGENESIS
|
48
|
6.66e-01
|
8.07e-01
|
0.09400
|
0.062100
|
-0.070600
|
4.65e-01
|
4.07e-01
|
GOBP SENSORY PERCEPTION OF PAIN
|
5
|
8.94e-01
|
9.43e-01
|
0.09400
|
-0.090800
|
-0.024200
|
7.26e-01
|
9.26e-01
|
GOBP REGULATION OF NEURON DIFFERENTIATION
|
12
|
8.41e-01
|
9.09e-01
|
0.09400
|
0.092300
|
-0.017700
|
5.82e-01
|
9.16e-01
|
GOBP MORPHOGENESIS OF A POLARIZED EPITHELIUM
|
9
|
8.20e-01
|
8.95e-01
|
0.09380
|
0.090900
|
0.023100
|
6.38e-01
|
9.05e-01
|
GOBP GLYCEROLIPID BIOSYNTHETIC PROCESS
|
19
|
7.48e-01
|
8.61e-01
|
0.09340
|
0.092600
|
-0.011500
|
4.88e-01
|
9.32e-01
|
GOBP CELL CYCLE CHECKPOINT SIGNALING
|
13
|
8.47e-01
|
9.12e-01
|
0.09310
|
0.089700
|
-0.024900
|
5.78e-01
|
8.77e-01
|
GOBP REGULATION OF MRNA CATABOLIC PROCESS
|
20
|
5.96e-01
|
7.64e-01
|
0.09260
|
0.068700
|
0.062100
|
5.98e-01
|
6.34e-01
|
GOBP VESICLE ORGANIZATION
|
31
|
4.56e-01
|
6.69e-01
|
0.09240
|
-0.073100
|
-0.056500
|
4.87e-01
|
5.91e-01
|
GOBP ESTABLISHMENT OF RNA LOCALIZATION
|
13
|
7.20e-01
|
8.44e-01
|
0.09220
|
-0.051900
|
-0.076200
|
7.48e-01
|
6.36e-01
|
GOBP TERPENOID METABOLIC PROCESS
|
12
|
7.35e-01
|
8.53e-01
|
0.09190
|
-0.068500
|
-0.061400
|
6.83e-01
|
7.14e-01
|
GOBP PROTEIN POLYUBIQUITINATION
|
27
|
6.79e-01
|
8.14e-01
|
0.09190
|
0.091000
|
-0.013200
|
4.19e-01
|
9.06e-01
|
GOBP PROTEIN MONOUBIQUITINATION
|
5
|
9.59e-01
|
9.78e-01
|
0.09160
|
-0.067600
|
0.061800
|
7.94e-01
|
8.12e-01
|
GOMF ENDONUCLEASE ACTIVITY
|
6
|
9.15e-01
|
9.58e-01
|
0.09140
|
-0.010600
|
0.090800
|
9.64e-01
|
7.01e-01
|
GOMF PHOSPHOPROTEIN BINDING
|
10
|
9.04e-01
|
9.49e-01
|
0.09130
|
-0.082200
|
0.039700
|
6.54e-01
|
8.29e-01
|
GOBP SMOOTH MUSCLE CELL PROLIFERATION
|
16
|
7.21e-01
|
8.44e-01
|
0.09100
|
-0.088400
|
-0.021300
|
5.43e-01
|
8.83e-01
|
GOBP MITOTIC SISTER CHROMATID SEGREGATION
|
16
|
6.87e-01
|
8.19e-01
|
0.09060
|
-0.042800
|
-0.079900
|
7.69e-01
|
5.83e-01
|
GOBP NEGATIVE REGULATION OF CELL CYCLE
|
23
|
7.53e-01
|
8.64e-01
|
0.09050
|
0.022400
|
-0.087700
|
8.54e-01
|
4.71e-01
|
GOBP ENDOTHELIAL CELL MIGRATION
|
15
|
8.46e-01
|
9.12e-01
|
0.09010
|
0.029100
|
-0.085200
|
8.46e-01
|
5.70e-01
|
GOMF PHOSPHATASE BINDING
|
16
|
7.58e-01
|
8.65e-01
|
0.09000
|
-0.089800
|
-0.006080
|
5.37e-01
|
9.67e-01
|
GOBP POSITIVE REGULATION OF PHAGOCYTOSIS
|
8
|
9.32e-01
|
9.66e-01
|
0.08950
|
0.076800
|
-0.046100
|
7.08e-01
|
8.22e-01
|
GOBP NUCLEIC ACID CATABOLIC PROCESS
|
29
|
5.68e-01
|
7.42e-01
|
0.08930
|
0.086900
|
0.020700
|
4.24e-01
|
8.49e-01
|
GOBP VIRAL LIFE CYCLE
|
34
|
7.01e-01
|
8.29e-01
|
0.08930
|
0.031400
|
-0.083600
|
7.55e-01
|
4.05e-01
|
GOBP WOUND HEALING
|
42
|
4.53e-01
|
6.67e-01
|
0.08890
|
-0.019100
|
-0.086800
|
8.33e-01
|
3.39e-01
|
GOBP DEVELOPMENTAL MATURATION
|
16
|
7.23e-01
|
8.44e-01
|
0.08880
|
0.085100
|
0.025400
|
5.58e-01
|
8.62e-01
|
GOBP HORMONE BIOSYNTHETIC PROCESS
|
7
|
8.48e-01
|
9.12e-01
|
0.08880
|
0.050300
|
0.073200
|
8.19e-01
|
7.38e-01
|
GOBP POSITIVE REGULATION OF DNA METABOLIC PROCESS
|
20
|
6.65e-01
|
8.07e-01
|
0.08860
|
-0.027300
|
-0.084300
|
8.34e-01
|
5.18e-01
|
GOBP ORGANELLE ASSEMBLY
|
82
|
5.52e-01
|
7.33e-01
|
0.08860
|
0.061300
|
-0.063900
|
3.53e-01
|
3.33e-01
|
GOBP CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY
|
14
|
7.67e-01
|
8.70e-01
|
0.08800
|
0.019400
|
0.085800
|
9.01e-01
|
5.81e-01
|
GOBP NOTCH SIGNALING PATHWAY
|
8
|
9.22e-01
|
9.61e-01
|
0.08770
|
0.081900
|
-0.031300
|
6.90e-01
|
8.79e-01
|
GOBP LIPID BIOSYNTHETIC PROCESS
|
79
|
5.36e-01
|
7.20e-01
|
0.08770
|
-0.074600
|
0.046100
|
2.67e-01
|
4.93e-01
|
GOBP EMBRYONIC PLACENTA DEVELOPMENT
|
12
|
8.32e-01
|
9.02e-01
|
0.08750
|
-0.087500
|
0.000274
|
6.02e-01
|
9.99e-01
|
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION
|
158
|
5.71e-02
|
2.17e-01
|
0.08740
|
-0.030500
|
-0.081900
|
5.35e-01
|
9.60e-02
|
GOBP NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION
|
5
|
9.03e-01
|
9.48e-01
|
0.08720
|
-0.082200
|
-0.029200
|
7.51e-01
|
9.10e-01
|
GOBP EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING
|
54
|
3.65e-01
|
5.91e-01
|
0.08680
|
-0.024300
|
-0.083300
|
7.62e-01
|
3.00e-01
|
GOBP PROTEIN LOCALIZATION TO LYSOSOME
|
8
|
8.32e-01
|
9.02e-01
|
0.08670
|
-0.061400
|
-0.061200
|
7.64e-01
|
7.65e-01
|
GOBP CHROMOSOME ORGANIZATION
|
37
|
4.71e-01
|
6.78e-01
|
0.08660
|
-0.034600
|
-0.079400
|
7.20e-01
|
4.11e-01
|
GOBP POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS
|
48
|
4.58e-01
|
6.69e-01
|
0.08660
|
-0.009560
|
-0.086000
|
9.11e-01
|
3.12e-01
|
GOBP MORPHOGENESIS OF AN EPITHELIUM
|
35
|
7.41e-01
|
8.56e-01
|
0.08650
|
0.039800
|
-0.076800
|
6.88e-01
|
4.39e-01
|
GOBP EPIDERMIS DEVELOPMENT
|
24
|
6.11e-01
|
7.70e-01
|
0.08620
|
-0.035600
|
-0.078500
|
7.65e-01
|
5.10e-01
|
GOBP PRIMARY ALCOHOL METABOLIC PROCESS
|
12
|
8.73e-01
|
9.29e-01
|
0.08590
|
-0.020500
|
0.083400
|
9.02e-01
|
6.19e-01
|
GOBP REGULATION OF CELL CYCLE PROCESS
|
54
|
3.74e-01
|
5.95e-01
|
0.08590
|
-0.023700
|
-0.082500
|
7.68e-01
|
3.05e-01
|
GOBP EMBRYO DEVELOPMENT
|
85
|
5.06e-01
|
7.00e-01
|
0.08570
|
0.040000
|
-0.075800
|
5.38e-01
|
2.43e-01
|
GOBP MUSCLE CELL DIFFERENTIATION
|
30
|
5.98e-01
|
7.65e-01
|
0.08560
|
-0.015100
|
-0.084200
|
8.87e-01
|
4.30e-01
|
GOBP SECONDARY METABOLIC PROCESS
|
6
|
8.90e-01
|
9.39e-01
|
0.08540
|
0.080700
|
0.028100
|
7.33e-01
|
9.06e-01
|
GOMF MOLECULAR ADAPTOR ACTIVITY
|
134
|
3.67e-01
|
5.92e-01
|
0.08530
|
0.040900
|
-0.074800
|
4.39e-01
|
1.57e-01
|
GOBP RESPONSE TO CARBOHYDRATE
|
26
|
8.23e-01
|
8.97e-01
|
0.08480
|
0.070100
|
-0.047800
|
5.41e-01
|
6.77e-01
|
GOBP MUSCLE SYSTEM PROCESS
|
29
|
8.14e-01
|
8.92e-01
|
0.08410
|
0.067200
|
-0.050600
|
5.36e-01
|
6.41e-01
|
GOCC SYNAPSE
|
156
|
3.79e-01
|
6.00e-01
|
0.08380
|
0.065400
|
-0.052400
|
1.87e-01
|
2.90e-01
|
GOBP POSITIVE REGULATION OF JNK CASCADE
|
6
|
8.79e-01
|
9.33e-01
|
0.08370
|
-0.056400
|
-0.061900
|
8.11e-01
|
7.94e-01
|
GOBP RESPONSE TO NITROGEN COMPOUND
|
109
|
3.77e-01
|
5.98e-01
|
0.08360
|
0.079300
|
-0.026500
|
1.71e-01
|
6.47e-01
|
GOBP GLYCEROPHOSPHOLIPID METABOLIC PROCESS
|
25
|
5.93e-01
|
7.60e-01
|
0.08360
|
-0.053900
|
-0.063900
|
6.44e-01
|
5.85e-01
|
GOBP REGULATION OF LEUKOCYTE DIFFERENTIATION
|
22
|
6.54e-01
|
7.99e-01
|
0.08300
|
-0.074600
|
-0.036400
|
5.48e-01
|
7.70e-01
|
GOMF MICROTUBULE BINDING
|
15
|
7.39e-01
|
8.54e-01
|
0.08300
|
-0.043800
|
-0.070500
|
7.70e-01
|
6.39e-01
|
GOCC CULLIN RING UBIQUITIN LIGASE COMPLEX
|
12
|
8.17e-01
|
8.93e-01
|
0.08260
|
0.019000
|
0.080400
|
9.10e-01
|
6.32e-01
|
GOBP CHAPERONE MEDIATED PROTEIN FOLDING
|
7
|
9.35e-01
|
9.68e-01
|
0.08240
|
-0.078600
|
0.024800
|
7.20e-01
|
9.10e-01
|
GOBP CYTOKINE PRODUCTION
|
48
|
6.53e-01
|
7.99e-01
|
0.08240
|
0.077400
|
-0.028300
|
3.63e-01
|
7.40e-01
|
GOMF ACYLTRANSFERASE ACTIVITY
|
68
|
4.83e-01
|
6.86e-01
|
0.08230
|
0.081000
|
-0.014300
|
2.61e-01
|
8.43e-01
|
GOBP STRIATED MUSCLE CELL DIFFERENTIATION
|
21
|
6.87e-01
|
8.19e-01
|
0.08200
|
-0.028100
|
-0.077000
|
8.25e-01
|
5.45e-01
|
GOBP ACTIVATION OF IMMUNE RESPONSE
|
37
|
5.18e-01
|
7.07e-01
|
0.08190
|
0.076300
|
0.029700
|
4.29e-01
|
7.58e-01
|
GOBP CILIUM MOVEMENT
|
10
|
8.32e-01
|
9.02e-01
|
0.08160
|
0.075000
|
0.032200
|
6.83e-01
|
8.61e-01
|
GOBP CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY
|
10
|
8.32e-01
|
9.02e-01
|
0.08160
|
0.075000
|
0.032200
|
6.83e-01
|
8.61e-01
|
GOBP REPRODUCTIVE PROCESS
|
79
|
6.11e-01
|
7.70e-01
|
0.08100
|
0.050500
|
-0.063300
|
4.53e-01
|
3.46e-01
|
GOBP SMOOTH MUSCLE CONTRACTION
|
6
|
9.32e-01
|
9.66e-01
|
0.08090
|
-0.008990
|
0.080400
|
9.70e-01
|
7.34e-01
|
GOBP TRANSLATIONAL ELONGATION
|
11
|
8.32e-01
|
9.02e-01
|
0.08050
|
0.023300
|
0.077000
|
8.94e-01
|
6.60e-01
|
GOBP CELLULAR RESPONSE TO OXIDATIVE STRESS
|
27
|
7.71e-01
|
8.71e-01
|
0.08030
|
-0.077700
|
0.019900
|
4.89e-01
|
8.59e-01
|
GOCC ENDOPLASMIC RETICULUM GOLGI INTERMEDIATE COMPARTMENT MEMBRANE
|
10
|
8.69e-01
|
9.26e-01
|
0.07980
|
-0.079400
|
-0.007710
|
6.65e-01
|
9.66e-01
|
GOBP POSITIVE REGULATION OF TORC1 SIGNALING
|
9
|
9.42e-01
|
9.71e-01
|
0.07970
|
0.045000
|
-0.065800
|
8.16e-01
|
7.34e-01
|
GOBP REGULATION OF CELL CYCLE G1 S PHASE TRANSITION
|
15
|
7.86e-01
|
8.77e-01
|
0.07960
|
-0.076800
|
-0.021000
|
6.09e-01
|
8.89e-01
|
GOMF SIGNALING ADAPTOR ACTIVITY
|
10
|
8.61e-01
|
9.22e-01
|
0.07960
|
0.078400
|
0.013500
|
6.69e-01
|
9.42e-01
|
GOBP PHAGOCYTOSIS
|
16
|
7.38e-01
|
8.54e-01
|
0.07930
|
-0.052600
|
-0.059400
|
7.18e-01
|
6.83e-01
|
GOCC PHAGOPHORE ASSEMBLY SITE
|
5
|
9.24e-01
|
9.62e-01
|
0.07910
|
-0.076500
|
-0.020300
|
7.68e-01
|
9.38e-01
|
GOBP MALE GAMETE GENERATION
|
29
|
8.32e-01
|
9.02e-01
|
0.07910
|
-0.064000
|
0.046500
|
5.56e-01
|
6.69e-01
|
GOBP CYTOKINE MEDIATED SIGNALING PATHWAY
|
31
|
8.22e-01
|
8.96e-01
|
0.07910
|
0.047000
|
-0.063600
|
6.55e-01
|
5.45e-01
|
GOBP PROTEIN CATABOLIC PROCESS
|
117
|
3.45e-01
|
5.76e-01
|
0.07860
|
-0.077100
|
0.015700
|
1.70e-01
|
7.80e-01
|
GOBP REGULATION OF TUBE SIZE
|
15
|
8.57e-01
|
9.19e-01
|
0.07850
|
0.013000
|
-0.077400
|
9.31e-01
|
6.06e-01
|
GOBP POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS
|
5
|
9.18e-01
|
9.59e-01
|
0.07840
|
0.031400
|
0.071900
|
9.04e-01
|
7.81e-01
|
GOBP BIOLOGICAL PROCESS INVOLVED IN INTERSPECIES INTERACTION BETWEEN ORGANISMS
|
130
|
4.21e-01
|
6.39e-01
|
0.07830
|
-0.034300
|
0.070400
|
5.22e-01
|
1.89e-01
|
GOMF ATP DEPENDENT ACTIVITY
|
48
|
4.36e-01
|
6.52e-01
|
0.07830
|
-0.039400
|
-0.067600
|
6.43e-01
|
4.27e-01
|
GOBP ACTIVATION OF INNATE IMMUNE RESPONSE
|
27
|
8.28e-01
|
9.01e-01
|
0.07820
|
-0.069200
|
0.036400
|
5.38e-01
|
7.46e-01
|
GOBP REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION
|
23
|
6.74e-01
|
8.12e-01
|
0.07780
|
-0.036400
|
-0.068700
|
7.65e-01
|
5.72e-01
|
GOBP POSITIVE REGULATION OF CELL POPULATION PROLIFERATION
|
61
|
5.68e-01
|
7.42e-01
|
0.07720
|
0.075700
|
-0.015000
|
3.18e-01
|
8.43e-01
|
GOBP REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION
|
5
|
9.41e-01
|
9.71e-01
|
0.07710
|
-0.000654
|
-0.077100
|
9.98e-01
|
7.66e-01
|
GOBP MACROPHAGE CHEMOTAXIS
|
5
|
9.54e-01
|
9.76e-01
|
0.07710
|
0.075200
|
-0.017000
|
7.72e-01
|
9.48e-01
|
GOMF PEPTIDASE ACTIVITY
|
47
|
6.24e-01
|
7.82e-01
|
0.07660
|
0.009470
|
-0.076000
|
9.12e-01
|
3.77e-01
|
GOBP SINGLE FERTILIZATION
|
5
|
9.19e-01
|
9.60e-01
|
0.07650
|
0.035600
|
0.067600
|
8.91e-01
|
7.94e-01
|
GOBP REGULATION OF LYMPHOCYTE DIFFERENTIATION
|
14
|
8.30e-01
|
9.02e-01
|
0.07620
|
0.010500
|
0.075500
|
9.46e-01
|
6.27e-01
|
GOBP VIRAL PROCESS
|
50
|
4.84e-01
|
6.86e-01
|
0.07620
|
-0.021800
|
-0.073000
|
7.94e-01
|
3.82e-01
|
GOCC EXTRINSIC COMPONENT OF MEMBRANE
|
18
|
8.81e-01
|
9.33e-01
|
0.07560
|
-0.031300
|
0.068800
|
8.20e-01
|
6.16e-01
|
GOBP NUCLEAR CHROMOSOME SEGREGATION
|
24
|
7.43e-01
|
8.58e-01
|
0.07560
|
-0.006430
|
-0.075300
|
9.57e-01
|
5.27e-01
|
GOBP CARBOHYDRATE CATABOLIC PROCESS
|
26
|
8.13e-01
|
8.92e-01
|
0.07530
|
0.022600
|
-0.071800
|
8.43e-01
|
5.31e-01
|
GOBP REGULATION OF RESPONSE TO BIOTIC STIMULUS
|
42
|
7.95e-01
|
8.81e-01
|
0.07470
|
0.046400
|
-0.058500
|
6.09e-01
|
5.19e-01
|
GOBP VESICLE LOCALIZATION
|
11
|
8.86e-01
|
9.37e-01
|
0.07420
|
-0.074200
|
0.000597
|
6.72e-01
|
9.97e-01
|
GOMF MONOSACCHARIDE BINDING
|
8
|
9.52e-01
|
9.76e-01
|
0.07320
|
0.064500
|
-0.034600
|
7.53e-01
|
8.66e-01
|
GOMF HYDROLASE ACTIVITY ACTING ON ESTER BONDS
|
74
|
6.22e-01
|
7.80e-01
|
0.07270
|
0.027900
|
-0.067100
|
6.88e-01
|
3.33e-01
|
GOBP REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION
|
8
|
9.52e-01
|
9.76e-01
|
0.07260
|
0.034200
|
-0.064100
|
8.68e-01
|
7.55e-01
|
GOBP LEUKOCYTE DIFFERENTIATION
|
39
|
8.21e-01
|
8.96e-01
|
0.07260
|
0.049800
|
-0.052800
|
5.96e-01
|
5.74e-01
|
GOBP REGULATION OF NEURON APOPTOTIC PROCESS
|
26
|
7.54e-01
|
8.64e-01
|
0.07260
|
0.072600
|
0.002370
|
5.26e-01
|
9.84e-01
|
GOCC NUCLEAR PROTEIN CONTAINING COMPLEX
|
100
|
3.42e-01
|
5.76e-01
|
0.07250
|
-0.006420
|
-0.072200
|
9.15e-01
|
2.31e-01
|
GOBP GAMETE GENERATION
|
38
|
5.99e-01
|
7.66e-01
|
0.07200
|
-0.067800
|
-0.024000
|
4.76e-01
|
8.01e-01
|
GOMF CYSTEINE TYPE DEUBIQUITINASE ACTIVITY
|
7
|
8.97e-01
|
9.43e-01
|
0.07180
|
0.044400
|
0.056300
|
8.39e-01
|
7.97e-01
|
GOBP RETINOL METABOLIC PROCESS
|
7
|
9.64e-01
|
9.79e-01
|
0.07140
|
0.056800
|
-0.043300
|
7.95e-01
|
8.43e-01
|
GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION
|
24
|
8.72e-01
|
9.28e-01
|
0.07120
|
0.034300
|
-0.062400
|
7.73e-01
|
6.01e-01
|
GOBP REGULATION OF DNA METABOLIC PROCESS
|
36
|
7.82e-01
|
8.75e-01
|
0.07090
|
0.022800
|
-0.067200
|
8.15e-01
|
4.92e-01
|
GOCC EXOCYTIC VESICLE
|
13
|
8.51e-01
|
9.13e-01
|
0.07040
|
-0.068200
|
-0.017600
|
6.72e-01
|
9.13e-01
|
GOMF TRANSLATION REGULATOR ACTIVITY
|
9
|
9.52e-01
|
9.76e-01
|
0.07020
|
-0.036300
|
0.060000
|
8.51e-01
|
7.56e-01
|
GOMF ADENYL NUCLEOTIDE BINDING
|
144
|
4.07e-01
|
6.26e-01
|
0.06980
|
-0.066800
|
0.020300
|
1.93e-01
|
6.91e-01
|
GOBP EMBRYONIC ORGAN DEVELOPMENT
|
28
|
7.70e-01
|
8.71e-01
|
0.06960
|
0.002020
|
-0.069500
|
9.85e-01
|
5.29e-01
|
GOBP RESPONSE TO XENOBIOTIC STIMULUS
|
51
|
6.04e-01
|
7.69e-01
|
0.06930
|
0.003880
|
0.069200
|
9.63e-01
|
4.03e-01
|
GOMF NUCLEAR ANDROGEN RECEPTOR BINDING
|
6
|
9.65e-01
|
9.79e-01
|
0.06870
|
-0.028100
|
0.062700
|
9.06e-01
|
7.91e-01
|
GOBP POSITIVE REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION
|
8
|
9.61e-01
|
9.79e-01
|
0.06840
|
0.037100
|
-0.057500
|
8.57e-01
|
7.79e-01
|
GOMF PHOSPHATIDYLINOSITOL BISPHOSPHATE BINDING
|
8
|
9.47e-01
|
9.73e-01
|
0.06820
|
0.018700
|
-0.065600
|
9.27e-01
|
7.49e-01
|
GOBP SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE
|
17
|
8.82e-01
|
9.33e-01
|
0.06790
|
0.013500
|
-0.066600
|
9.24e-01
|
6.37e-01
|
GOBP FERTILIZATION
|
8
|
9.46e-01
|
9.73e-01
|
0.06770
|
0.065500
|
-0.017200
|
7.49e-01
|
9.33e-01
|
GOBP CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT
|
8
|
9.46e-01
|
9.73e-01
|
0.06710
|
0.065300
|
-0.015600
|
7.50e-01
|
9.39e-01
|
GOMF DAMAGED DNA BINDING
|
5
|
9.34e-01
|
9.67e-01
|
0.06710
|
-0.052900
|
-0.041200
|
8.38e-01
|
8.74e-01
|
GOBP CELLULAR RESPONSE TO LIGHT STIMULUS
|
8
|
9.01e-01
|
9.47e-01
|
0.06690
|
0.032800
|
0.058400
|
8.73e-01
|
7.76e-01
|
GOBP CELLULAR RESPONSE TO UV
|
8
|
9.01e-01
|
9.47e-01
|
0.06690
|
0.032800
|
0.058400
|
8.73e-01
|
7.76e-01
|
GOBP NEGATIVE REGULATION OF CHEMOKINE PRODUCTION
|
5
|
9.63e-01
|
9.79e-01
|
0.06610
|
0.065400
|
-0.009800
|
8.01e-01
|
9.70e-01
|
GOBP REGULATION OF AUTOPHAGY
|
44
|
5.68e-01
|
7.42e-01
|
0.06610
|
-0.051400
|
-0.041600
|
5.63e-01
|
6.39e-01
|
GOBP MUSCLE CONTRACTION
|
18
|
8.70e-01
|
9.28e-01
|
0.06580
|
0.007110
|
-0.065500
|
9.59e-01
|
6.33e-01
|
GOBP SKIN DEVELOPMENT
|
19
|
7.95e-01
|
8.81e-01
|
0.06580
|
-0.059700
|
-0.027800
|
6.55e-01
|
8.35e-01
|
GOMF PHOSPHATASE INHIBITOR ACTIVITY
|
7
|
9.20e-01
|
9.60e-01
|
0.06570
|
-0.025000
|
-0.060800
|
9.09e-01
|
7.81e-01
|
GOBP POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS
|
77
|
5.61e-01
|
7.37e-01
|
0.06560
|
0.005500
|
-0.065400
|
9.36e-01
|
3.36e-01
|
GOBP POSITIVE REGULATION OF MOLECULAR FUNCTION
|
48
|
7.87e-01
|
8.77e-01
|
0.06550
|
0.058800
|
-0.028600
|
4.89e-01
|
7.36e-01
|
GOBP REGULATION OF MUSCLE CELL DIFFERENTIATION
|
13
|
8.49e-01
|
9.12e-01
|
0.06510
|
-0.053300
|
-0.037400
|
7.41e-01
|
8.16e-01
|
GOBP RESPONSE TO WOUNDING
|
56
|
5.29e-01
|
7.14e-01
|
0.06510
|
-0.059300
|
-0.026800
|
4.53e-01
|
7.35e-01
|
GOBP NEGATIVE REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION
|
10
|
8.87e-01
|
9.37e-01
|
0.06490
|
-0.057800
|
-0.029700
|
7.53e-01
|
8.71e-01
|
GOBP CELL DIVISION
|
52
|
5.56e-01
|
7.34e-01
|
0.06490
|
-0.025900
|
-0.059500
|
7.52e-01
|
4.67e-01
|
GOCC TRANSFERASE COMPLEX TRANSFERRING PHOSPHORUS CONTAINING GROUPS
|
20
|
8.95e-01
|
9.43e-01
|
0.06480
|
0.060600
|
-0.022800
|
6.42e-01
|
8.61e-01
|
GOBP HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS
|
5
|
9.80e-01
|
9.88e-01
|
0.06430
|
-0.042800
|
0.048000
|
8.69e-01
|
8.53e-01
|
GOBP AMINO SUGAR METABOLIC PROCESS
|
5
|
9.56e-01
|
9.77e-01
|
0.06420
|
0.004250
|
0.064100
|
9.87e-01
|
8.05e-01
|
GOBP TORC1 SIGNALING
|
13
|
9.30e-01
|
9.66e-01
|
0.06420
|
0.021800
|
-0.060300
|
8.93e-01
|
7.08e-01
|
GOBP CELL MATURATION
|
5
|
9.40e-01
|
9.71e-01
|
0.06390
|
0.042800
|
0.047400
|
8.69e-01
|
8.55e-01
|
GOBP REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY
|
12
|
9.42e-01
|
9.71e-01
|
0.06380
|
-0.057900
|
0.026700
|
7.30e-01
|
8.73e-01
|
GOBP REGULATION OF DEFENSE RESPONSE
|
56
|
7.94e-01
|
8.81e-01
|
0.06370
|
0.052800
|
-0.035700
|
5.04e-01
|
6.51e-01
|
GOBP TEMPERATURE HOMEOSTASIS
|
18
|
8.07e-01
|
8.87e-01
|
0.06370
|
0.053800
|
0.034200
|
6.95e-01
|
8.03e-01
|
GOBP PROTEIN K48 LINKED UBIQUITINATION
|
16
|
9.37e-01
|
9.69e-01
|
0.06350
|
0.039000
|
-0.050200
|
7.89e-01
|
7.30e-01
|
GOBP MITOTIC CELL CYCLE PHASE TRANSITION
|
29
|
8.93e-01
|
9.42e-01
|
0.06350
|
-0.046900
|
0.042800
|
6.66e-01
|
6.93e-01
|
GOBP REGULATION OF ENDOTHELIAL CELL MIGRATION
|
12
|
9.47e-01
|
9.73e-01
|
0.06330
|
0.030800
|
-0.055300
|
8.54e-01
|
7.41e-01
|
GOBP SISTER CHROMATID SEGREGATION
|
20
|
8.00e-01
|
8.84e-01
|
0.06320
|
-0.027000
|
-0.057200
|
8.36e-01
|
6.61e-01
|
GOBP REGULATION OF VACUOLE ORGANIZATION
|
7
|
9.20e-01
|
9.60e-01
|
0.06280
|
-0.036900
|
-0.050700
|
8.66e-01
|
8.17e-01
|
GOBP LAMELLIPODIUM ORGANIZATION
|
6
|
9.64e-01
|
9.79e-01
|
0.06250
|
0.014700
|
-0.060800
|
9.50e-01
|
7.97e-01
|
GOBP REGULATION OF LAMELLIPODIUM ORGANIZATION
|
6
|
9.64e-01
|
9.79e-01
|
0.06250
|
0.014700
|
-0.060800
|
9.50e-01
|
7.97e-01
|
GOBP MEIOSIS I CELL CYCLE PROCESS
|
6
|
9.42e-01
|
9.71e-01
|
0.06230
|
-0.059700
|
-0.017700
|
8.01e-01
|
9.40e-01
|
GOBP HEMOSTASIS
|
19
|
9.24e-01
|
9.62e-01
|
0.06210
|
-0.052600
|
0.033000
|
6.94e-01
|
8.05e-01
|
GOMF EXOGENOUS PROTEIN BINDING
|
7
|
9.55e-01
|
9.76e-01
|
0.06200
|
-0.061300
|
0.009350
|
7.80e-01
|
9.66e-01
|
GOBP REGULATION OF HORMONE LEVELS
|
41
|
8.47e-01
|
9.12e-01
|
0.06180
|
0.032800
|
-0.052400
|
7.20e-01
|
5.68e-01
|
GOMF ORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY
|
9
|
9.63e-01
|
9.79e-01
|
0.06140
|
0.031300
|
-0.052800
|
8.71e-01
|
7.85e-01
|
GOBP REGULATORY NCRNA MEDIATED GENE SILENCING
|
9
|
9.15e-01
|
9.58e-01
|
0.06140
|
0.058500
|
0.018600
|
7.62e-01
|
9.23e-01
|
GOMF PROTEIN DOMAIN SPECIFIC BINDING
|
60
|
7.32e-01
|
8.52e-01
|
0.06110
|
0.017300
|
-0.058600
|
8.22e-01
|
4.44e-01
|
GOBP PHOSPHOLIPID METABOLIC PROCESS
|
37
|
6.85e-01
|
8.18e-01
|
0.06070
|
-0.054200
|
-0.027300
|
5.74e-01
|
7.78e-01
|
GOBP REGULATION OF INSULIN RECEPTOR SIGNALING PATHWAY
|
9
|
9.66e-01
|
9.80e-01
|
0.05970
|
0.050600
|
-0.031700
|
7.93e-01
|
8.70e-01
|
GOBP REGULATION OF PROGRAMMED CELL DEATH
|
131
|
3.25e-01
|
5.60e-01
|
0.05950
|
0.055700
|
0.020700
|
2.97e-01
|
6.98e-01
|
GOBP RESPONSE TO RADIATION
|
37
|
8.76e-01
|
9.30e-01
|
0.05940
|
-0.048300
|
0.034500
|
6.16e-01
|
7.21e-01
|
GOBP KETONE BIOSYNTHETIC PROCESS
|
9
|
9.49e-01
|
9.74e-01
|
0.05920
|
-0.010400
|
0.058300
|
9.57e-01
|
7.63e-01
|
GOBP ENDOPLASMIC RETICULUM ORGANIZATION
|
12
|
9.59e-01
|
9.78e-01
|
0.05910
|
0.037500
|
-0.045600
|
8.23e-01
|
7.86e-01
|
GOBP MULTI MULTICELLULAR ORGANISM PROCESS
|
20
|
9.33e-01
|
9.67e-01
|
0.05890
|
0.046300
|
-0.036400
|
7.22e-01
|
7.80e-01
|
GOBP POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS
|
9
|
9.55e-01
|
9.76e-01
|
0.05880
|
0.056600
|
-0.015700
|
7.70e-01
|
9.35e-01
|
GOBP CELLULAR RESPONSE TO STRESS
|
184
|
2.27e-01
|
4.61e-01
|
0.05870
|
-0.021700
|
-0.054500
|
6.38e-01
|
2.38e-01
|
GOBP CELL CYCLE PHASE TRANSITION
|
33
|
8.95e-01
|
9.43e-01
|
0.05860
|
-0.044700
|
0.037900
|
6.61e-01
|
7.10e-01
|
GOBP CHROMOSOME SEGREGATION
|
28
|
7.67e-01
|
8.70e-01
|
0.05820
|
-0.052000
|
-0.026200
|
6.38e-01
|
8.13e-01
|
GOMF BETA TUBULIN BINDING
|
5
|
9.78e-01
|
9.87e-01
|
0.05730
|
0.020300
|
-0.053600
|
9.38e-01
|
8.36e-01
|
GOMF NUCLEOSOME BINDING
|
12
|
9.36e-01
|
9.68e-01
|
0.05730
|
0.056500
|
-0.009380
|
7.36e-01
|
9.55e-01
|
GOBP REGULATION OF RESPONSE TO STRESS
|
105
|
6.28e-01
|
7.85e-01
|
0.05720
|
0.015800
|
-0.055000
|
7.89e-01
|
3.51e-01
|
GOBP REGULATION OF MITOTIC CELL CYCLE
|
35
|
7.14e-01
|
8.39e-01
|
0.05710
|
0.045400
|
0.034600
|
6.47e-01
|
7.27e-01
|
GOBP MYELOID LEUKOCYTE ACTIVATION
|
10
|
9.17e-01
|
9.59e-01
|
0.05700
|
0.019400
|
0.053700
|
9.16e-01
|
7.70e-01
|
GOMF ANTIPORTER ACTIVITY
|
15
|
9.53e-01
|
9.76e-01
|
0.05690
|
0.043800
|
-0.036400
|
7.70e-01
|
8.09e-01
|
GOCC COATED VESICLE MEMBRANE
|
19
|
8.95e-01
|
9.43e-01
|
0.05600
|
0.055900
|
-0.003740
|
6.76e-01
|
9.78e-01
|
GOBP MYELOID LEUKOCYTE DIFFERENTIATION
|
13
|
8.87e-01
|
9.37e-01
|
0.05510
|
-0.038100
|
-0.039900
|
8.13e-01
|
8.05e-01
|
GOBP HORMONE TRANSPORT
|
23
|
9.35e-01
|
9.68e-01
|
0.05490
|
0.039200
|
-0.038400
|
7.48e-01
|
7.52e-01
|
GOBP CELL CYCLE G1 S PHASE TRANSITION
|
18
|
8.50e-01
|
9.13e-01
|
0.05480
|
-0.042700
|
-0.034300
|
7.56e-01
|
8.03e-01
|
GOBP POSITIVE REGULATION OF AUTOPHAGY
|
18
|
9.47e-01
|
9.73e-01
|
0.05460
|
0.043700
|
-0.032800
|
7.50e-01
|
8.11e-01
|
GOCC CATALYTIC STEP 2 SPLICEOSOME
|
9
|
9.52e-01
|
9.76e-01
|
0.05450
|
-0.005100
|
0.054300
|
9.79e-01
|
7.79e-01
|
GOBP PROTEIN CONTAINING COMPLEX ORGANIZATION
|
161
|
4.42e-01
|
6.56e-01
|
0.05400
|
-0.000855
|
0.054000
|
9.86e-01
|
2.69e-01
|
GOBP RESPONSE TO COCAINE
|
5
|
9.85e-01
|
9.91e-01
|
0.05400
|
-0.045100
|
0.029700
|
8.62e-01
|
9.09e-01
|
GOBP ADAPTIVE THERMOGENESIS
|
18
|
9.34e-01
|
9.67e-01
|
0.05310
|
0.049900
|
-0.018000
|
7.16e-01
|
8.96e-01
|
GOBP REGULATION OF PH
|
11
|
9.28e-01
|
9.64e-01
|
0.05300
|
0.010600
|
0.051900
|
9.52e-01
|
7.67e-01
|
GOBP REGULATION OF PHAGOCYTOSIS
|
11
|
9.45e-01
|
9.73e-01
|
0.05280
|
0.052700
|
-0.004030
|
7.63e-01
|
9.82e-01
|
GOCC CUL4 RING E3 UBIQUITIN LIGASE COMPLEX
|
5
|
9.61e-01
|
9.79e-01
|
0.05250
|
-0.046400
|
-0.024500
|
8.58e-01
|
9.25e-01
|
GOBP REGULATION OF JUN KINASE ACTIVITY
|
5
|
9.68e-01
|
9.81e-01
|
0.05210
|
-0.051300
|
-0.008820
|
8.43e-01
|
9.73e-01
|
GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION
|
9
|
9.30e-01
|
9.66e-01
|
0.05150
|
-0.037000
|
-0.035900
|
8.48e-01
|
8.53e-01
|
GOBP POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS
|
33
|
8.14e-01
|
8.92e-01
|
0.05110
|
0.010700
|
0.050000
|
9.16e-01
|
6.24e-01
|
GOBP DNA REPAIR
|
40
|
7.44e-01
|
8.58e-01
|
0.05080
|
-0.043200
|
-0.026700
|
6.42e-01
|
7.74e-01
|
GOCC TRANSFERASE COMPLEX
|
73
|
7.85e-01
|
8.76e-01
|
0.05070
|
-0.047700
|
0.017000
|
4.94e-01
|
8.07e-01
|
GOBP NEURON APOPTOTIC PROCESS
|
32
|
7.91e-01
|
8.80e-01
|
0.05060
|
0.025400
|
0.043800
|
8.06e-01
|
6.73e-01
|
GOBP REGULATION OF INNATE IMMUNE RESPONSE
|
33
|
9.18e-01
|
9.59e-01
|
0.05000
|
-0.041600
|
0.027700
|
6.83e-01
|
7.86e-01
|
GOBP POSITIVE REGULATION OF PROTEIN UBIQUITINATION
|
6
|
9.57e-01
|
9.78e-01
|
0.04990
|
0.043300
|
0.024800
|
8.55e-01
|
9.16e-01
|
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE
|
31
|
8.06e-01
|
8.87e-01
|
0.04930
|
-0.042800
|
-0.024500
|
6.84e-01
|
8.16e-01
|
GOMF UBIQUITIN LIKE PROTEIN LIGASE ACTIVITY
|
28
|
9.32e-01
|
9.66e-01
|
0.04910
|
0.027100
|
-0.041000
|
8.06e-01
|
7.11e-01
|
GOMF PROTEIN HETERODIMERIZATION ACTIVITY
|
32
|
8.49e-01
|
9.13e-01
|
0.04740
|
0.007100
|
0.046800
|
9.45e-01
|
6.51e-01
|
GOMF CATALYTIC ACTIVITY ACTING ON A NUCLEIC ACID
|
36
|
8.06e-01
|
8.87e-01
|
0.04720
|
-0.043600
|
-0.018100
|
6.55e-01
|
8.53e-01
|
GOMF AMINOACYLTRANSFERASE ACTIVITY
|
41
|
9.15e-01
|
9.58e-01
|
0.04720
|
0.029900
|
-0.036600
|
7.45e-01
|
6.90e-01
|
GOBP REGULATION OF CATABOLIC PROCESS
|
115
|
7.68e-01
|
8.71e-01
|
0.04710
|
0.041000
|
-0.023100
|
4.69e-01
|
6.83e-01
|
GOBP POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS
|
7
|
9.64e-01
|
9.79e-01
|
0.04710
|
-0.046300
|
-0.008420
|
8.33e-01
|
9.69e-01
|
GOBP RESPONSE TO PEPTIDE
|
78
|
7.73e-01
|
8.73e-01
|
0.04680
|
-0.009700
|
0.045800
|
8.86e-01
|
4.98e-01
|
GOBP CELLULAR HOMEOSTASIS
|
85
|
6.50e-01
|
7.97e-01
|
0.04680
|
0.045500
|
0.010600
|
4.83e-01
|
8.71e-01
|
GOMF SIGNALING RECEPTOR BINDING
|
93
|
7.34e-01
|
8.53e-01
|
0.04640
|
0.008240
|
-0.045700
|
8.95e-01
|
4.64e-01
|
GOCC SECRETORY GRANULE
|
78
|
6.37e-01
|
7.92e-01
|
0.04620
|
-0.021400
|
-0.041000
|
7.52e-01
|
5.45e-01
|
GOBP PHOSPHATIDYLINOSITOL METABOLIC PROCESS
|
9
|
9.44e-01
|
9.72e-01
|
0.04600
|
-0.029500
|
-0.035300
|
8.79e-01
|
8.55e-01
|
GOBP EAR MORPHOGENESIS
|
7
|
9.65e-01
|
9.79e-01
|
0.04590
|
-0.045100
|
-0.008650
|
8.37e-01
|
9.68e-01
|
GOBP CELLULAR SENESCENCE
|
11
|
9.75e-01
|
9.85e-01
|
0.04590
|
-0.039100
|
0.024000
|
8.23e-01
|
8.91e-01
|
GOBP NUCLEOSOME ORGANIZATION
|
6
|
9.68e-01
|
9.81e-01
|
0.04510
|
0.015000
|
0.042500
|
9.49e-01
|
8.57e-01
|
GOMF CYSTEINE TYPE PEPTIDASE ACTIVITY
|
18
|
9.58e-01
|
9.78e-01
|
0.04480
|
0.040100
|
-0.020100
|
7.70e-01
|
8.84e-01
|
GOBP NEGATIVE REGULATION OF PROGRAMMED CELL DEATH
|
80
|
7.24e-01
|
8.44e-01
|
0.04360
|
0.043300
|
0.005070
|
5.17e-01
|
9.40e-01
|
GOBP RESPONSE TO LIGHT STIMULUS
|
28
|
9.31e-01
|
9.66e-01
|
0.04280
|
-0.012900
|
0.040900
|
9.07e-01
|
7.12e-01
|
GOBP INSULIN SECRETION
|
13
|
9.55e-01
|
9.76e-01
|
0.04260
|
-0.000886
|
0.042600
|
9.96e-01
|
7.91e-01
|
GOBP NEGATIVE REGULATION OF CELL CYCLE PROCESS
|
21
|
9.62e-01
|
9.79e-01
|
0.04260
|
0.025800
|
-0.033900
|
8.39e-01
|
7.90e-01
|
GOBP NEGATIVE REGULATION OF PROTEIN UBIQUITINATION
|
9
|
9.59e-01
|
9.78e-01
|
0.04190
|
-0.039700
|
-0.013300
|
8.37e-01
|
9.45e-01
|
GOCC NUCLEAR MATRIX
|
18
|
9.70e-01
|
9.82e-01
|
0.04120
|
0.025300
|
-0.032500
|
8.54e-01
|
8.13e-01
|
GOBP PROTEIN K63 LINKED UBIQUITINATION
|
8
|
9.67e-01
|
9.80e-01
|
0.04030
|
-0.038500
|
-0.012100
|
8.51e-01
|
9.53e-01
|
GOBP NEGATIVE REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION
|
14
|
9.53e-01
|
9.76e-01
|
0.04030
|
-0.002000
|
-0.040200
|
9.90e-01
|
7.96e-01
|
GOMF CADHERIN BINDING
|
55
|
9.17e-01
|
9.59e-01
|
0.04010
|
0.024400
|
-0.031900
|
7.60e-01
|
6.89e-01
|
GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE BINDING
|
6
|
9.77e-01
|
9.86e-01
|
0.03980
|
-0.008860
|
-0.038800
|
9.70e-01
|
8.70e-01
|
GOBP EPIBOLY
|
6
|
9.72e-01
|
9.84e-01
|
0.03970
|
0.033000
|
0.022100
|
8.89e-01
|
9.26e-01
|
GOBP POSITIVE REGULATION OF DNA REPAIR
|
11
|
9.73e-01
|
9.84e-01
|
0.03920
|
-0.008060
|
0.038400
|
9.63e-01
|
8.27e-01
|
GOCC SECRETORY VESICLE
|
87
|
6.89e-01
|
8.21e-01
|
0.03880
|
-0.025200
|
-0.029400
|
6.95e-01
|
6.47e-01
|
GOBP MEMBRANE ORGANIZATION
|
79
|
7.14e-01
|
8.38e-01
|
0.03870
|
-0.024000
|
-0.030300
|
7.21e-01
|
6.52e-01
|
GOBP KERATINOCYTE PROLIFERATION
|
7
|
9.90e-01
|
9.94e-01
|
0.03830
|
0.030400
|
-0.023400
|
8.90e-01
|
9.15e-01
|
GOBP REGULATION OF KERATINOCYTE PROLIFERATION
|
7
|
9.90e-01
|
9.94e-01
|
0.03830
|
0.030400
|
-0.023400
|
8.90e-01
|
9.15e-01
|
GOBP PEPTIDE TRANSPORT
|
17
|
9.53e-01
|
9.76e-01
|
0.03800
|
0.038000
|
-0.000971
|
7.88e-01
|
9.95e-01
|
GOBP MACROMOLECULE CATABOLIC PROCESS
|
150
|
7.34e-01
|
8.53e-01
|
0.03780
|
-0.037100
|
0.007120
|
4.61e-01
|
8.88e-01
|
GOBP CELLULAR RESPONSE TO CHEMICAL STRESS
|
37
|
9.12e-01
|
9.56e-01
|
0.03770
|
0.004100
|
-0.037500
|
9.66e-01
|
6.98e-01
|
GOCC ANCHORING JUNCTION
|
96
|
8.35e-01
|
9.04e-01
|
0.03760
|
0.035900
|
-0.011100
|
5.59e-01
|
8.57e-01
|
GOBP POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION
|
5
|
9.80e-01
|
9.88e-01
|
0.03710
|
0.019300
|
0.031700
|
9.41e-01
|
9.03e-01
|
GOBP POSITIVE REGULATION OF DEFENSE RESPONSE
|
35
|
8.89e-01
|
9.39e-01
|
0.03510
|
-0.031900
|
-0.014500
|
7.47e-01
|
8.84e-01
|
GOCC ENDOCYTIC VESICLE
|
33
|
9.10e-01
|
9.55e-01
|
0.03440
|
-0.007650
|
-0.033500
|
9.40e-01
|
7.43e-01
|
GOBP DNA TEMPLATED TRANSCRIPTION INITIATION
|
12
|
9.60e-01
|
9.78e-01
|
0.03340
|
0.022500
|
0.024800
|
8.93e-01
|
8.82e-01
|
GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE II PROMOTER
|
12
|
9.60e-01
|
9.78e-01
|
0.03340
|
0.022500
|
0.024800
|
8.93e-01
|
8.82e-01
|
GOBP NUCLEOBASE CONTAINING COMPOUND TRANSPORT
|
18
|
9.73e-01
|
9.84e-01
|
0.03280
|
-0.009450
|
0.031400
|
9.45e-01
|
8.19e-01
|
GOCC UBIQUITIN LIGASE COMPLEX
|
23
|
9.72e-01
|
9.84e-01
|
0.03230
|
0.029100
|
-0.014100
|
8.11e-01
|
9.08e-01
|
GOBP REGULATION OF DNA REPLICATION
|
6
|
9.84e-01
|
9.90e-01
|
0.03060
|
-0.026700
|
-0.015000
|
9.10e-01
|
9.49e-01
|
GOMF ADP BINDING
|
12
|
9.89e-01
|
9.94e-01
|
0.02970
|
-0.023800
|
0.017800
|
8.87e-01
|
9.15e-01
|
GOBP VASCULATURE DEVELOPMENT
|
59
|
9.41e-01
|
9.71e-01
|
0.02870
|
0.026600
|
-0.010700
|
7.30e-01
|
8.89e-01
|
GOBP REGULATION OF CELLULAR RESPONSE TO STRESS
|
48
|
9.20e-01
|
9.60e-01
|
0.02860
|
-0.028500
|
-0.002560
|
7.38e-01
|
9.76e-01
|
GOBP POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY
|
8
|
9.83e-01
|
9.90e-01
|
0.02660
|
0.021700
|
0.015400
|
9.16e-01
|
9.40e-01
|
GOBP MEMBRANE LIPID CATABOLIC PROCESS
|
6
|
9.88e-01
|
9.93e-01
|
0.02580
|
-0.018300
|
-0.018300
|
9.38e-01
|
9.38e-01
|
GOBP REGULATION OF PROTEIN UBIQUITINATION
|
19
|
9.73e-01
|
9.84e-01
|
0.02550
|
-0.002520
|
-0.025400
|
9.85e-01
|
8.49e-01
|
GOMF TRANSMEMBRANE TRANSPORTER BINDING
|
19
|
9.81e-01
|
9.88e-01
|
0.02490
|
-0.024600
|
0.004220
|
8.54e-01
|
9.75e-01
|
GOBP BIOLOGICAL PROCESS INVOLVED IN SYMBIOTIC INTERACTION
|
24
|
9.75e-01
|
9.85e-01
|
0.02450
|
0.003110
|
-0.024300
|
9.79e-01
|
8.39e-01
|
GOBP DNA METABOLIC PROCESS
|
67
|
9.22e-01
|
9.61e-01
|
0.02400
|
-0.023800
|
-0.002360
|
7.43e-01
|
9.74e-01
|
GOBP SMOOTH MUSCLE CELL APOPTOTIC PROCESS
|
6
|
9.90e-01
|
9.94e-01
|
0.02360
|
0.011700
|
0.020400
|
9.60e-01
|
9.31e-01
|
GOBP NEGATIVE REGULATION OF PROTEOLYSIS
|
18
|
9.90e-01
|
9.94e-01
|
0.02300
|
-0.018800
|
0.013300
|
8.91e-01
|
9.23e-01
|
GOBP PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION
|
71
|
9.03e-01
|
9.48e-01
|
0.02230
|
-0.014100
|
-0.017400
|
8.42e-01
|
8.06e-01
|
GOBP INTRACELLULAR MONOATOMIC ION HOMEOSTASIS
|
48
|
9.76e-01
|
9.86e-01
|
0.02230
|
0.018000
|
-0.013100
|
8.32e-01
|
8.77e-01
|
GOMF PHOSPHOLIPID TRANSPORTER ACTIVITY
|
6
|
9.97e-01
|
9.99e-01
|
0.02110
|
-0.017200
|
0.012300
|
9.42e-01
|
9.59e-01
|
GOBP AMIDE TRANSPORT
|
21
|
9.74e-01
|
9.84e-01
|
0.02040
|
0.013100
|
0.015700
|
9.18e-01
|
9.02e-01
|
GOBP SEXUAL REPRODUCTION
|
49
|
9.42e-01
|
9.71e-01
|
0.02040
|
-0.013900
|
-0.014900
|
8.69e-01
|
8.60e-01
|
GOCC SIDE OF MEMBRANE
|
43
|
9.64e-01
|
9.79e-01
|
0.01740
|
-0.008180
|
-0.015400
|
9.27e-01
|
8.64e-01
|
GOCC ENDOCYTIC VESICLE MEMBRANE
|
20
|
9.93e-01
|
9.96e-01
|
0.01660
|
-0.015600
|
0.005710
|
9.04e-01
|
9.65e-01
|
GOCC TRANSPORT VESICLE MEMBRANE
|
19
|
9.89e-01
|
9.94e-01
|
0.01650
|
-0.016500
|
-0.000696
|
9.02e-01
|
9.96e-01
|
GOBP REGULATION OF PROTEIN METABOLIC PROCESS
|
158
|
9.27e-01
|
9.64e-01
|
0.01460
|
-0.004090
|
-0.014000
|
9.34e-01
|
7.76e-01
|
GOBP REGULATION OF CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY
|
10
|
9.95e-01
|
9.98e-01
|
0.01240
|
-0.007550
|
-0.009840
|
9.67e-01
|
9.57e-01
|
GOBP RESPONSE TO ABIOTIC STIMULUS
|
103
|
9.86e-01
|
9.92e-01
|
0.01160
|
-0.010100
|
0.005730
|
8.65e-01
|
9.23e-01
|
GOBP REACTIVE NITROGEN SPECIES METABOLIC PROCESS
|
15
|
9.97e-01
|
9.99e-01
|
0.00873
|
-0.008130
|
-0.003190
|
9.57e-01
|
9.83e-01
|
GOBP RESPONSE TO LEUKEMIA INHIBITORY FACTOR
|
11
|
9.99e-01
|
1.00e+00
|
0.00678
|
-0.000896
|
-0.006720
|
9.96e-01
|
9.69e-01
|
GOCC LATE ENDOSOME MEMBRANE
|
18
|
9.98e-01
|
9.99e-01
|
0.00627
|
0.002200
|
0.005870
|
9.87e-01
|
9.66e-01
|
GOBP PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL
|
13
|
9.99e-01
|
1.00e+00
|
0.00623
|
0.005690
|
-0.002530
|
9.72e-01
|
9.87e-01
|
GOBP POST TRANSLATIONAL PROTEIN MODIFICATION
|
84
|
9.98e-01
|
9.99e-01
|
0.00333
|
-0.003220
|
-0.000853
|
9.61e-01
|
9.90e-01
|
GOMF AMIDE BINDING
|
28
|
1.00e+00
|
1.00e+00
|
0.00221
|
-0.000238
|
0.002200
|
9.98e-01
|
9.84e-01
|